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Abstract: Purpose. Type 2 diabetes mellitus (T2DM) is poorly managed in the Caribbean region;
therefore, conducting an assessment on the content and quality of clinical guidelines could assist
guideline developers in detecting and addressing information gaps. Hence, this study aimed to
benchmark and compare the clinical guidelines for T2DM management from the Caribbean to guide-
lines developed internationally and by high-income countries. Methods. Seven T2DM management
clinical guidelines were a priori selected from international and high-income country-specific clinical
guidelines and then compared to the country-specific T2DM management clinical guidelines of
the Caribbean region. Two reviewers independently assessed content (using a previously piloted
data extraction form) and quality using the Appraisal of Guidelines for Research and Evaluation II
(AGREE II) tool. Results. The Caribbean clinical guideline was found to contain similar levels of
T2DM management topics when compared to international and high-income country-specific clinical
guidelines; however, one country-specific clinical guideline from New Zealand was found to have
substantially lower levels of content. The clinical guideline from the Caribbean was found to be of
low quality and could not be used in practice; however, only three comparator clinical guidelines
were found to be of high quality and could be recommended for use in clinical practice. A further
three comparator clinical guidelines could be used in practice with minor modifications. Conclusion.
Although the T2DM management clinical guidelines from the Caribbean region contained high levels
of content with regards to relevant topics, it was of insufficient quality to be used in clinical practice.
Therefore, an alternative high-quality clinical guideline, as identified within this study, should be
adopted and used within the Caribbean region to manage T2DM until a high-quality region-specific
clinical guideline can be developed.
Keywords: Caribbean; clinical guidelines; high-income countries; improved outcomes; international;
management; type 2 diabetes mellitus
1. Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic condition that has major
health, social, and economic consequences [1]. Patients with T2DM are known to be
at increased risk for microvascular and macrovascular complications (such as diabetic
retinopathy, diabetic neuropathy/foot, diabetic nephropathy, coronary heart disease, stroke,
and peripheral arterial disease) and even death [2]. Approximately 90% of people with
diabetes mellitus have T2DM. Globally, in 2019, approximately 463 million adults were
living with T2DM [3]. In 2015, the prevalence of T2DM in the Caribbean region was
approximately 9%, and T2DM accounted for about 14% of all deaths [4]. This may be due
to the Caribbean’s ethnic makeup, which is predominantly Black or Afro-Caribbean with
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some people of South Asian descent. These ethnic groups are at significantly higher risks
of developing T2DM than compared to other ethnicities [4].
Healthcare practitioners are advised to follow clinical guidelines for managing T2DM,
which should contain the best available evidence on how to support and guide both
practitioners’ and patients’ decisions on suitable healthcare [5]. Clinical guidelines can
improve health outcomes by reducing morbidity and mortality and enhancing quality of
life, allowing patients to make informed healthcare decisions, making new procedures and
services available to address healthcare issues, and improving the quality of healthcare
decisions [6]. Usually, high-quality clinical guidelines reduce differences in clinical practice,
encourage the use of effective procedures and services, and eliminate the use of ineffective
or less effective procedures and services [6]. Thus, due to the positive impacts that a
clinical guideline could have on health outcomes and healthcare, its quality is of great
significance. In order to ensure its quality, all steps for developing a clinical guideline
should be systematically followed [7].
In the Caribbean region, a national clinical guideline is available for managing diabetes
mellitus by primary care doctors, nurses, and allied healthcare professionals [8]. The
guideline was first introduced over 25 years ago and, despite the most recent upgrade in
2006, research has shown that the quality of T2DM care and management in the Caribbean
has not improved [9]. To date, the content and quality of the clinical guideline have not been
robustly evaluated. Therefore, this study aimed to benchmark and compare the content and
quality of the Caribbean guideline to international and high-income country-specific clinical
guidelines for managing T2DM. Assessing its content will allow for the identification and
comparison of information and evidence that support recommendations. Assessing its
quality will allow for the evaluation of methodological rigour and transparency of the
guideline’s development, and this includes precisely recording and reporting methods
and procedures [10]. The issues identified during this research appraisal could be used to
improve the clinical guideline.
2. Methods
2.1. Selection of Clinical Guidelines for Managing T2DM
A priori, a decision was made to compare the existing Caribbean clinical guideline
(which is now 15 years old but still in use) [8] to clinical guidelines developed interna-
tionally and those from high-income countries. High-income countries usually follow
a robust process to develop evidence-based guidelines, which is important for setting a
benchmark and for improving healthcare systems. Relevant websites were searched on 29
January 2021 to identify the most recent published versions from the National Institute for
Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN),
International Diabetes Federation (IDF), American Diabetes Association (ADA), The Royal
Australian College of General Practitioners (RACGP), New Zealand Guidelines Group
(NZGD), and Canadian Diabetes Association (CDA). All clinical practice guidelines were
required to meet the eligibility criteria of focusing on T2DM management in adults and
had to be written in English. Other clinical guidelines were excluded from comparison
if they focused on managing specific issues in T2DM (e.g., hyperglycaemia) or if they
focused on managing several health conditions together (e.g., prediabetes, diabetes, and
cardiovascular diseases), and the extraction of T2DM-specific information was not possible.
In short, these were not typical T2DM management guidelines suitable for comparison. We
selected one international guideline published by IDF [11] and six high-income country-
specific guidelines from Australia [12], Canada [13], New Zealand [14], United States
(US) [15], England and Wales [16], and Scotland [17] (see Table 1). Please note that the
clinical guideline from Scotland, number 116 [17], also referred to clinical guideline number
154 [18], which provided additional information and, as such, was included as part of
clinical guideline number 116 [17].
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Table 1. Outline of selected clinical guidelines for managing T2DM.
Publishing Societies/Organisations/Associations Geography of the Guideline Name of the Guideline Last Updated
1 Caribbean Health Research Council (CHRC) andPan American Health Organization (PAHO) [8] Country-specific (Caribbean)
Managing diabetes in primary care in
the Caribbean 2006
2 International Diabetes Federation (IDF) [11] International Recommendations for managing type 2diabetes in primary care 2017
3 The Royal Australian College of GeneralPractitioners (RACGP) [12] Country-specific (Australia)
General practice management of type 2
diabetes 2016
4 Diabetes Canada and Canadian DiabetesAssociation (CDA) [13] Country-specific (Canada)
Diabetes Canada 2018 clinical practice
guidelines for the prevention and
management of diabetes in Canada
2018
5 New Zealand Guidelines Group (NZGD) [14] Country-specific (New Zealand) Guidance on the management of type 2diabetes 2011 2011
6 American Diabetes Association (ADA) [15] Country-specific (United States) Standards of medical care in diabetes 2020
7 National Institute for Health and Care Excellence(NICE) [16]
Country-specific
(England and Wales) Type 2 diabetes in adults: management 2020
8 Scottish Intercollegiate Guidelines Network (SIGN)[17]
Country-specific
(Scotland)
Management of diabetes: a national
clinical guideline 2017
2.2. Comparison of Content of Selected Clinical Guidelines for Managing T2DM
The content of the clinical guidelines was compared based on the following topics by
using a previously piloted data extraction form: blood glucose management; body weight
assessment and management; blood pressure measurement and management; blood lipids
measurement and management; T2DM-associated complications assessment and manage-
ment; and other healthcare-related issues and advice. Each guideline was read several times to
identify topics/subtopics and related recommendations. A full star “
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editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
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the guideline. Two independent reviewers (AN and GY) were involved in the process, and
disagreements were resolved through discussion or with a third reviewer (KC).
2.3. Comparison of Quali y of Selected Clinical Guidelines for Managing T2DM
T quality of th clinical guidelin s was assessed independently by two reviewers
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE II)
tool, which is a standardised and validated instrument [10]. The AGREE II tool comprises
23 items separated into six domai s ((i) cope and purpose; (ii) stakeholder involvement;
(iii) rigour of developme t; (iv) clarity of presentatio ; (v applicability; and (vi) editorial
independence) and two global rating items ((i) overall quality score and (ii) recommenda-
tion for use in practice) [10]. Each item within the AGREE II tool was rated on a seven-point
scale (from 1 = strongly disagree t 7 = strongly agree). Av rage appraisal scores were cal-
cul for each appraiser by using the average ra ing (1 (str ngly disagree) to 7 (strongly
agree)) for all items in each domain. Scaled perce tages for each domain were then cal-
culated for inter-domain comparison by summing the appraisal ratings of items within a
single domain (obtained score), scaling by maximum and minimum possible domain scores,
and by converting to a percentage [10]. The overall quality of all included guidelines was
summarised and presented using summary statistics (mean). Mean scores of the domains
were compared, and the highest and lowest scores were identified. Disagreements in scores
were resolved through discussion. Clinical guidelines with a median threshold of ≥70%
across all six domains were considered to be of high quality [19].
Two reviewers (ALN and GY) independently scored an overall assessment for each
clinical guideline by using a 7-point scale (1 being lowest possible quality to 7 being
highest possible quality) together with a statement regarding whether the reviewer rec-
ommended the guideline for use (YES, YES with modifications, or NO). Discrepancies
between reviewers were discussed and a consensus was reached.
3. Results
The Caribbean clinical guideline, last updated in 2006, was developed by the Caribbean
Health Research Council (CHRC) and Pan American Health Organization (PAHO) [8] and
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is between 5 [14] and 14 years [15] older than the other selected guidelines. The clinical
guideline encompassed type 1 diabetes mellitus, T2DM, and gestational diabetes in pri-
mary care settings. Whilst all of the comparative clinical guidelines focused on primary
care as the setting, only three clearly stated the setting (one international clinical guideline,
developed by IDF [11] and two country-specific clinical guidelines: one guideline from
Canada, developed by CDA, and the other guideline from New Zealand, developed by
NZGD [13,14]). Additionally, two country-specific clinical guidelines (Canada, developed
by CDA, and New Zealand, developed by NZGD [13,15]) focused on type 1 diabetes
mellitus, T2DM, gestational diabetes, and diabetes mellitus in children. A further five com-
parative clinical guidelines focused solely on T2DM—one international clinical guideline
developed by IDF [11] and four country-specific clinical guidelines (Australia, developed
by RACGP [12]; Scotland, developed by SIGN [17]; and the joint England and Wales clinical
guideline, developed by NICE [16]).
3.1. Comparison of Content of Selected Clinical Guidelines for Managing T2DM
The clinical guideline from the Caribbean [8] (developed by CHRC and PAHO) scored
well in terms of including a wide range of topics on blood glucose management; body
weight assessment and management; blood pressure measurement and management; and
T2DM-associated complications assessment and management but generally scored poorly
for blood lipid measurement and management and other healthcare-related issues and
advice, where limited information was available (Table 2). The clinical guideline from the
Caribbean [8] was found to contain similar levels of T2DM management topics compared to
six of the comparative clinical guidelines (one international guideline, by IDF [11], and five
country-specific guidelines (US ADA [15], Canada CDA [13], England and Wales NICE [16],
Australia RACGP [12], and Scotland SIGN [17])). However, for the remaining comparative
clinical guideline from New Zealand NZGD [14], the Caribbean clinical guideline [8] was
found to possess higher content (28/44 items versus 12/44 items) (Table 2).
3.2. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM
Overall, the clinical guidelines only scored more than 70% for two of the six domains:
scope and purpose, and clarity of presentation (Table 3). The clinical guideline from the
Caribbean [8] scored less than 70% for all domains, where the lowest score of 3% related to
the rigour of development and the highest score of 64% related to stakeholder involvement.
Domain scores for the seven comparison clinical guidelines demonstrated that three of
the clinical guidelines scored 70% or more across all six domains [13,16,17]. A further
two of the comparative clinical guidelines (US [15] and Australia [12]) only scored more
than 70% in one domain, and another comparative guideline (IDF [11]) scored over 70%
in two domains. The remaining comparison clinical guideline from New Zealand scored
less than 70% for all domains [14]. The overall quality score for the clinical guidelines
ranged from 2 (New Zealand [17]) to the maximum score of 7 (Canada [13], Scotland [17],
and England and Wales [16]). The overall quality score for the clinical guideline from the
Caribbean [8] was 3, which was the second lowest of all included clinical guidelines. With
regards to recommendations for use in clinical practice, the clinical guideline from the
Caribbean [8] could not be recommended for use due to its low-quality score; additionally,
the clinical guideline from New Zealand [14] was also identified as not recommended for
use due to a low-quality score. A further three of the comparison clinical guidelines were
recommended for use with modifications (international IDF [11] and two country-specific
clinical guidelines from the US ADA and Australia RACGP [12,15]), and the remaining
three clinical guidelines were recommended for use without modifications (Canada CDA,
England and Wales NICE, and Scotland SIGN [13,16,17]).
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The conte t of the clinical gu d lines as co pared based on the following topics by 
usin  a previous y pil ted data extractio  for : blood glucose anagement; body weight 
sess ent and anage ent; blood pr ssure measurement and management; blood li-
pids measurement n  man gement; T2DM-associ ted complicatio s assessment and 
manage en ; and other healthc re-rel t d issues and advice. Each guideline was read 
veral i  to ide tify topics/subtopics a d rel ed recommendation . A full star “
” was as g ed to topics/subtopics ith dequate in ormation. A half- tar “ ” was 
assign  to topic /subtopics ith limited inform tion. “NR” was assigned to topics/sub-
topics that are n t reporte  i  the guid lin . Two ind pendent reviewers (AN and GY) 
were involved in th  proce s, and disagreem nts were resolved thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comp riso  of Qual ty of S lected Clinical Gu delines for Managing T2DM 
The qu ity of the clinical guid lines as ass ss d in epend ntly by t o reviewers 
(AN and GY) using the Appr isal of Guidelines for Research and Evaluation II (AGREE 
II) ool, which is a standardised and validated instru ent [10]. The AGREE II tool com-
rises 23 items sep r ted int  s x d m ins ((i) scope and purpose; (ii) stakeholder involve-
m nt; (iii) rig ur of develop e t; (i ) larity of presentation; (v) applicability; and (vi) 
editorial independence) and two g obal rating items ((i) v rall quality score and (ii) rec-
ommendat on for use in pr ctice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scal  (from 1 = strongly disa re to 7 = trongly gree). Average appraisal 
scores w r  calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree))  all items in each domain. Scaled percentages for each domain 
w re the  c lculated for nte -domain co pariso  by summing the appraisal ratings of 
items within a singl domain (obtaine score), scaling by maxi um and minimum possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
clude  guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
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2.2. Comp r s n f C ntent of Selected Clinical Guide nes for Managing T2DM 
Th  content of the clinical guide ines was co pared based on the following topics by 
using a previously piloted ata xtraction f rm: blood glucose management; body weight 
ssess t and manag me t; blood pressure measurement and management; blood li-
pi s measur me  and anagement; T2DM-associated complications assessment and 
managem nt; and other healthcare-related issues nd advice. Each guideline was read 
ev ral tim  to identi y topic /subtopics a d related recommendations. A full star “
” as assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to top cs/subtopics with limited information. “NR” was assigned to topics/sub-
topics that a  not report d i  th  guideline. Two independent reviewers (AN and GY) 
we e involved i  the pr ces , a d disagreements were resolved through discussion or 
with a third reviewer (KC). 
.3. Compar on of Quality of Selected Cli ical Guidelines for Managing T2DM 
Th  qu lity of the clinical guidelines was assessed independently by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, whic  is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 it ms separated into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; ( ) rigour of development; ( v) clarity of presentation; (v) applicability; and (vi) 
edit ial independence) and two global rati g items ((i) overall quality score and (ii) rec-
mmendation for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calcul ted for e ch ppraiser by us ng th  average rating (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each domain 
were then c lcul ted for inter-domain comp r son by summing the appraisal ratings of 
it m  within single do ain (obtained score), scaling by aximum and minimum possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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2017 
2.2. Comp r son of Conte t of Selected Clini al Gu delines for Managing T2DM 
Th  content of the clinical guidelines was co pared based on the following topics by 
using a previously pil ted ata xtraction for : blood glucose anagement; body weight 
assessment and manag ment; blood pressure measurement and management; blood li-
pi s measureme t and man gement; T2DM-associated complicatio s assessment and 
managemen ; and other healthcare-rel ted issues and advice. Each guideline was read 
v ral ime  to identi y t pics/subtopics and rel ed r commendations. A full star “
” w s as igned to topics/subtopics with dequate in ormation. A half- tar “ ” as 
assigned to topics/subtopics with limited inform tion. “NR” was assigned to topics/sub-
topics that  not reported i  the guid lin . Two ind pendent reviewers (AN and GY) 
we e involved in the proces , a d disagreem nts were resolved thr ugh discussion or 
ith a third reviewer (KC). 
2.3. C mpar son of Qual ty of S lected Clinical Gu de ines for Ma aging T2DM 
Th  qu ity of the clinical guid lines was assessed independ ntly by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ool, whic  is a standardised and validated instrument [10]. The AGREE II tool com-
rises 23 it ms separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
edit rial independence) and two global rating items ((i) v rall quality score and (ii) rec-
mmendation f r use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
sco es w re calculated for each pprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly ree)) for all ite s in each domain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
items within a singl  do ain (obtained score), scaling by maximum and minimum possi-
b e domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s wa  summarised and presented using su mary statistics (mean). Mean 
scores of th  domains were compared, and the highest and lowest scores were identified. 
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2.2. omp ris n of Conte t f Selected Clinical Guide in s for Managing T2DM 
The content of th  clinic l guidelines as compared based on the following topics by 
using a previous y piloted data extraction f rm: blood glucose management; body weight 
ssess  and management; blood pressure measurem nt and management; blood li-
pid mea urement nd management; T2DM-associ te  complications assessment and 
m nag m nt; and other healthc re-related ssues and a vice. Each gui eline was read 
everal times to identify topics/subt pics a d related recommend tions. A full star “
” as assigned o top cs/subtopics with adequate inform tion. A half-star “ ” was 
assign to top c /subtopics ith limited information. “NR” was assigned to topics/sub-
t pics that are n t reported i  th  guideline. Two independent reviewers (AN and GY) 
were inv lved in the proc ss, a d disa reement were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison o  Qua ty of Selected Clinical Guidelines for Managing T2DM 
Th  qu lity of the clinic l guidelines was assessed independently by two reviewers 
(AN nd GY) using the Appr isal of Guidelines for ese rch and Evaluation II (AGREE 
II) tool, which s  standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 it ms separated into ix dom ins ((i) scope and purpos ; (ii) stakeholder involve-
ment; (i i) rigour of development; (iv) l r ty of presentation; (v) applicability; and (vi) 
editorial independ nce) and two global rating items ((i) overall quality score and (ii) rec-
mm nd tion for use in practice) [10]. Each item within the AGREE II tool was rated on a 
s ven-point scale (from 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
scor  wer calculat d fo  each appraiser by using the average rating (1 (strongly disagree) 
to 7 (str ngly agree)) for all items in e ch domai . Scaled per entages for each domain 
were then calculated for inter-domain co parison by summing the appraisal ratings of 
items within a single domain (obt i e  score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
clude g id lines w s summarised nd presented using sum ary statistics (mean). Mean 
score of the dom ins were compared, and the highest and lowest scor s were identified. 
Self-monitoring of bloo
glucose
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8 Scottish Intercollegiate Guidelines 
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Country-spec fic 
(Sc tland) 
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clin cal gu d line 
2017 
2.2. Comparis n of Co tent of Selected Clinic l Guid in s f r Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: bl od glucose man ement; body weight 
assessment and anage ent; blood pressure measurement and management; blood li-
pids measurement and management; T2DM-associated complications assessment and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics a d related rec mmendations. A full st r “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolve  through iscussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Select d Clinical Guideli es for Manag ng T2DM 
The quality of the clinical guidelines was assessed in ependently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comparis n of Conte t f Selected Clini l Gu de ines f r Managing T2DM 
The content of the clinical guidelines was co pared based on the following topics by 
using a previously pil ted dat  extraction for : blood glucose anagement; body weight 
assessment and management; blood pressure measurement and management; blood li-
pids measurement and man gement; T2DM-associated complicatio s assessment and 
managemen ; and other healthcare-rel ted issues and advice. Each guideline was read 
veral ime  to identify topics/subtopics a d rel ed rec mmendation . A full star “
” was as igned to topics/subtopics with dequate in ormation. A half- tar “ ” was 
assigned to topics/subtopics with limited inform tion. “NR” was assigned to topics/sub-
topics that are not reported in the guid lin . Two ind pendent reviewers (AN and GY) 
were involved in the process, and disagreem nts were resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comparison of Qu l ty of S lect d Clinical Guideli es for Manag g T2DM 
The qu ity of the clinical guid lines was assessed independ ntly by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ool, which is a standardised and validated instrument [10]. The AGREE II tool com-
rises 23 items separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) v rall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
scores w re calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  calculate  for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by aximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comparis n of Co e t f Selected Clinical Guid in s for Managing T2DM 
The content of the clinical guid lines as c mpared based on the following topics by 
using a previous y piloted data extractio  f r : blood glucose management; body weight 
assessment and anagement; blood pr ssure measurement and management; blood li-
pids measurem nt n  manage ent; T2DM-assoc ted complications assessment and 
manag ment; and other healthc re-relat d issues and a vice. Each guideline was read 
several times to identify topics/subt pics a d related recommendations. A full st r “
” was a signed to topics/subtopics with adequate information. A half-star “ ” was 
a sign  to topics/sub opics ith l mited information. “NR” was a signed to topics/sub-
t pics that are n t reporte  i  the guideli e. Two independent revie ers (AN and GY) 
were inv lved i th  process, and disag ements ere resolve  through iscussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Sel ct d Clinic l Guidelines for Managing T2DM 
The quality of the clinical guidelines as ass ss d in ependently by two reviewers 
(AN and GY) u ing the Appr i al of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is  standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 item  sep rated int ix dom ins ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rig ur of development; (iv) l rity of presentation; (v) applicability; and (vi) 
e itorial i ependence) and two g obal rating items ((i) overall quality score and (ii) rec-
mmendat on for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point cale (from 1 = strongly disagre to 7 = trongly agree). Average appraisal 
scor s were alculated for each appraiser by using the ave age rating (1 (strongly disagree) 
to 7 (strong y agree)) for all items in e ch do ain. Scaled percentages for each domain 
were then c lculated for inter-domain co pariso  by summing he appraisal ratings of 
tems within a single domain (obta e score), scaling by aximum and mini um possi-
ble domain scor s, and by conv rting to a percentage [10]. The verall quality of all in-
clude  guidelines w s summarised and presented using sum ary statistics (mean). Mean 
score  of the dom ins were compared, the highest and lowest scores were identified. 
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2.2. Comp ris n of Cont t f Selected Cli i l Gu d ines for Managin  T2DM 
The conte t of the clinical gu d lines as co pared based on the following topics by 
u in  a previous y pil ted data extractio  for : blood glucose anagement; body weight 
sess ent and anage ent; blood pr ssure measurement and management; blood li-
pids measurement n  man gement; T2DM-associ ted complicatio s assessment and 
manage en ; and other healthc re-rel t d issues and advice. Each guideline was read 
veral i  to ide tify topics/subtopics a d rel ed recommendation . A full star “
” was as g ed to topics/subtopics ith dequate in ormation. A half- tar “ ” was 
assign  to topic /subtopics ith limited inform tion. “NR” was assigned to topics/sub-
topics that are n t reporte  i  the guid lin . Two ind pendent revie ers (AN and GY) 
were involved in th  proce s, and disagreem nts ere resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comp riso  of Qual ty of S l ct d Clinical Gu delin s for Managi g T2DM 
The qu ity of the clinical guid lines as ass ss d in epend ntly by t o reviewers 
(AN and GY) using the Appr isal of Guidelines for Research and Evaluation II (AGREE 
II) ool, which is a standardised and validated instru ent [10]. The AGREE II tool com-
rises 23 items sep r ted int  s x d m ins ((i) scope and purpose; (ii) stakeholder involve-
m nt; (iii) rig ur of develop e t; (i ) larity of presentation; (v) applicability; and (vi) 
editorial independence) and two g obal rating items ((i) v rall quality score and (ii) rec-
ommendat on for use in pr ctice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scal  (from 1 = strongly disa re to 7 = trongly gree). Average appraisal 
scores w r  calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree))  all items in each domain. Scaled percentages for each domain 
w re the  c lculated for nte -domain co pariso  by summing the appraisal ratings of 
items within a singl domain (obtaine score), scaling by maxi um and mini um possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
clude  guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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 P bl shing 
Societies/Organ a io s/Assoc a ions 
Geography of the 
Guidelin  
Nam of the Guideline Last 
Upd ted 
1 
Caribbe n Health Research Cou cil 
(CHRC) nd Pan A eric  Health 
Organization (PAHO) [8] 
Country-specific 
( aribbean) 
Ma ag ng diabetes in primary care in 
the Caribbean 2006 
2 I rn tio al Di bet s F dera i (IDF)[11] International  
R co mendati ns for managing typ  
 diabetes in primary care 2017 
3 
Th R yal Austr lian Coll ge of General 
Practition rs (RACGP) [1 ]
un ry-specific
(A st li ) 
Ge ral practice management of type 
2 diabetes 2016  
4 
Diabetes Canada nd Canadian Diabetes 
Associatio  (CDA) [13]  
Country-specific 
(C ada) 
D C n d  2018 clinical practic  
guid lines for the reventio  and 
m nagement of di betes in Can d  
2018 
5 N w Zealand Guid l nes Gr p (NZGD) [14]
Country-specific (New
Zealand) 
Guidan e o the management f type 
2 diabetes 2011 2011
6 American Diabetes Association (ADA) [15] 
Co try-spe fic (U i d 
States) St ndards of medical care in diabetes 2020 
7 Nat on l Institut  for He lth nd Care
Exc l e e (NICE) [16] 
C untry-specific 
(E gland and Wa es) 
Type 2 diab es in adults: 
manageme t 
2020 
8 Sco tish Int rcollegiate Guidelines
Netw rk ( IGN) [17] 
C untry-sp cific 
(Scotla d) 
Mana emen  f diabetes: a national 
clinical guideline 
2017 
2. . Comp riso  f Conte  of Sel cted Cl i al Guidelin s for Managi g T2DM 
The con e  of th  clinical gui elines was co pared based n the following topics by 
usin  a previously pi ted dat  extraction for : blood glucose mana ement; body weight 
sess ent and manageme t; bl od pr ssure measurement and management; blood li-
pid  mea urement and man geme t; T2DM-associated complications assessment and 
man g ment; nd other h alth are-related issues an  advice. Each guideline was read 
v ral ti  to i entify topics/subtopics and related recommendations. A full star “
” as sig ed to t pics/subtopics with adequate information. A half-star “ ” was 
a s gned t  topic /subtopics with l mited inf rm tion. “NR” was a signed to topics/sub-
top cs that are not r orted in the guid lin . Two independent reviewers (AN and GY) 
were involv d n th  p ocess, and disagreements were resolved thr ugh iscussion or 
ith a third reviewer (KC). 
2.3. Com ari  f Quality of S l cted Clinical Gui elines or Managi g T2DM 
The quality of the clinical guid lines was assessed in epend ntly by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a sta ardised and validated instrument [10]. The AGREE II tool com-
rises 23 ems separat d into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (ii ) rigou of develop e t; iv clarity of presentation (v) applicability; and (vi) 
editori l independ nce) and two global ati g items ((i) verall quality score and (ii) rec-
ommend ion for use in practic ) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = s rongly dis ree to 7 = stron ly agree). Average appraisal 
scor s w re calcul t d f r ach app is  by using th  avera e ratin  (1 (strongly disagree) 
to 7 (st ongly agre )) all ite s in each do ain. Scaled percentages for each do ain 
were the  calculated f r inte -domain co parison by summing the appraisal ratings of 
tems within a si le do a n (obt ined score), scaling by maxi um and mini um possi-
ble d ma n scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidel ne was summ ri ed and presented us g u mary statistics (mean). Mean 
scores of t e domains were compar , and th  high st and low st scores were identified. 
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G graphy of the 
Guideline 
Nam of he Guideline Last 
Updated 
1 
Caribbean Health Rese ch Council 
(CHRC) d Pa A erican He lth
Org nization (PAHO) [8] 
Country-specific
(Ca i bean) 
Managing diabetes in primary care in 
the Caribbean 2006 
2 International Di betes F d r tion (IDF) [11] International  
R co mendations for managing
2 diabetes in primary care 7
3 
The R yal Austral  College of  
Practiti ners (RAC P) [12] 
Country-specifi  
(Australia) 
G neral pr ctice manag ment of typ  
2 diabetes 2016  
4 
Diabetes Canada and Canadian Diabetes 
Associatio  (CDA) [13]  
Country-specific 
(C nad ) 
Diabetes Canada 2018 clinical practice 
guid lines for the prevention and 
management of di betes in Canada 
2018
5 N w Z land G idel n s Group ( ZGD) [14] 
Coun ry-specific (New 
Z ala d)
Guidance o  the management of type 
2 diabet s 2011 11 
6 Ameri n Diabetes Association (ADA) [15]
Country-specific (United 
Stat s) Standards of m dical care in diabetes  
7 N ti na  I s itut  for H alth an  C re 
Exce lence (NICE) [16] (Engl nd and Wales) 
Type 2 diabetes in adults: 
mana ement 
20
8 S t ish I ercollegiate Guidelines 
Network (SIGN) [17] 
C untry-s c fic
(Sc tl d) 
Management f di betes: a ational
clinical guid line 
2017 
2.2. Comp r s n f tent of Sel cte  Clinic l Guid nes for M ing T2DM 
Th  content of th  clinical guide ines was co pared based n the following topics by 
us ng a previously p loted ata xtraction f r : blood glucose mana ement; body weight 
ssess t and anag e t; blood pr ssure me sure ent and management; blood li-
pi s measur me  and anagement; T2DM-associated complications assessment and 
managem nt; nd other healthcare-related issues nd advice. Each guideline was read 
ev ral tim  to identi y topic /subtopics a d related recommendations. A full st r “
” as a signed to topics/subtopics with adequate information. A half-star “ ” was 
a signed to top cs/subtopics with limited information. “NR” was a signed to topics/sub-
opics hat a  not report d i  th  guideline. Two independent reviewers (AN and GY) 
we e involved i  the p ces , a d disagreemen s were resolve  through discussion or 
ith a third reviewer (KC). 
.3. Compar on f Quality f Selected Cli ic l Guidelines for Managing T2DM 
Th  qu lity of th  clinic l guidelines was assessed in ep ndently by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, whic is a st n rdised and validated instrument [10]. The AGREE II tool com-
prises 23 it ms separated into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; ( ) rigour of development; ( v) clarity of presentat on; (v) applicability; and (vi) 
edit i l independence) and two global rati g items ((i) overall quality score and (ii) rec-
mmend tion for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly disagree to 7 = stron ly agree). Average appraisal 
scores were c lcul ted for e ch ppr iser by us g th  avera e ratin  (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each domain 
were then c lcul ted f r inter-domain co p r son by summing the appraisal ratings of 
it m  within single do ain (obtained score), scali g by axi um and mini um possi-
ble domain sco es, and by con ting to a p rcentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using u mary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and low s  scores were identified. 
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Geography of the 
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Name of he Guidel ne Last 
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1
Caribbean Health Rese rch Council 
(CHRC) d P  A erica  Heal h
Org nization ( AHO) [8] 
Country-specific 
(Ca i bean) 
Ma aging diabet s in primary care in 
the Caribbean 2006 
2 t rnatio l Di betes F der ion (IDF) [11] International  
R commendations for managing
2 diabet s in primary care 7
3 
Th Royal Austral  College of Ge eral 
Practiti ner  (RACGP) [12] 
Country-specific
(Aus r lia) 
G eral pr ctice a a e e t f typ  
2 diabetes 2016  
4 
Diabetes Canada nd Canadian Diabetes 
Associatio  (CDA) [13]  
Country-specific 
(Canada) 
D  C n d 2018 clinical practice 
guid li s f r the prevention and 
management of iabetes in C nada 
2018 
5 N w Z la  Guideli s Gr p (NZGD) [14] 
Coun ry-specific (New 
Zealand) 
Gu da ce on the management of type 
2 diabetes 2011 11
6 Americ n Diab tes ssociation (ADA) [15]
Cou try-sp cific (United 
States) Stand ds of medical care in diabetes 
7 Nati nal I stitu e for H alth an  Care 
Excel e ce (NICE) [16] (Engl nd and Wales) 
Type 2 d abetes in adults: 
mana ement 
20
8 Sc t ish I rcollegiate Guidel es 
Ne w rk (SIGN) [17] 
C untry-s ecific
(Sc tland) 
Manageme t f diabetes: a national
l ical g i eline
2017 
2.2. Comp r s n of Conte t of Selected Clini al Gu de ines for Managing T2DM 
Th  content of the clinical guidelines was co pared based on the following topics by 
using a p eviously pil ted ata xtraction f r : blood glucose anagement; body weight 
assessment and manag me t; blood pressure measurement and management; blood li-
pi s measureme t and an gement; T2DM-associated complicatio s assessment and 
man gemen ; and other h alth are-rel ted issues and advice. Each guideline was read 
v ral ime  to identi y t pics/subtopics a d rel ed r commendations. A full star “
” w s as igned to topics/subtopics with dequate in ormation. A half- tar “ ” as 
assigned to topics/subtopics with limited inform tion. “NR” was assigned to topics/sub-
topics that  not re orted i  the guid lin . Two ind pendent reviewers (AN and GY) 
we e involved in th proces , a d disagreem nts were resolved thr ugh discussion or 
ith a third reviewer (KC). 
2.3. C mpar son of Qu l ty of S lect d Clinical Gu de ines for Ma agi g T2DM 
Th  qu ity of the clinical guid lines was assessed independ ntly by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ool, whic  is a sta dardised and validated instrument [10]. The AGREE II tool com-
rises 23 it ms separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (ii ) rigou  of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
edit rial independence) and two global ati g items ((i) v rall quality score and (ii) rec-
mmendation f r use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = st ongly dis ree to 7 = strongly gree). Average appraisal 
sco es w re calculated for each pprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly ree)) for all ite s in each domain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
item  within a s l  do ain (obt ined score), scaling by maximum and minimum possi-
b e d main scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guidelin  wa  su mari ed and prese ted usi g su mary statistics (mean). Mean 
scores of th  domains were compar d, and the highest and lowest scores were identified. 
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1 
Caribb n Health Research Council 
(CHRC) nd Pa  Am ric n Health 
Organization (PAHO) [8] 
Coun ry-spec fic 
(Ca ib ean) 
Managing diabetes in primary care in 
the Caribbean 2006 
2 Int n tio al Di b tes Fed ration (IDF)[11] International  
R com nda i ns for managing
2 diabetes in primary care 7
3 
The Roya  Austr li College of Ge er l 
Practiti ers (RAC P) [1 ] 
C untry-specif  
(Australia) 
Gen r l pr ctice manag ment of typ  
2 diabetes 2016  
4
i t  C nada a d Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Can da) 
Diab t s Ca ada 2018 clinical practice 
guid lines for the revention and 
m nag ment of diabetes in Canada 
2018 
5 New Zealand G idel n s Gr up (NZGD) [14] 
Coun ry-specific (New 
Zealand) 
Guidanc  on the management of type 
2 diabet s 2011 11 
6 meri n Diabet s Associat on (ADA) [15] 
Cou try-sp cific (Unite
States) Standards of medical care in diabetes  
7 Nati n l Inst tute for H alth nd Ca e
Exc lle ce (NICE) [16] (Engl d an  Wales) 
Type 2 diabetes in adults: 
mana ement 
20
8 Sco tish I ercol gi te Guideli es 
Netw rk (SIGN) [17]
Country-spec fic 
(S tland) 
Manag ment of di betes: a national 
clinical guideline 
2017 
2.2. omparis n of Cont t f Selected Clinical Guid in s for Managing T2DM 
The conte  of th  clinic l guidelines as compared based on the following topics by 
usin  a previous y piloted data extraction f r : blood glucose management; body weight 
sess  and management; bl od pressure measurem nt and management; blood li-
pid mea urement nd manageme t; T2DM-associ te  complications assessment and 
m nag m nt; nd other healthc re-related ssues and a vice. Each gui eline was read 
ev ral ti  to identify topics/subt pics a d rel ted recommend tions. A full star “
” as assig ed o top cs/subtopics with adequate inform tion. A half-star “ ” was 
assign to top c /subtopics ith limited information. “NR” was assigned to topics/sub-
t pics that are n t reported i  th  guideline. Two independent reviewers (AN and GY) 
ere inv lved in the proc ss, a d disa reement ere resolve  through discussion or 
with a third reviewer (KC). 
2.3. Compariso  o  Qua ty of Sel cted Clinical Guidelines for Managing T2DM 
Th  qu lity of the clinic l guid lines was assessed independently by two reviewers 
(AN nd GY) using the Appr isal of Guidelines for ese rch and Evaluation II (AGREE 
II) tool, which s  standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 it ms separat d into x dom ins ((i) scope and purpos ; (ii) stakeholder involve-
ment; (i ) rigour of developme t; iv l r ty of presentation; (v) applicability; and (vi) 
editorial independ nce) and two global rating items ((i) overall quality score and (ii) rec-
mm nd tion for use in practic ) [10]. Each item within the AGREE II tool was rated on a 
s ven-point scale (from 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
scor  wer calculat d f  each app aiser by using the average rating (1 (strongly disagree) 
to 7 (str ngly agre ))  all items in e ch domai . Scaled per entages for each domain 
were then calculated for inte -domain co parison by summing the appraisal ratings of 
tems within a single domain (obt i e  score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
clude g id lines w s summ rised nd presented using sum ary statistics (mean). Mean 
score of the dom ins were compar , and the highest and lowest scor s were identified. 
Blood glucose targets
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Societies/Organisations/Ass ciatio s 
Ge graphy of t e 
uideline 
Name of he Guideline Last 
Updated
1 
Caribbean Health esea ch Council 
(CHRC) nd Pa  American He l h 
Organization (PAHO) [8] 
Country-specific 
(Ca ibbean) 
Managing diabetes in primary care in 
the Caribbean 2006 
2 International Di betes Federation (IDF) [11] International  
R commendations for managing
2 diabetes in prima y care 7 
3 
The Royal Australian College of General 
Practitioners (RAC P) [12] 
Country-specific 
(Australia) 
General pr ctice manag ment of typ  
2 diab tes 2016  
4 
Diabetes Canada and Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Canad ) 
Di betes Canada 2018 clinical pr ctice 
guidelines for th  prevention and 
management of di betes in Canad  
2018 
5 New Zealand G idelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidance o  the managem nt of typ  
2 diabet s 2011 2011
6 American Diabetes Association (ADA) [15] 
Co n ry-specific (U it  
States) Standards of medical care in diabetes  
7 Nati nal Ins itute for H alth and Care 
Excellence (NICE) [16] (E l nd and Wales) 
Ty e 2 iabetes i  ad lts: 
m a ent 
20
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-spec fic 
(Sc tland) 
Managem nt of di b tes: a natio l 
clin cal gu d line 
2017 
2.2. Comparis n of Co tent of Selected Clinic l Guid in  f r Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: blood glucose management; body weight 
assessment and anage ent; blood pressure measurement and management; blood li-
pids measurement and management; T2DM-associated co plications assessment and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics a d related rec mmendations. A full st r “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolve  through iscussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Select d Clinical Guideli es for Manag ng T2DM 
The quality of the clinical guidelines was assessed in ependently by t o reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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1
Caribbean Health esearch Council 
(CHRC) and Pa  Americ n Heal h 
Organization ( AHO) [8] 
Country-specific 
(Ca ibbean) 
Ma aging diabet s in primary care in 
the Caribbean 2006 
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5 New Zealand G idelines Gr p (NZGD) [14] 
Cou try-specific (New 
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Guida ce on the manage ent of type 
2 diabet s 2011 2011
6 American Diabetes ssociation (ADA) [15] 
Coun ry-sp cific (Uni  
States) Stand ds of medical care in diabetes  
7 Nati nal Ins itute for H alth and Care 
Excellence (NICE) [16] (England and Wales) 
Ty 2 ab tes  adul s: 
ana ent 
20
8 Scottish Int rcollegiate Guideli es 
Network (SIGN) [17] 
Country-spec ic 
(Scotla d) 
M nageme t f diabetes: a nation l 
cli ical g i li e 
2017 
2.2. Comparis n of Conte t f Selected Clini l Gu de ines f r Managing T2DM 
The content of the clinical guidelines was co pared based on the following topics by 
using a previously pil ted data extraction for : blood glucose anagement; body weight 
assessment and management; blood pressure measurement and management; blood li-
pids measurement and man gement; T2DM-associated complicatio s assessment and 
managemen ; and other healthcare-rel ted issues and advice. Each guideline was read 
veral ime  to identify topics/subtopics a d rel ed rec mmendation . A full star “
” was as igned to topics/subtopics with dequate in ormation. A half- tar “ ” was 
assigned to topics/subtopics with limited inform tion. “NR” was assigned to topics/sub-
topics that are not reported in the guid lin . Two ind pendent reviewers (AN and GY) 
were involved in the process, and disagreem nts were resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comparison of Qu l ty of S lect d Clinical Guideli es for Manag g T2DM 
The qu ity of the clinical guid lines was assessed independ ntly by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ool, which is a standardised and validated instrument [10]. The AGREE II tool com-
rises 23 items separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) v rall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
scores w re calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  calculate  for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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(Australia) 
Gen ral pr ctice manag ment of typ  
2 diab tes 2016  
4 
Diabetes Can da and Canadian Diabete  
ssociation (CDA) [13]  
Country-specific 
(Can da) 
Di betes Canada 2018 clinical pr ctice 
guid lines for th revention an  
manag ment of di betes in Canada 
2018 
5 New Z aland G idelin s Gr p (NZGD) [14] 
Country-sp cific (New 
Zealand) 
Guidance  he managem t of t pe 
2 diabet s 2011 2011
6 merican D abetes Association (ADA) [15] 
Co ry-specif c (Unite  
States) Standards of medical care in diabetes  
7 Nati nal Ins itute fo  Health a d Care 
xcellence (NICE [16] 
 
(E l d an  W l s)
Ty e 2 iabet i  adults: 
an ent 
20
8 Scottish Intercollegiat  Guidelines 
Netw rk (SIGN) [17] 
Country- pec fic
(Scotlan ) 
Manag nt of di be es: a national 
clin cal gui elin  
2017 
2.2. Comparis n of Co e t f Selected Clinical Gu d in s for Managing T2DM 
The content of the clinical guid lines as c mpared based on the following topics by 
using a previous y piloted data extractio  f r : blood glucose management; body weight 
assessment and anagement; blood pr ssure measurement and management; blood li-
pids measurem nt n  management; T2DM-assoc ted complications assessment and 
manag ment; and other healthc re-relat d issues and a vice. Each guideline was read 
several times to identify topics/subt pics a d related recommendations. A full st r “
” was a signed to topics/subtopics with adequate information. A half-star “ ” was 
a sign  to topics/sub opics ith l mited information. “NR” was a signed to topics/sub-
t pics that are n t reporte  i  the guideli e. Two independent revie ers (AN and GY) 
were inv lved i th  process, and disag ements ere resolve  through disc ssion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Sel ct d Clinic l Guidelines for Managing T2DM 
The quality of the clinical guidelines as ass ss d in ependently by two reviewers 
(AN and GY) u ing the Appr i al of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is  standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 item  sep rated int ix dom ins ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rig ur of development; (iv) l rity of presentation; (v) applicability; and (vi) 
e itorial i ependence) and two g obal rating items ((i) overall quality score and (ii) rec-
mmendat on for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point cale (from 1 = strongly disagre to 7 = trongly agree). Average appraisal 
scor s were alculated for each appraiser by using the ave age rating (1 (strongly disagree) 
to 7 (strong y agree)) for all items in e ch do ain. Scaled percentages for each domain 
were then c lculated for inter-domain co pariso  by summing he appraisal ratings of 
tems within a single domain (obta e score), scaling by aximum and mini um possi-
ble domain scor s, and by conv rting to a percentage [10]. The verall quality of all in-
clude  guidelines w s summarised and presented using sum ary statistics (mean). Mean 
score  of the dom ins were compared, the highest and lowest scores were identified. 
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ana ent 
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8 S ottish Int rcollegiat Guideli es 
Netw rk (SIGN) [17] 
Country-spec fic
(Scotland) 
Managemen  f d abetes: a national 
clin cal guideline 
2017 
2.2. Comp ris n of Co t t f Selected Cli i l Gu d ines for Managin  T2DM 
The conte t of the clinical gu d lines as co pared based on the following topics by 
usin  a previous y pil ted data extractio  for : blood glucose anagement; body weight 
sess ent and anage ent; blood pr ssure measurement and management; blood li-
pids measurement n  man gement; T2DM-associ ted complicatio s assessment and 
manage en ; and other healthc re-rel t d issues and advice. Each guideline was read 
veral i  to ide tify topics/subtopics a d rel ed recommendation . A full star “
” was as g ed to topics/subtopics ith dequate in ormation. A half- tar “ ” was 
assign  to topic /subtopics ith limited inform tion. “NR” was assigned to topics/sub-
topics that are n t reporte  i  the guid lin . Two ind pendent revie ers (AN and GY) 
were involved in th  proce s, and disagreem nts ere resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comp riso  of Qual ty of S l ct d Clinical Gu delin s for Managi g T2DM 
The qu ity of the clinical guid lines as ass ss d in epend ntly by t o reviewers 
(AN and GY) using the Appr isal of Guidelines for Research and Evaluation II (AGREE 
II) ool, which is a standardised and validated instru ent [10]. The AGREE II tool com-
rises 23 items sep r ted int  s x d m ins ((i) scope and purpose; (ii) stakeholder involve-
m nt; (iii) rig ur of develop e t; (i ) larity of presentation; (v) applicability; and (vi) 
editorial independence) and two g obal rating items ((i) v rall quality score and (ii) rec-
ommendat on for use in pr ctice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scal  (from 1 = strongly disa re to 7 = trongly gree). Average appraisal 
scores w r  calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree))  all items in each domain. Scaled percentages for each domain 
w re the  c lculated for nte -domain co pariso  by summing the appraisal ratings of 
items within a singl domain (obtaine score), scaling by maxi um and minimum possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
clude  guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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Geography of the 
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Upd te  
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R co mendati ns for managing
 diabetes in primary care 7
3 
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un ry-specific
(A st li ) 
Ge ral practice management of type 
2 diabet s 2016  
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Country-specific 
(C ada) 
D C n d 2018 clinical practic  
guid lines for the reventio  and 
m nagement of di b tes in Can d  
2018 
5 N w Zealand Guid l nes Gr p (NZGD) [14]
Country-specific (New
Zealand) 
Guidan e o the management of type 
2 diabetes 2011 11
6 American Diabetes Association (ADA) [15] 
Co try-spe fic (U i d 
States) St ndards of medical care in diabetes 
7 N t l Ins itut  for H lth nd Care
Exc l e e (NICE) [16] (E gland and Wa es) 
Type 2 diab e  i  adults: 
mana eme t 
20
8 Sco tish Int rcollegiate Guidelines
Netw rk ( IGN) [17] 
C untry-sp cific 
(Sc tla d) 
Ma a emen  f diabetes: a national 
clinical guideline 
2017 
2. . Comp ris  f Conte  of Sel cted Cli i al G ide in s for Man gi  T2DM 
The con e  of th  clinical gui elines was co pared based n the following topics by 
usin  a previously pi ted dat  extraction for : blood glucose mana ement; body weight 
sess ent and manageme t; bl od pr ssure measurement and management; blood li-
pid  mea urement and man geme t; T2DM-associated complications assessment and 
man g ment; nd other h alth are-related issues an  advice. Each guideline was read 
v ral ti  to i entify topics/subtopics a d related recommendations. A full star “
” as sig ed to t pics/subtopics with adequate information. A half-star “ ” was 
a s gned t  topic /subtopics with l mited inf rm tion. “NR” was a signed to topics/sub-
top cs that are not r orted in the guid lin . Two independent reviewers (AN and GY) 
were involv d n th  p ocess, and disagreements were resolved thr ugh iscussion or 
ith a third reviewer (KC). 
2.3. Com ari  f Quality of S l cted Clinical Gui elines or Managi g T2DM 
The quality of the clinical guid lines was assessed in epend ntly by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a sta ardised and validated instrument [10]. The AGREE II tool com-
rises 23 ems separat d into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (ii ) rigou of develop e t; iv clarity of presentation (v) applicability; and (vi) 
editori l independ nce) and two global ati g items ((i) verall quality score and (ii) rec-
ommend ion for use in practic ) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = s rongly dis ree to 7 = stron ly agree). Average appraisal 
scor s w re calcul t d f r ach app is  by using th  avera e ratin  (1 (strongly disagree) 
to 7 (st ongly agre )) all ite s in each do ain. Scaled percentages for each do ain 
were the  calculated f r inte -domain co parison by summing the appraisal ratings of 
tems within a si le do a n (obt ined score), scaling by maxi um and mini um possi-
ble d ma n scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidel ne was summ ri ed and presented us g u mary statistics (mean). Mean 
scores of t e domains were compar , and th  high st and low st scores were identified. 
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Caribbean Health ese ch Council 
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Org nization (PAHO) [8] 
Country-specific
(Ca i bean) 
Managing diabetes in primary care in 
the Caribbean 2006 
2 International Di b tes F der tio  (IDF) [11] International  
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3 
The R yal Austral  College of  
Practiti ners (RAC P) [12] 
Country-specifi  
(Australia) 
G neral pr ctice manag ment of typ  
2 diabetes 2016  
4 
Diabetes Canada and Canadian Diabetes 
Associatio  (CDA) [13]  
Country-specific 
(C nad ) 
Di betes Canada 2018 clinical pr ctice 
guid lines for th prevention and 
management of di betes in Canada 
2018
5 N w Z la d G idel nes Group ( ZGD) [14] 
Coun ry-specific (New 
Z aland)
Guidance o  the managem nt of typ  
2 diabet s 2011 2011
6 Ameri n Diabetes Association (ADA) [15]
Co ntry-specific (United 
Stat s) Standards of m dical care in diabetes  
7 N ti na  I s itut  for H lth an  C re 
Exce l nce (NICE) [16] (Engl nd and Wales) 
Ty e 2 iabetes i  adults: 
mana nt 
20
8 S t ish I ercollegiate Guidelines 
Network (SIGN) [17] 
C untry-s c fic
(Sc tl d) 
Managem nt f di betes: a ational
clin cal guid line 
2017 
2.2. Comp r s  f tent of Sel cte  C inic l Guid n s for M ing T2DM 
Th  content of th  clinical guide ines was co pared based n the following topics by 
us ng a previously p loted ata xtraction f r : blood glucose mana ement; body weight 
ssess t and anag e t; blood pr ssure me sure ent and management; blood li-
pi s measur me  and anagement; T2DM-associated complications assessment and 
managem nt; nd other healthcare-related issues nd advice. Each guideline was read 
ev ral tim  to identi y topic /subtopics a d rel ted recommendations. A full st r “
” as a signed to topics/subtopics with adequate information. A half-star “ ” was 
a signed to top cs/subtopics with limited information. “NR” was a signed to topics/sub-
opics hat a  not report d i  th  guideline. Two independent reviewers (AN and GY) 
we e involved i  the p ces , a d disagreemen s were resolve  through iscussion or 
ith a third reviewer (KC). 
.3. Com ar on f Quality f Select d Cli ic l Gui elines for Managing T2DM 
Th  qu lity of th  clinic l guidelines was assessed in ep ndently by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, whic is a st n rdised and validated instrument [10]. The AGREE II tool com-
prises 23 it ms separated into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; ( ) rigour of develop ent; ( v) clarity of presentat on; (v) applicability; and (vi) 
edit i l independence) and two global rati g items ((i) overall quality score and (ii) rec-
mmend tion for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly disagree to 7 = stron ly agree). Average appraisal 
scores were c lcul ted for e ch ppr iser by us g th  avera e ratin  (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each domain 
were then c lcul ted f r inter-domain co p r son by summing the appraisal ratings of 
it m  within single do ain (obtained score), scali g by axi um and mini um possi-
ble domain sco es, and by con ting to a p rcentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using u mary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and low s  scores were identified. 
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Stat s) Stand ds of medical care in diabetes  
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C untry-s ec fic
(Sc tland) 
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2.2. Comp r s n of Conte t of Selected Cli i al Gu de ines for Managing T2DM 
Th  content of the clinical guidelines was co pared based on the following topics by 
using a p eviously pil ted ata xtraction f r : blood glucose anagement; body weight 
assessment and manag me t; blood pressure measurement and management; blood li-
pi s measureme t and an gement; T2DM-associated complicatio s assessment and 
man gemen ; and other h alth are-rel ted issues and advice. Each guideline was read 
v ral ime  to identi y t pic /subtopics a d rel ed r commendations. A full star “
” w s as igned to topics/subtopics with dequate in ormation. A half- tar “ ” as 
assigned to topics/subtopics with limited inform tion. “NR” was assigned to topics/sub-
topics that  not re orted i  the guid lin . Two ind pendent reviewers (AN and GY) 
we e involved in th proces , a d disagreem nts were resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. C mpar son of Qu l ty of S lect d Clin cal Gu de ines for Ma agi g T2DM 
Th  qu ity of the clinical guid lines was assessed independ ntly by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ool, whic  is a sta dardised and validated instrument [10]. The AGREE II tool com-
rises 23 it ms separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (ii ) rigou  of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
edit rial independence) and two global ati g items ((i) v rall quality score and (ii) rec-
mmendation f r use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = st ongly dis ree to 7 = strongly gree). Average appraisal 
sco es w re calculated for each pprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly ree)) for all ite s in each do ain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
item  within a s l  do ain (obt ined score), scaling by maximum and minimum possi-
b e d main scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guidelin  wa  su mari ed and prese ted usi g su mary statistics (mean). Mean 
scores of th  domains were compar d, and the highest and lowest scores were identified. 
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(S tland) 
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2.2. omparis n of Co t  f Selected Clinical Guid in s for Managing T2DM 
The conte  of th  clinic l gui elines as compared based on the following topics by 
usin  a previous y piloted data extraction f r : blood glucose management; body weight 
sess  and management; bl od pressure measurem nt and management; blood li-
pid mea urement nd manageme t; T2DM-associ te  complications assessment and 
m nag m nt; nd other healthc re-related ssues and a vice. Each gui eline was read 
ev ral ti  to identify topics/subt pics a d rel ted recommend tions. A full star “
” was assig ed o top cs/subtopics with adequate inform tion. A half-star “ ” was 
assign to top c /subtopics ith limited information. “NR” was assigned to topics/sub-
t pics that are n t reported i  th  guideline. Two independent reviewers (AN and GY) 
ere inv lved in the proc ss, a d disa reement ere resolve  through discussion or 
with a third reviewer (KC). 
2.3. Comparis  o  Qua ty of Sel cted Clinical Guidelines for Managing T2DM 
Th  qu lity of the clinic l guid lines was assessed independently by two reviewers 
(AN nd GY) using the Appr isal of Guidelines for ese rch and Evaluation II (AGREE 
II) tool, which s  standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 it ms separat d into x dom ins ((i) scope and purpos ; (ii) stakeholder involve-
ment; (i ) rigour of developme t; iv l r ty of presentation; (v) applicability; and (vi) 
editorial independ nce) and two global rating items ((i) overall quality score and (ii) rec-
mm nd tion for use in practic ) [10]. Each item within the AGREE II tool was rated on a 
s ven-point scale (from 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
scor  wer calculat d f  each app aiser by using the average rating (1 (strongly disagree) 
to 7 (str ngly agre ))  all items in e ch domai . Scaled per entages for each domain 
were then calculated for inte -domain co parison by summing the appraisal ratings of 
tems within a single domain (obt i e  score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
clude g id lines w s summ rised nd presented using sum ary statistics (mean). Mean 
score of the dom ins were compar , and the highest and lowest scor s were identified. 
Healthy diet
Int. J. Environ. Res. Public Health 2021, 18, x FOR PEER REVIEW 3 of 13 
 
 
Table 1. Outline of selected clinical guidelines for m naging T2DM. 
 Publishing 
Societies/Organisations/Ass ciatio s 
Ge graphy of t e 
uideline 
Name of he Guideline Last 
Updated
1 
Caribbean Health esea ch Council 
(CHRC) nd Pa  American He l h 
Organization (PAHO) [8] 
Country-specific 
(Ca ibbean) 
Managing diabetes in primary care in 
the Caribbean 2006 
2 International Di betes Federation (IDF) [11] International  
R commendations for managing
2 diabetes in prima y care 7 
3 
The Royal Australian College of General 
Practitioners (RAC P) [12] 
Country-specific 
(Australia) 
General pr ctice manag ment of typ  
2 diabet s 2016  
4 
Diabetes Canada and Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Canad ) 
Di betes Canada 2018 clinical pr ctice 
guidelines for th  prevention and 
management of di betes in Canad  
2018 
5 New Zealand G idelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
Guida ce o  the manag m nt of typ  
2 diab t s 2011 2011
6 American Diabetes Association (ADA) [15] 
C n ry-specific (U it  
States) Standards of medical care in diabetes  
7 Nati nal Ins itute for H alth and Care 
Excellence (NICE) [16] (E l nd and Wales) 
Ty e 2 iabetes i  ad lts: 
m a ent 
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(Sc tland) 
Managem nt of di b tes: a natio l 
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2.2. Comparis n of Co tent of Selected Clinic l Guid in s f r Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: blood glucose management; body weight 
assessment and anage ent; blood pressure measurement and management; blood li-
pids measurement and management; T2DM-associated complications assessment and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics a d related rec mmendations. A full st r “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolve  through iscussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Select d Clinical Guideli es for Manag ng T2DM 
The quality of the clinical guidelines was assessed in ependently by t o reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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Network (SIGN) [17] 
Country-spec ic 
(Scotla d) 
M nageme t f diabetes: a nation l 
cli ical g i li e 
2017 
2.2. Comparis n of Conte t f Selected Clini l Gu de ines f r Managing T2DM 
The content of the clinical guidelines was co pared based on the following topics by 
using a previously pil ted data extraction for : blood glucose anagement; body weight 
assessment and management; blood pressure measurement and management; blood li-
pids measurement and man gement; T2DM-associated complicatio s assessment and 
managemen ; and other healthcare-rel ted issues and advice. Each guideline was read 
veral ime  to identify topics/subtopics a d rel ed rec mmendation . A full star “
” was as igned to topics/subtopics with dequate in ormation. A half- tar “ ” was 
assigned to topics/subtopics with limited inform tion. “NR” was assigned to topics/sub-
topics that are not reported in the guid lin . Two ind pendent reviewers (AN and GY) 
were involved in the process, and disagreem nts were resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comparison of Qu l ty of S lect d Clinical Guideli es for Manag g T2DM 
The qu ity of the clinical guid lines was assessed independ ntly by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ool, which is a standardised and validated instrument [10]. The AGREE II tool com-
rises 23 items separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) v rall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
scores w re calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  calculate  for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comparis n of Co e t f Selected Clinical G d in s for Man ging T2DM 
The content of the clinical guid lines as c mpared based on the following topics by 
using a previous y piloted data extractio  f r : blood glucose management; body weight 
assessment and anagement; blood pr ssure measurement and management; blood li-
pids measurem nt n  management; T2DM-assoc ted complications assessment and 
manag ment; and other healthc re-relat d issues and a vice. Each guideline was read 
several times to identify topics/subt pics a d related recommendations. A full st r “
” was a signed to topics/subtopics with adequate information. A half-star “ ” was 
a sign  to topics/sub opics ith l mited information. “NR” was a signed to topics/sub-
t pics that r  n t reporte  i  the guideli e. Two independent revie ers (AN and GY) 
were inv lved i th  process, and disag ements ere resolve  through disc ssion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Sel ct d Clinic l Guidelines for Ma aging T2DM 
The quality of the clinical guidelines as ass ss d in ependently by two reviewers 
(AN and GY) u ing the Appr i al of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is  standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 item  sep rated int ix dom ins ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rig ur of development; (iv) l rity of presentation; (v) applicability; and (vi) 
e itorial i ependence) and two g obal rating items ((i) overall quality score and (ii) rec-
mmendat on for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point cale (from 1 = strongly disagre to 7 = trongly agree). Average appraisal 
scor s were alculated for each appraiser by using the ave age rating (1 (strongly disagree) 
to 7 (strong y agree)) for all items in e ch do ain. Scaled percentages for each domain 
were then c lculated for inter-domain co pariso  by summing he appraisal ratings of 
tems within a single domain (obta e score), scaling by aximum and mini um possi-
ble domain scor s, and by conv rting to a percentage [10]. The verall quality of all in-
clude  guidelines w s summarised and presented using sum ary statistics (mean). Mean 
score  of the dom ins were compared, the highest and lowest scores were identified. 
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Country-spec fic
(Scotland) 
Mana em n  f d betes: a national 
clinical guideline 
2017 
2.2. Comp ris n of Co t t f Select d Cli i l Gu d ines for Managin  T2DM 
The conte t of the clinical gu d lines as co pared based on the following topics by 
usin  a previous y pil ted data extractio  for : blood glucose anagement; body weight 
sess ent and anage ent; blood pr ssure measurement and management; blood li-
pids measurement n  man gement; T2DM-associ ted complicatio s assessment and 
manage en ; and other healthc re-rel t d issues and advice. Each guideline was read 
veral i  to ide tify topics/subtopics a d rel ed recommendation . A full star “
” was as g ed to topics/subtopics ith dequate in ormation. A half- tar “ ” was 
assign  to topic /subtopics ith limited inform tion. “NR” was assigned to topics/sub-
topics that are n t reporte  i  the guid lin . Two ind pendent revie ers (AN and GY) 
were involved in th  proce s, and disagreem nts ere resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comp riso  of Qual ty of S l ct d Clinical Gu delin s for Managi g T2DM 
The qu ity of the clinical guid lines as ass ss d in epend ntly by t o reviewers 
(AN and GY) using the Appr isal of Guidelines for Research and Evaluation II (AGREE 
II) ool, which is a standardised and validated instru ent [10]. The AGREE II tool com-
rises 23 items sep r ted int  s x d m ins ((i) scope and purpose; (ii) stakeholder involve-
m nt; (iii) rig ur of develop e t; (i ) larity of presentation; (v) applicability; and (vi) 
editorial independence) and two g obal rating items ((i) v rall quality score and (ii) rec-
ommendat on for use in pr ctice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scal  (from 1 = strongly disa re to 7 = trongly gree). Average appraisal 
scores w r  calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree))  all items in each domain. Scaled percentages for each domain 
w re the  c lculated for nte -domain co pariso  by summing the appraisal ratings of 
items within a singl domain (obtaine score), scaling by maxi um and minimum possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
clude  guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2. . Comp ris  f Conte  of Sel cted Cli i al G ide in s for Man gi  T2DM 
The con e  of th  clinical gui elines was co pared based n the following topics by 
usin  a previously pi ted dat  extraction for : blood glucose mana ement; body weight 
sess ent and manageme t; bl od pr ssure measurement and management; blood li-
pid  mea urement and man geme t; T2DM-associated complications assessment and 
man g ment; nd other h alth are-related issues an  advice. Each guideline was read 
v ral ti  to i entify topics/subtopics a d related recommendations. A full star “
” as sig ed to t pics/subtopics with adequate information. A half-star “ ” was 
a s gned t  topic /subtopics with l mited inf rm tion. “NR” was a signed to topics/sub-
top cs that are not r orted in the guid lin . Two independent reviewers (AN and GY) 
were involv d n th  p ocess, and disagreements were resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Com ari  f Quality of S l cted Clinical Gui elines or Managi g T2DM 
The quality of the clinical guid lines was assessed in epend ntly by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a sta ardised and validated instrument [10]. The AGREE II tool com-
rises 23 ems separat d into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (ii ) rigou of develop e t; iv clarity of presentation (v) applicability; and (vi) 
editori l independ nce) and two global ati g items ((i) verall quality score and (ii) rec-
ommend ion for use in practic ) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = s rongly dis ree to 7 = stron ly agree). Average appraisal 
scor s w re calcul t d f r ach app is  by using th  avera e ratin  (1 (strongly disagree) 
to 7 (st ongly agre )) all ite s in each do ain. Scaled percentages for each do ain 
were the  calculated f r inte -domain co parison by summing the appraisal ratings of 
tems within a si le do a n (obt ined score), scaling by maxi um and mini um possi-
ble d ma n scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidel ne was summ ri ed and presented us g u mary statistics (mean). Mean 
scores of t e domains were compar , and th  high st and low st scores were identified. 
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2.2. Co par s  f tent of Sel cte  C inic l Guid n s for M i g T2DM 
Th  content of th  clinical guide ines was co pared based n the following topics by 
us ng a previously p loted ata xtraction f r : blood glucose mana ement; body weight 
ssess t and anag e t; blood pr ssure me sure ent and management; blood li-
pi s measur me  and anagement; T2DM-associated complications assessment and 
managem nt; nd other healthcare-related issues nd advice. Each guideline was read 
ev ral tim  to identi y topic /subtopics a d rel ted recommendations. A full st r “
” as a signed to topics/subtopics with adequate information. A half-star “ ” was 
a signed to top cs/subtopics with limited information. “NR” was a signed to topics/sub-
opics hat a  not report d i  th  guideline. Two independent reviewers (AN and GY) 
we e involved i  the p ces , a d isagreemen s were resolve  through iscussion or 
ith a third reviewer (KC). 
.3. Com ar on f Quality f Select d Cli ic l Gui elines for Managing T2DM 
Th  qu lity of th  clinic l guidelines was assessed in ep ndently by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, whic is a st n rdised and validated instrument [10]. The AGREE II tool com-
prises 23 it ms separated into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; ( ) rigour of develop ent; ( v) clarity of presentat on; (v) applicability; and (vi) 
edit i l independence) and two global rati g items ((i) overall quality score and (ii) rec-
mmend tion for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly disagree to 7 = stron ly agree). Average appraisal 
scores were c lcul ted for e ch ppr iser by us g th  avera e ratin  (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each domain 
were then c lcul ted f r inter-domain co p r son by summing the appraisal ratings of 
it m  within single do ain (obtained score), scali g by axi um and mini um possi-
ble domain sco es, and by con ting to a p rcentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using u mary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and low s  scores were identified. 
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2.2. Comp r s n of Conte t of Selected Cli i al Gu de ines for Managing T2DM 
Th  content of the clinical guidelines was co pared based on the following topics by 
using a p eviously pil ted ata xtraction f r : blood glucose anagement; body weight 
assessment and manag me t; blood pressure measurement and management; blood li-
pi s measureme t and an gement; T2DM-associated complicatio s assessment and 
man gemen ; and other h alth are-rel ted issues and advice. Each guideline was read 
v ral ime  to identi y t pic /subtopics a d rel ed r commendations. A full star “
” w s as igned to topics/subtopics with dequate in ormation. A half- tar “ ” as 
assigned to topics/subtopics with limited inform tion. “NR” was assigned to topics/sub-
topics that  not re orted i  the guid lin . Two ind pendent reviewers (AN and GY) 
we e involved in th proces , a d disagreem nts were resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. C mpar s n of Qu l ty of S lect d Clin cal Gu de ines for Ma agi g T2DM 
Th  qu ity of the clinical guid lines was assessed independ ntly by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ool, whic  is a sta dardised and validated instrument [10]. The AGREE II tool com-
rises 23 it ms separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (ii ) rigou  of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
edit rial independence) and two global ati g items ((i) v rall quality score and (ii) rec-
mmendation f r use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = st ongly dis ree to 7 = strongly gree). Average appraisal 
sco es w re calculated for each pprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly ree)) for all ite s in each do ain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
item  within a s l  do ain (obt ined score), scaling by maximum and minimum possi-
b e d main scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guidelin  wa  su mari ed and prese ted usi g su mary statistics (mean). Mean 
scores of th  domains were compar d, and the highest and lowest scores were identified. 
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2.2. omparis n of Co t  f Sel cted Clinical Guid in s for Managing T2DM 
The conte  of th  clinic l gui elines as compared based on the following topics by 
usin  a previous y piloted data extraction f r : blood glucose management; body weight 
sess  and management; bl od pressure measurem nt and management; blood li-
pid mea urement nd manageme t; T2DM-associ te  complications assessment and 
m nag m nt; nd other healthc re-related ssues and a vice. Each gui eline was read 
ev ral ti  to identify topics/subt pics a d rel ted recommend tions. A full star “
” was assig ed o top cs/subtopics with adequate inform tion. A half-star “ ” was 
assign to top c /subtopics ith limited information. “NR” was assigned to topics/sub-
t pics that are n t reported i  th  guideline. Two independent reviewers (AN and GY) 
ere inv lved in the proc ss, a d disa reement ere resolve  through discussion or 
with a third reviewer (KC). 
2.3. Compari  o  Qua ty of Sel cted Clinical Guidelines for Managing T2DM 
Th  qu lity of the clinic l guid lines was assessed independently by two reviewers 
(AN nd GY) using the Appr isal of Guidelines for ese rch and Evaluation II (AGREE 
II) tool, which s  standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 it ms separat d into x dom ins ((i) scope and purpos ; (ii) stakeholder involve-
ment; (i ) rigour of developme t; iv l r ty of presentation; (v) applicability; and (vi) 
editorial independ nce) and two global rating items ((i) overall quality score and (ii) rec-
mm nd tion for use in practic ) [10]. Each item within the AGREE II tool was rated on a 
s ven-point scale (from 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
scor  wer calculat d f  each app aiser by using the average rating (1 (strongly disagree) 
to 7 (str ngly agre ))  all items in e ch domai . Scaled per entages for each domain 
were then calculated for inte -domain co parison by summing the appraisal ratings of 
tems within a single domain (obt i e  score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
clude g id lines w s summ rised nd presented using sum ary statistics (mean). Mean 
score of the dom ins were compar , and the highest and lowest scor s were identified. 
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2.2. Comparis n of Co tent of Selected Clinic l Guid in s f r Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: blood glucose managem nt; body weight 
assess ent and an ge ent; bl od pressure meas rement n  man geme t; blood li-
pids measurement and management; T2DM-associated complications assessment and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics a d related rec mmendations. A full st r “
” was assigned to topics/subtopics with adequat  information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolve  through iscussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Select d Clinical Guideli es for Manag ng T2DM 
The quality of the clinical guidelines was assessed in ependently by t o reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comparis n of Co ent f Selected Clinical G d in s for Man ging T2DM 
The content of the clinical guid lines as compared based on the following topics by 
using a previous y piloted data extractio  for : blood glucose management; body weight 
assess ent an  an geme t; bl od pr ssure measurement n  manageme t; blood li-
pids measurement n  management; T2DM-associ ted complications assessment and 
management; and other healthc re-relat d issues and advice. Each guideline was read 
several times to identify topics/subt pics a d related recommendations. A full st r “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assign  to topics/subtopics ith limited information. “NR” was assigned to topics/sub-
topics that are n t reporte  i  the guideline. Two independent revie ers (AN and GY) 
were involved in th  process, and disagreements ere resolve  through disc ssion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Sel ct d Clinic l Guidelines for Ma aging T2DM 
The quality of the clinical guidelines as ass ss d in ependently by two reviewers 
(AN and GY) using the Appr isal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 items sep rated int  six dom ins ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rig ur of development; (iv) larity of presentation; (v) applicability; and (vi) 
editorial independence) and two g obal rating items ((i) overall quality score and (ii) rec-
ommendat on for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagre to 7 = trongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each do ain. Scaled percentages for each domain 
were then c lculated for inter-domain compariso  by summing the appraisal ratings of 
items within a single domain (obtaine score), scaling by maximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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” was as g ed to topics/subtopics ith dequate in ormation. A half- tar “ ” was 
assigned to topic /subtopics with limited inform tion. “NR” was assigned to topics/sub-
topics that are not reported in the guid lin . Two ind pendent revie ers (AN and GY) 
were involved in the proce s, and disagreem nts ere resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comp riso  of Qual ty of S l ct d Clinical Gu delin s for Managi g T2DM 
The qu ity of the clinical guid lines was assessed in epend ntly by t o reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ool, which is a standardised and validated instrument [10]. The AGREE II tool com-
rises 23 items separ ted into s x d mains ((i) scope and purpose; (ii) stakeholder involve-
m nt; (iii) rigour of develop e t; (i ) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) v rall quality score and (ii) rec-
ommendation for use in pr ctice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scal  (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
scores w r  calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree))  all items in each domain. Scaled percentages for each domain 
w re the  calculated for nte -domain co parison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maxi um and minimum possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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Th  content of the clinical guide ines was co pared based on the following topics by 
using a previously piloted ata xtraction f rm: blood glucose management; body weight 
assess ent and an g e t; blood pressure meas rement nd management; blood li-
pi s measureme  and anagement; T2DM-associated complications assessment and 
management; and other healthcare-related issues nd advice. Each guideline was read 
ev ral tim  to identi y topic /subtopics a d rel ted recommendations. A full st r “
” as assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to top cs/subtopics with limited information. “NR” was assigned to topics/sub-
topics that a  not report d i  th  guideline. Two independent reviewers (AN and GY) 
we e involved in the pr ces , a d isagreements were resolve  through iscussion or 
with a third reviewer (KC). 
2.3. Com ar on f Quality f Select d Cli ical Gui elines for Managing T2DM 
Th  qu lity of the clinical guidelines was assessed in ependently by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, whic  is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 it ms separated into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (i i) rigour of develop ent; ( v) clarity of presentation; (v) applicability; and (vi) 
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were then calcul ted for inter-domain comp r son by summing the appraisal ratings of 
it m  within  single do ain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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2.2. Comparis n of Content of Selected Clinic l Guide in s f r Mana ing T2DM 
The content of the clinical gui elines wa  compared b sed o  th  fo lowi g topic by
using a previously piloted data extraction form: blood glucose management; body weight 
assess ent and man gement; bl od pressure meas rement n  man geme t; blood li-
pids measurement and management; T2DM-associated complications assessment and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics a d related rec mmendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolve  through iscussion or 
ith a third revie er (KC). 
2.3. Comparison of Quality of Select d Clinical Guideli es for Manag ng T2DM 
The qua ty of th  clin c l guidelines was ass ssed indep nd ntly by two r viewers
(AN and GY) using the Appraisal f Gui elines for R earc  and Evaluation II (AGREE
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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ment; (iii) rigour of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
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seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
scores w re calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  calculate  for inte -domain comparison by summing the appraisal ratings of 
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cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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Country- pec fic
(Scotland) 
Ma ag nt of di be es: a national 
clin cal gui elin  
2017 
2.2. Comparis n of Co te t f Selected Clinical G id in s for Man ging T2DM 
The c nt nt of the clinic l gui lines as c mpared b sed o  th  followi g topi s by 
using a previous y piloted data extrac io  f rm: blood glucose management; body weight 
assess ent an  an geme t; bl od pr ssure measurement n  manageme t; bl od li-
pids measurem nt n  management; T2DM-assoc ted complications assessment and 
manag ment; and other healthc re-relat d issues and a vice. Each guideline was read 
several times to identify topics/subtopics a d related recommendations. A full st r “
” was a signed to topics/subtopics with adequate infor ation. A half-star “ ” was 
a sign  to topics/sub opics ith l mited information. “NR” was a signed to topics/sub-
t pics that are n t reporte  i  the guideli e. Two independent revie ers (AN and GY) 
were inv lved i th  process, and disag ements ere resolve  through disc ssion or 
ith a third revie er (KC). 
2.3. Comparison of Quality of Sel ct d Clinical Guidelines for Ma aging T2DM 
The qua ty of th clin c l guideline  as ss ss d in ep nde tly by t o reviewers
(AN and GY) u ing the Appr i al of Gui e ines for Res arch and Evaluation II (AGREE
II) tool, which is  standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 item  sep rated int ix dom ins ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rig ur of development; (iv) l rity of presentation; (v) applicability; and (vi) 
e itorial i ependence) and two g obal rating items ((i) overall quality score and (ii) rec-
mmendat on for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point cale (from 1 = strongly disagre to 7 = trongly agree). Average appraisal 
scor s were alculated for each appraiser by using the ave age rating (1 (strongly disagree) 
to 7 (strong y agree)) for all items in e ch domain. Scaled percentages for each domain 
were then c lculated for inter-domain co pariso  by summing he appraisal ratings of 
tems within a single domain (obta e score), scaling by aximum and mini um possi-
ble domain scor s, and by conv rting to a percentage [10]. The verall quality of all in-
clude  guidelines w s summarised and presented using sum ary statistics (mean). Mean 
score  of the dom ins were compared, the highest and lowest scores were identified. 
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2.2. Comp ris n of Cont t f Select d Cli i l Gu d ines for Managin  T2DM 
The cont t of the linic l gu lines as co pared based o  th  fol wing t pics by 
usin  a previous y pil ted data extractio  for : blood glucose anagement; body weight 
sess ent an  an ge e t; blood pr ssure measurement nd manage ent; blo d li-
pids measurement n  man gement; T2DM-associ ted complicatio s assessment and 
manage en ; and other healthc re-rel t d issues and advice. Each guideline was read 
veral i  to ide tify topics/subtopics a d rel ed recommendations. A full star “
” was as g ed to topics/subtopics ith dequate in ormation. A half- tar “ ” was 
assign  to topic /subtopics ith limited inform tion. “NR” was assigned to topics/sub-
topics that are n t reporte  i  the guid lin . Two ind pendent reviewers (AN and GY) 
were involved in th  proce s, and disagreem nts ere resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comp riso  of Qual ty of S l ct d Clinical Gu delin s for Managi g T2DM 
The qu ty of the clinical guid lin  as as s d in epe d nt y by two revi wers
(AN GY) using the Appr i al of Gui elin  f r Research and Evaluation II (AGREE
II) ool, which is a standardised and validated instru ent [10]. The AGREE II tool com-
rises 23 items sep r ted int  s x d m ins ((i) scope and purpose; (ii) stakeholder involve-
m nt; (iii) rig ur of develop e t; (i ) larity of presentation; (v) applicability; and (vi) 
editorial independence) and two g obal rating items ((i) v rall quality score and (ii) rec-
ommendat on for use in pr ctice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scal  (from 1 = strongly disa re to 7 = trongly gree). Average appraisal 
scores w r  calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree))  all items in each domain. Scaled percentages for each domain 
w re the  c lculated for nte -domain co pariso  by summing the appraisal ratings of 
items within a singl domain (obtaine score), scaling by maxi um and minimum possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
clude  guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
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the Caribbean 2006 
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The Royal Austral  College of  
Practiti ners (RA P) [12] 
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(A stralia) 
General pr ctice manag ment of typ  
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Diabetes Canada and Canadian Diabetes 
Associatio  (CDA) [13]  
Country-specific 
(C ad ) 
Di betes Canada 2018 clinical pr ctice 
guideli es for the prevention and 
management of diabetes in Canada 
2018 
5 New Z la d G idel nes Group ( ZGD) [14] 
Coun ry-specific (New 
Z ala d)
Guidance on the management of typ  
2 diabetes 2011 2011
6 Americ n Diabetes Association (A A) [15]
C try-specific (U ited 
Stat s) Standards of medical care in diabetes  
7 N ti nal I stitut  for H lth an  C re 
Exce l nc  (NICE) [16] 
 
(E l nd and Wales) 
Ty e 2 iabetes i  adults: 
ma a nt 
20
8 S t ish I ercollegiate Guide es 
Network (SIGN) [17] 
C untry-s ec fic
(Sc tl d) 
Managem nt of di betes: a ational
clin cal guid line 
2017 
2.2. Co par s  f C ntent of Selecte  Clinical Guid n s for M i g T2DM 
Th  co te t o  the clinical gui e ines was compared based o  the following topic  by 
using a previously piloted ata xtraction f rm: blood glucose management; body weight 
ssess t and man g me t; bl od pressure meas rement n  management; blood li-
pi s measur me  and anagement; T2DM-associated complications assessment and 
anagem nt; and other healthcare-related issues nd advice. Each guideline was read 
sev ral tim  to identi y topic /subtopics a d related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to top cs/subtopics with limited information. “NR” was assigned to topics/sub-
topics that a  not report d i  th  guideline. Two independent reviewers (AN and GY) 
we e involved i  the pr ces , a d isagreements were resolve  through iscussion or 
ith a third reviewer (KC). 
.3. Compar on f Quality f Select d Clinical Guidelines for Managing T2DM 
Th  qu ty of the clinic l guidelines was as ssed independently by two reviewers
(AN nd GY) using th Apprai al of Gui elines or Research and Evaluation II (AGREE
II) tool, whic  is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 it ms separated into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; ( ) rigour of development; ( v) clarity of presentation; (v) applicability; and (vi) 
edit ial independence) and two global rati g items ((i) overall quality score and (ii) rec-
mmendation for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calcul ted for e ch ppraiser by us ng th  average rating (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each domain 
were then c lcul ted for inter-domain comp r son by summing the appraisal ratings of 
it m  within single do ain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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4 
Diab es Cana a a d Canadia  i betes
Associatio (CDA) [ 3]  
Cou try-sp cif c 
(Can d ) 
Diabetes Canada 8 clinical practice 
gui elines for th  prevention nd 
management of diabetes in Canada 
2018 
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Cou try-spec fic (New 
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Country-speci ic (United 
States) Standards of dical c re in diabet s 2020 
7 National In titute f r H alth and Care 
Excellence (NICE) [16] 
Country-specific 
(Englan  and Wales) 
Typ  2 diabetes in adults: 
management 
2020 
8 Scottish I tercollegiate Guidelines 
N tw rk (SIG ) [17] 
Country- pecific 
(S otland) 
M nagem nt of diabetes: a ation l 
c inic l guideline 
2017 
2.2. Compar o  of Content of Selected Clinical Guidelines for M nagi g T2DM 
Th ntent of th  clinical guideli es was c mpared based on the following topics by 
usi g  r iously pil ted da a ex raction for : bloo glucose management; body weigh  
assessment and ma agem t; bloo pressur  m asur ment and management; blood li-
pids easu ment an mana me t; T2DM-associated complication  a essment and 
ma ag m nt; and oth r ealthcare-related issues and advice. Each guideline was read 
severa t m s t  entify t pics/subtopics nd related rec mmendatio s. A full star “
” a  assigned to topics/sub opics ith ad q t  information. A half-star “ ” was 
ssi n d to t pic /subtopics with limited informati . “NR” w s assigne  to topics/sub-
t pics that are ot re rted n th  gui line. Two indepe nt reviewers (AN and GY)
were involv d i  the r ce s, d isagree ents were reso ved t ough discussion or 
with a third reviewe  (KC . 
2.3. Com ari o of Quality of Selected Cli ical Guidelines for M naging T2DM 
Th  quality f h  c i ical guidelines was ass ss d ind pendent by two re iewers 
( N a d GY) using the Appr isal of u eline  f r Research d Evaluat on II (AGREE 
II) tool, whi h is a stand d se  d validated instru ent [10]. The AGREE II tool co -
prises 23 it m separ ted i t  six do ains ((i) scope and purpose; (ii) st keholder involve-
nt; (iii) r gour f development; (iv  clar ty of presentation; (v) a plicability; and (vi) 
editorial independe e) d tw  g obal rati g items ((i) verall q ality sc re and (ii) rec-
nd o for u  in r ctice) [10]. Each item withi  the AGREE II tool w s r ted on  
s ven-p int cal (from 1 = stro gly isag e  o 7 = stro gly agree). Average appraisal 
scores were calc lated for each ap raiser by sin  the average rating (1 (strongly disagree) 
t  7 (str ngly agree)) f r all items in each d mai . Scaled perce tages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. omp rison of Co t nt f Sel cted Clinical Guid lin s for Managing T2DM 
The content of th  clinic l gui elines as compared based o  the following topics by 
using a previous y piloted data extraction form: blood glucose management; body weight 
ssess  an  man geme t; blood pressure measurement nd management; blood li-
pid mea urement nd management; T2DM-associ te  complications assessment and 
m nagem nt; and other healthc re-related issues and advice. Each guideline was read 
everal times to identify topics/subt pics and related recommendations. A full star “
” was assigned o topics/subtopics with adequate information. A half-star “ ” was 
assign to topic /subtopics ith limited information. “NR” was assigned to topics/sub-
topics that are n t reported i  th  guideline. Two independent reviewers (AN and GY) 
ere involved in the process, and disa reement  ere resolve  through discussion or 
ith a third reviewer (KC). 
2.3. Compari  o  Quality of Sel cted Clinical Guidelines for Managing T2DM 
Th  qu ty of the clinic l guidelines was ssess d independently by two reviewers
(AN nd GY) using the Appr isal of Gui lines for esearch and Evaluation II (AGREE
II) tool, which s a standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 it ms separated into ix dom ins ((i) scope and purpose; (ii) stakeholder involve-
ment; (i i) rigour of development; (iv) lar ty of presentation; (v) applicability; and (vi) 
editorial independ nce) and two global rating items ((i) overall quality score and (ii) rec-
mmend tion for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
score  were calculat d fo  each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtaine  score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guid lines was summarised nd presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
Smoking c ssa ion
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Caribbean Health esea ch Council 
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8 Scottish Intercollegiate Guidelines 
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(Sc tland) 
Management of diab tes: a natio l 
clinical gu d lin  
2017 
2.2. Comparis n of Co tent of Selected Clinic l Guid ines f r Managing T2DM 
The content of the clinical gu elin s wa  compar d b sed o  th  fo lowi g topic by
using a previou ly pil ted ata extraction form: bloo glucose ma age ; body w igh  
asses ent and n ge ent; bl d pre sure m as reme  n man g e t; blood l
pids measurement and manage T2DM-associated c mplications ssess t and
management; a  o her healthcare-related issu s a d advice. Each guidel e as r ad 
ral times to id ntify t pic /subtopic  a d related rec mm ndations. A full t r “
” wa  assigned to opics/subtopics with ad quate inform tion. A h lf- tar “ ” wa
assigned to topics/subt pics with limited inf rma ion. “NR” was assigned to topics/sub-
topics that are no  rep ted in the guideline. Tw  independ t revi wers (AN nd GY)
were involved  the process, and disagreements were resolve  through d sc ssion or
ith a third revi er (KC). 
2.3. Comparison of Quality of Selected Clinical Guideli s for Manag ng T2DM 
The qua ty of th  clin c l guidelines was ass ssed in ep nd ntly by two r viewers
(AN and GY) using the Appraisal f Gui elines for R earc  and Evaluation II (AGREE
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comparis n of Conte t f Selected Clini l Gu de ines f r Managing T2DM 
The cont nt of the linical gui elin s wa co par d based o  the llowin  t pic by
using a previou ly pil ted ata extraction for : blood g ucose anagement; body weigh  
asses e  and m nagem nt; blo d pre sur  m as reme t nd man g ment; blood li
pids m asurement and man ge T2DM-assoc ated c mplicatio s ssessme t and
ma agemen ; a  other healthcar -rel ted issu s a d advice. Each guidel e was read 
ral imes t  identify topics/subtopic  a d rel d rec mmendation . A full st  “
” wa  as igned to opics/s btopics with adequate in orm tion. A half- tar “ ” was
assigned to topics/sub pics with limited inf r tion. “NR” was assig t  topics/sub-
topics that are no  rep ted in the guid li . Two ind pend t review rs (AN nd GY)
were involved  the pr c ss, a d disagreem n s were resolved thr ugh disc ssio  or
ith a third re i wer (KC).
2.3. Comparison of Qu l ty of S lect d Clinical Guideli s for Manag g T2DM 
The qu ty of the clinic l guid lines was as esse  indepe ntly by two viewers
(AN and GY) u ing the Appraisal f Gui elin  for Researc  and Evaluati n II (AGREE
II) ool, which is a standardised and validated instrument [10]. The AGREE II tool com-
rises 23 items separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) v rall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
scores w re calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  calculate  for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by aximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comparis n of Co e t f Selected Clinical Guid in s for Managing T2DM 
The c nt nt f the cl nic l gu lin s as c mpar d b sed o th  followi g topi s by
using  prev ou y pil ted ata extraction f r : bloo glucose ma age ; bo y w ight
asses ent an  geme t; bl d pr sure measu ment n  man g me t; bl od li
pids me surem nt n  ma agement; T2DM-assoc t d compl cations ssessme t and
manag me t; a  her he lthc re-relat d issu s n  a vice. Each guid line was read 
ral tim s to id ntify t pic /subt pic  a d relat d rec mm dations. A full st r “
” wa  a signed to opics/subtopics with adequate infor tion. A half- tar “ ” wa
a sign  to topics/sub pics ith l mited inf rmation. “NR” was a signed to top cs/sub-
t pics that are n  rep te   the guideli e. Tw  inde ende t revie ers (AN n  GY)
wer inv lved th  process and disag e ents ere resolve  through disc ssion or
ith a third revi er (KC).
2.3. Comparis n of Quality of Sel ct d Clinic l Guid lin  f  Managing T2DM 
The qua ty of th clin c l guideline  as ss ss d in ep nde tly by t o reviewers
(AN and GY) u ing the Appr i al of Gui e ines for Res arch and Evaluation II (AGREE
II) tool, which is  standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 item  sep rated int ix dom ins ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rig ur of development; (iv) l rity of presentation; (v) applicability; and (vi) 
e itorial i ependence) and two g obal rating items ((i) overall quality score and (ii) rec-
mmendat on for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point cale (from 1 = strongly disagre to 7 = trongly agree). Average appraisal 
scor s were alculated for each appraiser by using the ave age rating (1 (strongly disagree) 
to 7 (strong y agree)) for all items in e ch do ain. Scaled percentages for each domain 
were then c lculated for inter-domain co pariso  by summing he appraisal ratings of 
tems within a single domain (obta e score), scaling by aximum and mini um possi-
ble domain scor s, and by conv rting to a percentage [10]. The verall quality of all in-
clude  guidelines w s summarised and presented using sum ary statistics (mean). Mean 
score  of the dom ins were compared, the highest and lowest scores were identified. 
NR NR
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2.2. Comp r s n f Content of Selected Clinical Guide nes for Managing T2DM 
Th  co te t o  the clinical gui elines was co par d b sed o  th following topic  by
sing a prev u ly piloted ata xtraction form: bl od glucose management; body weight 
sses t a d m n g ment; bl d pre su e meas reme  n  man g ment; blood li
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anag m n ;  other healthcare-rel ted issu s a d advice. Each guideli e was read 
r l time  to identi y topic /subtopic  a d related rec mmendations. A full st r “
” a  assig ed to opics/subtopics with adequ te inform tion. A h lf- tar “ ” was
assigned to topics/subt ics with l mited inf rmatio . “NR” was assigned to top cs/sub-
to i s th t a  no  rep ted i  the guid line. Two indepe d t reviewers (AN nd GY)
we e involved  the proces , a d disagreements were resolve  through disc ss on or
ith a th rd revi er (KC).
.3. Compar o  of Quality f Selected Cli ical Guidelin s for Managing T2DM 
Th  qua ty of th  clin c l guidelines was as ssed independently by two reviewers
(AN nd GY) using th Apprai al of Gui elines or Research and Evaluation II (AGREE
II) tool, whic  is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 it s separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; ( i ) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
edit rial independence) and two global rating items ((i) overall quality score and (ii) rec-
mmendation for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each ppraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each do ain 
were then c lcul ted for inter-domain comparison by summing the appraisal ratings of 
items within a single do ain (obtained score), scaling by aximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines wa  summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comparison of Conte t of Selected Clini al Gu delines for Managing T2DM 
The co t nt of the lin cal gui elin s was co pared based o  the following topics by
sing a previously pil ted data extraction for : blood glucose anagement; body weight 
ass ss e  and management; blood pressure measurement nd a agement; blood li-
i s m asureme t and man gem nt; T2DM-associated complicatio s assessment and 
ma agemen ; n  ther healthcare-r l te  issues and advice. Each guid line was read 
v ral ime  t  identify t pics/subtopics and el d r commendations. A full star “
” w s as igned to topics/s btopics with adequate in o mation. A half- t r “ ” as 
a sign d to topics/subt pics with l mited infor t on. “NR” w s assig ed to topics/sub-
topics that are not reported in the guid lin . Two in pendent reviewers (AN and GY) 
we e involved n the pr c ss, and disagreem nts were resolved thr ugh d sc ssio  or 
ith a third reviewer (KC).
2.3. C mpari on of Qu l ty of S lect d Clinical Gu de ines for Ma agi g T2DM 
The qu ty of the clinic l guid lines w s as essed ind pe d ntly by two eviewers
(AN and GY) u ing th  Appraisal of Gui elin  for Research and Evaluati n II (AGREE
II) ool, which is a standardised and validated instru ent [10]. The AGREE II tool com-
rises 23 items separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
edit rial independence) and two global rating items ((i) v rall quality score and (ii) rec-
mmendation f r use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
sco es w re calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree)) for all ite s in each domain. Scaled percentages for each domain 
w re the  calculated for inte -domain comparison by summing the appraisal ratings of 
items within a singl  do ain (obtained score), scaling by maximum and minimum possi-
b e domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of th  domains were compared, and the highest and lowest scores were identified. 
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2.2. omp ris n of Cont t f Selected Clinical Guid in s for Managing T2DM 
The c ntent f th  clinic l gui elines s compar d based o  the following topics by
using  previou y piloted ata extraction f rm: blood glucose management; body weight 
a ses nt an  m n geme t; blo d pre sure measurem nt nd man g ment; blood li
pids measurement nd ma agement; T2DM-associ te  complications ssessme t and
m nag me t; a  other h althc re-related ssu s and a vice. Each gui eline was read 
ral times to identify topics/subt pic  a d related rec mmend tions. A full st r “
” a  assigned o op cs/subtopics with adequate inform tion. A half- tar “ ” was
a s gn to top cs/subt pics ith limited inf rmation. “NR” was assigned to topics/sub-
t pics th t are rep ted i  th  g i eline. Two independe t reviewers (AN nd GY)
er  inv lved  the proc ss, a d disa ree ent ere resolved through disc ssion or 
ith a third revi wer (KC)
2.3. Compariso  of Qua ty of Sel cted Clinical Gui lin s for Managing T2DM 
Th  qu ty of the clinic l guideline was sse s d independently by two reviewers
(AN and GY) using the Appr isal of Gui lines for ese rch and Evaluation II (AGREE
II) tool, which s  standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 items separated into ix dom ins ((i) scope and purpos ; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) l r ty of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
mm ndation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
s ven-point scale (from 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
scor  wer  calculated fo  each appraiser by using the average rating (1 (strongly disagree) 
to 7 (str ngly agree)) for all items in e ch domai . Scaled per entages for each domain 
were then calculated for inter-domain co parison by summing the appraisal ratings of 
items within a single domain (obt i e  score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
clude g id lines w s summarised nd presented using sum ary statistics (mean). Mean 
score of the dom ins were compared, and the highest and lowest scor s were identified. 
Reductio in lc l
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were involved  the process, an  isa ree e ts ere resolve  through sc ssion or
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2.3. Comparison of Quality of Select d Clinical Guideli s for Manag ng T2DM 
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(AN and GY) using the Appraisal f Gui elines for R earc  and Evaluation II (AGREE
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to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.3. Comparis n of Quality of Sel ct d Clinic l Guid lin  f  Managing T2DM 
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II) tool, which is a standardised and validated instru ent [10]. The AGREE II tool com-
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scores were calculated for each appraiser by using the average rating (1 (strongly disagre ) 
to 7 (strongly agree)) for all items in each do ain. Scaled percentages for each domain 
were then c lculated for inter-domain compariso  by summing the appraisal ratings of 
items within a single domain (obtaine score), scaling by maximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR NR
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we e involve   the proces , a  isa reements were resolve  through disc ss on or
ith a th rd revi er (KC).
2.3. Compar o  f Quality f Selected Cli ical Guidelin s for Managing T2DM 
Th  qua ty of th  clin c l g idelines was a ssed in ependen ly by two reviewers
(AN nd GY) using th Apprai al of Gui elines or Resea ch and Evaluation II (AGREE
II) tool, whic  is a standardi ed and validated instrument [10]. The AGREE II tool com-
prises 23 it s separated into six domains ((i scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of pr sentatio ; (v) applicability; and (vi) 
edit rial independence) and t o global rating items ((i) overall quality score and (ii) rec-
mmendation for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each ppraiser by using the average r ting (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each domain 
were then calcul ted for inter-domain comparison by summing the appraisal ratings of 
items within a single do ain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines wa  summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
Int. J. Environ. Res. Public Health 2021, 18, x FOR PEER REVIEW 3 of 13 
 
Table 1. Outline of selected clinical guidelines for m naging T2DM. 
 Pub shing 
Societies/Organisations/Associations 
Geo raphy   
Guideline 
Name of the Guideline Last 
Updated 
1 
Caribb an Health Research Council 
(CHRC) and Pan Americ n H lth 
Or a ization (PAHO) [8] 
C untry-specific
(Car b an) 
Managing diabetes in primary care in 
the Cari b an 2006 
2 I ternational Diabetes Federation (IDF) [11] Int rnational  
Recommendations for managing typ  
2 diabetes in primary c re 2017 
3 
The Royal Australian College of G neral 
Practitio ers (RA P) [12] 
Country-specific 
(Australia) 
General practice manag ment of type 
2 diabetes 2016  
4 
Diab es Canada a d Canadia  Di betes
Associatio (CDA) [13]  
Cou try-specif c 
(Can d ) 
Diabetes Ca ada 8 clinical practice 
gui elines for th  prevention and 
anag ent of diabetes in Canada 
2018 
5 N w Ze land G id li s Group (NZGD) [14] 
Co try-sp cific (New 
Zealand) 
Gu dance on the management of type 
2 diabet s 2011 11 
6 Americ  Diab tes Associ tion (ADA) [15] 
Cou try-speci ic (Unite  
States) Standards of medical c re in diabetes 20 
7 N tion l Institute for Health a d Care 
Excellence (NICE) [16] 
Country- pecific 
(Englan  a d Wale ) 
Typ  2 diabetes in dults: 
man gement 
2020 
8 Scotti h I tercollegiate Gu delines 
N t rk (SIG ) [17] 
Country- pec fic 
(S tla d) 
M nagem nt of diabetes: a ation l 
c inical guideline 
2017 
2.2. Compar o  of Content of Sel cted Clin al Guidelines for M nagi  T2DM 
Th ntent of th  clinical guideli es was c mpared based on the following topics by 
usi g  reviously pil ted data ex raction for : blood glucose management; body weight 
assessment and managem t; bloo pressur  m asur ment and management; blood li-
pids measu ment an mana ment; T2DM-associated complication  a essment and 
ma ag m nt; and oth r healthcare-related issues and advice. Each guideline was read 
s vera t m s t  e tify t pics/subtopics nd related rec mmendatio s. A full star “
” a  a signed to topics/sub opics i h ad q t  information. A half-star “ ” was 
ssi ned to topic /subtopic  wit  limited informati . “NR” w s assigne  to topics/sub-
t pics that are ot re rted n th  gui line. Two indepe nt reviewers (AN and GY)
were involv d i  the r ce s, d isagree ents were reso ve  t ough discussion or 
ith a third revi we  (KC . 
2.3. Com ari o of Qu lity of Selected Cli c l Guidelines for M naging T2DM 
Th  quality f h  c i ical guidelines was ass ss d ind pendent by two re iewers 
( N a d GY) using the Appr isal of u deline  f r Research nd Evaluat on II (AGREE 
II) tool, whi h is a stand d sed d validated instrument [10]. The AGREE II tool co -
prises 23 it m separ ted i t  six do ains ((i) scope and purpose; (ii) st keholder involve-
nt; (iii) r gour f development; (iv  clar ty of presentation; (v) applicability; and (vi) 
editorial independen e) d two g obal rating items ((i) verall quality sc re and (ii) rec-
o nd o for u  in r ctice) [10]. Each item withi  the AGREE II tool w s r ted on  
s ven-p int cal (from 1 = stro gly isag e  o 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
t  7 (strongly agree)) for all items in each d main. Scaled percentages for each domain 
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scores of the domains were compared, and the highest and lowest scores were identified. 
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ev n-point scal  (from 1 = strong y disa r t  7 = trongl gree). Average apprais l 
cores w r  c lcul te  for each apprai r by sing the avera e r t ng (1 (strongly disagree) 
to 7 (st ongly agre ))  all it m n ach domain. S al d per ages for eac  do in 
w re the  c lculated for nte -domain co pariso  by sum ing the appraisal ratings of 
items within a singl do ain (obtaine score), scaling by maximu  and minimum possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
clude  guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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 Publish  
Societies/Org nisati ns/Associ tions
Geography of the 
Guidelin  
Na e of th  Gui eline Last 
Upd t d 
1 
Caribbean Health Researc  Co ncil 
(CHRC) and Pa  American Health 
Orga z tio  (PAHO) [8]
ou try-sp cif c 
(Caribbean) 
Managing diabetes in prim  care n 
the Caribbean 2006 
2 International Di betes F de ation (IDF) [11] Int r ati l  
Recom endations for managing type 
2 diabetes in primary care 2017 
3 
The Royal Australian College of General 
Practitioners (RACGP) [12] 
Country-specific 
(Australia) 
General practice management of type 
2 diabetes 2016  
4 
Diab tes C nada an  a i  D abetes 
A ociatio  (CDA) [13] 
Cou try-s ec fic
(C a) 
Diabetes Canada 2018 clinical practice 
guidelines for the pr vention and 
management of diabetes in C da 
2018 
5 New Zeal nd Guideli es Group (NZGD) [14] 
Country-specific (N  
Zealand) 
Guidance on the anagement of type 
2 di betes 2011 2011 
6 American Di b es Associ tio  (ADA) [15]
Country- pecific (Unit d 
State ) St n ards of medic l care in iabetes 2020 
7 National Institute for H alth and are 
Exc llence (NICE) [16] 
Co try-sp cific 
(E gland d W l s) 
Ty e 2 diabetes in adults: 
m n t 
2020 
8 S ottish Int rcoll giat  Gu d line  
Netw rk (SIGN) [17] 
Coun ry-specific 
(Sc tland) 
Management of diabet s:  national 
li l ideli e 
2017 
2.2. Com ari on of Co t f Select d Cl ca  Guid l s for Man i T2DM 
The c nte t of the c ic l gui lin s wa  c pare  b ed on the f llowing topics by 
si g a re i sl p loted d ta ext acti  f rm: blo gl c e m nage e t; b y weight
ass ssment and ag e t; bl od press re surement  man g me t; bloo  li-
p ds easurem nt an g me t; T2DM- s ci t  plic ti s a sess t nd 
mana ment; and other healthc re-relate  iss s and advice. Each guideline was read 
s v l tim s t  identify topics/subtopics nd r late  co me dations. A full star “
” wa  ssig e  to t pic /subtop cs w th adequat  in ormation.  half-st  “ ” w s 
ssig ed to t ics/s b opi s ith li it d info ati . “NR” wa  assi ne  t opics/sub-
pi s that re n r ported the guid ine. Tw  ind p de t reviewers (AN and GY) 
er  nvolv in the pr cess,  d gre ents we e e lved thr ug  disc ssi n or 
ith  third r vie er (KC). 
2.3. Compa iso  of Q ality of Selecte  Cli i al G i li es for Man gi g T2DM 
T e quality of t clinica g i el e  w s assessed ind e entl by two revie ers 
(AN GY) usin  the Appr isal of Guidelines for R se ch d Evalu tion II (AGR E 
II) to l, wh h is a standardi d an  vali ated instrument [10]. The AGREE II tool com-
prises 23 ite s separated into six do ains ((i) scope nd purpos ; (ii) st keh lder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rat  on a 
seven-point scale (from 1 = strongly di agree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by sum ing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guidelines was sum arised an  presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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Tabl  1. Outli e of selected clinical guidelines for managing T2DM. 
 Publishi  
S c i s/Org s tio /Associ io s 
G ography of th
Guid line 
Name of the Guideline Last 
Update  
1 
Caribb a  H alth R se rch ouncil 
(C RC) and Pa A er a Health 
Orga z tio  (PAHO) [8]
Country-specific
(Cari bean)
Managing iabetes in pri ary care in 
the Caribbean 2006
2 Int r a io l Di b es F er ti  (IDF) [11] International  
R c mendatio  for man ging type 
2 diabe es in primary ar   
3 
The R y l Australi lleg  of  
Practiti ne  (RACGP) [1 ]
o try-s ecific
(A tr li ) 
G eral ractic  manage ent of type 
2 i b t s 2016  
4
Diabetes Canada an  Canadian Diabetes 
Associati n (CDA) [13]  
Country-specific 
(Canad ) 
Di etes Canada 2018 clinical practice
gu l for the r ve tio  and 
m gement of ia et  in Canada 
2018 
5 New Zeala Guidelin s Group (NZGD) [14]
Cou ry- ific (N w 
Z aland)
G id nce o  the manageme  of type 
2 iab te 2011 2011 
6 Americ  Diabetes A soc tion (ADA) [15]
Country- pecific (U ite  
States) Stan ard of me ical care in diab tes 2020 
7 National I stitut  for Health and Care 
Exce lence (NICE) [16] 
Country-specific 
(Engl  nd W les) 
Type 2 diabetes in adults: 
m n gement 
2020 
8 Scottish I ercollegiate Guidelines 
Network (SIGN) [17] 
C untry-sp cific 
(Scotland) 
Man gement of iabetes:  national 
clinical guideline 
2017 
2.2 Co p n of C nten of Select d Cl nic l Guidelines for Managing T2DM 
Th  co t nt f the clinical guide ine  was comp red b sed on t e f llo ing topics by 
u i g a pr vi usly piloted ta extrac on f rm: blo d glucose managem nt; body weight 
s s e t  m nag me ; bl d r sur  m ur e t and m nagem nt; blood li-
pi s easur me  an  anageme t; T2DM- ssociated omplic i s ass ss e t and 
managem nt; a d the  he lthcar - l ted iss es  advice. Each guid lin  as r ad 
sever l tim t  ide i y to ics/ ubtopics d r lated r comm dations. A full star “
” was a signed  topics/subtopics w t  adequ te informat on. A h lf-star “ ” w  
assig e  to t p cs/s bt ics w th li ite  in ormatio . “NR” a  ssig d to topics/ ub-
topi s that a n t r port  i  th  guideline. Two indepen ent reviewers (AN and GY) 
w  involv d i  th  pr ces ,  disagre ents were res lv d throug  discussion or 
with  th rd revi wer (KC).
.3. Compar son of Quality of Selected Cli ica  Guidelines for Managing T2DM 
Th qu lity of th  cli ical gui lines w sse sed independentl  by wo rev ew rs 
(AN  Y) using th  Appraisal of Guid li es for Rese ch nd Evalu tion II (AGREE
II) t l, whic  is a stand rdi ed and valida d instrument [10]. Th AGREE II ol com-
pri  23 it m  separated i to x d ain  ((i) sco e and purpo e; (ii) st k holder involv -
ment; ( ) rigour f develop nt; ( v) clarit  of pr sentation; (v) pplicability; d (vi)
edito i l d p nd nce) d wo global r ting t ms ((i) overall qualit score nd (ii) r c-
ommendation for use pr c ice) [10]. Eac  te  within the AGREE II tool w s rated  a
ve -p i t scal (f m 1 = str ngly dis gr  to 7 = strongly agre ). Aver g  apprais
scor s ere calcul ed for ch ppr iser by us g th  average r ing (1 (strongly disagree)
to 7 ( tr ngly r e)) for all ite s in e ch domain. Scal percentages for eac  domain
were then c lcul ted for inter-domain comp r son by su ing the appraisal ratings of 
it m  within single domain (obtained score), scaling by maxi um and minimum possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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Geography of th  
Guid lin  
Name of the Guideline Last 
Up ated 
1
Caribb a H alth Research Counci  
(C RC) and Pa A erican He th 
Or a iz tion (PAHO) [8]
Country-specific 
(Caribbean)
Ma aging diabet s in pri ary care in 
the Caribbean 2006 
2 I r a io l Diab s F ratio  (IDF) [11] International  
R com end ti  for an ging type 
2 di bet s in primary ca   
3 
Th Royal Au trali  C lleg  f G er l 
Prac i ioner  (RACGP) [12] 
o try-s ecific
(Austr li ) 
Ge eral ractice ma age e t of type 
2 di bete  2016  
4
Diabetes Canada d Cana ia  Diabetes 
Associati  (CD ) [13]  
Country-specific 
(Canada) 
Diabetes C na  2018 clinical practice
gui l s for the r venti n and 
ma agem nt of iab te  in Canad  
2018 
5 New Z al Guideli es Gr p (NZGD) [14] 
Cou ry- cific (New 
Z aland) 
Guid nc   the manageme t of type 
2 diabet s 2011 2011 
6 Americ n Diab tes ssoc ation (ADA) [15]
Country- pecific (U ited 
States) Stand s f me ical care in diabetes 2020 
7 Natio al Institute for Health and Care 
Excell n  (NICE) [16] 
Country-specific 
(Engla d nd W les) 
Type 2 diabetes in adults: 
manag ment 
2020 
8 Scottish In rc llegiate Guideli s 
Network (SIGN) [17] 
C untry-specific 
(Scotlan ) 
Man gement of diabetes:  national 
clinical guideline 
2017 
2.2. Co p r on of Content o  S lec Clinical Gu del nes for Managing T2DM 
Th  content of the clinical guid li es was co pared based on the followi g topics by 
u ing previou ly pil ed a xtrac i  for : blood glucos  nag me t; bo y weight 
ass s ment and m nagem n ; blood pr sure m as r ent a d m nag me t; blood li-
pi s measureme t an  anagement; T2DM- s oc at  c pli tio s assessment a d 
man gemen ; a d othe  h lthcar -r l ssues d advic . Each guideline was read
s ver l ime  to i enti y to ics/subtopics and rel ed recommendations. A full star “
” w s as ign  o topic /s btopic  with dequate in ormati n. A half- tar “ ” was 
s igne  to t pics/s bt pic  with limit d inform ti n. “NR” was as igned to topics/sub-
t pics tha   ot reported i  the gui lin . Two ind pendent reviewers (AN and GY) 
w e involved in th proces , a d disagr em nts were resolved thr ugh di cussion or 
ith a thi d reviewer KC). 
2.3. Compar son of Qual ty of Selected Cli ical Gu delines fo Managing T2DM 
Th qu ty of th  cli ical guid lines w s ass sed ind pend ntl  by two rev ew rs 
(AN  GY) u ing the Appraisal of Guid lines for Research and Evaluation II (AGREE
II) ol, w ic  i  a stand r i ed and validat d i strument [10]. Th AGREE II tool com-
ri  23 it ms sep r ted into six d mains ((i) sc a d purpose; (ii) takeholder involv -
m nt; (iii) rig ur of evelop t; (iv) cl rity of pr sentation; (v) pp icability; and (vi)
edit r al indep nd nce) d tw  global rating te s ((i) v rall qu lity score and (ii) rec-
om end tion f r use in p c i ) [10]. Each ite  within the AGREE II tool was rated n a 
s ven-p i t sca (fr 1 = strongly isa re  t  7 = s rongly gre ). Aver ge appr isal 
co s w re calculat  for each ppr is r by using the ave a e r t ng (1 (strongly di agree)
to 7 ( t ongly ree)) for all ite s in e ch do ain. Sc le p rc ages for each domain
w re the  calcul ted for inte -domain co parison by sum ing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maximum and minimum possi-
b e domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s wa  summarised and presented using su mary statistics (mean). Mean 
scores of th  domains were compared, and the highest and lowest scores were identified. 
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Soc i Org isatio s/Assoc tion  
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Name of the Guideline Last 
Updated 
1 
C ribb n H lth R search ouncil
(CHRC) a  Pa Am ri a  Health 
Orga iz ion (PAHO) [8] 
Coun ry-spec fic 
(C rib ean) 
Managing iabetes in pri ary care in 
the Caribbean 2006 
2 I te a i al Di b s F d r ti n (IDF) [11] Int rnational  
Reco en ati n  for man ging type 
2 di b tes in primary car   
3 
The R ya  A stralia llege of G r l 
Practi io r (RACGP) [12] 
o try-s ecific
(Aust l ) 
G r l r ct ce a age ent of type 
2 di betes 2016  
4
i t  C nada a d Canadian Diabe es 
Assoc ati n (CDA) [13]  
Country-specific 
(Canad ) 
Diab tes Ca ada 2018 clinical practice
gui l es for the revention and 
m nag t of d abetes in Canada 
2018 
5 N w Z land Guidelin  Group (NZGD) [14] 
C u ry-specif  (New
Z aland) 
Guid nc  on the manag me t of type 
2 diab tes 2011 2011 
6 meri n Diab t s Associ t on (ADA) [15] 
C untry- pecific (United 
Stat s) Standards of medical care in diabetes 2020 
7 Nation l I stitute for Health and Ca e 
Excelle ce (NICE) [16] 
Country-s ecific 
(E gl d and Wales) 
Type 2 iabetes in adults: 
management 
2020 
8 Scottish I ercol iate Guideli es 
Network (SIGN) [17] 
C untry-specific 
(Scotla ) 
Ma g ment of di betes:  n tional 
clinical guideline 
2017 
2.2. ompari on of Co te  of Selected Cl ic l Guidelines for Managing T2DM 
T e co tent f th  clinic l guidelines s compared b sed on t e f llo ing topics by 
i g a pr v u y piloted data ex raction rm: blo d glucose managem nt; body weight 
sses  and ma g men ; blood pr ssure m sur e t and m nagement; blood li-
pid mea ure e t nd anag me t; T2DM-as oci te  complic tions ass ssment and 
manag m nt; and th  healthc re-related ssues a  a vic . E ch gui eline was read 
s ver l t mes to ide tify topics/subt pics nd related recommend tions. A full star “
” was ssigned  top c /subtopic w th adequate info m tion. A h lf-star “ ” w  
sign t  t p /s btopics th limited nformati n. “NR” a  assigned to topics/sub-
t ics th t are n reporte  i  th  guideline. Tw  independent reviewers (AN and GY) 
wer  inv lved in the process, a disa re ment were resolv d throug  discussion or 
with third review r (KC). 
2.3. Comparison of Qu ty of Selected Clinical Guidelines for Managing T2DM 
Th qu lity of th  cli ic l idelines was sse sed indepe entl  by two rev ew rs 
(AN  GY) using the Appr isal of Guid lines for ese rch nd Evalu tion II (AGREE
II) to l, which s standardi d and validat d inst u ent [10]. Th AGREE II tool com-
pris  23 it ms epar ted i to x dom ins ((i) scope and purpos ; (ii) stakeholder involv -
me t; (i i) rigour of develo m nt; (iv) l r ty of pres tation; (v) ppl cability; and (vi)
ditorial i d pend nce) a d two glo al rating t ms ((i) overal quality score and (ii) rec-
mm nd tio for se in pr ctice) [10]. Each t  withi  the AGREE II tool was rated n a 
ven-poi t scal  (from 1 = strongly disagre  t  7 = trongly agre ). Aver ge appraisal 
scor  er calculat d fo  each appr iser by using the average r ti g (1 (strongly disagree)
to 7 ( tr ngly agre )) for a l it ms in ch d mai . Scale per entages for each domain
were then calculated for inter-domain co parison by summing the appraisal ratings of 
items within a single domain (obt i e  score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
clude g id lines w s summarised nd presented using sum ary statistics (mean). Mean 
score of the dom ins were compared, and the highest and lowest scor s were identified. 
Dual therapy
(co binatio therapy,
i clud g oral ugs a d
insulin) c
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Geogra hy of e 
Guid line 
Name of the Gu deli e L st 
Update  
1 
Caribbea  Health ese rc Co ncil 
(CHRC) and Pan American Health 
Orga iza ion (PAHO) [8] 
Country-specific
(Caribbean) 
M aging diab tes in primary re i  
t e Caribbean 2006 
2 International Diabetes Federation (IDF) [11] International  
Recommen ations for managing typ  
2 d ab tes i  pri ary car 2017 
3 
The Royal Australian College of Gen ral 
Practitioners (RACGP) [12] 
C u t y-sp cific 
(Au tr lia)
Gen ral p e m geme t f yp  
2 diab s 2016  
4 
Diabetes Canada and Canadian Diabetes 
Association (CDA) [13]  
Country- pecific 
(C n da) 
Diabetes ad  2018 cli ical pr tice 
gui ines for th pr v ntion an  
manageme t of di b t s i  Ca d  
2018
5 New Zealand Guidelines Group (NZGD) [14] 
Co ntr -specific (New 
Ze l nd) 
G idanc  on the manag t of typ  
2 diabet s 2011 2011 
6 American Diabetes Associati n (ADA) [15] 
Cou try-specifi  (U ited 
St tes) S andards of m dic l car  iab tes 2020 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Country-specific 
(E gland and Wales  
Ty  2 diab t s in adults: 
man ge  
2020 
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-s ecific 
(Sc l d  
M n g ment f i be : ati al
cl i l guid lin  
2017 
2.2. Co p rison f C nte t of Sele ted Clinical Guidelin s for Ma ag ng T2DM 
The content of the cli ical gui lin s was compare  b se  on th f l w g t cs y 
using a previously pilote  da xtr ction form: bl od glucose anage t; body eight
ass ssme t and management; blood pressur asurement and a agem ; bl od li-
pids measurement and m nagem nt; T2DM-asso i ted compl ation as s e  n
manageme t; nd other hea thca -rel ted issues a d advic . E ch uideli  w s r a
several times to id ntify topics/s btopic  an  relate  r co dations. A full r “
” was ass gned to topics/subtopics with dequat  infor ati n. A h lf-star “ ” s
assigned to topic /subtopics w th i ite  information. “NR” wa  assig d to topic / ub-
topic that are not reported in the guideline. Two i e nd nt revi w rs (AN a d GY)
were involved in the proces , and dis gree ent  er  resolved through discussion or 
with a th rd revi wer (KC). 
2.3. Comparison of Quality of Select  Clinic l Guid lin s fo  Managing T2DM 
The quality of the clinical guidelines was assessed independently by two eview rs 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II to l com-
prises 23 items separated into six domains ((i) scope and pur ose; (ii) stake old r involve-
ment; (iii) rigo r of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality scor  and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly isagree to 7 = strongly agree). Average apprai al 
scores were calculated for each a praiser by using t e average rating (1 (strongly isagr e) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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8 Scottish I t rcollegiate Guid li es 
Network (SIGN) [17] 
Country-sp cific 
(S l d
Management f di betes: a n ti n l 
cl i al guid line 
2017 
2.2. Co p ris n f C ntent of Selec ed Cli ical Gu delin s fo M aging T2DM 
The content of the cl ical gui el nes w s c mpared b s on th  fo l wing t cs y 
using a eviously pil te  da a xtr cti n for : blood glucose anag m t; body eight
ass ssme t and management; blood pressur surement an  ma gem t; bl od li-
pids measurement and n gem nt; T2DM- sso i ted compl tio a s s ent n
manageme ; nd other althcar -rel ted iss e  advic . E ch guideline w s r ad
everal ime  to i entify topic / btopic  an  rel d reco ndati s. A full s r “
” was as gned to topics/subt pics with dequat  orm ti n.  half- tar “ ” as 
assig ed to topi /subtop cs with i ited info m tio . “NR” wa ig to top cs/ u -
topic that are not p rt d in the guid line. Two i d n ent revi wer (AN a d GY)
were inv lve  in the process, and disag ee ts ere resolved thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comparison of Qu l ty of Sel cted Clinical Gu delines fo Managi g T2DM 
The qu ity of the clinical guid li es was assessed in epend tly by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research a  Evaluation II (AGREE 
II) ool, which is a standardised and validated instrument [10]. The AGREE II tool com-
rises 23 items separ ted into six domains ((i) scope and purpo e; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rati g items ((i) v all quality scor  and (ii) rec-
ommendatio  for use in practice) [10]. Each item within th  AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Av rage appraisal 
scores w re calculated for each apprais r by using the avera e rat g (1 (strongly disagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled p rcen ages for each domain 
w re the  calculated for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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Caribb  Health se rc cil 
(CHRC) a d Pan Americ n He lth
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u t y-sp cific 
(Au tr lia)
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Diab es C n d  and Cana a  Diabetes 
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Country- pecif c 
(C n da) 
Diab t s C nad  2018 cli ical cti e 
guid ines for t prevention nd 
m n g me t f di bet s in a ada 
2018 
5 N w Z aland Guideli s Gr up (NZ D) [14] 
Co ntr -specific (New 
Ze l nd) 
G i anc  on h  a ag nt of type 
 iabet  2011 2011 
6 merican D ab tes Associati n (ADA) [15] 
C u try- p cifi (Unit  
St tes) Stand ds of m dic l c re  iabe es 2020 
7 Natio l In titut  fo  He lth and Care 
xc llenc  (NICE) [16] 
Country- pecific 
(E gl d and W l  
Typ 2 b t s in adult :
man ge ent 
2020 
8 Scottish In erco l giat  Guide ines 
Network (SIGN) [17] 
Country- ecific
(S l d  
M ag m nt f di be s: a n ti nal 
cl ic l guideli  
2017 
2.2. Co p riso  f C nte t of Sele d Cli ic l Gui elin s fo  Man ing T2DM 
The content of the cli ica i lin s as c mp re b s on the foll wing to cs b  
sing a pr vious y pilote  dat xtr cti n f rm: bl od glucos  m e nt; body w ig t
ass ss e t and a ag ment; blood pr ssur measurem n  d an g nt; bl d li-
pids meas re t  n em nt; T2DM- s oc t  compl cation  assessme t and
ma ag e t; nd oth r ea thc -rel t  s u s d a vic . E ch uidelin  was rea
sev ral ti s  id tif topic / btopic  a d r lat  r co m datio . A full star “
” w s a s gn d to topics/subtopics with adequat informati n. A h f-star “ ” s
a sign to top c / b o ic  th l mit inf r ation. “NR” w s a sig ed to topic /sub-
t pic that ar  n t reporte  i the gui el e. Two n e nt re we s ( N a d GY)
were in lved i th  proces , and dis g e ent wer resolved through iscu sion r
with a th rd revi wer (KC). 
2.3. Co pa ison f Q ality of S lect d Clinic l Gui lin  fo  M naging T2DM 
The quality of the clinical guidelines as ass ssed i pende tly by two reviewer  
(AN and GY) u ing the Appr i al of Guidelin s for Research a d Evaluation II (AGREE 
II) tool, which is  standardised and validat d instru ent [10]. The AGREE II tool com-
prises 23 item  sep rated int ix dom ins ((i) scope and pur ose; (ii) stakeholder involve-
ent; (iii) rig r of development; (iv) l rity of presentation; (v) pplicability; an  (vi) 
e itorial i ependence) and two g obal rating items ((i) overall quality sc re a d (ii) rec-
mmendat on for use in prac ice) [10]. Each item withi  the AGREE II tool was rated on a 
seven-point cale (from 1 = strongly isagre to 7 = strongly agree). A age appraisal 
scor s were alculated for each a praiser by using t e ave age rating (1 (strongly isagree) 
to 7 (strong y agree)) for all items in e ch domain. Scaled percentages for each domain 
were then c lculated for inter-domain co pariso  by summing he appraisal ratings of 
tems within a single do ain (obta e score), scaling by aximum and minimum possi-
ble domain scor s, and by conv rting to a percentage [10]. The verall quality of all in-
clude  guidelines w s summarised and presented using sum ary statistics (mean). Mean 
score  of the dom ins were compared, the highest and lowest scores were identified. 
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2018 
5 New Zea n Guidelin s Gr p (NZ D) [14] 
Co tr -s cific (New 
Ze l n ) 
G idance on t e manage nt of type 
2 diab t s 2011 2011 
6 merican Diab tes ssociati  (ADA) [15] 
C u t y- pecifi (U it d 
St tes) St ds of m dic l care n iab tes 2020 
7 Natio l Institu  f r H lth an Care
Exc llenc  (NICE) [16] 
Country-sp cific 
(E gl d and W les  
Type 2 iabet s i  a ult : 
m nage  
2020 
8 Scottish I t rcoll gia  Gui i s 
Network (SIGN) [17] 
Country-sp c fic
(Sc l nd  
M agem nt f di be es: a nati n l 
cl ical guid li e 
2017 
2.2. Co p ris  f Content of Selec ed Clinical Gu in s f M ing T2DM
The conte t of the cli ica d l n s s comp r d b sed on the f ll wing to cs b  
usin a vious y pilote da xtr c i for : blo d gl c se ma ag m nt; ody w ight
s ss e t and anag e t; bl od pr ssur m sur ment  man ge t; bl d li-
pids meas e e t n  n em nt; T2DM-as oci t  c mpl c i ss ssme t n
ma g me ; nd other h althc re- l t d iss s a vic . E ch gui line was ad
ev ral i s o i e tif topic / ubtopic  a d rel d r co dati s. A full tar “
” was as g d to topics/subtopics ith dequate in orm ti n.  ha f- tar “ ” w s 
a ig  to topic / btopics ith limited inform ion. “NR” was a s g to t p cs/ b-
topic that ar  n t report d  the guid lin . Tw  nd pen ent rev w rs (AN a d GY)
were i v lve  in th  proce s, a  disagree nts were re olv d th ough discuss on or 
ith a third r viewer (KC). 
2.3. Comp iso  of Q l ty of Select d Clinical Gu delin  for Managing T2DM 
The qu ity of the clinical guid lines as ass ss d independ ntly by two revi ers 
(AN and GY) using the Appr isal of Guideli es for Research an  Evaluation II (AGREE 
II) ool, which is a standardised a d v idated instru e t [10]. The AGREE II t ol com-
rises 23 items sep r ted int  s x d m ins ((i) sc p and u pose; (ii) stakeholder involve-
m nt; (iii) rig ur of developme t; (i ) larity f presentation; (v) applicability; and (vi) 
editorial independe ce) a d two g obal r ting items ((i) v rall quality core a d (ii) rec-
ommendat o  for use in pr ctice) [10]. Each item w thin the AGREE II tool was rated on a 
seven-point scal  (from 1 = strongly disa re to 7 = trongly gree). Aver  appraisal 
scores w r  calculated for each apprais r by u ing the vera e rat g (1 (strongly disagree) 
to 7 (st ongly agree))  all items in each domain. Scaled percentag s for ach omain 
w re the  c lculated for nte -domain compariso  by summing the appraisal ratings of 
items within a singl do ain (obtaine score), scaling by maximum and minimum possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
clude  guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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1 
C ribb a  He lth Res rc Co c l 
(CHRC) a  P n A rica He lth 
Orga ization (PAHO) [8]
Coun ry-spec fic 
( aribbean) 
M g ng diabetes i  primary care n 
the Caribbea  2006 
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R co m n ati s for managi g type 
2 di es in rimary care 2017 
3 
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2 di b s 2016  
4 
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C un ry- ecific 
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Diabe es C ada 2018 clin c l pr ctic
uid lines f  the prev ntio  a d 
t of diab tes  Ca ad  
2018 
5 N w Z al nd Guidel s Gr up (NZGD) [14]
Cou try-specific (N w
Z land)
Guidan e n the a age ent f type 
2 d bete  2011 2011 
6 Am rica  Diab tes Associati n (AD ) [15] 
Country-sp cifi  (Unit  
St te ) St dards of m cal care n iab tes 2020 
7 Na ional I stitute f r He lth a  Care
Exc l e e (NICE) [16] 
Co try-specific 
Engl nd and Wales  
Ty e 2 i bet s in a ul s: 
m nageme t 
2020 
8 Sco ti h Int colle iate Guidelines
N twork (SIGN) [17] 
C untry-specific
(Sco la d) 
Ma ge  f diabe s: a ati nal
clinical g id li e 
2017 
2. . Co p riso  of C n en  f Sel cted Clini l u delin s f r M n g  T2DM 
The co  of the cli c l guidel s w s compar d b s  n the f ll wing top cs 
usin  a pr v ously pi t d d xt acti fo : blood gluc s  mana eme t; body weig t
s s ent an  nag m ; bl od r sur m s reme t an  an g ment; bl od li-
pi  mea ur ment and eme t; T2DM- ss i compl ation ss ssment a d
man g men ; d other h alth re-r ted iss s  advic . E ch gui line was read
s v ral t o i tif  to c /sub opi  and rel te r co d ti n . A f ll st  “
” was s g  o t pics/subt pics wit  equate i form t on. A h lf-st r “ ” w s 
a s gned t p c / bt pics with l ited inf rm ion. “NR” was a sig to top cs/sub-
t p c that ar  not o te  the g id lin . Tw  ind pe nt rev w rs (AN GY)
were nv lv d n the p ocess, and dis gree e ts were resolved thr ugh discussion or 
ith a third revie er (KC). 
2.3. Compariso  of Quality f Sel ted Clinic l Guideli s f  M aging T2DM 
The quality of th  clini al guid lines w s assessed i epe d ntly by two review rs 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a t ardised and validate  instrument [10]. The AGREE II tool com-
rises 23 ms separat d into s x dom ins ((i) scope and purpose; (ii) stakeholde  i volve-
ment; (ii ) rigou of dev lopme t; iv clarity of presentation (v) applicability; and (vi) 
editori l independ nce) and two global ati g items ((i) verall quality score and (ii) rec-
ommend ion for use i  practic ) [10]. E ch item within the AGREE II tool was rated o  a
seven-point sc le (fr m 1 = s rongly dis ree to 7 = stron ly agree). Average appraisal
scor s w re calcul t d f r ch app is  by using th  avera e ratin  (1 (strongly disagree  
to 7 (st ongly agr )) all it ms in each omain. Scaled percentag for each domain 
were the  calculated f r inte -domain co parison by summing the appraisal ratings of 
tems within a si le doma n (obt ined score), scaling by maximum and minimum possi-
ble d ma n scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidel ne was summ ri ed and presented us g u mary statistics (mean). Mean 
scores of t e domains were compar , and th  high st and low st scores were identified. 
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2 diabet s 2011 2011 
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7 Nati I stit t  for Health nd Care 
Exc lence (NICE) [16] 
Cou try-specific
(E gl nd and Wales  
Type 2 diabet s in a lts: 
manage ent 
2020 
8 Scottish I ercollegi te Guidelin s
N twork (SIGN) [17] 
C u try-sp cif c
(Sc tl  
M n gement f di bet :  n i nal 
cl ical gu d lin  
2017
2.2. C mp r son f nte t of Sel cte  Cli ical Guideli s for M aging T2DM 
Th content of the cli ical gui in s was comp re b sed n th foll wing o cs by 
ng a pr viously p te at x ction f : bl o g uco e mana ement; body w igh
s ss t d ma ag m nt; bl od pr ssur ure ent and n gem nt; bl od li-
p ds ur me  and na em nt; T2DM-associ ted compl catio  assess e t and
m nagem t; d ot r hea thc -rel t  issues  advi . E ch uidelin  was rea
veral ti s to id ti y t pics/ btopic  nd relat  r co d tio s. A full star “
” w s s g d to topics/subt pics with d quate formati n. A h lf star “ ” was
s igned to op c /sub opics w th l ite  info matio . “NR” w s a sig to topic / ub-
opic hat a  n t rep t d i t  guid lin . Two dent revi wers (AN a d GY)
e e involved i  the p ces , a d dis gre en  wer  resolved through discus ion or 
with a th rd revi wer (KC). 
.3. Compar son of Quality of Selected Clinic l Guid lines fo  Managing T2DM 
Th  qu lity of th  clinic l guidelin  was assessed indep ndently by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Re arch and Evaluation II (AGREE 
II) tool, whic is a st n r ed and valida ed instru ent [10]. The AGREE II tool com-
prises 23 it ms separated nto s x domains ((i) scope and pur ose; (ii) stake older involve-
ment; ( rigo r of development; ( v) clarity of p esentat on; (v) applicab lity; and (vi) 
edit i l independence) d two global rati g items ((i) overall quality score and (ii) rec-
mmend ti n for use in prac ice) [10]. Each ite  within the AGREE II tool was rated on a 
seven-poi t scale (f m 1 = strongly isagree to 7 = stron y agree). Average appraisal 
scor s ere c lcul ted for e ch pr iser by u g t  avera e ratin  (1 (strongly isagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled perc ntag s for each domain 
were then c lcul ted f r inter-domain co p r son by summing the appraisal ratings of 
it m  within single domain (obtained score), scali g by maxi um and minimum possi-
ble domain sco es, and by con ting to a p rcentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using u mary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and low s  scores were identified. 
Int. J. nviron. Res. Public Health 2021, 18, x FOR PEER REVIEW 3 of 13 
 
T le 1. Outline of selected clini l guidelines for managing T2DM. 
 P lish ng 
Societies/Org is tio s/ ssocia ions 
G ography of the
Guidelin  
Name of th  Guideline Last 
Updated 
1
C r bb a Health R s rc Cou cil 
CHRC) and Pan Ameri an He l h
Organiza ion (PAHO) [8] 
Country-specific 
(Cari bean) 
Ma gin  diabet s in primary care i  
the Caribbean 2006 
2 nt rnation l Dia et s F d ration IDF) [11] Inter ion l  
R commen ations for mana ng type 
2 d b t s in pri ary care 2017 
3
Th  Roy Australian Coll e of Ge r l 
Pr ition r (RACGP) [12] 
C untry-sp cific
(A s ral a)
G eral practice management of ype 
2 di b tes 2016  
4 
Diabe e  Cana  nd C nadian Diabetes 
Ass i i  (CDA) [13]  
Co n ry- pec fic 
(Can a) 
Di betes C nad  2018 clinical pr ctice 
gui li es for th  pr vention and 
n eme t of iabetes in Can d  
2018 
5 New Z al  Guid li es Gr p (NZGD) [14] 
Cou ry-sp cific (New 
Z ala )
Guidance o  the manage ent of type 
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6 Am ric n Diab tes Associati n (ADA) [15]
C nt y- pecific (U ited 
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Excel e ce (NICE) [16] 
Cou ry-sp cific
(Engl nd and Wales) 
Type 2 diabetes i ults: 
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2020 
8 Scotti h I rcol egi te G i li es
Network (SIGN) [17] 
C untry-sp cific 
(Sc l ) 
Manage nt f diab tes: a n tion
clinical guideline 
2017 
2.2. Co p r s n f C ntent of Selec ed Clinical Gu deline  fo M aging T2DM 
Th con nt of the cli ical gu del nes w s c mpared b sed n the foll wing to cs by 
u ing a eviously pi t ta xtr cti  f : bl od glucos  anag ment; body weight
a s s me t a d m ag me t; blood pressur urement an  man gem nt; bl d li-
pids asureme t and n gem n ; T2DM-assoc ted compl c tio ssessment and
m n g me ; nd other h lth r - l t  iss e   advic . Each gui eline was read
veral im  to i enti y topic / btopi  nd el d reco n ati s. A full st r “
” w s s gn d to topics/subt pics ith dequate in or ti n.  ha f- t r “ ” was 
a sig ed to topics/ ubtop cs with lim ted inform t o . “NR” wa  a si e to t pics/su -
topic that  n  re o d i  th  gui lin . T o ind en nt revi w rs (AN a d GY)
we e inv lve  in h proces , a d isag ee ts were r solved thr ugh di cussion or 
ith a thir  review r (KC). 
2.3. Compar son of Qu l ty of Sel cted Clinical Gu delines fo Managing T2DM 
Th  qu ity of the clinical guid li es was assessed independ ntly by two reviewers 
( N nd GY) using th  Appraisal of Guidelines fo  R search and Ev luation II (AGREE 
II) ool, whic  is a sta dardised and validated instrument [10]. The AGREE II tool com-
rises 23 it ms separ ted into six domains (i) scope and purpose; (ii) stakeholder involve-
m nt; (ii ) rigou  of development; (iv) clarity of presentat on; (v) applicability; and (vi) 
it rial inde endence) and two global ti g tems ((i) v rall quality score and (ii) rec-
mmendatio  f r use  prac ice) [10]. E ch item within the AGREE II tool was rated on a 
seven-point scal (from 1 = st ongly dis ree to 7 = strongly gree). Average appraisal 
sco s w re calculated for each pprais r by using the avera e rat g (1 (strongly disagree) 
t  7 (st ongly ree)) for all ite s in each domain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
item  within a s l  domain (obt ined score), scaling by maximum and minimum possi-
b e d main scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guidelin  wa  su mari ed and prese ted usi g su mary statistics (mean). Mean 
scores of th  domains were compar d, and the highest and lowest scores were identified. 
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2.2. o p rison f C nte t of Selected Cli ical Gui elin s for Managing T2DM 
The conte  of th  cli ic guidelines as comp d bas d on the foll wing to cs by 
sin a previous y pil ted da  xtr c on f rm: blood gluc se m nagement; body weight
s ss nd a a ment; bl od pressur asur m nt nd man gem nt; bl od li-
pid mea ur e t nd n gem t; T2DM- ssoci t  compl cation  assessment and
m g m t; nd oth r healthc re-r l t ss es and advic . Each gui eline was read
s v ral ti s to id tif topics/ b pic  a d r l t d r co mendation . A full star “
” was ss g d o op cs/su t pics with a equate inform t n. A h lf-star “ ” was 
sign d to top c / bto ics ith lim ted nf r ation. “NR” was assigned t  topics/sub-
t c that ar  n t p rted  t  gui eline. Two nde ndent r vi wers (AN a d GY)
w re in lv  i  the proc ss, and d s reement wer  resolved through discussion or 
ith  th rd revi wer (KC). 
2.3. C pariso  f Q a ty of Selected Clini l Guid lines fo  Managing T2DM 
Th qu lity of the clinic l guid lines as assessed independentl  by two reviewers 
(AN nd GY) using the Appr is l of Guideline  for ese rch and Evaluation II (AGREE 
II) t ol, which s stand rdis d and validated instru ent [10]. The AGREE II tool com-
pr ses 23 it ms s p rat d into x dom ins ((i) scope and pur os ; (ii) stakeholder involve-
ment; (i ) rigo r of developme t; iv l r ty of presentation; (v) applicability; and (vi) 
editorial independ nce) and two global rating ite s ((i) overall quality score and (ii) rec-
mm nd tion for use in practic ) [10]. Each tem withi  the AGREE II tool was rated on a 
s ven-point scale (from 1 = strongly isagre  to 7 = trongly agree). Average appraisal 
scor wer calculat d f  each a p iser by using t e average rating (1 (strongly isagree) 
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2.2. Comparison of Content of Selected Clinical Guidelines for Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction for : blood glucose management; body weight 
assessment and management; blood pressure measurement and management; blood li-
pids measurement and management; T2DM-associated complications assessment and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics and related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinical guidelines was assessed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinical guidelines was assessed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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s veral ime  to identify topics/subtopics and rel ed recommendations. A full star “
” was as igned to topics/subtopics with dequate in ormation. A half- tar “ ” as 
assigned to topics/subtopics with limited inform tion. “NR” was assigned to topics/sub-
topics that are not reported in the guid lin . Two ind pendent reviewers (AN and GY) 
were involved in the process, an  disagreem nts were resolved thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comparison of Qual ty of Selected Clinical Gu delines for Managing T2DM 
The qu ity of the clinical guid lines was assessed independ ntly by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ool, which is a standardised and validated instrument [10]. The AGREE II tool com-
rises 23 items separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) v rall quality score and (ii) rec-
ommendation for use in practice) [10]. Each ite  within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
scores re calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  calculated for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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Caribbean Health Research Council 
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General practice manage ent of type 
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4 
Diabetes Can da and Canadian Diabete  
ssociation (CD ) [13]  
Country-specific 
(Canada) 
Diabetes Canada 2018 clinical practice 
guid lines for the prevention and 
manag ment of di betes in Canada 
2018 
5 New Z aland Guidelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidance on he management of type 
2 diabetes 2011 2011 
6 merican D abetes Association (ADA) [15] 
Cou try-specific (United 
States) Standards of medical care in diabetes 2020 
7 National Institute fo  Health and Care 
xcellence (NICE) [16] 
Country-specific 
(Engl d and Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Scottish Intercollegiat  Guidelines 
Network (SIGN) [17] 
Country-sp ific
(Scotlan ) 
Manag ment of di betes: a national 
clinical guideline 
2017 
2.2. Comparison of Conte t of Selected Clinical Guidelines for Managing T2DM 
The content of the clinical guid lines as c mpared based on the following topics by 
using a previous y piloted data extractio  f rm: blood glucose management; body weight 
assessment and management; bl od pr ssure measurement and management; blood li-
pids measurem nt n  mana ement; T2DM-assoc ted complications assess ent and 
manag ment; and other healthc re-relat d issues and a vice. Each guideline was read 
several times to identify topics/subtopics and related recommendations. A full star “
” was a signed to topics/subtopics ith adequate information. A half-star “ ” was 
a sign  to topics/sub opics ith l mited information. “NR” was a signed to topics/sub-
t pics that are n t reporte  i  the guideli e. Two independent reviewers (AN and GY) 
were inv lved i th  process, and disag ements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinical guidelines as ass ss d independently by two reviewers 
(AN and GY) u ing the Appr i al of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is  standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 item  sep rated int ix dom ins ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rig ur of development; (iv) l rity of presentation; (v) applicability; and (vi) 
e itorial i ependence) and two g obal rating items ((i) overall quality score and (ii) rec-
mmendat on for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point cale (from 1 = strongly disagre to 7 = trongly agree). Average appraisal 
scor s were alculated for each appraiser by using the ave age rating (1 (strongly disagree) 
to 7 (strong y agree)) for all items in e ch domain. Scaled percentages for each domain 
were then c lculated for inter-domain co pariso  by summing he appraisal ratings of 
tems ithin a single do ain (obta e score), scaling by aximum and minimum possi-
ble domain scor s, and by conv rting to a percentage [10]. The verall quality of all in-
clude  guidelines w s summarised and presented using sum ary statistics (mean). Mean 
score  of the dom ins were compared, the highest and lowest scores were identified. 
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(CHRC) and Pan American Health 
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Country-specific 
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Ma aging diabet s in primary care in 
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Country-specific 
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Zealand) 
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2 diabetes 2011 2011 
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Country-specific (United 
States) Stand ds of medical care in diabetes 2020 
7 National Institute for Health and Care 
Exc llence (NICE) [16] 
Country-specific 
(Engl d and Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Scottish Int rcollegiat  Guideli es 
Network (SIGN) [17] 
Country-sp cifi
(Scotla ) 
Manag me t of diab tes: a national 
clinical guideline 
2017 
2.2. Comp rison of Content of Selected Clinical Gu delines for Managing T2DM 
The conte t of the clinical gu d lines as compared based on the following topics by 
usin  a previous y pil ted data extractio  for : blood glucose management; body weight 
sess ent a d anage ent; blood pr ssure measurement and management; blood li-
pids measurement n  an gement; T2DM-associ ted complicatio s assessment and 
managemen ; and other healthc re-rel t d issues and advice. Each guideline was read 
s veral i  to ide tify topics/subtopics and rel ed recommendations. A full star “
” was as g ed to topics/subtopics ith dequate in ormation. A half- tar “ ” was 
assign  to topic /subtopics ith limited inform tion. “NR” was assigned to topics/sub-
topics that are n t reporte  i  the guid lin . Two ind pendent reviewers (AN and GY) 
were involved in th  proce s, and disagreem nts were resolved thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comp riso  of Qual ty of Selected Clinical Gu delines for Managing T2DM 
The qu ity of the clinical guid lines as ass ss d independ ntly by two reviewers 
(AN and GY) using the Appr isal of Guidelines for Research and Evaluation II (AGREE 
II) ool, which is a standardised and validated instru ent [10]. The AGREE II tool com-
rises 23 items sep r ted int  s x d m ins ((i) scope and purpose; (ii) stakeholder involve-
m nt; (iii) rig ur of developme t; (i ) larity of presentation; (v) applicability; and (vi) 
editorial independence) and two g obal rating items ((i) v rall quality score and (ii) rec-
ommendat on for use in pr ctice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scal  (from 1 = strongly disa re to 7 = trongly gree). Average appraisal 
scores w r  calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree))  all items in each domain. Scaled percentages for each domain 
w re the  c lculated for nte -domain compariso  by summing the appraisal ratings of 
items within a singl do ain (obtaine score), scaling by maximu  and minimum possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
clude  guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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1 
Caribbean Health Research Council 
(CHRC) and Pan American Health 
Organization (PAHO) [8] 
Cou try-specific 
( aribbean) 
Ma ag ng diabetes in pri ary care in 
the Caribbean 2006 
2 In rnatio l Diab tes Federation (IDF)[11] International  
Reco mendations for managing type 
2 diabetes in primary care 2017 
3 
Th R yal Australian College of General 
Practitioners (RAC P) [1 ] 
C untry-specific 
(Australia) 
G eral practice management of type 
2 diabetes 2016  
4 
Diabetes Canada nd Canadian Diabetes 
Associatio  (CD ) [13]  
Country-specific 
(Canada) 
Diabetes C nada 2018 clinical practice 
guidelines for the prevention and 
management of diabetes in Canada 
2018 
5 N w Zealand Guidel nes Gr p (NZGD) [14]
Country-specific (New
Zealand) 
Guidance on the management of type 
2 diabetes 2011 2011 
6 American Diabetes Association (ADA) [15] 
Country-specific (United 
States) St ndards of medical care in diabetes 2020 
7 Nation l Institute for He lth and Care
Exc l e ce (NICE) [16] 
Country-specific 
(England and Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Sco tish Int rcoll giate Guideli es
Network (SIGN) [17] 
C untry- pecifi  
(Scotlan ) 
Man g me  f diabetes: a national 
cli ical guideline 
2017 
2. . Compariso  of Content of Sel cted Clinical Guidelines for Managing T2DM 
The con e  of th  clinical guidelines was co pared based n the following topics by 
usin  a previously pi ted dat  extraction for : blood glucose mana ement; body weight 
sess ent and manageme t; bl od pr ssure measurement and management; blood li-
pid  mea urement and man geme t; T2DM-associated complications assessment and 
man g ment; nd other h alth are-related issues an  advice. Each guideline was read 
s v ral ti  to i entify topics/subtopics and related recommendations. A full star “
” was sig ed to t pics/subtopics with adequate information. A half-star “ ” was 
a s gned t  topic /subtopics with l mited inf rm tion. “NR” was a signed to topics/sub-
top cs that are not r orted in the guid lin . Two independent reviewers (AN and GY) 
were involv d n th  p ocess, and disagreements were resolved thr ugh disc ssion or 
ith a third reviewer (KC). 
2.3. Compariso  of Quality of Sel cted Clinical Guidelines for Managing T2DM 
The quality of the clinical guid lines was assessed independ ntly by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a sta ardised and validated instrument [10]. The AGREE II tool com-
rises 23 ems separat d into s x do ains ((i) scope and purpose; (ii) stakeholder involve-
ment; (ii ) rigou of developme t; iv clarity of presentation (v) applicability; and (vi) 
editori l independ nce) and two global ati g items ((i) verall quality score and (ii) rec-
ommend ion for use in practic ) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = s rongly dis ree to 7 = stron ly agree). Average appraisal 
scor s w re calcul t d f r ach app is  by using th  avera e ratin  (1 (strongly disagree) 
to 7 (st ongly agre )) all items in each domain. Scaled percentages for each domain 
were the  calculated f r inte -domain co parison by sum ing the appraisal ratings of 
tems within a si le doma n (obt ined score), scaling by maximum and minimum possi-
ble d ma n scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidel ne was summ ri ed and presented us g u mary statistics (mean). Mean 
scores of t e domains were compar , and th  high st and low st scores were identified. 
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1 
Caribbean Health Research Council 
(CHRC) and Pan American Health 
Organization (PAHO) [8] 
Country-specific
(Cari bean) 
Managing iabetes in primary care in 
the Caribbean 2006 
2 International Diabetes F deration (IDF) [11] International  
R co mendations for managing type 
2 diabetes in primary care 2017 
3 
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(Australia) 
General practice management of type 
2 diabetes 2016  
4 
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Association (CDA) [13]  
Country-specific 
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6 Ameri n Diabetes Association (ADA) [15]
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States) Standards of m dical care in diabetes 2020 
7 Nationa  Institut  for Health and Care 
Exce lence (NICE) [16] 
Country-specific
(Engl nd and Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Scottish I ercoll giate Guidelines 
Network (SIGN) [17] 
C untry- p cific 
(Scotland) 
Man gement f diabetes: a national 
cli ical guideline 
2017 
2.2. Comp r son of ntent of Sel cted Clinic l Guidelines for Managing T2DM 
Th  content of th  clinical guide ines was compared based n the following topics by 
us ng a previously p loted ata xtraction f r : blood glucose mana ement; body weight 
ssess t and manag me t; blood pr ssure me sure ent and management; blood li-
pi s measur me  and anagement; T2DM-associated complications assessment and 
managem nt; nd other healthcare-related issues nd advice. Each guideline was read 
several tim s to identi y topics/subtopics and related recommendations. A full star “
” was a signed to topics/subtopics with adequate information. A half-star “ ” was 
a signed to top cs/subtopics with limited information. “NR” was a signed to topics/sub-
opics hat a  not report d i  th  guideline. Two independent reviewers (AN and GY) 
we e involved i  the p ces , a  disagreemen s were resolve  through discussion or 
ith a third reviewer (KC). 
.3. Co par son of Quality of Selected Clinic l Guidelines for Managing T2DM 
Th  qu lity of th  clinic l guidelines was assessed indep ndently by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, whic is a st n rdised and validated instrument [10]. The AGREE II tool com-
prises 23 it ms separated into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; ( ) rigour of development; ( v) clarity of presentat on; (v) applicability; and (vi) 
edit i l independence) and two global rati g items ((i) overall quality score and (ii) rec-
mmend tion for use in prac ice) [10]. Each ite  within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly disagree to 7 = stron ly agree). Average appraisal 
scores ere c lcul ted for e ch ppr iser by us g th  avera e ratin  (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each domain 
were then c lcul ted f r inter-domain co p r son by summing the appraisal ratings of 
it m  within single domain (obtained score), scali g by maxi um and minimum possi-
ble domain sco es, and by con ting to a p rcentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using u mary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and low s  scores were identified. 
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C untry-specific 
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2017 
2.2. Comp r son of Content of Selected Clinical Gu delines for Managing T2DM 
Th  content of the clinical guidelines was compared based on the following topics by 
using a p eviously pil ted ata xtraction f r : blood glucose management; body weight 
assessment and manag me t; blood pressure measurement and management; blood li-
pi s measureme t and an gement; T2DM-associated complicatio s assessment and 
man gemen ; and other h alth are-rel ted issues and advice. Each guideline was read 
s veral ime  to identi y topics/subtopics and rel ed recommendations. A full star “
” w s as igned to topics/subtopics with dequate in ormation. A half- tar “ ” was 
assigned to topics/subtopics with limited inform tion. “NR” was assigned to topics/sub-
topics that  not re orted i  the guid lin . Two ind pendent reviewers (AN and GY) 
we e involved in th proces , a  disagreem nts were resolved thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Compar son of Qual ty of Selected Clinical Gu delines for Managing T2DM 
Th  qu ity of the clinical guid lines was assessed independ ntly by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ool, whic  is a sta dardised and validated instrument [10]. The AGREE II tool com-
rises 23 it ms separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (ii ) rigou  of development; (iv) clarity of presentation; (v) applicability; and (vi) 
edit rial independence) and two global ati g items ((i) v rall quality score and (ii) rec-
mmendation f r use in prac ice) [10]. Each ite  within the AGREE II tool was rated on a 
seven-point scale (from 1 = st ongly dis ree to 7 = strongly gree). Average appraisal 
sco es re calculated for each pprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly ree)) for all ite s in each domain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain co parison by sum ing the appraisal ratings of 
item  within a s l  domain (obt ined score), scaling by maximum and minimum possi-
b e d main scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guidelin  wa  su mari ed and prese ted usi g su mary statistics (mean). Mean 
scores of th  domains were compar d, and the highest and lowest scores were identified. 
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2.2. ompariso  of Conte t of Selected Clinical Guidelines for Managing T2DM 
The conte  of th  clinic l guidelines as compared based on the following topics by 
usin  a previous y piloted data extraction f rm: blood glucose management; body weight 
sess  and management; bl od pressure measurem nt and management; blood li-
pid mea urement nd anageme t; T2DM-associ te  complications assessment and 
m nag m nt; nd other healthc re-related ssues and a vice. Each gui eline was read 
sev ral ti s to identify topics/subt pics and related recommend tions. A full star “
” was assig ed o top cs/subtopics ith adequate inform tion. A half-star “ ” was 
assign to top c /subtopics ith limited information. “NR” was assigned to topics/sub-
t pics that are n t reported i  th  guideline. Two independent reviewers (AN and GY) 
were inv lved in the proc ss, a d disa reement were resolved through discussion or 
with a third reviewer (KC). 
2.3. Compariso  of Qua ty of Selected Clinical Guidelines for Managing T2DM 
Th  qu lity of the clinic l guid lines was assessed independently by two reviewers 
(AN nd GY) using the Appr isal of Guidelines for ese rch and Evaluation II (AGREE 
II) tool, which s  standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 it ms separat d into x dom ins ((i) scope and purpos ; (ii) stakeholder involve-
ment; (i ) rigour of developme t; iv l r ty of presentation; (v) applicability; and (vi) 
editorial independ nce) and two global rating items ((i) overall quality score and (ii) rec-
mm nd tion for use in practic ) [10]. Each item within the AGREE II tool was rated on a 
s ven-point scale (from 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
scor  wer calculat d f  each app aiser by using the average rating (1 (strongly disagree) 
to 7 (str ngly agre ))  all items in e ch domai . Scaled per entages for each domain 
were then calculated for inte -domain co parison by summing the appraisal ratings of 
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clude g id lines w s summ rised nd presented using sum ary statistics (mean). Mean 
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2.2. Comparis n of Co tent of Selected Clinical Guid ines f r Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extrac on form: blood glucose management; body weight 
assessment and an ge ent; blo d re sure mea urement and management; blood li-
pids measurement and management; T2DM-associated complic s assessment nd 
management; and other healthcare- lated issues and advice. Each guid lin  was r ad 
several times to identify topics/subtopics a d related rec mmendations. A full st r “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited in ormation. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guideli es for Manag ng T2DM 
The quality of the clinical gui lines was assessed in ependently by t o reviewers 
(AN and GY) using th  Appraisal of Guidelines for Rese rch and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) sco e and purpo e; (ii) st k holder involve-
ment; (iii) rigour f development; (iv) clarity of presentation; (v) applicability; a d (vi)
editorial independ nce) a d two global rating items ((i) overall qualit  score and (ii) rec-
ommendation for use in practice) [10]. Each tem within the AGREE II tool s rated o  a
seven-point scale (from 1 = str ngly disagree to 7 = strongly agree). Average appraisa
scores were calculated for each appraiser by using the average ra ing (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
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2.2. Comparis n of Co ent f Selected Clinical Gu d ines for Managing T2DM 
The content of the clinical guid lines as compared based on the following topics by 
usi g a previou y piloted data extractio  for : blood glucose m nagement; b dy weight 
assessment and anage ent; blood p ssure measurement and management; l od li-
pids measurement n  management; T2DM-as oci ted complicat on  ass ssment and 
managem nt; and other healthc re-related issues and advice. Each guidelin  was r ad 
sev ral times to identify topics/subt pics a d related recommendations. A full st r “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assign  t topics/subtopics th limited information. “NR” wa  assigned o topics/sub-
topics that r  n t reporte  i  the guideline. Two independent revie ers (AN and GY) 
were involved in th  process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Sel cted Clinic l Guidelines for Managing T2DM 
The quality of the clin cal guidelines as ass ss d in epe ently by two reviewers 
(AN and GY) using the Appr isal of Guid lines for Research and Evaluat on II (AGREE 
II) to l, which is a stand rdised and validated instru t [10]. The AGREE II tool com-
pris s 23 items se rat d int  six dom ins ((i) scope and purpos ; (ii) st kehold r involve-
m nt; (iii) rig ur of d velopment; (iv) larity of pres ntation; (v) pplicability; and (v ) 
editorial ind pendence) and two g obal rating items ((i) over l quality score a d (ii) rec-
ommendation for use in practice) [10]. Each ite  within the AGREE II ool was rated o  a 
seven-point scal  (from 1 = st ongly disagre to 7 = trongly agree). Average appraisal 
score  were c lculated for each appra ser by using the average rating (1 (strongly isagree) 
to 7 (strongly agree)) for all items in e ch do ain. S al d p rc ntages for eac  dom in 
were then c lculated for inter-domain compariso  by summing the appraisal ratings of 
items within a single domain (obtaine score), scaling by maximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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(AN and GY) using the Appraisal of Guidelines for Research nd Evaluat on II (AGREE 
II) ool, which is a standardised and alid ted instrum t [ 0]. The AGREE II tool com-
prises 23 items separ ted into s x d main  ((i) scope and purpos ; (ii) st kehold r involv -
m t; (iii) rigour of develop t; (i ) cla ity of pres tation; (v) pplicability; and (v ) 
editorial independence) and two global ting items ((i) v rall quality score a d (ii) rec-
ommendation for use in pr ctice) [10]. Each item w thin the AGREE II tool as rated o  a
seven-point scal  (from 1 = strongly disa ree t  7 = strongl gree). Average appraisal 
scores w r  calculated for each apprai r by sing the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agre ))  all it m in ach domain. S al d per ntages for eac  dom in 
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cluded guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
Int. J. Environ. Res. Public Health 2021, 18, x FOR PEER REVIEW 3 of 13 
 
 
Tabl  1. Outli e of selected clinical guidelines for managing T2DM. 
 Publishing 
Societies/Organ sations/Associations 
G graphy of the 
Guideline 
Name of he Guideline Last 
Updated 
1 
Caribbean Health Resea ch Council 
(CHRC) d Pa  A erican He lth
Org nization (PAHO) [8] 
Country-specific
(Ca i bean)
Managing diabetes in pri ary care in 
the Caribbean 2006 
2 International Di b tes F d ratio  (IDF) [11] International  
R com dations for managing
2 diabetes in primary care 7
3 
The Royal Austral an College of  
Practiti ners (RACGP) [12] 
Country-specific 
(Australia) 
G neral pr ctice m nagement of typ  
2 diabetes 2016  
4 
Diabetes Canada and Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Canada) 
Diabetes Canada 2018 clinical practice 
guidelines for th prevention and 
management of di betes in Canada 
2018
5 N w Z aland Guidel nes Group (NZGD) [14] 
Coun ry-specific (New 
Z aland)
Guidance o  the management of type 
2 diabetes 2011 11
6 Americ n Diabetes Association (ADA) [15]
Country-specific (United 
Stat s) Standards of medical care in diabetes 
7 N ti nal I s itut  for H alth an  C re 
Exce lence (NICE) [16] 
s e
(Engl nd and W les) 
Type 2 diabetes in adults: 
mana ement 
20
8 Scottish In ercollegiate Guidelines 
Network (SIGN) [17] 
C untry-specific 
(Sc tland) 
Management of diabetes: a national 
clinical guideline 
2017 
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sses ment and n g e ; blo d re sure m a ure ent and m nagement; blood li-
pi s measureme  and anagement; T2DM-associated complic s assessment and 
management; a d othe  healthcare- lated issues  advic . Each guid lin  was r ad
ev r l tim  to identi y topic /subtopics a d rel ted recommendations. A full st r “
” as assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to t p cs/s btopics with limited in ormation. “NR” was assigned to topics/sub-
topics that a  not report d i  th  guideline. Two independent reviewers (AN and GY) 
we e involved in the pr ces , a d disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Com ar on of Quality of Selected Cli ical Gui elines for Managing T2DM 
Th qu lity of th  cli ical gui lines was asse sed in ependentl  by two rev ew rs 
(AN  GY) using th  Appraisal of Guidelines for Rese rch and Evaluation II (AGREE
II) tool, whic  is a standardi ed and validat d instrument [10]. Th AGREE II tool com-
pri  23 it m  separated into s x domains ((i) sco e and purpo e; (ii) st k holder involv -
ment; (i i) rigour f develop nt; ( v) clarity of presentation; (v) pplicability; a d (vi)
edit ial independ nce) a d two global rating tems ((i) overall qualit  score and (ii) rec-
mmendation for use in prac ice) [10]. Each tem within the AGREE II tool w s rated  a
seven-poi t scal (f m 1 = str ngly disagre  to 7 = strongly agre ). Aver ge appraisa
scor s were calcul ted for e ch ppr iser by us ng th  average r ing (1 (strongly disagree)
to 7 ( trongly r e)) for all ite s in e ch domain. Scale percentages for each domain
were then calcul ted for inter-domain comp r son by summing the appraisal ratings of 
it m  within  single do ain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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2.2. Comp r s n of Conte t of Selected Cli i al Gu de ines for Managing T2DM 
Th  content of the clinical guidelines was co pared based on the following topics by 
using a previously pil ted ata xtracti n for : blood glucose anagement; body weight 
asses ment and manag m n ; blood pressure m asure ent and m nagement; blood li-
pids measureme t an  man geme t; T2DM-assoc ated c mpl tio s assessment and 
managemen ; a d othe  h althcare-r l ted issues a  advic . Each guideline was read
v r l ime  to identi y t pic /subtopics a d rel ed r commendations. A full star “
” w s as igned to topics/subtopics with dequate in ormation. A half- tar “ ” as 
assigned to t pics/s btopics with limited inform tion. “NR” was assigned to topics/sub-
topics that  not reported i  the guid lin . Two ind pendent reviewers (AN and GY) 
were involved in the proces , a d disagreem nts were resolved thr ugh discussion or 
ith a third reviewer (KC). 
2.3. C mpar son of Qual ty of S lected Clin cal Gu de ines for Ma aging T2DM 
Th qu ity of th  cli ical guid lines w s asse sed independ ntl  by two rev ew rs 
(AN  GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE
II) ol, whic  is a standardi ed and validat d instrument [10]. Th  AGREE II tool com-
ris  23 it ms sep r ted into six domains ((i) scope and purpose; (ii) stakeholder involv -
m nt; (iii) rigour of develop nt; (iv) clarity of presentation; (v) pplicability; and (vi)
edit rial independ nce) a d tw  global rating tems ((i) v rall quality score and (ii) rec-
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to 7 ( t ongly ree)) for all ite s in e ch do ain. Scale perc ages for each domain
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
items within a singl  do ain (obtained score), scaling by maximum and minimum possi-
b e domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s wa  summarised and presented using su mary statistics (mean). Mean 
scores of th  domains were compared, and the highest and lowest scores were identified. 
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2.2. Compari on of Conte t of Selected Clinical Guidelines for Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted da  extraction form: blood glucose management; body weight 
ssess ent and management; blood pressure measurement and management; blood li-
p ds measurement and management; T2DM-associated complications assessment and 
manag ment; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics and related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
as igned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinical guid lines was assessed independently by two reviewers 
(AN and GY) using the App isal f Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separa ed into s x domains ((i) scope and purpose; (ii) stakeholder involve-
m t; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
ditori l independence) and two lobal rating items ((i) overall quality score and (ii) rec-
mmend tion for use in practice) [10]. Each item within the AGREE II tool was rated on a 
sev n-po nt scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores wer  calcul ed for each appraiser by using the average rating (1 (strongly disagree) 
t  7 (strongly agree)) for all it ms in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
Waist circumference
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were involved in the process, and disagreements were resolve  through iscuss on or 
with a third review r (KC).
2.3. Comparison of Quality of Select d Clinical Guideli es for Manag ng T2DM 
The quality of the clinical guidelines wa  assessed indep ndently by two revi w rs 
(AN and GY) using the Appr isal of Guid lines for Research a d Evaluation II (AGREE 
II) tool, which is a standardised and validated instrum nt [10]. The AGREE II tool com-
prises 23 items separated i to six domains ((i) scope and purpose; (ii) stakeholder involv -
ment; (iii) rigour of development; (iv) clarity of pres ntation; (v) applicability; and (vi) 
editorial independ nce) and tw  global rating items ((i) verall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was r ted on a 
seven-point scale (from 1 = str ngly disagree to 7 = stro gly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
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were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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assigned to topics/subtopics with limited information. “NR” wa  assigned to topics/sub-
topics that are not reported in the guideline. Two indepen ent reviewers (AN and GY) 
were involved in the process, and di agre ents wer resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Cli ical Guidelines for Managing T2DM 
The quality of the cli ical guid lines wa  assessed ind pendently by two revi wers 
(AN and GY) u ing the Appraisal f Guidelines for R earch and Ev luation II (AGREE 
II) tool, which is a standardised and validated in trument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) s ope d pur ose; (ii) stakehold r involve-
ment; (iii) rigour of developme t; (iv) clarity of pr sentatio ; (v) applicability; and (vi) 
editorial independence) d two global r ting it ms ((i) overall qu lity score and (ii) r c-
ommendation for us  in practic ) [10]. Each item within th  AGREE II tool was rated o  a 
seven-point scale (from 1 = strongly disagr e to 7 = trongly agre ). Average ap raisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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The content of the clinical guid lines as comp red based on the following topics by 
using a previous y piloted data extractio  form: blood lucose management; body weight 
assessment a d anagement; blood pr ssur  measurement nd manag ment; blood li-
pids measureme t n  management; T2DM-associ t d complications assessment and 
management; and other healthc re-relat d issues and advice. Each guideline was r ad 
sever l times to identify topics/subtopics a d related recom endati ns. A full st r “
” was assigned to topics/subtopics with a quate informa ion. A half-star “ ” was 
assign  to topics/subtopics ith limited information. “NR” was as gned to to ics/ ub-
topics th t are n t reporte  i  the g id line. Two independent revie ers (AN an GY)
were involved in th  process, and disagreements ere resolve  through isc s on r 
with a third reviewer (KC). 
2.3. Comparison of Quality of Sel ct d Cli ical Guidelines for Ma aging T2DM 
The quality of the clinical guidelines as ss s d i ep ndently by tw  review rs 
(AN and GY) using th  Appr isal of Guidelines for Re arch and Evaluation II (AGREE 
II) tool, which is a standardised a d v lidated instru ent [10]. The AGREE II tool com-
prises 23 items sep rated int  six dom ins ((i) scope and urpose; (ii) stakeh lder involve-
ment; (iii) rig ur of development; (iv) larity of pres ntation; (v) applicability; and (vi) 
editorial independe ce) and two g obal rating items ((i) over ll quality score nd (ii) rec-
ommendat on for use in practic ) [10]. Each item within the AGREE II tool was rated on  
seven-point scale (from 1 = strongly disagre to 7 = trongly agree). Av rage apprais l 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then c lculated for inter-domain compariso  by summing the appraisal ratings of 
items within a single domain (obtaine score), scaling by maximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
Int. J. Environ. Res. Public Health 2021, 18, x FOR PEER REVIEW 3 of 13 
 
 
T bl  1. Outli e of select d clinic l guidelines for m naging T2DM. 
 P blishing 
Societies/Orga isati s/As ociat o s 
Geography of the 
Guid li  
Name of he Guidel ne Last 
Updated 
1
Caribbean Health Research Council 
(CHRC) and Pa  American He lt  
Organization (PAHO) [8] 
Country-specific 
(Ca ibbean) 
Ma aging diabet s in pri ary care in 
the Caribbean 2006 
2 Int rnation l Di betes F d tion (IDF) [11] Intern tional  
R commendati ns for managing
2 diabet s in prim ry care 7
3 
The Royal Australian Col ge of Gener l 
Practitio ers (RAC P) [1 ]
ountry-specific 
(Austr lia) 
Ge eral pr ctice man g ment of typ  
2 diabet s 2016  
4 
Diabetes Canada nd Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Ca da) 
D  C n d 2018 clinical pr ctic  
guid li es f r the prevention and 
management of iab tes in Canada 
2018
5 New Zealand G idelines Gr p (NZGD) [14] 
Country-s cific (New 
Zealand) 
Guida ce on the management of t pe 
2 diabet s 2011 11 
6 American Diabetes ss ciation (ADA) [15] 
Cou try-specif c (Unite  
States) Stand ds of medical care in diabetes  
7 Nati nal Ins itute for H alth and Care 
Exc llence (NICE) [16] (England and Wales) 
Type 2 d abet in adults: 
mana eme t 
20
8 S ottish Int rcollegiate Guideli es 
Netw rk (SIGN) [17] 
Country-spec fic
(Scotland) 
Mana em n  f d betes: a national 
clinical guideline 
2017 
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ith a thi d review r (KC). 
2.3. Comp riso  of Qual ty of S l ct d Clinical Gu delin s for Managi g T2DM 
The qu ity of the clinical uid lines was ses d i epend ntly by two r viewers 
(AN and GY) using th  Appr isal of Guidelines for R s arch nd Evaluation II (AGREE 
II) ool, which is a standardised and validated instrument [10]. The AGREE II t ol com-
rises 23 items epar ted into s x d mains ((i) s ope nd purpos ; (ii) stakeh lder inv lve-
m nt; (iii) rigour of develop e t; (i ) clarity of pre ntation; (v) applicability; and (vi) 
editorial ind p dence) and two global rating items ((i) v r ll quality score and (ii) rec-
ommendatio  for use in pr ctice) [10]. Each it m within the AGREE II tool as rated on  
seven-point scal  (from 1 = strongly disa r e to 7 = strongly gree). Average appraisal 
scores w r  calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree))  all items in each domain. Scaled percentages for each domain 
w re the  calculated for nte -domain co parison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maxi um and mini um possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comparis n of Content of Selected Clinic l Guide ines f r Managing T2DM 
The content of the clinical guidelines was compared based on the follo ing topics by 
using a previously piloted data extraction form: blood glucose management; body weight 
assessment and management; blood pressure mea urement and manag ment; b od li-
pids measurement and management; T2DM-associated complications assess ent and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics a d elated rec mme dations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited inf rmati n. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent revi wers (AN and GY) 
were involved in the process, and disagreements were esolve  through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guideli es for Manag  T2DM 
The quality of the clinical guidelines was assessed independe tly by two revi wers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrum nt [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakehold r involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each do ain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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were involv d i  the process, and disagreem nts were resolved thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comparison of Qu l ty of S lect d Clinical Guideli s for Manag g T2DM 
The qu ity of the clinical guid lines was assessed independe tly by two revi wers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ool, which is a standardised and valid ted instru ent [10]. The AGREE II tool com-
rises 23 items separ ted into six domains ((i) scope and purpo e; (ii) stakeholder involve-
ment; (iii) rigour of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) v rall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
scores w re calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree)) for all ite s in each domain. Scaled percentages for each do ain 
w re the  calculate  for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by aximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR NR NR
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.3. C mpari on of Quality f Select d Clinical Guidelin s for Managi  T2DM 
The quality of the clinical guideline  was assessed ind penden ly by two reviewers 
(AN nd GY) using the Appr isal f Guidelines for Res arch and Evaluation II (AGREE 
II) tool, which is a stand r ised a d validated instrument [10]. Th  AGREE II tool com-
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scores of the domains were compared, and the highest and lowest scores were identified. 
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using a previou y pilo ed data extraction form: blood glucose nagement; body weight 
ssessm nt an  managemen ; blood pressur  measurement and management; blood li-
pids measurement nd manag me t; T2DM-associ te com lications assessment and 
management; and other ealthc re-related i sues and advice. Each guideline was read 
everal t mes to identify topics/subt pic  and related recommendations. A full star “
” was ssigned o t pics/s btopic  with adequate information. A h lf-star “ ” was 
assign to t pics/subtopics ith limited informati n. “NR” was assigned to topics/sub-
topics th t are n t reported i  th  guideline. Two independent reviewers (AN and GY) 
ere involved in the process, and disa re ment  ere resolve  through discussion or 
with a third reviewer (KC). 
2.3. Comparis of Qu lity of Sel cted Clinical Guidelines for Managing T2DM
Th  qu lity of the cli ical guidelines was assessed independently by tw  reviewers 
(AN nd GY) using the Appr isal of Guidelines for esearch and Ev luation II (AGREE 
II) tool, whi h s a standardised and valid ted instru ent [10]. The AGREE II t ol com-
pri es 23 items s parated into ix dom ins ((i) scope and purpos ; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) lar ty f presentation; (v) applicability; nd (vi) 
editorial independence) and two global rating items ((i) overall qual ty score and (i ) rec-
ommendati n for use in practice) [10]. Each item within the AGREE II tool was rated on a
seven-point scale (fro  1 = strongly disagre  to 7 = trongly agree). Average appraisal 
score  we  calculated fo  each appraiser by usi g t  average rating (1 ( rongly disagre ) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtaine  score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude guid lines was summarised nd presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
Bariatric/metabolic
urgery f NR
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2.2. Comparis n of Conte t f Selected Clini l Guide ines for Managing T2DM 
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assessment an  managemen ; blood pressur  measurement an  management; blood li-
pids measurement and manag me t; T2DM- ssociated com lic tions assessment a  
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everal times to identify topics/subtopics a d related recommendation . A full star “
” was assigned to t pics/s btopics with adequate information. A h lf-star “ ” was 
assigned to topics/subtopics with limit d information. “NR” w s assigned to t pics/sub-
topics that are not reported in the guidelin . Two inde end nt reviewers (AN and GY) 
were involved in the process, and disagreements w re r solved throu h discussion or 
with a third reviewer (KC). 
2.3. Comparison of Qu lity of S lect d Clinical Guidelines for Managi g T2DM 
The quality of the clinical guidelines wa assessed indep ently by t reviewe s
(AN and GY) using the Appraisal of Guidelin s for Rese rch and Ev lu tio  II (AGREE 
II) tool, which is a stand rdised and valid ted instrument [10]. Th  AGREE II t ol com-
prises 23 items separated into six domains ((i) scope and purpo ; (ii) stakeholder involv -
ment; (iii) rigour of develop ent; (iv) clar ty f presentation; (v) applic bility; nd (vi) 
editorial independence) and two global rating items ((i) overall qual ty core and (i ) rec-
ommendati n for use in practice) [10]. Each item within the AGREE II t ol s rated on a
seven-point scale (from 1 = strongly disagree to 7 = strongly a ree). Average appraisal 
scores we  calculated for each appraiser by usi g t  average rating (1 ( rongly disagre ) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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The conte t of th  clin al guid lines was co pared based on the following topics by 
using a previously piloted dat  extr ctio  f r : blood gluco e manag m nt; body weight 
sse s t and m n ge ent; blood press r  measurement nd man gement; blood li-
pi s m asur m nt and a agement; T2DM-associat d complications assessment and 
anagem t; and ther h lthcar -related issues an  advic . Each guideline was read 
everal times to identify topics/subtopics a d r lated rec mmendations. A full star “
” as assig ed to topics/subtopics with adequate information. A half-star “ ” was 
assigned t  topics/subtopics with limit d inf rmation. “NR” w s assigned to topics/sub-
topics that are not reported i  the guideline. Two inde ndent reviewers (AN and GY) 
w re involved i  the proc ss, nd isagreements were r sol d through dis ussion or 
with  third reviewer (KC). 
.3. Comparison of Quality f Selected Cli ical Guidelines for Managing T2DM 
The quality of h cli ic l guid lin s wa  assessed independently by two reviewers 
(AN an  GY) using t e Appr isal of Gui eli s for Re a ch and Evaluat on II (AGREE 
II) tool, which is a stand rdised and validat d i strument [10]. Th AGREE II tool com-
prises 23 it ms separated to six domains ((i) sco e and purpose; (ii) stakehol er involve-
ment; ( i ) rigour of development; (iv) clarity of presentation; (v) applicability; nd (vi) 
editori  independence) and two global rating items ((i) overall quality sc re and (ii) r c-
omm ndation for use in practice) [10]. E ch item within the AGREE II tool was rated on a 
s ven-point scal  (from 1 = strongly disagree to 7 = strongly agree). Aver ge appraisal 
score  were calculated for each appraiser by using th  average rating (1 (s rongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then c lculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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pi s measurem nt and gement; T2DM-associated complicatio s assessment and 
manage ; and her h althcar -rel ted issue  and advice. Each guideline was read 
veral ime  to identify t pics/subtopics and rel ed r commendations. A full star “
” was as gned to topic /subtopics with dequate in ormation. A half- tar “ ” as 
ssigned t  topics/subtopics wit  limit d inform tion. “NR” was assigned to topics/sub-
topics that are not reported i the guidelin . Two ind pendent reviewers (AN and GY) 
w e involved in the process, nd is reem nts were resolved thr ugh discussion or 
it  a third reviewer (KC). 
2.3. Comparison of Qual ty of S lected Clinical Gu de ines for Ma aging T2DM 
The qu ity of the cl ical guid lin s wa  as ssed independ ntly by two reviewers 
(AN nd GY) using he Appraisal of Gui lines for Research and Evaluation II (AGREE 
II) ool, which is a stand rdis d and v lida ed i strument [10]. The AGREE II tool com-
rise  23 items separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of develop e t; (iv) cl rity of p esentation; (v) applic bility; and (vi) 
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w re the  calculated for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. omp ris n of Conte t of Selected Clinical Guide in s for Managing T2DM 
Th co tent f th  cli ic l guidelines as compared based on the following topics by 
u ing a previous y piloted data extraction f rm: blood glucose managem nt; body weight 
assessm t a d m ageme t; blood pre sure m asurem nt and management; blood li-
pi s measurement nd anagement; T2DM-associ te  complications assessment and 
ma ag ment; and other healt c r -related ssues and a vice. Each gui eline was read 
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” was as igne  o top cs/subtopic w th adeq at  form tion. A alf-star “ ” was 
assign  t p cs/subtopics ith l mited inform tion. “NR” was assigned to topics/sub-
t pics that are n t reported i  th  guidelin . Two inde endent reviewers (AN and GY) 
ere i v lve  in th  pr c ss, a d disa reement were resolved through dis ussion or 
with a th rd rev ew r (KC). 
2.3. Compariso  o  Qua ty of Selected Clinical Guidelines for Managi  T2DM 
Th  qu lity of the clinic l guidelines w s assessed indep ndently by two reviewers 
(AN and GY) using th  Appr is l of Guid lines for ese rch and Evaluation II (AGREE 
II) tool, whic s  s andar ised and validated instru e t [10]. The AGREE II tool com-
prises 23 items separated into ix dom ins ((i) scop  and purpos ; (ii) stakehol er i volve-
ment; (iii) rigour of development; (iv) l r ty of pr sentation; (v) applicability; and (vi) 
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were then calculated for inter-domain co parison by summing the appraisal ratings of 
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ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
clude g id lines w s summarised nd presented using sum ary statistics (mean). Mean 
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2.2. Comparison of Co tent of Selected Clinical Guid lin s for Manag ng T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: blood glucose m nag me t; b dy g t 
assess ent and an ge ent; bl od pressure meas rement n man g ; blo d li-
pids measurement and management; T2DM-associated compl cations ass ssm n  and 
management; and other healthcare-related issues and a vi . Each guid li e was read 
several times to identify topics/subtopic  and related recomme dations. A full st r “
” was assigned to topics/subtopics with ad quate information. A half- ta  “ ” w s 
assigned to topics/subtopics with limited information. “NR” was ssigned to t pics/sub-
topics that are not reported in the guid lin . Two indepen ent reviewers (AN and GY) 
were involved in the process, and disagreements were r solve  thr ugh iscussi n r 
with a third reviewer (KC). 
2.3. Comparison of Quality of Select d Clini al Guidelines for Managin T2DM 
The quality of the clinical guidelines was assessed in ep ndently by two reviewers 
(AN and GY) using the Appraisal of Guid lines for R search and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) an  two global rating items ((i) overall quality score an  (ii) r c-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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ment; (iii) rigour of development; (iv) clarity of pr sentation; (v) applicability; and (vi) 
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ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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6 merican D abetes Associati  (ADA) [15] 
C u try-sp cif c (Unite  
States) Stan ards of medical care in diabetes 2020 
7 National Institute fo  Health a d Care 
xcellence (NICE) [16] 
Country-spec fic 
(E l d and W l s) 
Ty e 2 iabet i  adults: 
ma ag ent 
2020 
8 Scottish Intercollegiat  Guidelines 
Netw rk (SIGN) [17] 
Country- pecific
(Scotlan ) 
Manag m nt of di be es: a national 
clinical gui elin  
2017 
2.2. Comparison of Co e t f Selected Cli ical Guid lines for Managing T2DM 
The content of the clinic l guid l nes as c mpared based on t e foll wing opics by 
using a previ us y piloted data xtractio  f r : bloo  glucose management; body weight 
ass ss ent an  man geme t; bl od pr ssur  m asur ment n manageme t; bl od li-
pids m asurem nt n manage ent; T2DM-ass c t d c mplications assessment and 
manag ment; and other healthc re-relat  issues and a vice. E ch guideline was read 
several times t  identify topics/sub pics and related re ommendations. A full sta  “
” was a signed to topic /subt pics with ad quat  information. A h lf-star “ ” was 
a sign  to topics/sub opics ith mited f rmati n “NR” was s gned t  top cs/sub-
t pics that r  t report  i  the guideli e. Two indep ndent ev e ers (AN nd GY) 
were inv lved i th  proce s, and disag men s ere esolv d thro gh discu sion or
with a thir  reviewer (KC). 
2.3. Compari on of Quality f Sel cted Clinic l Guidelines for Man gi g T2DM 
The quality of the clinical guidelines s ass ss d independently by t o reviewers 
(AN nd GY) u ing the Appr i al of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is  standardised and validated instru ent [10]. The AGREE II to l com-
prises 23 it m  sep rated i t ix dom ins ((i) scope and purpose; (ii) stakeh lder involve-
ment; (iii) rig ur of development; (iv) l rity of pres ntation; (v) applicability; and (vi) 
e itorial i ependence) and two g obal rati  ite s ((i) over ll quality score d (ii) rec-
mmendat on for use in prac ice) [10]. Each it m within the AGREE II tool was r te  on a 
seven-point cale (from 1 = strongly disagre to 7 = trongly agree). Average appraisal 
scor s were alculated for each appraiser by using the ave age rating (1 (strongly disagree) 
to 7 (strong y agree)) for all items in e ch do ain. Scaled percentages for each domain 
were then c lculated for inter-domain co pariso  by summing he appraisal ratings of 
tems within a single do ain (obta e score), scaling by aximum and mini um possi-
ble domain scor s, and by conv rting to a percentage [10]. The verall quality of all in-
clude  guidelines w s summarised and presented using sum ary statistics (mean). Mean 
score  of the dom ins were compared, the highest and lowest scores were identified. 
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 Publishi g 
S cieties/Organisati ns/Ass ciatio s 
Geography of the 
Guideline 
Name of the Guidel ne La t 
Updated 
1
Caribbean Health earch Council 
(CHRC) and Pan American Healt  
Organization (PAHO) [8] 
Country-specific 
(Carib ean) 
Ma aging diabet s in primary care in 
th  Caribbean 2006 
2 I ternation l Diabetes F d r tion (IDF) [11] International  
R comm ndati ns for managing typ  
2 diabet s in primary care 2017 
3 
The Royal Australian Col ege of Gen r l 
Practitioners (RACGP) [1 ]
ountry-specifi  
(Australia) 
Ge ral practice management of type 
2 diabet  2016  
4 
Diabetes Canada nd Canadian Di betes 
Association (CDA) [13]  
Country- pecific 
(Can da) 
Di betes C nad  2018 clinical practice 
guid li es for th  prevention and 
man gement of iabetes in Canada 
2018
5 New Z ala d Guideli es Gr p (NZGD) [14] 
Country-s cific (New
Zealand) 
Guida ce o the m nag t of t pe 
2 i b tes 2011 2011 
6 merican Diab tes ssociation (ADA) [15] 
C u try-specif c (Unite  
States) Stand ds of me ical care in diabetes 2020 
7 National Institute for Health and Care 
Exc llence (NICE [16] 
Country-spec fic
(Engl  an  Wales) 
Ty  2 iabet i  adults: 
anag ment 
2020 
8 S ottish Int rcollegiat  Guideli s 
Netw rk (SIGN) [17] 
Country-spec fic
(Scotland) 
Managemen  of d abetes: a national 
clin cal guideline 
2017 
2.2. Comp rison of Content f Selected Cli ic l Gu d lines for Managin  T2DM 
T e conte t of the clinical gu d l nes a c m ed based on t e followi g opics by 
usi  a previous  pil te ta extr ctio  for : bloo  glucose man gemen ; body weight 
sess ent an  an ge e t; bl d pr ssure measureme t nd manage e t; blo d li-
p ds measurement man gement; T2DM- ssoci t d complica io s ass sment and 
manag men ; a  other he lthc re-rel t d issu s and advice. E ch u deline was re d 
s veral i  t ide tify topic /subtopics and rel ed r comme d tion . A full sta  “
” wa  as g ed to topic /subt pi s ith d qu te in ormation. A half- tar “ ” wa  
assign  to t pic /subtopics i h i ited form ti n. “NR” w s assigned to topics/sub-
topics that re t report  i  the guid lin . Two i d p nd nt rev e ers (AN nd GY) 
were involved in th  proce s, and disagre m nts er resolved thr gh discuss  or
i h a thir  reviewer (KC).
2.3. Comp ri o  of Qual ty of Sel cted Cl nical Gu in s for Man gi g T2DM 
The qu ity of the clinical guid li es as ass ss d in pend ntly by t o reviewers 
(AN and GY) using the Appr isal of Guidelines for Research and Evaluation II (AGREE 
II) ool, which is a standardised and validated instru e t [10]. The AGREE II tool com-
rises 23 it ms sep r ted int  s x d ains ((i) scope and purpose; (ii) stakeholder involve-
m t; (iii) rig ur of developme t; (i ) larity of present tio ; (v) applicability; and (vi) 
editorial inde endence) an  two g obal rating ite s ((i) v rall quality score and (ii) rec-
om endat on for use in pr ctice) [10]. Ea h item within the AGREE II tool as rated on a 
seven-point scal  (from 1 = strongly disa re to 7 = trongly gree). Average appraisal 
scores w r  calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree))  all items in each domain. Scaled percentages for each domain 
w re the  c lculated for nte -domain co pariso  by summing the appraisal ratings of 
items within a singl do ain (obtaine score), scaling by maxi um and mini um possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
clude  guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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1 
Caribbe n Health Research Cou cil 
(CHRC) and Pan A erica  Health 
Organization (PAHO) [8] 
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un ry-specific 
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G eral practice management of type 
2 di betes 2016  
4 
Diabet s C ad  d Ca adian Di bet  
Associat o  (CDA) [13]  
Country-specific 
(Canada) 
Diabetes C nada 2018 clinical practice 
guidelines for the reventio  and 
gement of di betes in Can d  
2018 
5 N w Zealand Guidel ne  Gr p (NZGD) [14]
C untry-specific (New
Zealand) 
Guidan e on he man ge ent f type 
2 di b tes 2011 2011
6 A erican Di betes Associ tion (ADA) [15] 
Co try-spe ific (Unit d 
States) St dards of edical car  in diab tes 2020 
7 N tio l Institute for He lth and Care
Exc l e ce (NICE) [16] 
Country-specific 
(E gland and Wales) 
Type 2 diab es in adults: 
ma ageme t 
2020 
8 Sco tish Int rcollegiate Guideli s
Netw rk (SIGN) [17] 
C untry-sp cific 
(Scotland) 
Mana emen  f diabe es: a national 
clinical guideline 
2017 
2. . Compariso  of Conte  of Sel cted Cl ical Guidelines for Managing T2DM 
The co e  f th  clinical gu l nes was c mpared based n t e following opics by 
usin  a previously pi te  d t  extractio for : bloo  glucose mana em nt; body weight 
s ent a d man ge e t; bl od r sur  m a urement nd management; blood li-
id  mea urement a d man geme t; T2DM-associate complications assessment and 
man ment; d other h alth are-r l ted issu s an  dvice. Each guideline was read 
s v ral ti t  i tify topics/subtopics and r lat d recommendations. A full sta  “
” was sig e to t ics/subt pic  w th adeq at formation. A alf- ta  “ ” was 
a s gned  topic /subtopics with ited f rm ti n. “NR” was signed to topics/sub-
top cs that are ot r ort in the uid lin . Two inde endent rev ew rs (AN nd GY) 
were involv d n th  p ces , nd disagre e ts were resolve  thr gh s ussion or
ith a th r  rev ew r (KC).
2.3. Compari o of Quality of Sel c ed Clinical Guidelines or Man gi  T2DM 
The quality of the clinical guid lines was assessed in ep nd ntly by two reviewers 
(AN d GY) using the Apprais l of Guidelines for Research and Evaluation II (AGREE 
II) to l, whic  is a sta ar ised nd validated instrume t [10]. The AGREE II tool com-
rises 23 ems separ t d i to s x domains ((i) scop  and purpose; (ii) stakehol er i volve-
ment; (ii ) rigou of developme t; iv clarity of pr sentation (v) applicability; and (vi) 
editori l i depen nc ) nd two global ati g items ((i) verall quality score and (ii) rec-
ommend io for use in practic ) [10]. E ch item within t  AGREE II tool was rat d on a 
seven-point scale (from 1 = s rongly dis ree to 7 = stron ly agree). Average appraisal 
scor s w re calcul t d f r ach app is  by using th  avera e ratin  (1 (strongly disagree) 
to 7 (st ongly agre )) all items in each domain. Scaled percentages for each do ain 
were the  calculated f r inte -domain co parison by summing the appraisal ratings of 
tems within a si le doma n (obt ined score), scaling by maxi um and mini um possi-
ble d ma n scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidel ne was summ ri ed and presented us g u mary statistics (mean). Mean 
scores of t e domains were compar , and th  high st and low st scores were identified. 
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 Publishing 
S cieties/Org sations/Associat ons 
G graphy of the 
Guideline 
Nam of he Guideline Last 
Updated 
1 
Caribbean Health Resea ch Council 
(CHRC) nd Pa A erican He lth
Organization (PAHO) [8] 
Country-specific
(Ca i be n) 
Managing diabetes in primary care in 
he Caribbe n 2006 
2 International Di betes F deration (IDF) [11] International  
R co mendati ns for man ging
2 diabetes in primary care 
3 
The R yal Australi  College of  
Practiti ners (RAC P) [12] 
Country-specifi  
(Australia) 
General pr ctice manag ment of typ  
2 di betes 2016  
4 
Diabetes Canada and Ca adian Diabet  
Associatio  (C A) [13]  
C untry-specific
(Canad ) 
Diabetes Canada 2018 clinical practice 
guid lines for the prevention and 
management of di betes in Canada 
2018
5 New Z la d G idelines Group ( ZGD) [14] 
Cou ry-specific (New 
Z aland)
Guid nce o  the manageme  of type 
2 diabete 2011 11 
6 Ameri n Diabetes Association (A A) [15]
C untry-specific (United 
States) Standards of m dical care in diabetes  
7 N ti na  Ins itut  for H alth and Care 
Exce l nce (NICE) [16] (Engl nd an  Wales) 
Type 2 diabetes in adults: 
mana ement 
20
8 S t ish I rcollegiate Guid lines 
Network (SIGN) [17] 
C untry-sp c fic 
(Sc tland) 
M nagement f d betes: a ational
clinical guid line 
2017 
2.2. Comp r s  of tent of Sel cte  Clinic l Guid i es for M ing T2DM
Th content f th  clinic l guide ines w s co p red b sed n the following topics by 
us ng pr viously p loted a a x racti n f r : blo d glucos  mana ement; body weight 
ess  an  an g e t; bl od r ssure me re ent n  managem t; blood li-
pi s measureme  and anagement; T2DM-associated compl cations assessment and 
managem nt; nd other healthc re-r la ed issues nd advice. Each gu deline was read 
evera tim s to identi y top cs/subto ics d related recommendat ons. A ful st r “
” as igned to to ics/ ubtopic  wi  adequate inform tion. A half-sta  “ ” was 
a sign d to to cs/subtopics with limited inf mation. “NR” was sig ed to topics/sub-
opics h t a  t rep rt d i  th  guideline. Tw  independ nt reviewers (AN nd GY) 
we e volved the p cess, a d disagree en s were resolve  hrough discussion or 
ith  thir  revi w r (KC).
.3. Comp r son f Quality of Selec e Cli c l Guid lines for Managin  T2DM
Th  qu lity of th  clinic l g idelines was assessed in ep ndently by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluatio  II (AGREE 
II) tool, whic is a st n rdised and validated instrument [10]. The AGREE II tool com-
prises 23 it s separated into s x dom ins ((i) scope and purpose; (ii) stakeholder involve-
ment; ( ) rigour of development; ( v) clarity of pr sentat on; (v) applicability; and (vi) 
edit i l independence) two global rati g ite s ((i) overall quality score and (ii) rec-
mmend tion for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly disagree to 7 = stron ly agree). Average appraisal 
scores were c lcul ted for e ch ppr iser by us g th  avera e ratin  (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each domain 
were then c lcul ted f r inter-domain co p r son by summing the appraisal ratings of 
it m  within single domain (obtained score), scali g by axi um and mini um possi-
ble domain sco es, and by con ting to a p rcentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using u mary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and low s  scores were identified. 
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1
Caribbean Health Research Council 
(C RC) a d Pa  American Heal h 
Org nization ( AHO) [8] 
Country-specific 
(Ca i be n) 
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5 New Z la Guidelines Gr p (NZGD) [14] 
Cou ry-specific (New 
Zealand) 
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2 diabet s 2011 11
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States) Stand ds f medical care in diabetes 
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mana ement 
20
8 Sc t ish In rcollegiate Guideli es 
Ne work (SIGN) [17] 
C unt y-specific 
(Scotl nd) 
Manageme t f diabetes: a national
l ical g i eline
2017 
2.2. Comp r s n of Conte t of Selected Clini al Gu de ines for Manag g T2DM 
Th conte t of the clinical guidelines was co pared based on the following topics by 
usi g a p v ously pilote  ata x racti n f r : blood glucose anagement; body weight 
a sess ent an  an g me t; bl od press re measurement nd management; blood li-
pi s measureme t and an gement; T2DM-associ ted complicatio s assessment and 
managemen ; other h alth re-rel ted issues nd a vice. Each guideline was read 
v ral im  to identi y topics/subto ics d rel ed r commendations. A full star “
” w s assigned to topics/ ubtopics with dequate in ormatio . A half- tar “ ” as 
assigne t  to ics/sub opics with limi d in m tion. “NR” w s assigned to topics/sub-
topics that  not reported i  the u d line. Two ind pendent reviewers (AN and GY) 
we e i olved in th proces , d dis gr e nts w re resolved thr ugh discussion or 
ith  third revi w r (KC). 
2.3. C mp r son of Qu l ty of Select  Clin cal Gu de ines for Ma gi g T2DM
Th  qu ity of the clinical guid lines was assessed independ ntly by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ol, whic  is a sta dardised a d validated instrument [10]. The AGREE II tool com-
rises 23 it ms separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (ii ) rigou  of develop ent; (iv) cl rity of presentation; (v) applicability; and (vi) 
edit rial independ nce) and two global ati g items ((i) v rall quality score and (ii) rec-
mendation f r use in pr c ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = st ongly dis ree to 7 = strongly gree). Average appraisal 
sco es w re calculated for each pprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly ree)) for all ite s in each domain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
item  within a s l  domain (obt ined score), scaling by maximum and minimum possi-
b e d main scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guidelin  wa  su mari ed and prese ted usi g su mary statistics (mean). Mean 
scores of th  domains were compar d, and the highest and lowest scores were identified. 
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Type 2 diabetes in adults: 
mana ement 
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8 Sco tish I ercol gi te Guideli es 
Netw rk (SIGN) [17] 
Country-spec fic 
(S tland) 
Manag ment of di betes: a n ti al
clinical guideline 
2017 
2.2. om aris  of Cont f Selected Clinical Guid in s for Managing T2DM 
The con e of th  clinic l guidelines as compared based on the following topics by 
usin  a previous y pilot d data extraction f r : blood glucose management; body weight 
ss  an  man geme t; bl od pressure measurem nt nd management; blood li-
pid measureme t  man geme t; T2DM-associ te  complications assessment and 
m nag m nt; nd other healthc re-related ssues nd a vice. Each gui eline was read 
sev ral ti  to id tify topics/subt pics a d rel ted recommend tions. A full star “
” was assig ed o top cs/subt pics w th ad quate inf rm tion. A half-star “ ” was 
assign to top c /subtopics ith li ited information. “NR” w s assigned to topics/sub-
t p cs that are not report d i  th  guidelin . Two ind pendent r viewers (AN and GY) 
were inv lved n the roc ss, a d disa reement ere resolve  through discussion or 
with  hird rev ew r (KC).
2.3. Compari o o  Qu ty of Sel ct d Cli ical Guidelines for Man ging T2DM 
Th  qu lity of the clinic l guid lines was assessed independently by two reviewers 
(AN d GY) using the Appr isal of Guidelines for ese rch and Evaluation II (AGREE 
II) to l, which s  standardised nd validated instru ent [10]. The AGREE II tool com-
prises 23 it ms separat d i to x dom ins ((i) scope and purpos ; (ii) stakeholder involve-
ment; (i ) rigour of developme t; iv l r ty of presentation; (v) applicability; and (vi) 
editorial i depend nce) nd two global rati g items ((i) overall quality score and (ii) rec-
mm nd tio  for use in practic ) [10]. Each item within the AGREE II tool was rated on a 
s ven-point scale (from 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
scor  wer calculat d f  each app aiser by using the average rating (1 (strongly disagree) 
to 7 (str ngly agre ))  all items in e ch domai . Scaled per entages for each domain 
were then calculated for inte -domain co parison by summing the appraisal ratings of 
tems within a single domain (obt i e  score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
clude g id lines w s summ rised nd presented using sum ary statistics (mean). Mean 
score of the dom ins were compar , and the highest and lowest scor s were identified. 
Antihyperte sive
tr atment
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man g ment
2020 
8 Scottish Intercollegiate Gu delines 
Network (SIGN) [17] 
Country-specific 
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Man gemen  f diabe es:  na ional
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2017 
2.2. Compari on f Content f Selected Clinical Guidelines for M ag T2DM 
The c ntent of the clinical guideli s was c mpared ba d n the foll wi g topics by
using a reviously piloted data extracti n form: blood glucos  anage en ; b dy we ght 
assessment and managem nt; bloo p ssure measur me t and anagement; bl d li-
pids measu ement and manageme t; T2DM-associated complication  a essment an  
manag m nt; and other ealthcare-related iss es an  advice. Each guideline as read 
several times to e tify to ics/subtopi s an  rel e  r c menda ons. A full tar “
” as assigned to topics/sub pics t adeq t  information. A h lf-st r “ ” as 
assigned to t pics/subt pics with limited info matio . “NR” was a sig ed to topics/sub-
topics that are ot re orted i  the gu eline. Two n ep dent r iew s (AN a d GY)
were involv d in the pr cess, d disagre e ts were r so ved t rough di cussion or
ith a third reviewer (KC . 
2.3. Comparison of Quality of Sel cted Clinical Gui elines for Ma ging T2DM 
The quality f t e cli ical guidelines was assessed ind pen e tly by two rev e ers 
(AN a d GY) usi g the Apprai al of Guidelines  Rese rch and Evaluat on II (AGREE 
II) tool, which is a standardise  nd validat d instrument [10]. The AGREE II tool com-
prises 23 items separated into six do ains ((i) scope and purpose; (ii) st keh lder inv lve-
ment; (iii) rigour of develop ent; (iv clar y of prese tat on; (v) applicability; and (v  
editorial independe e) and tw  global rati g ite s ((i) o rall quality sc r  d (ii) rec-
omm ndation for use in practice) [10]. Each item within the AGREE II tool wa r ted o  a 
seven-p int scale (from 1 = strongl  disagre  o 7 = strongly agre ). Averag  appraisal 
scores were calculate  for each ap raiser by si  the average rating (1 (strongly disagree) 
to 7 (str ngly agree)) for all items in each domai . Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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6 American Diab tes Association (ADA) [15] 
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Excellence (NICE) [16] (England and Wales) 
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ana ment 
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8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-spec fic 
(Sc tla d) 
Management of diabe es: a n ti al
cli ical g i li e 
2017 
2.2. Com aris n of Conte f Selected Clini al Guide ines f r Managing T2DM 
The cont nt of the linical gui elines wa  co pared based  the llowin  t pic by 
using a previously piloted data extraction form: blood glucose anagement; body weight 
assessment and management; blood pressur  m as rement and management; blo d li-
pids measurement and management; T2DM-associated co plications assessment and 
management; and other healthcare-related issues nd advice. Each guideline was read 
everal times to identify topics/subtopics a d related rec mmendation . A full star “
” was assigned to topics/subtopics with adequate inf r ation. A half-star “ ” was 
assigned to topics/subtopics ith li ited infor ation. “NR” w s assigned to topics/sub-
topics that are not report d in the guideline. Two indep ndent r viewers (AN and GY) 
were involved in the process, and disagreements were resolve  through discussion or 
ith a third reviewer (KC). 
2.3. Compari on of Qu lity of S lected Clinical Guideli es for Man g ng T2DM 
The qu ty of the clinic l guidelines was as esse  indep ntly by two vi wers
(AN and GY) u ing the Appraisal f Gui elin  for R earc  and Evaluati n II (AGREE
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculate  for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comparison of Co e t f Sel cted Clinical Gu in fo  Man ging T2DM 
The c nt nt of the clinic l gui lines w s c mpared b sed o  th  fo lowi g topi s by 
using a previously piloted data extraction f r : blood glucose manage ent; body weight 
assess ent an  an ge e t; bl od pressure measure ent n  manageme t; bl od li-
pids measurem nt and anagement; T2DM-assoc ated complications assessment and 
manag ment; and other healthcare-relat d issues and a vice. Each guideline was read 
several times to identify topics/subt pics and r lated recommen ations. A full st r “
” was a sign  to topics/subtopics with adequate infor ation. A half-star “ ” was 
a signed to topics/sub opics with l mited information. “NR” was a signed to topics/sub-
t pics that are not rep rted in the guideli e. Two independent revie ers (AN and GY) 
were inv lved i  the process, and disag e ts were resolved through disc ssion or 
ith  third revie er (KC). 
2.3. Comparison of Quality of S l cte  Clin c l Guideli s for Managing T2DM 
The qua ty of th clin c l guideline  as ss ssed in ep nde tly by t o reviewers
(AN and GY) u ing the Apprai al of Gui e ines for Re arch and Evaluation II (AGREE
II) tool, which is  standardised and validated instrument [10]. The AGREE II tool com-
prises 23 item  separated into ix domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) cl rity of presentation; (v) applicability; and (vi) 
e itorial i ependence) and two global rating items ((i) overall quality score and (ii) rec-
mmendation for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point cale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scor s were alculated for each appraiser by using the ave age rating (1 (strongly disagree) 
to 7 (strong y agree)) for all items in e ch do ain. Scaled percentages for each domain 
were then calculated for inter-domain co parison by summing he appraisal ratings of 
tems within a single domain (obta ed score), scaling by aximum and mini um possi-
ble domain scor s, and by conv rting to a percentage [10]. The verall quality of all in-
cluded guidelines w s summarised and presented using sum ary statistics (mean). Mean 
score  of the dom ins were compared, the highest and lowest scores were identified. 
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2.2. Compar s n of Co t t f Se cted Cli i l Gu d ine for Managin  T2DM 
The cont t of the linic l gui lines as co pared based o  th  fol wing t pi s by 
using a previous y pil ted data extractio  for : blood glucose anagement; body weight 
assess ent and man gement; blood pr ssure measure ent nd manage ent; blood li-
pids measurement n  an gement; T2DM-associ ted complicatio s assessment and 
manage en ; and other h alt c re-rel t d issues and advice. Each guideline was read 
v ral ime  to id nt fy opics/subtopic nd rel e recommen ation . A full star “
” was as igned to topics/subtopics with dequate in or ation. A half- tar “ ” was 
assign  to topics/subtopics ith limited infor tion. “NR” was assigned to topics/sub-
topics that re n t reporte  i  the guid lin . Two i pendent revie ers (AN and GY) 
were involved in th  process, and disagreem nts er resolved thr ugh discussion or 
ith a third revie er (KC). 
2.3. Compariso  of Quality of S lected Cli ical Gu delin s for Ma aging T2DM 
The qu ty of th clinical guid lin  as as s d in pe d t y by t o revi wer
(AN GY) using the Appr i al of Gui elin  f r Res arch and Evalu tion II (AGREE
II) ool, which is a standardised and validated instru ent [10]. The AGREE II tool com-
rises 23 items sep r ted int  six dom ins ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rig ur of develop ent; (iv) larity of presentation; (v) applicability; and (vi) 
editorial independence) and two g obal rating items ((i) v rall quality score and (ii) rec-
ommendat on for use in practice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disa re to 7 = trongly gree). Average appraisal 
scores w re calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  c lculated for inte -domain co pariso  by summing the appraisal ratings of 
items within a singl domain (obtaine score), scaling by maxi um and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. C mp r  f C nt of Selec  C in cal Guid s for M ing T2DM 
Th  co te t o  the c inical gui e ines w s co pared b sed o  th  followi g topic  by 
using a previously piloted ata xtraction f rm: blood glucose management; body weight 
ssess t and an g e t; bl od pressure measurement n  management; blood li-
pids measur me  and anagement; T2DM-associated complications assessment and 
anagem nt; and other healthcare-related issu s  advice. Each guideline was read 
ev ral tim  to identi y topic /subtopics a d related recommendations. A full star “
” as assigned t  topics/subtopic  with adeq ate information. A half-star “ ” was 
assigned to top cs/subtopics with li ited information. “NR” was assig ed to topics/sub-
to ics that a  not report d i  th  guideline. Two independent reviewers (AN and GY) 
were inv lved i  th  pr ces , a d disagreements were resolve  through iscussion or 
ith a third revi er (KC). 
.3. Com ar on f Quality of Select d Cl ical Gui elines for Managing T2DM 
Th  qu ty of th  clin c l g idelines was a ssed in ependently by two reviewers
(AN nd GY) using th Apprai al of Gui elines or Resea ch and Evaluation II (AGREE
II) tool, whic  is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 it ms separated into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; ( ) rigour of develop ent; ( v) clarity of presentation; (v) applicability; and (vi) 
edit ial independence) and two global rati g items ((i) overall quality score and (ii) rec-
ommendation for use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calcul ted for e ch ppraiser by us ng th  average rating (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each domain 
were then c lcul ted for inter-domain comp r son by summing the appraisal ratings of 
it m  within single do ain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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2.2. Comp r s  of Conte t of Selected Cli i al Gu de ines for Managing T2DM 
Th  co t nt of the li cal ui elines was co pared based o  the following topics by
using a previously pil ted ata xtraction for : blood glucose anagement; body weight 
assess ent and man g ment; blood pressure measurement nd management; blood li-
pi s measureme t and man gement; T2DM-associated complicatio s assessment and 
managemen ; and other healthcare-r l ted issues and advice. Each guideline was read 
v ral ime  to i enti y t pic /subtopics a d rel ed r commendations. A full star “
” w s as igned to t ics/subto ic  with dequate in ormation. A half- tar “ ” as 
assigned to topics/subtopics with li ited inform tion. “NR” was assigned to topics/sub-
topics that  ot reported i  the g id lin . Two ind pendent reviewers (AN and GY) 
we e involved in the proces , a d disagreem nt  w re resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. C mpar son of Qu l ty of S lect d Clin cal Gu de ines f r Ma agi g T2DM 
Th  qu ty of the clinic l guid lines w s as essed ind pe d ntly by two eviewers
(AN nd GY) u ing th  Apprai al of Gui eline  for Research and Evaluati n II (AGREE
II) ool, whic  is a standardised and validated instrument [10]. The AGREE II tool com-
rises 23 it ms separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
edit rial independence) and two global rating items ((i) v rall quality score and (ii) rec-
mmendation f r use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
sco es w re calculated for each pprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly ree)) for all ite s in each do ain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
items within a singl  do ain (obtained score), scaling by maximum and minimum possi-
b e domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s wa  summarised and presented using su mary statistics (mean). Mean 
scores of th  domains were compared, and the highest and lowest scores were identified. 
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Coun ry-specific (New 
Zealand) 
Guidance o  the managemen  f ype 
2 diab t s 2011 2011
6 American Diabetes Association (ADA) [15] 
C un ry-sp ific (Unit  
States) Sta dards f me ic l care in diabetes  
7 Nati nal Ins itute for H alth and Ca e 
Excellence (NICE) [16] (England and W es)
Ty e 2 iabetes  adul s: 
mana e t 
20
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-spec ic 
(Sc tla d) 
M ageme t f diabet s: a nati n l 
cli ical g i li e 
2017 
2.2. Comparis n of Content of Selected Clinic l Guide ines f r Managing T2DM 
The cont nt of the linical guidelin s wa  compar d based on the llowin  t pic by
using a previou ly piloted ata extraction form: blood g ucose management; body weigh  
asses me  and m nagem nt; blo  pre sur  m as r me t and man g ment; blood l
pids m asurement and manage T2DM-assoc ated c mplicati ns ssess  and
ma agement; a  other healthcar -related issu s a d adv ce. Each guidel e as r ad 
ral times t  identify topics/subtopic  a d relat d r c mend tion . A full st  “
” wa  assigned to opics/s btopics with adequate inform tion. A half- tar “ ” was
assigned to topics/sub pics with limited inf r ati n. “NR” was assig t  topics/sub-
topics that are no  rep ted in the guideli . Two independ t revi w rs (AN nd GY)
were involved  the pr c ss, a d disagreemen s were resolve  through disc ssio  or
with a third re i wer (KC).
2.3. Comparison of Qu lity of Select d Clinical Guideli s for Manag g T2DM 
The qu lity of the clinical guidelines was as esse  indepe ntly by two viewers 
(AN and GY) u ing the Appraisal f Guidelin  for Researc  and Evaluati n II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 ite s separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each ite  within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculate  for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
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The Royal Australian Coll ge of Gen l 
Practitio ers (RAC P) [12]
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4 
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States) Sta dar s f medical care i  diabetes  
7 Nati nal In titute for Health a d Care 
Excellence (NICE [16] 
 
(En l d nd Wal s) 
Ty e 2 d abet in a ults: 
man e t 
20
8 S ottish Intercollegiat Guidelines 
Netw rk (SIGN) [17] 
Cou try-spec fic
(Scotland) 
Man m n  f d betes: a ati nal 
clinic l guideline 
2017 
2.2. Co paris n of Conte t f Select d Cli i l Guid ines for Managin  T2DM 
The ont t f the linical g i lin s as co par d bas d o th fol owing topi s by
using  previou y piloted ata extrac i form: bloo glucose a age ent; bo y weight
asses e  and gement; blo d pr sure easu m nt nd man g ment; blood li
ids m surement n  ma agem nt; T2DM-associ t  compl cations ssessme t and
a ageme t; a  o her he lthc re-relat d ssu s an  advice. Each gu d line was read 
ral tim s t  id ntify t pics/subtopic  a d relat d rec m dation . A full st r “
” wa  assigned to pics/s btopics with ad quate infor tion. A half- ta  “ ” was
assign  to topics/subt pics ith limited inf rmation. “NR” was assig ed to top cs/sub-
topic  that are n rep t   he guideline. Tw  independe t evie rs (AN n  GY)
wer  inv lved  th  pr c ss, and disagree ents er  resolve  through disc s ion or
ith a third r i w r (KC). 
2.3. Comparison of Quality of S l ct d Clinical Guid lin  f  Managi g T2DM 
The qu ty of the clinical guid lin s as as s d in epe de tly by t o reviewers
(AN GY) using the Appr isal of Gui elin  f r Res arch and Evaluation II (AGREE
II) tool, which is a standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 items sep rated int  six dom ins ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rig ur of develop ent; (iv) larity of presentation; (v) applicability; and (vi) 
editorial independence) and two g obal rating items ((i) overall quality score and (ii) rec-
ommendat on for use in practice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scale (fro  1 = strongly disagre to 7 = trongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then c lculated for inter-domain co pariso  by summing the appraisal ratings of 
items within a single domain (obtaine score), scaling by maxi um and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
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2 diabet s 2011 2011
6 Americ n Diabetes Ass ciati n (A A) [15] 
C ntry-specific (U ited 
Stat s) Stan ards of medical care i  diab tes  
7 N ti nal Ins itut  for H alth n  C re 
Exce lence (NICE) [16] (E l n and Wale ) 
Ty e 2 iabetes i  adults: 
ma a nt 
20
8 S t ish I tercoll giate Guide es 
Network (SIGN) [17] 
Country-s c fic
(Sc tl d) 
Managem nt of di betes: a ational
clin cal guid line 
2017 
2.2. Co par s  f C tent of Selecte  Clinical Guid n s for M a i g T2DM 
Th  co te t the clinical gu e in s was co p r d b sed o  th following topics by
ing a prev u ly pil ted ata xtraction f rm: bl o glucose ma age ; body w ight 
sses t a d nage e t; blo d pre su measureme  and man g ment; blood li
ids measur men  and anage t; T2DM-associat d c mplications ssessme t and
anag m n ;  o her heal hcare-rel t d issu s d advice. Each guideli e was read 
r l tim  to id ntify t pic /subtopic  a d related rec mm ndations. A full st r “
” a  assig ed to opics/subtopics with adequ te info m tion. A h lf- tar “ ” wa
assigned to op cs/subt ics with l mit  inf rmatio . “NR” was ass gned to top cs/sub-
o i s th t are no  rep t d in th  guid line. Tw indepe d  reviewers (AN nd GY)
w re involved  the pr ces , and isagree ents were resolve  through isc ss on or
ith a th rd revi er (KC).
.3. Compari o  f Qu lity f Select d Cli ical Guidelin s for Managi g T2DM 
The qu ty of th  clin c l guidelines was ass ssed in ependently by two reviewers
(AN and GY) using th Apprai al of Gui elines or Research and Evaluation II (AGREE
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 it ms separated into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; ( ) rigour of development; ( v) clarity of presentation; (v) applicability; and (vi) 
edito ial independence) and two global rati g items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calcul ted for e ch appraiser by us ng th  average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then c lculated for inter-domain comp r son by summing the appraisal ratings of 
it m  within single do ain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines was su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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8 Sco tish I erc llegi t  Gui eli es 
etw rk (SIGN) [17]
Country- pec fic 
(S tland) 
Managem nt of diabetes: a national 
clinical guideline 
2017 
2.2. omp ris n of Co t nt f Sel cted Clinical Guid in s for Managing T2DM 
T e ntent f th  clinic l guidelines s compar d based on the following topics by
using  previou y piloted a a extraction for : blood glucose manage ent; body weight 
ses  and m nagement; blo d pre sure measurem nt and man g ment; blood li
pid mea ure ent nd ma agement; T2DM-associ te  complic tions ssessme t and
manag m t; a  other h althc re-related issu s nd advice. Each guideline was read 
al time  to identify topics/subt pic  a d rel ted rec mmendations. A full st r “
” wa  assigned o opics/subtopics with adequ e inform tion. A half- tar “ ” was
a s gn to topic /subt pics ith limited inf rmation. “NR” was assigned to topics/sub-
topic  th t are re ted i  th  guideline. Two independe t reviewers (AN nd GY)
er  inv lved  the process, and d sa ree ent  ere resolve  through disc ssion or 
with a third revi wer (KC)
2.3. Compari  of Quality of Sel cted Clinical Gui lin s for Managing T2DM 
Th  qu lity of the clinical guideline was sse s d independently by two reviewers 
(AN nd GY) using the Appr isal of Guid lines for esearch and Evaluation II (AGREE 
II) tool, which s a standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 it ms separated into ix dom ins ((i) scope and purpose; (ii) stakeholder involve-
ment; (i i) rigour of development; (iv) lar ty of presentation; (v) applicability; and (vi) 
editorial independ nce) and two global rating items ((i) overall quality score and (ii) rec-
ommend tion for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
score  were calculat d fo  each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtaine  score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guid lines was summarised nd presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
Lipid m dificatio
th rapy (e.g., statin)
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(Scotl nd) 
Manage nt of di b t s: a natio l 
clin cal g d li e 
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2.2. Comparison of Co tent of Selected Cli ic l Guid lin s f r M naging T2DM 
Th  content f the cli ical gui elines w  c mpar d based o  the fo lowing topic by
usi g a previou ly pilo ed ata extraction form: blo d glucose nagement; body w igh  
asses ent an  ge en ; bl d pre sur  m asureme  n an g me t; bloo  l
pids measurement and manag  T2DM-ass ciated c m lications ssess  a d 
management; a  other ealthcare-related i su s a d advice. Each guidel e as r  
ral times to id ntify t pics/subtopic  a  rel ted rec mm nd io s. A full t r “
” wa  assigned to pics/s btopic  it ad quate inform tion. A h lf- tar “ ” as
assigned to topic /subt pics with li ited inf r io . “NR” w s ssi ned to topics/su -
topics that are no  rep ted i  the guideline. Two in epend t revi wers (AN d GY)
were involved  the process, an  isa ree e ts ere resolved through sc ssion or
ith a third revi wer (KC). 
2.3. Comparison of Quality of Select d Clinical Guidelin s for Managing T2DM 
The qua ty of the clinic l guidelines was assessed in ep nd ntly by tw  r viewers
(AN and GY) using the Appraisal f Gui elines for R earc  and Ev luation II (AGREE
II) tool, which is a stand rdised and valid ted instrument [10]. The AGREE II t ol com-
prises 23 items separated into six domains ((i) scope and purpos ; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clar ty f presentation; (v) applicability; nd (vi) 
editorial independence) and two global rating items ((i) overall qual ty score and (i ) rec-
ommendati n for use in practice) [10]. Each item within the AGREE II tool was rated on a
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores we  calculated for each appraiser by usi g t  average rating (1 ( rongly disagre ) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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.2. Compar on of Content of Selected Clinical Gui elines for M n g  T2DM
The c ntent of the clinical gui elines was mpared based  the following t i  by 
using a r iou ly pilo ed data ex raction form: blo d gluc s  ma ge e t; body weight 
assessment and managem t; bloo  pressure measu ment a d man em t; blood li-
pids measurement and managem t; T2DM-associated complication  a ess nt a d 
manag m nt; and other e lthc r -relat d issues nd advic . Each guideli  was rea  
several times to dentify to ics/subtopics and related reco me atio s. A full star “
” a  assigned to topics/subtopi s ith ad q at  information. A half- ta  “ ” was 
assigned to topic /subtopics with limited inf rmati . “NR” w  ssigne  t  t pics/sub-
topics that are ot re orted in the gui eline. Two indepe ent revie ers (AN and GY) 
were involv d in the pr ce s, d disagreements were reso ved t rough discussion or 
ith a third reviewer (KC . 
2.3. Com ariso  of Qu l ty of Select d Cli ical Guidelines for M nagi g T2DM 
The qua ty of the cli ic l guidelines was assessed ind p d ntly by two revi wers
(AN a d GY) using the Appraisal of ui elines for R earc  a d Evaluat on II (AGREE
II) tool, which is a standardise  d validated i strument [10]. The AGREE II tool com-
prises 23 items separated int  six do ains ((i) scope and pur os ; (ii) st keholder inv lve-
ment; (iii) rigour of development; (iv  clarity of presentation; (v) applicability; an  (vi) 
editorial independe e) and tw  global rati g items ((i) overal  q ality sc re and (ii) rec-
omm ndation for use in practice) [10]. Each ite  withi  the AGREE II tool was r te  on a 
seven-p int scale (from 1 = str ngly disagre  o 7 = strongly agree). Average appraisal 
scores were calculated for each ap raiser by si  the average rating (1 (strongly disagree) 
to 7 (str ngly agree)) for all items in each d mai . Scaled perce tages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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s v ral t m s to i e tify topics/s bt pics a  rel ted recommenda ions. A full star “
” was a sig ed to topics/subtopic  ith adequate information. A h lf-star “ ” w s 
a s gn  to topic /sub pics with l mit d inf r ti n. “NR” a  signed to t pic /sub-
t pics that are ot reported in the guideli e. Two independent reviewers (AN a d GY) 
were inv lved in the proces , and disag em n  w re r solved through discussio  or 
ith a third revie er (KC). 
2.3. Comparison of Quality of Sel c d Clinical Guidelines fo  M aging T2DM 
The quality f th  clinical guidelines was ss sed indep nd tly by t  reviewers 
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cluded guidelines w s summarised and presented using sum ary statistics (mean). Mean 
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ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comparison of Content of Selected Clinical Guidelines for Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: blood glucose management; body weight 
assessment and management; blood pressure measurement and management; blood li-
pids measurement and management; T2DM-associated complications assessment and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics and related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinical guidelines was assessed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. E ch item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
Int. J. Environ. Res. Public Health 2021, 18, x FOR PEER REVIEW 3 of 13 
 
 
Table 1. Outline of selected clinical guidelines for managing T2DM. 
 Publishing 
Societies/Organisations/Associations 
Geography of the 
Guideline 
Name of the Guideline Last 
Updated 
1 
Caribbean Health Research Council 
(CHRC) and Pan American Health 
Organization (PAHO) [8] 
Country-specific 
(Caribbean) 
Managing diabetes in primary care in 
the Caribbean 2006 
2 International Diabetes Federation (IDF) [11] International  
Recommendations for managing type 
2 diabetes in primary care 2017 
3 
The Royal Australian College of General 
Practitioners (RACGP) [12] 
Country-specific 
(Australia) 
General practice management of type 
2 diabetes 2016  
4 
Diabetes Canada and Canadian Di betes 
Association (CDA) [13]  
Country-specif c 
(Can d ) 
Diabetes Canada 8 clinical practice 
guidelines for the prevention and 
management of diabetes in Canada 
2018 
5 New Zealand Guidelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidance on the management of type 
2 diabetes 2011 2011 
6 American Diabetes Association (ADA) [15] 
Country-specific (United 
States) Standards of medical care in diabetes 2020 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Country-specific 
(England and Wales) 
Typ  2 diabetes in adults: 
management 
2020 
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-specific 
(Scotland) 
Management of diabetes: a national 
clinical guideline 
2017 
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The quality of the clinical guidelines was assessed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
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ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
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scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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m nt; (iii) rigour of developme t; (i ) clarity of presentation; (v) applicability; and (vi) 
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scores of t e domains were compar , and the high st and lowest scores were identified. 
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Country-specific 
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2020 
8 Scottish In ercollegiate Guidelines 
Network (SIGN) [17] 
Country-specific 
(Scotland) 
Management of diabetes: a national 
clinical guideline 
2017 
2.2. Compar son of C ntent of Selected Clinical Guidelines for Managing T2DM 
The content of the clinical guide ines was compared based on the following topics by 
using a previously piloted data extraction f rm: blood glucose management; body weight 
assessment and manageme t; blood pressure measurement and management; blood li-
pi s measureme  a d anagement; T2DM-associated complications assessment and 
management; and other healthcare-related issues nd advice. Each guideline was read 
several tim s to identify topics/subtopics and related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to top cs/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not report d in th  guideline. Two independent reviewers (AN and GY) 
we e involved in the pr cess, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The qu lity of the clinical guidelines was assessed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (i i) rigour of development; ( v) clarity of presentation; (v) applicability; and (vi) 
edito ial independence) and two global rati g items ((i) overall quality score and (ii) rec-
mmendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calcul ted for e ch appraiser by us ng th  average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comp r son by summing the appraisal ratings of 
it m  within  single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines was su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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2.2. Comparison of Content of Selected Clinical Guidelines for Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a p eviously piloted data extraction f rm: blood glucose management; body weight 
assessment and ma ageme t; blood pressure measurement and management; blood li-
pi s measureme t and anagement; T2DM-associated complications assessment and 
man gement; and other h alth are-related issues and advice. Each guideline was read 
several times to identify topics/subtopics and related recommendations. A full star “
” w s assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that re not re orted in the guideline. Two independent reviewers (AN and GY) 
we e involved in th process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Compar son of Quality of Selected Clinical Guidelines for Managing T2DM 
The qu lity of the clinical guidelines was assessed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a sta dardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (ii ) rigou  of development; (iv) clarity of presentation; (v) applicability; and (vi) 
edit rial independence) and two global ati g items ((i) overall quality score and (ii) rec-
mmendation f r use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = st ongly dis ree to 7 = strongly agree). Average appraisal 
sco es were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
item  within a s le domain (obt ined score), scaling by maximum and minimum possi-
b e d main scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guideline  wa  su mari ed and prese ted usi g summary statistics (mean). Mean 
scores of th  domains were compar d, and the highest and lowest scores were identified. 
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2017 
2.2. Compariso  of Conte t of Selected Clinical Guidelines for Managing T2DM 
The conte  of the clinic l guidelines was compared based on the following topics by 
usin  a previously piloted data extraction f rm: blood glucose management; body weight 
sessm nt and management; bl od pressure measurem nt and management; blood li-
pids measurement and manageme t; T2DM-associated complications assessment and 
m nag ment; nd other healthcare-related ssues and a vice. Each gui eline was read 
sev ral ti s to identify topics/subtopics and related recommend tions. A full star “
” was assig ed to top cs/subtopics with adequate inform tion. A half-star “ ” was 
assigned to top c /subtopics with limited information. “NR” was assigned to topics/sub-
t pics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were inv lved in the proc ss, a d disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Compariso  of Qua ty of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinic l guid lines was ass ssed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Rese rch and Evaluation II (AGREE 
II) tool, which is  standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separat d into s x domains ((i) scope and purpos ; (ii) stakeholder involve-
ment; (ii ) rigour of developme t; iv cl r ty of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
mm ndation for use in practic ) [10]. Each item within the AGREE II tool was rated on a 
s ven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scor s wer  calculated f r each app aiser by using the average rating (1 (strongly disagree) 
to 7 (str ngly agre ))  all items in e ch domai . Scaled per entages for each domain 
were then calculated for inte -domain co parison by summing the appraisal ratings of 
tems within a single domain (obt i ed score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
cluded g idelines w s summ rised and presented using sum ary statistics (mean). Mean 
score of the dom ins were compar , and the highest and lowest scor s were identified. 
Diabetic ketoacidosis
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Country-specific 
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Management of diabetes: a national 
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2.2. Comparis n of Content of Selected Clinical Guide ines for Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: blood glucose management; body weight 
assessment and management; blood pressure measureme t and management; blood li-
pids measurement and management; T2DM-associated complications assess ent and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics a d related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independe t reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinical guidelines was assessed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool co -
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each do ain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
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1 
Caribbean Health Resea ch Council 
(CHRC) and Pa  American He lth 
Organization (PAHO) [8] 
Country-specific 
(Carib e n) 
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the C ribbean 2006 
2 International Diabetes Federation (IDF) [11] International  
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Type 2 diabet in adults: 
management 
2020 
8 Scottish Intercollegiat  Guidelines 
Network (SIGN) [17] 
Country-specific
(Scotland) 
Management of diabetes: a national 
clinical guideline 
2017 
2.2. Comparison of Co tent f Selected Clinical Guid lines for Managing T2DM 
The content of the clinical guid lines as co pared based on the following topics by 
using a previous y piloted data extractio  form: blood glucose management; body weight 
assessment and anage ent; blood pr ssure measurement and a agement; bloo  li-
pids measurement n  management; T2DM-associ ted complications assessment and 
management; and other healthc re-relat d issues and advice. Each guideline was read 
several times to identify topics/subtopics and related recommendations. A full st r “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assign  to topics/subtopics ith limited information. “NR” was assigned to topics/sub-
topics that are n t reporte  i  the guideline. Two in ependent revie ers (AN and Y) 
were involved in th  process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinical guidelines as ass ss d in ependently by two reviewers 
(AN and GY) using the Appr isal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 items sep rated int  six dom ins ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rig ur of development; (iv) larity of presentation; (v) applicability; and (vi) 
editorial independence) and two g obal rating items ((i) overall quality score and (ii) rec-
ommendat on for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagre to 7 = trongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all ite s in each domain. Scaled percentages for each domain 
were then c lculated for inter-domain compariso  by summing the appraisal ratings of 
items within a single do ain (obtaine score), scaling by maximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comp ris n of Cont t of Selected Cli ic l Gu de ines for Managing T2DM 
The conte t of the clinical gu delines was compared based on the following topics by 
usin  a previously pil ted data extraction for : blood glucose management; body weight 
sess e t and anage ent; blood pressure easureme t and management; blood li-
pids measurement and man gement; T2DM-associated complicatio s assessment and 
manage en ; and other healthcare-rel ted issues and advice. Each guideline was read 
s veral i  to ide tify topics/subtopics a d rel ed recommendations. A full star “
” was as g ed to topics/subtopics ith dequate in ormation. A half- tar “ ” was 
assigned to topic /subtopics with limited inform tion. “NR” was assigned to topics/sub-
topics that are not reported in the guid lin . Two ind pendent reviewers (AN and GY) 
were involved in the proce s, and disagreem nts were resolved thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comp riso  of Qual ty of Selected Clinical Gu delines for Managing T2DM 
The qu ity of the clinical guid lines was assessed in epend ntly by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ool, which is a standardised and validated instrument [10]. The AGREE II tool com-
rises 23 ite s separ ted into s x d mains ((i) scope and purpose; (ii) stakeholder involve-
m nt; (iii) rigour of developme t; (i ) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) v rall quality score and (ii) rec-
ommendation for use in pr ctice) [10]. Each ite  within the AGREE II tool as rated on a 
seven-point scal  (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
scores w r  calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree))  all items in each domain. Scaled percentages for each do ain 
w re the  calculated for nte -domain co parison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maxi um and minimum possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comp r s n f C ntent of Selected Clinical Guide nes for Managing T2DM 
Th  content of the clinical guide ines was compared based on the following topics by 
using a previously piloted ata xtraction f rm: blood glucose management; body weight 
assessment and manag me t; blood pressure measureme t and management; blood li-
pi s measureme  and anagement; T2DM-associated complications assess ent and 
management; and other healthcare-related issues nd advice. Each guideline was read 
sev ral tim s to identi y topic /subtopics a d related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to top cs/subtopics with limited information. “NR” was assigned to topics/sub-
topics that a  not report d i  th  guideline. Two independe t reviewers (AN and GY) 
we e involved in the pr ces , a d disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Compar on of Quality of Selected Clinical Guidelines for Managing T2DM 
Th  qu lity of the clinical guidelines was assessed independently by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, whic  is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 it ms separated into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (i i) rigour of development; ( v) clarity of presentation; (v) applicability; and (vi) 
edit ial independence) and two global rati g items ((i) overall quality score and (ii) rec-
mmendation for use in prac ice) [10]. Each ite  within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calcul ted for e ch ppraiser by us ng th  average rating (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each do ain 
ere then calcul ted for inter-domain comp r son by summing the appraisal ratings of 
it m  within  single do ain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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Network (SIGN) [17] 
Country-specific 
(Sc tland) 
Management of diabetes: a national 
cli ical g i eline 
2017 
2.2. Comparis n of Content of Selected Cli ical Guide ines for Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: blood glucose management; body weight 
assessment and management; blood pressure measurement and management; blood li-
pids measurement and management; T2DM-associated complications assessment and 
management; and other healthcare-related issues and advice. Each guideline was read 
sev ral times to identify t pic /subtopics a d related r commendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” as 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. C mparison of Quality of Selected Clin cal Gu de ines for Ma aging T2DM 
The quality of the clinical guidelines was assessed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each do ain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single do ain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comparis n of Conte  of Selected Clinical Guide ines for Managing T2DM 
The content of the clinic l gui elines was compared based on the following topics by 
using a previously piloted data extraction f r : blood glucose management; body weight 
assessm nt and management; blood pressure measurem nt and management; blood li-
pids measurement and management; T2DM-associated complications assessment and 
manag ment; and other healthcare-related ssues and a vice. Each gui eline was read 
everal time  to identify topics/subtopics a d rel ted recommend tions. A full star “
” was assigned to top cs/subtopics with adequate inform tion. A half-star “ ” was 
assigned to top cs/subtopics with limited information. “NR” was assigned to topics/sub-
t pics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were inv lved in the proc ss, a d disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Qua ty of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinic l guidelines was ass ssed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Rese rch and Evaluation II (AGREE 
II) tool, which is  standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpos ; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) cl r ty of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
mm ndation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
s ven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scor s wer  calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (str ngly agree)) for all items in e ch domai . Scaled per entages for each domain 
were then calculated for inter-domain co parison by summing the appraisal ratings of 
items within a single domain (obt i ed score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
cluded g idelines w s summarised and presented using sum ary statistics (mean). Mean 
score of the dom ins were compared, and the highest and lowest scor s were identified. 
Diabetic retinopathy
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2.2. Comparis n of Content of Selected Clinical Guide ines f r Managing T2DM 
The content of the clinical guidelines was co ared ased on the following topics by 
using a previously piloted dat  extraction f rm: blood glucose m nagement; b dy weight 
assessment and management; blo d re ure mea urement an  management; blood li-
pids measurement and management; T2DM-associated complications assessm t nd 
management; and other healthcare-related issues and a vice. Each guidelin wa  rea  
several times to identify topics/subtopics a d related rec mmendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolve  through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guideli es for Manag ng T2DM 
The quality of the clinical guidelines was assessed ind penden ly by two reviewers 
(AN and GY) using the Appraisal of Guid lines f r Res arch and Evaluation II (AGREE 
II) tool, which is a standardi ed and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i sc pe and purpose; (ii) stakeh lder inv lve-
ment; (iii) rigour of development; (iv) cla ity of pr sentatio ; (v) applicability; and (vi) 
editorial independence) and t o global rating items ((i) ov rall quality score and (ii) re -
ommendation for use in practice) [10]. Each ite  within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagr e to 7 = strongly agree). Average appraisal
scores were calculated for each appraiser by using the average r ting (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comparison of Conte t f Selected Clini l Gu de ines f r Managing T2DM 
Th  content of the cli ical guidelines was c pared bas d o  the following topic  by 
using a previou ly pil ed data extracti n for : blood glucose nagement; body weight 
assessment an  manageme ; bl od pre sur  measurement an  management; blood l -
pids measurement and man g me t; T2DM-associa ed com c tio s assessment a d 
managemen ; and other althcar -rel ted i sues and adv ce. Each guidelin was r ad 
veral ime  to identify topics/subtopics and rel ed rec mmendation . A full star “
” was as igned to t pics/s bto ic  with dequate in ormation. A h lf- tar “ ” was
assigned to topics/subtopics with limited inform tion. “NR” was assigned to topics/sub-
topics that are not reported in the guid lin . Two ind pendent reviewers (AN and GY) 
were involved in the process, and disagreem nts were resolved thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comparison of Qu l ty of S lect d Clinical Guideli es for Manag g T2DM 
The qu ity of the clinical guid lines was assessed indep ntly by tw reviewers 
(AN and GY) using the Appra sal of Guidelines for Research and Ev luation II (AGREE 
II) ool, which is a stand dised and valid ted instrument [10]. Th  AGREE II t ol com-
rises 23 items separ ted into six domains ((i) scope and purpo ; (ii) st keholder involv -
ment; (iii) rigour of dev lop ent; (iv) clar ty f presentat on; (v) pplic ility; nd (vi) 
editorial independence) and two global rating items ((i) v rall qual ty core and (i ) rec-
ommendati n for use in practice) [10]. Each item within the AGREE II t ol s rated on a
seven-point scale (from 1 = strongly disa ree to 7 = strongly ree). Avera e appraisal 
scores w  calculated for each apprais r by usi g t ave a e rat ng (1 ( rongly isagre ) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  calculate  for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by aximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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8 Scottish Intercollegiate Guidelines 
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Ma agem nt of diabe es: a national 
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2.2. Comparison of Co tent of Selected Clinical G idelines for Man ging T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: blood glucose management; body weight 
assessment and management; blood pressure measurement and management; blood li-
pids measurement and management; T2DM-associated complications assessment and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics and related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent revie ers (AN and GY) 
were involved in the process, and disagreements were resolve  through disc ssion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Ma aging T2DM 
The quality of the clinical guidelines was assessed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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sess ent and anage ent; blo d r ure mea urement an manageme t; bl od li-
pids m as rement n  managem ; T2DM-associ ted complications assessm  a d 
manage nt; and other healthc re-r la d issues an  advice. Each gui eline was r a
everal ti s to ide tify topics/subtopics a d related recommendations. A full star “
” was ass g ed to topics/subt pics ith adequate information. A h lf-star “ ” was 
assign  to topic /subtopics ith limited information. “NR” was assigned to topics/sub-
topics that are n t reporte  i  the guideline. Two independent reviewers (AN and GY) 
were involved in th  proce s, and disagreements were resolve  through discussion or 
with a third reviewer (KC). 
2.3. Comp riso  of Quality of S lected Clinical Guidelin s for Managing T2DM 
The quality of the clin cal guid lines as ass s d in ependently by two reviewers 
(AN a d GY) using the Appr isal of Guidelines for Research a d Ev luation II (AGREE 
II) tool, which is a standardis d and valid ted inst u ent [10]. The AGREE II tool com-
pris s 23 tems sep r ted int  x s ((i) sco e and purpose; (ii) stakeh lder involve-
m nt; (iii) rigour of evelop e t; (i ) larity f pr sentation; (v) appl cability; and (vi) 
edit rial in ependence) an  t o g obal rating items ( i) overall quality sc r  an  (ii) rec-
ommend t on for use i pr ctice) [10]. Each item w hin the AGREE II tool as rated on a 
seven-point scal  (f om 1 = strongly i agre to 7 = trong y ag e). Average appraisal 
scores wer  c lculated for each appraiser by u ing the aver g  rating (1 (str ngly disagre ) 
to 7 (strongly agree))  all items in each domain. Scaled percentages for each do ain 
were then c lculated for nte -domain co pariso  by summing the appraisal ratings of 
items within a single domain (obtaine score), scaling by maxi um and minimum possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
clude  guidelines was summ rised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
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2.2. Compar s n f C ntent of Selected Clinical Guide nes for Managing T2DM 
The ntent of the clin al guid ines was co ared ased on the following topics by 
sing a p eviously piloted dat  extractio f r : blood gluc e m nagement; b dy weight 
ssess t and manage t; bl d re sur  mea ureme t an  manage ent; blo d li-
pi s m asur men  and anageme t; T2DM-associat d complicat ons assess t and 
management; and ot er he lthcare-relat d issues n  a vice. Each gui eline wa  r a  
sev ral tim  to identify topic /subtopics a d related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A ha f-star “ ” was 
assigned to top cs/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not report d in th  guideline. Two independe t reviewers (AN and GY) 
we e involved i  the pr cess, and disagreements were resolve  through discussion or 
with a third reviewer (KC). 
.3. Compari on of Quality f Selected Clinical Guidelines for Managing T2DM 
T e qu lity of he clinic l guid lines was assessed ind penden ly by two reviewers 
(AN and GY) usin  the pp isal of Guid lines for Res arch and Evaluat on II (AGREE 
II) tool, which is a stand rdi ed and validat d instrumen [10]. The AGREE II tool com-
prises 23 it ms separated to s x domains ((i sco e and purpose; (ii) stakeholder inv lve-
ment; ( ) rigour of development; (iv) clarity of pr sentatio ; (v) applicab lity; and (vi) 
edito i  independence) and t o global rati g ems ((i) ov rall quality sc r  and (ii  rec-
mm ndation for use in practice) [10]. E ch item within the AGREE II tool was rated on a 
s ven-point scal (f m 1 = strongly dis gree to 7 = strongly agree). Aver ge appraisal 
score  were calcul ted for e ch appraiser by us ng th  average r ting (1 (s rongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each do ain 
were then c lculated for inter-domain comp r son by summing the appraisal ratings of 
it m  within single do ain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines was su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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using a previou ly pil ed at  xtracti n for : blood gluco e nageme t; body weight 
asse ment an  manag men ; blood pre sur  measuremen  and a gement; blood li-
pi s measureme t and man g me t; T2DM-associated com licatio s assessment and 
managemen ; and o her althcar -rel ed i sue  and advice. Each guideline was r ad 
v ral ime  to identi y topics/subtopics and rel ed recommendations. A full star “
” was as gned to t pic /s btopic  with dequate in ormat on. A h lf- tar “ ” was 
assigned to topics/subtopics with limited inform tion. “NR” was assigned to topics/sub-
topics that a  not reported i  the guid lin . Two in pendent reviewers (AN and GY) 
we e involved in the proces , a d disagreem nts were resolved thr ugh discussion or 
ith a third reviewer (KC). 
2.3. C mpar son of Qu l ty of S lect d Clinical Gu delines for Managi g T2DM 
Th qu ity of the cl ical guid lines was as essed independ ntly by tw  r viewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Ev luation II (AGREE 
II) ool, whic  is a tand rdised and valid ed instru ent [10]. The AGREE II t ol com-
rise  23 it ms separ ted into six domains ((i) scope and purpos ; (ii) st kehold r involve-
ment; (iii) rigour of develop ent; (iv) cl r ty f p esentation; (v) pplicability; nd (vi) 
edit rial ndependence) and two global rating ite s ((i) v rall qual ty score and (i ) rec-
mmendati n for use in prac ice) [10]. Each item within he AGREE II tool was rated on a
seven-point scale (from 1 = strong y disa ree to 7 = trongly gr e). Avera e appr isal 
scores w  calculated for ch pprais r by usi g t ave a e rat ng (1 ( rongly isagre ) 
to 7 (st ongly ree)) for all ite s in each domain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
items within a singl  do ain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s wa  summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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Caribb n Health Research Council 
(CHRC) and Pa  Am ric n Health 
Organization (PAHO) [8] 
Coun ry-spec fic 
(Carib ean) 
Managing diabetes in primary care in 
the aribbean 2006 
2 Int rnatio al iabetes Fed ration (IDF) [11] International  
Recom endations for managing type 
2 diabetes in primary care 2017 
3
The Roya  Australia College of Ge er l 
Practiti ers (RACGP) [12] 
Country-specif  
(Australia) 
Gen r l practice management of type 
2 diabetes 2016  
4
i t  C nada a d Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Ca da) 
Diab tes Cana a 2018 clinical practice 
guid lines for the prevention and 
m nag ment of diab tes in Canada 
2018 
5 New Zealand Guidelin s Group (NZGD) [14] 
Coun ry-specific (New 
Zealand) 
Guidanc  on the management of type 
2 diabetes 2011 2011 
6 mer c n Diabet s A sociat on (ADA) [15] 
Cou try-sp cific (United
States) Sta dards of medical care in diabetes 2020 
7 N tional Institute for Health nd Ca e 
Excelle ce (NICE) [16] 
Country-specific 
(Engl d an  Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Sco tish I ercoll gi te Guideli es 
Netw rk (SIGN) [17] 
Country-specific 
(S tland) 
Manag ment of di betes: a national 
clinical guideline 
2017 
2.2. omp rison of Cont t f Selected Clinical Guid lin s for Managing T2DM 
Th conten  of th  cli ic l guidelines as pare  bas d on the following topic  by 
usi g a previou y pilo ed data extraction f rm: blood glucose nagement; body weight 
sses  an  manageme ; blood pre sur  measurem nt a d a agement; blood li-
pid mea urement nd manag m t; T2DM-associ te com lications assessment and 
manag m nt; and other ealthc r -r la ed sues and a vice. Each g i eline was read 
everal times to identify topics/subt pics and related recommend tions. A full star “
” as as igned  t p s/s btopics w th adequate i form tion. A h lf-star “ ” was 
assign to top c /subtopics ith limited information. “NR” was assigned to topics/sub-
t pics that are n t reported i  th  g i eline. Two in ependent reviewers (AN and GY) 
were inv lved in the proc ss, a d disa ree ent ere resolved through discussion or 
with a third reviewer (KC). 
2.3. Compariso  o  Qua ty of Sel cted Clinical Guidelines for Managing T2DM 
Th qu lity of the clinic l guidelines w s assessed independently by tw reviewers 
(AN nd GY) using th  Appr isal of Guidelines for ese rch and Ev luation II (AGREE 
II) tool, which s  s and d d and valid ted instru e t [ 0]. The AGREE II t ol com-
prises 23 it ms separated into ix dom ins ((i) scope and purpos ; (ii) stakeholder involve-
ment; (i i) rig ur of development; (iv) l r t  f presentation; (v) applicability; nd (vi) 
ditorial independ nce) two global rating items ((i) overall qual ty score and (i ) rec-
mm nd ti n for use in practice) [10]. Each item within the AGREE II tool was rated on a
s v n-poi t cale (f om 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
scor  we calculat d fo  each appraiser by usi g t  average rating (1 ( rongly disagre ) 
to 7 (str ngly agree)) for all ite s in e ch domai . Scaled per entages for each domain 
were then calculated for inter-domain co parison by summing the appraisal ratings of 
items within a single domain (obt i e  score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
clude g id lines w s summarised nd presented using sum ary statistics (mean). Mean 
score of the dom ins were compared, and the highest and lowest scor s were identified. 
Diabetic neuropathy
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1 
Caribbean Health Research Council 
(CHRC) and Pan American Heal h 
Organization (PAHO) [8] 
ountry-specific
(Ca ibbea ) 
Ma agi g diabet s in prim r care i  
the C ribbean 2006 
2 Inter tional Di betes Federation (IDF) [11] Internati al  
R commend tions for ma aging type
2 diabetes in primary care 2017 
3 
The Royal Austr li n College of General 
Pr ctitioners (RACGP) [12] 
Cou try-spec fic 
(Australi ) 
General prac ic  man gement of type 
2 diabetes 2016  
4 
Diabetes Canada and Canadian iabetes 
Association (CDA) [13]  
Country-s c fic 
(Canada) 
Diabetes Can da 2018 clinic l pract ce 
guidelines for th  prev nti  and 
management of di betes in Canada 
2018 
5 New Zealand Guidelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidanc  on the managem nt of type 
2 diabetes 2011 2011 
6 Ameri an Diabetes Association (ADA) [15] 
Coun ry-specific (Unite  
States) Standards of dical are in diabetes 2020 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Country-sp cific 
(E l nd and Wales) 
Type 2 diabetes in adults: 
ma age ent 
2020 
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-specific 
(Scotland) 
Management of diabetes: a national 
clinical guideline 
2017 
2.2. Comparison of Content of Selected Clinical Guide ines f r Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: blood glucose management; ody weight 
assessment and management; bloo  pressure measurement and management; blood li-
pids measurement and manageme t; T2DM-associated complications assess ent and 
management; and other ealthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics and related rec mmendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assign d o topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guideli es for Manag ng T2DM 
The quality of the clinical guidelines was assesse  indepe dently by two reviewers 
(AN a d GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardise  and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independe ce) and two global rati g items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each ite  it i  the AGREE II tool was rated n a 
seven-p int scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each ap raiser by si  the average rating (1 (strongly disagree) 
to 7 (str ngly agree)) for all items in each domai . Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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Caribbean Health Research Council 
(CHRC) and Pa  American Heal h 
Organization ( AHO) [8] 
Country-specific 
(Ca ibb an) 
Managing diabetes in primary c r  in 
the Car bbean 2006 
2 International Di betes Federation (IDF) [11] International  
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3 
The Royal Australian College of General 
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Country-specific 
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General pr ctice t f typ  
2 diabetes 2016  
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Diabetes Canada and Canadian Diabetes 
Associati n (CDA) [13]  
Country-specific 
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D  Can d 20 8 clinical practice 
guid lines f r th  prevention and 
management of di betes in Canada 
2018 
5 New Zealand Guidelines Group (NZGD) [14] 
Cou try-specific (New 
Zealand) 
Guida ce on the management of type 
2 diabetes 2011 11
6 American Diab tes Associati n (ADA) [15] 
Coun ry-specific (Unit  
States) Sta dards of edical c r  in diab tes 
7 Nati nal Ins itute for H alth and Care 
Excellence (NICE) [16] (England and Wales) 
Typ 2 d abetes n adults: 
ana ement 
20
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-speci ic 
(Scotland) 
M nageme t f diabetes: a nation l 
clinical guid line 
2017 
2.2. Comparis n of Conte t of Selected Clini l Guide ines f r Managing T2DM 
The co tent f the clinical guidelines was co pared based on the following topics by 
using a previously piloted data extracti n form: bl od glucose anagem nt; body weight 
assessment a d managem nt; bloo  pressure m asurement nd managem nt; bl od li-
pids measurement and management; T2DM-associated complications ass ssment and 
management; and other healthcare-related issues and advice. Each guideline was read 
everal times to identify topics/subtopics a d r lated rec mmendation . A full star “
” was assigne to topics/subtopics w th adeq at  formation. A alf-star “ ” wa  
assigned  topics/subtopics wit  l m ted inform t on. “NR” was assig ed to topics/sub-
topics that are not repo ted in the guideline. Two inde end t reviewers (AN and GY) 
were involved in the pr cess, and disagreements w re resolved hr ugh dis ussi n or 
with a th rd rev ew r (KC). 
2.3. Comparison of Qu lity of S lect d Clinical Guideli es for Manag  T2DM 
The quality of the linical guidelines was assessed indep ndently by two reviewers 
(AN and GY) using the Apprais l of Guidelines for Research and Evaluation II (AGREE 
II) tool, whic  is a standar ised and validated i strume t [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scop  and purpose; (ii) st kehol er i volve-
ment; (iii) rigour of dev lop ent; (iv) clarity of pr sentation; (v) applic bility; and (vi) 
editorial indepen nc ) and two global rati g ite s ((i) overall q ality score and (ii) rec-
ommendation for use in practice) [10]. E ch item within t  AGREE II t ol as rat d on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by aximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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(Australia) 
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Diabetes Canada and Canadian iabetes 
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2018 
5 New Zealand Guidelines Group (NZGD) [14] 
Count y-specific (New 
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Country-sp cific (Un ted 
States) Standards of dical care in di betes 
7 Nati al Ins itute for H alth and Care 
Excellence (NICE) [16] (Engl d and Wales) 
Ty e 2 iabetes i  adults: 
ana ent 
20
8 Scottish Intercollegiat  Guidelines 
Network (SIGN) [17] 
Country-specific
(Sc tland) 
Manage ent of diabetes: a national 
clinical guideline 
2017 
2.2. Comparis n of Content of Selected Clinical Guide ines for Managing T2DM 
The content of the clinical guid lines as compared based on the following topics by 
usi g a previous y piloted data extractio  form: blood glucos  manage ent; b dy weight 
assessment and anagement; blood pr ssure measurement and anagement; blood li-
pids measurement n  mana ement; T2DM-associ ted complicati ns assessment and 
ma agement; and other healthc re-relat d iss es and advice. Each gui eline as read 
several times to identify topics/subtopics a d related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assign  to topics/subt pics ith limited informati n. “NR” was assigned to opics/sub-
topics that are n t reporte  i  the guideline. Two independent reviewers (AN and GY) 
were involved in th  process, and disagreements were resolved through disc ssion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality f the clinical guidelines as ass ss d independently by t  reviewers 
(AN and GY) usi g the Appr isal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 items sep rated int  six d m ins ((i) sc pe and purpose; (ii) stakeholder inv lve-
ment; (iii) rig ur of development; (iv) larity f prese tation; (v) applicability; a d (vi) 
editorial independence) and two g obal rati  items ((i) overall quality score and (ii) rec-
ommendat on for use in practice) [10]. Each item within the AGREE II tool was rated o  a 
seven-poi t scale (from 1 = strongl disagre to 7 = trongly agree). Average appraisal 
scores were calculate  for each appraiser by using the average rating (1 (strongly isagree) 
to 7 (strongly agree)) for all items in each domain. Scaled perce tages for each domain 
were then c lculated for inter-domain compariso  by summing the appraisal ratings of 
items within a single domain (obtaine score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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usi g a pr vious y pil ted ata extr cti  form: blood glucose managem nt; body weight 
assessme t and man gement; bl d pr ssur  easureme t and managem nt; bl d li-
pids measurement n  man gement; T2DM-associ ted complications assessmen  and 
manage ent; and other healthc re-relat d issues and advice. Each gui eline was r a
several tim s to identify topics/subtopics a related r comme dation . A full star “
” wa  assigned to topics/subtopi s with ad quate information. A h lf- tar “ ” was 
assign  o topics/subtopics i h limited inform tion. “NR” was assigned to topics/sub-
topics that re t reporte  i  the guid li e. Two independ nt rev e ers (AN and GY) 
were involved in th  process, and disagre m nts wer resolve  through discuss  or 
wi h a third reviewer (KC). 
2.3. Compariso  of Quality of Select d Clinical Guidelin s for Managi g T2DM 
The quality of the clinical guideli es as ss ss d in pendently by t o revi wers 
(AN and GY) using the Appr isal of Guidelines for Research a d Evaluati n II (AGREE 
II) tool, which is a standardised and validated instru e t [10]. T  AGREE II to l com-
prises 23 it s sep rated int  six do ains ((i) scope and purpose; (ii) stakeh ld r involve-
me t; (iii) rig ur f development; (iv) larity of present tio ; (v) ppli a ility; and (vi) 
editorial inde endenc ) an  two g obal rating ite s ((i) ov rall quality scor  an  (ii) r c-
om endat on for use in practice) [10]. Ea h ite  within the AGREE II tool s rated on a 
seven-point scale (from 1 = strongly disagre to 7 = trong y agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (str ngly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then c lculated for inter-domain co pariso  by summing the appraisal ratings of 
items within a single domain (obtaine score), scaling by maxi um and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Compar s n f C tent of Selected Clinical Guide es for Managing T2DM 
The content f the cli ical guide ines was co red ased on the following topics by 
using a pr viously piloted dat  extraction f rm: blood gluc s  m nagem nt; b dy weight 
ssess e t an  anage e t; bl d re sur  mea urement an  man ge ent; blo d li-
pids measur men  and anagement; T2DM-associated complicat ons assessm t and 
managem nt; and other healthcare-relat d issues nd a vice. Each gui eline wa  r a  
ev ral tim s to identify topic /subtopics a d r lated rec mme dations. A full st r “
” as assigned to topics/subt pics with adequate inform tion. A ha f- tar “ ” was 
assigned to op cs/subtopics with limited information. “NR” w s ssigned to topics/sub-
topics th t are n t rep rt d in th guid line. Tw  inde endent reviewers (AN and GY) 
were involved  the r cess, and disagreements were resol  hrough dis ussi  or 
with  third r viewer (KC). 
.3. Compari on of Quality f Selected Cli ical Guidelines for Managin  T2DM 
The qu lity of the clinical g i elines was assessed in p nden ly by two reviewers 
(AN and GY) using the Appraisal of Guid lines for R search and Evaluatio  II (AGREE 
II) tool, which is a standardi ed and validated i strumen  [10]. Th  AGREE II tool com-
prises 23 it s separated into s x dom ins ((i scope and purpose; (ii) stakehol er inv lve-
m t; ( ) rigour of development; ( v) clarity of pr sentatio ; (v) applicab lity; nd (vi) 
edito i l independence)  t o global r ti g e s ((i) ov rall quality scor  and (ii  r c-
ommend tion for use in practic ) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calcul ted for e ch appraiser by us ng th  average r ting (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then c lculated for inter-domain comp r son by summing the appraisal ratings of 
it m  within single do ain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines was su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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Country-specific 
(Canada) 
D  C n 2018 clinical practice 
guid li s f r the prevention and 
management of iabetes in C nada 
2018 
5 N w Z ala  Guideli es Gr p (NZGD) [14] 
Coun ry-specific (New 
Zealand) 
Gu da ce on the management of type 
2 diabetes 2011 11
6 Americ n Diabetes ssoci tion (ADA) [15]
Cou try-sp cific (United 
States) Sta d ds f edical c r  in diab tes 
7 N ional I stitute for H lth an  Care 
Excellence (NICE) [16] 
 
(England and Wales) 
Typ  2 d abetes in adults: 
ana ement 
20
8 Sc ttish I rcollegiate Guidel es 
Ne w rk (SIGN) [17] 
C untry-s ecific
(Sc tland) 
Management f diabetes: a national 
cli ical g i eline 
2017 
2.2. Comp r s n of Conte t of Selected Clini al Gu de ines for Managing T2DM 
Th  co te t f the cli ical guidelines was c pared based o  th  foll wing topic  by 
usi g a previou ly pil e  ata xtracti n for : blood glucose nagem t; body weight 
assessment a  anagemen ; bloo  pre s r  m asuremen  and a gement; bl od li-
pi s measureme t and m n g me t; T2DM-associated com licatio s assessment and 
managemen ; and other ealthcar -rel ed i sues and advice. Each guideline was r ad 
v ral im  t  identi y t pics/subtopics a d r l ed r commendations. A full star “
” w s s igne to t pics/s btopic  w th deq at  ormat on. A lf- tar “ ” as 
assigne  topics/sub opics wit  l mit d inform tion. “NR” was assigned to topics/sub-
top cs hat a  not reported i the gu d lin . Two ind endent reviewers (AN and GY) 
we e in olved in the pr ces , a d dis greem nts were resolved thr ugh dis ussion or 
ith a th rd rev ew r (KC). 
2.3. C mpar son of Qu l ty of S lect d Clinical Gu de ines for Ma agi  T2DM 
Th  qu it  of the clinical guid lines was assess d indep nd ntly by tw  r viewers 
(AN nd GY) using the Apprais l of Guidelines for Research and Ev luation II (AGREE 
II) ol, whic  is  sta d r is d a d v lid ted i strume t [10]. The AGREE II t ol com-
rises 23 it ms separ ted into six domains ((i) scop and purpos ; (ii) st kehol r i volve-
ment; (iii) rigour f develop e t; (iv) cl r ty f p sentation; (v) pplic bility; nd (vi) 
edit rial indepen nc ) and two global rati g ite s ((i) v rall qual ty score and (i ) rec-
mendati n for use in pr c ice) [10]. E ch item within  AGREE II tool was rat d on a
seven-point scale (from 1 = strong y disa ree to 7 = trongly gr e). Avera e appr isal 
scores w  calculated for ach pprais r by usi g t ave a e rat ng (1 ( rongly isagre ) 
to 7 (st ongly ree)) for all ite s in each domain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
items within a singl  do ain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s wa  summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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(Australia) 
Gen r l pr ctice management of typ  
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4
i t  C nada a d Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Can da) 
Diab tes Ca a a 2018 clinical practice 
guid lines for the revention and 
m nag ment of diabetes in Canada 
2018 
5 New Zealand Guidelin s Group (NZGD) [14] 
Coun ry-specific (New 
Zealand) 
Guidanc  on the management of type 
2 diabetes 2011 11
6 m r c n Di bet s A s ci t  (ADA) [15] 
Cou try-sp cific (Unite
States) Sta ards of edical c r  in diab tes 
7 Nati nal Ins tute for H alth nd Ca e 
Excelle ce (NICE) [16] (Engl d an  W les) 
Type 2 diabetes in adults: 
mana ement 
20
8 Sco tish I ercoll gi te Guideli es 
Netw rk (SIGN) [17]
Country-specific 
(S tland) 
Manag ment of di betes: a national 
clinical guideline 
2017 
2.2. omp ris n of Cont t of Selected Clinical Guid in s for Managing T2DM 
Th co ten  f th  cli ic l guidelines as pare  bas d on the following topic  by 
usi g a previou y pilo ed data extraction f r : blood glucose nagem nt; body weight 
ss ss  a  managemen ; blood pressur  m asur m nt a d management; blood li-
pi m a urement nd manag m t; T2DM-associ te com lications assessment and 
manag m nt; and other ealthc r -r la ed sues and a vice. Each g i eline was read 
several time  to id tify topics/subt pics a d r l ted recommend tions. A full star “
” as assigne t p s/s btopics w th adeq at  form tion. A lf-star “ ” was 
assign  top c /subtopics ith l mited inform tion. “NR” was assigned t  topics/sub-
t pic  that r  not reported i  th  guidelin . Two ind endent reviewers (AN and GY) 
ere in lved in the pr c ss, a d disa re ent ere resolved through dis ussion or 
with a th rd r v ew r (KC).
2.3. Compariso  o  Qua ty of Sel cted Clinical Guidelines for Managi  T2DM 
Th qu lity of t e clinic l guidelines w s assessed indep ndentl  by tw reviewers 
(AN d GY) using the Appr is l of Guidelines for ese rch and Ev luation II (AGREE 
II) to l, whic s  stand d nd valid ted instru e t [ 0]. The AGREE II t ol com-
prises 23 it ms separated i to ix dom ins ((i) scop  and purpos ; (ii) stakehol er i volve-
ment; (i i) rig ur of development; (iv) l r t  f pr sentation; (v) applicability; nd (vi) 
ditorial i depen nc ) nd two global rati g ite s ((i) overall qual ty score d (i ) rec-
mm nd ti  for use in practic ) [10]. E ch item within t  AGREE II tool was rat d on a
s v n-point cale (from 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
scor  we calculat d fo  each appraiser by usi g t  average rating (1 ( rongly disagre ) 
to 7 (str ngly agree)) for all items in e ch domai . Scaled per entages for each domain 
were then calculated for inter-domain co parison by summing the appraisal ratings of 
items within a single domain (obt i e  score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
clude g id lines w s summarised nd presented using sum ary statistics (mean). Mean 
score of the dom ins were compared, and the highest and lowest scor s were identified. 
Diabetic ephropathy
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1 
Caribbean Health esea ch Council 
(CHRC) and Pa  American He lth 
Organization (PAHO) [8] 
Country-specific 
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Managing diabetes in primary care in 
the C ribbean 2006 
2 International Diabetes Federation (IDF) [11] International  
Recommendations for managing typ  
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3 
The Royal Australian College of General 
Practitioners (RAC P) [12] 
Country-specific 
(Australia) 
General practice manag ment of type 
2 diabetes 2016  
4 
Diabetes Canada and Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Canada) 
Di betes Canada 2018 clinical pr ctice 
guidelines for th  prevention and 
management of diabetes in Canad  
2018 
5 New Zealand G idelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidance o  the managem nt of typ  
2 diabet s 2011 2011 
6 American Diabetes Association (ADA) [15] 
C ntry-specific (U ited 
States) Standards of medical care in diabetes 20 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Cou try-spec fic 
(England and Wales) 
Ty e 2 iabetes i  adults: 
m nag ent 
2020 
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-spec fic
(Scotland) 
M nagem nt of di b tes: a natio al 
clin cal gu delin  
2017 
2.2. Comparison of Co tent of Selected Cli ical Guid lin s for Managing T2DM 
The content of the clinical guidelines was co pared based on the following topics by 
using a previously piloted data extraction form: blood glucose management; body weight 
assessment and anage ent; blood pre ure measureme t and a agement; blood li-
pids measurement and management; T2DM-associated complications assessme t and 
management; and other healt care-related issues nd advic . Each guideline was r  
several times to identify topics/subtopics nd rel ted recommendations. A full st r “
” was assigned to topics/subtopics with ad quate inform tion. A half-star “ ” was 
assigned to topics/subtopics with limited i formation. “NR” was assig ed to topics/sub-
topics that are not reported in the guideline. Two in pendent revie rs (AN nd GY) 
were involved in the process, and disagreements wer  re olve  through iscussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Select d Clinical Guidelines for Managing T2DM 
The quality of the clinical guidelines was assessed in penden ly by two reviewers 
(AN and GY) using the Appraisal of Guid lines for Res arch and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool co -
prises 23 items separated into six domains ((i) sc pe and purpose; (ii) stakeholder inv lve-
ment; (iii) rigour of development; (iv) cla ity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) ov rall quality score and (ii) re -
ommendation for use in practice) [10]. Each ite  within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagr e to 7 = strongly agree). Average appraisal
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all ite s in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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Country-spec fic 
(Sc tl nd) 
Management f d abe es: a n ti l
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2017 
2.2. Com aris n of Conten of Selected Clinic l Gu de ines f r Managing T2DM 
The content of the clinical guidelines was c mpared based o  the following topics by 
using a previously pil ted data extracti n for : blood glucose management; body weight 
assessme t and manageme t; bl od pre sure easureme t and management; blood li-
pids measurement and man gement; T2DM-associa ed comp catio s assessment and 
managemen ; and other h althcar -rel ted issues nd a v ce. Each guidelin was r ad 
s veral ime  to identify topics/subtopics a d rel ed rec mmen ion . A full star “
” was as igned to topics/ ubto ic  with dequate in rmatio . A half- tar “ ” was
assigned to topics/subtopics with li ited inform tion. “NR” w s assigned to topics/sub-
topics that are not report d in the guid li . Two ind p ndent r view r  (AN and GY) 
were involved in the pr c ss, nd disagreem nts were resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Compari on of Qu l ty of Select d Clinical Gu deli es for Man g g T2DM 
The qu ity of the clinical guid lines was assessed independ ntly by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ool, which is a standa dised and validated instrument [10]. The AGREE II tool com-
rises 23 ite s separ ted into six domains ((i) scope and purpose; (ii) st keholder involve-
ment; (iii) rigour of dev lopment; (iv) clarity of presentat on; (v) pplica ility; and (vi) 
editorial independence) and two global rating items ((i) v rall quality score and (ii) rec-
ommendation for use in practice) [10]. Each ite  within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Avera e appraisal 
scores w re calculated for each apprais r by using the ave a e rat ng (1 (strongly isagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  calculated for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by aximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comparis n of Content f Selected Clinical Guide ines for Managing T2DM 
The content of he clinic  guidelines wa  comp r d based on the f llowing top cs by 
us g a previously piloted data extra ti n form: lood gluc s  manage ent; b dy weigh  
assessmen and anagem nt; bl o  pressure measur ment a  anagem nt; blood -
pids easurem t and mana eme t; T2DM-associated complicati ns assessment and 
ma agement; and other althcare-related iss es nd advice. Each gui eline as read 
several times to identify topics/subtopics a d re ated recommendations. A full star “
” was assigned to to ics/subt ics ith adequate information. A half-star “ ” was 
assigne  to topics/subt pics with limited informati n. “NR” was assigned to opics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, an  disagreements were resolve  through discussio  or 
with  third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality f the clinical guidelines was assessed indep ndently by t  reviewers 
(AN a d GY) u i g the Apprai al of Guidelin s for R arch and Evalu tion II AGREE
II) to l, which i  a stand rdise and validated strument [10]. Th  AGREE II tool com-
prises 23 items separated into six d m ins ((i) sc pe and purpose; (ii) stakehol er inv lve-
ment; (iii) rigour of development; (iv) clarity f pres tation; (v) applicability; a (vi) 
editorial i d pende ce) and two global rati tems ((i) overall quality score and (ii) rec-
ommendation for se in practice) [10]. E ch item within the AGREE II tool wa  rated o  a 
seven-p t scale (fr m 1 = st ongl  d sagree t 7 = strongly agree). Av rage appr isal 
scores were calculate  for each ap raiser by si  the average rating (1 (strongly isagree) 
to 7 (str ngly agree)) for all items in each domai . Scaled perce tages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Comp ris n of Content f S l ct d Cli ic l Guid ines for Managin  T2DM
Th  conte t of the clinical gu d lines as co pared based on the followin  topics by 
usin  a previous y piloted data extractio  for : bl od glucose managem nt; body weight 
sess e t and anage ent; blo d pr ssure easureme t and managem nt; blo d li-
pids measurement n  management; T2DM-associ ted complications assessment and 
managem nt; a d other h alt c re-relat d issues a  advice. Each guid line was re d 
sev ral ti s to id t fy opics/subtopic d relate r commendation . A full st r “
” wa  ass g ed to topics/subtopics ith dequate information. A half-star “ ” wa  
assign  to topic /subtopics ith limited information. “NR” was assigne  to topics/sub-
topics that re t reporte  i  the guideline. Two i ependent rev e rs (AN and GY)
were involved in th  proce s, and disagreements er res lve  th ough discuss on or 
with a thi d reviewer (KC). 
2.3. Comp ris  of Quality of Selected Cli ical Gui elin s for Ma aging T2DM 
The quality of the clinical guid lines as ass ss d in ependently by t o revi wers 
(AN and GY) using the Appr isal of Guidelines for Research and Ev luati n II (AGREE 
II) tool, which is a standardised and valid ted inst u ent [10]. T  AGREE II to l com-
prises 23 ite s sep r ted int  s x s ((i) sco e and purpose; (ii) stakehold r involve-
m nt; (iii) rig ur of evelopme t; (i ) larity of presentation; (v) ppl a ility; and (vi) 
editorial in ependence) an  two g obal rating items ((i) overall quality sc re an  (ii) r c-
ommend t on for use in pr ctice) [10]. Each ite  within the AGREE II tool s rated on a 
seven-point scal  (f o  1 = strongly isagre to 7 = trongly agree). Average appraisal 
scores wer  calculated for each appraiser by using the averag  rating (1 (strongly disagree) 
to 7 (strongly agree))  all items in each domain. Scaled percentages for each domain 
were then c lculated for nte -domain co pariso  by summing the appraisal ratings of 
items within a single domain (obtaine score), scaling by maxi um and mini um possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
clude  guidelines was summ rised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2 . C m riso  of Conte of S l cted Cl al G idelin s for Man gin  T2DM 
The con e  of th  clinical gui elines was co p red based n the following topics by 
usin  a previously pil ted dat  extraction or : blood glucose mana ement; body weight 
sess ent and man gement; bl o  pr ssur  measurement and management; blood li-
pid  mea urem nt and man geme t; T2DM- ssoci t d complications ass ssment and 
manag ent; nd other healthcare-related issues nd advice. Each guideline was read 
s v r l ti  to identify topics/subtopics and re ated recommendation . A full st r “
” was a sig ed to t ics/subtopic  with ad quate inf rmation. A half- tar “ ” wa  
a signed to topic /subto ics with li ite  inform tion. “NR” w s sign d to topics/sub-
topics that are not r port d in the guid lin . Two ind p nd n  r view rs (AN and GY) 
w re involved n the p oc ss, and disagre t  were resolv  thr ugh iscussi n or 
ith a third revi wer (KC). 
2.3. Com ari o of Qu lity of S l ct d Clinical Gui lines or Ma gi g T2DM 
The qu lity of the clinical guid lines was ass ssed in ependently by two r viewers 
(AN nd GY) using the Appraisal of Guidelines f r Research and Evaluation II (AGREE 
II) tool, which is a stan ardised and validated instrument [10]. The AGREE II to l com-
rises 23 i ems separat d into s x domains ((i) scope a d purpose; (ii) st kehold r involve-
ment; (ii ) rigour of developme t; iv cl rity f prese tati n (v) applicability; and (vi) 
editorial independ nce) and two global rating te s ((i) verall q ality score a  (ii) rec-
ommend ti n for us  in practic ) [10]. Each it m within the AGREE II t ol was rate  on a 
seven-point scal  (from 1 = rongly disagree to 7 = stron ly agree). Average appraisal 
scores w re calcul t d f r e ch app is  by using the avera e ratin  (1 (strongly disagree) 
to 7 (st ongly agre )) all items in each domain. Scaled percentages for each do ain 
ere the  calculated f r inte -domain co parison by summing the appraisal ratings of 
tems within a single domain (obtained score), scaling by maxi um and mini um possi-
ble doma n scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidel nes was summ rised and presented us ng u mary statistics (mean). Mean 
scores of the domains were compar , and th  highest and low st scores were identified. 
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 Publishing 
S cieties/Org sations/Ass ciat ons 
G graphy of the 
Guideline
Nam of he Guideline Last 
Updated 
1 
Carib ean Health esea ch Council 
(CHRC) nd Pa A erican He lth
Organization (PAHO) [8] 
Country-specific
(Ca i bean) 
Managing diabetes in primary care in 
the Caribbean 2006 
2 International Di betes Federation (IDF) [11] Intern ional  
R co mendations for managing
2 diabetes in primary care 7
3 
The R yal Australi  College of  
Practiti ners (RAC P) [12] 
Country-specifi  
(Australia) 
G neral pr ctice manag ment of typ  
2 diabetes 2016  
4 
Diabetes Canada and Can dian Diabetes 
Asso iation (CDA) [13]  
Country-specific 
(C nad ) 
Di betes Canada 2018 clinical pr ctice 
guid lines for the prevention and 
management of di betes in Canada 
2018
5 New Z la d G idel nes Group ( ZGD) [14] 
Country-specific (New 
Z aland)
Guidance o  the managem nt of typ  
2 diabet s 2011 2011
6 Ameri n Diabetes Ass ciation (ADA) [15] 
C ntry-specific (United 
Stat s) Standards of m ical care in diabetes  
7 N ti na  Ins itut  for H lth and C re 
Exce l nce (NICE) [16] (Engl nd and Wales) 
Ty e 2 iabetes i  adults: 
mana ent 
20
8 S ot ish I ercollegiate Guideli es 
Network (SIGN) [17]
C untry-sp c fic
(Sc tl ) 
M nagem n  f d betes: a ational
clin cal guid line 
2017 
2.2. C mpar  f t nt of Sel cte  Cli c l Guid s for M ing T2DM
The ntent of th  clinical guide ines was co pared based n the following topics by 
s ng a p eviously p loted data extraction f r : blood glucose mana em nt; body weight 
ssess t and anage t; bl od pr ssure me sure ent and man gement; blo d li-
pi s measur men  and anageme t; T2DM-associated complications assessment and 
manageme t; nd ot er healt car -r lated issu s  advice. Each guideline was r a  
ev ral tim s to id ntify topic /subt pics d r l ted rec mme dat ons. A full st r “
” as a signed t  topics/subtopic  with adeq ate inform tion. A half- tar “ ” was 
a sign d to top cs/subto i s with limited i formation. “NR” w s sig ed to topics/sub-
o ics hat ar  not report d in th  guid line. Two inde end nt review rs (AN nd GY) 
we e inv lv d i  th  p ocess, and disagreemen s wer resol  through is ussi  or 
ith a thi d revi wer (KC). 
.3. Compari on f Quality  Select d Cl ic l Guidelines for Managin  T2DM
T e qu lity of th  clinic l guid lines was assessed in ep ndently by two reviewers 
(AN and GY) usin  the pp isal of Guid lines for R search and Evaluation II (AGREE 
II) tool, which is a st n rdised and validated i strument [10]. Th  AGREE II tool com-
prises 23 it ms separated into s x domains ((i) scope and purpose; (ii) stakehol er involve-
ment; ( ) rigour of development; (iv) clarity of presentat on; (v) applicability; nd (vi) 
edito i l independence) a two global rati g items ((i) overall quality score and (ii) r c-
mmend tion for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly dis gree to 7 = stron ly agree). Average appraisal 
scores were c lcul ted for e ch appr iser by us g th  avera e ratin  (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then c lculated f r inter-domain co p r son by summing the appraisal ratings of 
it m  within single do ain (obtained score), scali g by axi um and mini um possi-
ble domain sco es, and by con ting to a p rcentage [10]. The overall quality of all in-
clu ed guid lines was su marised and prese ted using u mary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and low s  scores were identified. 
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1
Caribbean Health Rese rch Council 
(CHRC) a d Pa  A erican Heal h
Org nization ( AHO) [8] 
Country-specific 
(Ca i bean) 
Ma aging diabet s in primary care in 
the Caribbean 2006 
2 nt rnation l Di betes F dera ion (IDF) [11] International  
R commendations for managing
2 diabet s in primary care 7
3 
Th  Royal Austral  College of Ge eral 
Practiti ner  (RAC P) [12] 
Country-specific
(Aus r lia) 
G eral pr ctice a a e t f typ  
2 diabetes 2016  
4 
Diabetes C nada nd Canadian Diabetes 
Associatio  (CDA) [13]  
Country-specific 
(Canada) 
D  C n d 2018 clinical practice 
guid li s f r the prevention and 
management of iabetes in C nada 
2018 
5 N w Z la d G idelines Gr p (NZGD) [14] 
Coun ry-specific (New 
Zealand) 
Gu da ce on the management of type 
2 diabet s 2011 11 
6 Americ n Diabetes ssoci tion (ADA) [15]
Cou try-sp cific (United 
States) Sta d ds of edical c r  in diab tes  
7 N ional I stitu e f r H lt  an  Care 
Excel e ce (NICE) [16] 
 
(Engl nd and Wales) 
Typ  2 d abetes in ad lts: 
ana ement 
20
8 Sc t ish I rcollegiat Guideli es 
Ne w rk (SIGN) [17] 
C unt y-s ec fic
(Sc tl nd) 
Manageme t f diabetes: a n ti al
l ical g i eline
2017 
2.2. Com r s  of Conte of Selected Clini al Gu de ines for Manag g T2DM 
Th  co tent f the clinical guidelines was co pared based o  the foll wing topics by 
using a p eviously pil ted ata xtraction f r : blood glucose anagem nt; body weight 
asse ment a d manageme t; bloo  pressure m asurement and a agement; bl od li-
pi s measureme t and n gement; T2DM-associated complicatio s assessment and 
man gemen ; and other h alth are-r l ted issues nd a vice. Each guideline was read 
everal ime  to i enti y topics/subtopics a d r l ed r commendations. A full star “
” was as igne to t ics/subto ic  w th adeq at  rmatio . A alf- tar “ ” as 
assigned  topics/subtopics wit  l ited inform tion. “NR” w s assigned to topics/sub-
topics that a  not r ort d i the g id line. Two ind endent r viewers (AN and GY) 
we e inv lved in th pr c s , d disagr em nt  w re resolve  thr ugh dis ussion or 
ith a th rd rev ew r (KC). 
2.3. Compar on of Qu l ty of S lect d Clinical Gu de ines f r Ma gi  T2DM
Th  qu ity of the clinical guid lines was assessed indep nd ntly by two reviewers 
(AN nd GY) using the Apprais l of Guidelines for Research and Evaluation II (AGREE 
II) ool, whic  is a ta dar is d and v lidated i strume t [10]. The AGREE II tool com-
rises 23 it ms separ ted into six domains ((i) scop and purpose; (ii) stakehol er i volve-
ment; (ii ) rigou  of develop e t; (iv) cl rity of pr sentation; (v) applic bility; and (vi) 
edit ial indepen nc ) and two global ati g ite s ((i) v rall quality score and (ii) rec-
mmendation for use in prac ice) [10]. E ch item within t  AGREE II tool was rat d on a 
seven-point scale (from 1 = st ongly dis ree to 7 = strongly gree). Average appraisal 
scores w re calculated for each pprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly ree)) for all ite s in each domain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
item  within a s l  do ain (obt ined score), scaling by maximum and minimum possi-
ble d main scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guidelin  wa  su mari ed and prese ted usi g su mary statistics (mean). Mean 
scores of the domains were compar d, and the highest and lowest scores were identified. 
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1 
Caribb n Health Research Council 
(CHRC) nd Pa  Americ n Health 
Organization (PAHO) [8] 
Coun ry-spec fic 
(Ca ib ean) 
Managing diabetes in primary care in 
the Caribbean 2006 
2 Int rn tio al Di b tes Fed ration (IDF)[11] International  
R com nd i ns for managing
2 diabetes in primary care 7
3
The Roya  Australia  College of Ge er l 
Practiti ers (RAC P) [1 ] 
C untry-specif  
(Australia) 
Gen r l pr ctice manag ment of typ  
2 diabetes 2016  
4
i t  C nada a d Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Can da) 
Diab t s Ca ada 2018 clinical practice 
guid lines for the revention and 
m nag ment of diabetes in Canada 
2018 
5 New Zealand G idel n s Gr up (NZGD) [14] 
Coun ry-specific (New 
Zealand) 
Guidanc  on the management of type 
2 diabet s 2011 11 
6 mer c n Diabet s A s ci t  (ADA) [15] 
Cou try-sp cific (Unite
States) Sta ards of edical c r  in diab tes  
7 Nati nal Ins tute for H alth nd Ca e
Exc lle ce (NICE) [16] (Engl d an  W les) 
Type 2 diabetes in adults: 
mana ement 
20
8 Sco ish I ercoll gi t  Guideli es 
Netw rk (SIGN) [17] 
Country- pec fic 
(S tland) 
Manag t of di betes: a n ti al
clinical guideline 
2017 
2 2. m a is  of Co te of Selected Clinical Guid in s fo  Managing T2DM 
The co te  f th  clinic l guidelines as compared based on the following topics by 
usin  a previous y piloted data extraction f r : blood glucose managem nt; body weight 
ses  a d management; bl od pressure m asur m nt and management; blood li-
pi m a urement nd manageme t; T2DM-associ te  complications assessment and 
manag m nt; nd other healthc re-relat d ssues nd a vice. Each gui line was read 
s v ral ti  to identify topics/sub pics a d r l ted recommend tions. A full star “
” wa  assig e o t p cs/subtopics w th ad q at  f rm tion. A alf-star “ ” was 
assi n  top c /subto ics ith l ite  inform tion. “NR” w s assigned t  topics/sub-
t pic  that r  n t rep rt d i  th  guideline. Two ind endent r viewers (AN and GY) 
w r  inv lved in the pr c ss, d disa re ment ere resolve  through dis ussion or 
with a th rd r v ew r (KC). 
2.3. Compari o  Qu ty of S l ted Clinical Guidelines for Man gi T2DM 
Th  qu lity of t e clinic l guid lines w s assessed indep ndentl  by two reviewers 
(AN nd GY) using the Appr is l of Guidelines for ese rch and Evaluation II (AGREE 
II) tool, whic s  standar ised and validated instru e t [10]. The AGREE II tool com-
prises 23 it ms separat d into x dom ins ((i) scop  and purpos ; (ii) stakehol er i volve-
ment; (i ) rigour of developme t; iv l r ty of pr sentation; (v) applicability; and (vi) 
editorial indepen nc ) and two global rati g ite s ((i) overall quality score d (ii) rec-
mm nd tion for use in practic ) [10]. E ch item within t  AGREE II tool was rat d on a 
s ven-poi t scale (from 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
scor  wer calculat d f  each app aiser by using the average rating (1 (strongly disagree) 
to 7 (str ngly agre ))  all items in e ch domai . Scaled per entages for each domain 
were then calculated for inte -domain co parison by summing the appraisal ratings of 
tems within a single domain (obt i e  score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
clude g id lines w s summ rised nd presented using sum ary statistics (mean). Mean 
score of the dom ins were compar , and the highest and lowest scor s were identified. 
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 Publishing 
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Ge graphy of the 
uideline 
Name of h  Guideline Last 
Updated
1 
Caribbean Health esea ch Council 
(CHRC) nd Pa  American He lth 
Organization (PAHO) [8] 
Country-specific 
(Ca ibbean) 
Managing diabetes in primary care in 
the aribbean 2006 
2 International Di betes Federation (IDF) [11] International  
R commendations for managing
2 diabetes in prima y care 7 
3 
The Royal Australian College of General 
Practitioners (RACGP) [12] 
Country-specific 
(Australia) 
General pr ctice m nagement of typ  
2 diabetes 2016  
4 
Diabetes Canada and Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Canada) 
Di b tes Ca a a 2018 clinical pr ctice 
guidelines for th  prevention and 
management of diabetes in Canad  
2018 
5 New Zealand Guidelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidance o  the management of typ  
2 diabetes 2011 2011
6 American Diabetes Association (ADA) [15] 
C ntry-specific (U ited 
States) Standards of edical care in diab tes 
7 Nati nal Ins itute for H alth and Care 
Excellence (NICE) [16] 
 
(E l nd nd Wales) 
Ty e 2 iabetes i  a lts: 
m a ent 
20
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-specific 
(Sc tland) 
Managem nt of di b tes: a natio al 
clin cal gu deline 
2017 
2.2. Comparis n of Co tent of Selected Clinical Guid in s for Managing T2DM 
Th  content of the cli ical guidelines was co pared bas d on the following topic  by 
using a previou ly pilo ed data extraction form: blood glucose agement; body weight 
assess ent an  an ge en ; blood pre ur  measureme t nd man gement; blood li-
pids measurement and manag me t; T2DM-associated com lications assessme t and 
management; and other ealthcare-related i sues and advice. Each guideline was read 
several times to identify topics/subtopics and related recomm ndations. A full star “
” was assigned to t pics/s btopics with adequate information.  h lf-star “ ” was 
assigned to topics/subtopics with limited inf rmat on. “NR” was as igned to topics/sub-
topics that are not reported in the guidel n . Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through iscuss on or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Select d Clinical Guidelines for Managing T2DM 
The quality of the clinical guidelines was ass ssed in penden ly by t  reviewers 
(AN and GY) using the Appraisal of Guid lines for Res arch and Ev luation II (AGREE 
II) tool, which is a stand rdised and valid ted i strument [10]. The AGREE II t ol co -
prises 23 items separated into six domains ((i) sc pe and purpos ; (ii) stakehol er inv lve-
ment; (iii) rigour of development; (iv) cla ty f presentation; (v) applicability; nd (vi) 
editorial independence) and two global rating items ((i) ov rall qual ty score and (i ) re -
ommendati n for use in practice) [10]. Each ite  within the AGREE II tool as rated on a
seven-point scale (from 1 = strongly disagr e to 7 = strongly agree). Average appraisal
scores we  calculated for each appraiser by usi g t  average rating (1 ( rongly disagre ) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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(Australia) 
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2018 
5 New Zealand G idelines Gr p (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidance on the management of type 
2 diabet s 2011 2011
6 American Diabetes ssociati n (ADA) [15] 
Coun ry-specific (Uni  
States) Stand ds of medical care in diab tes  
7 Nati nal Ins itute for H alth and Ca e 
Excellence (NICE) [16] (England and Wales) 
Ty 2 ab te   adults: 
ana ent 
20
8 Scottish Int rcollegiate Guideli es 
Network (SIGN) [17] 
Country-spec fic 
(Sc tland) 
Management of diabetes: a n ti l 
linical guid line 
2017 
2.2. Comparis n of Conte t f Selected Clini l Gu de i es f r Managing T2DM 
Th  content of the clinical guidelines was c pared based on the following topics by 
using a previously pil ted data extracti n for : bl od glucose anagement; body weight 
assessment and manage t; bl  pre sure m as rement nd managem nt; bl d li-
pids measurement and man gement; T2DM-associa ed comp catio s assessment and 
managem n ; and other h althcar -rel ted issues an  adv ce. Each guidelin  was r ad 
veral ime  to identify topics/subtopics a d rel ed rec mendation . A full star “
” was as igned to topics/subto ic  with dequate in ormation. A half- tar “ ” was
assigned to topics/subtopics wit  lim ted inform t on. “NR” was assig ed to topics/sub-
topics that are not repo ted in the guid lin . Two ind pende t reviewers (AN and GY) 
were involved in the process, and disagreem nts w re resolve  hr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comparison of Qual ty of S lected Clinical Gu deli es for Manag ng T2DM 
The qu ity of the linical guid lines was assessed independ ntly by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Ev luation II (AGREE 
II) ool, which is a standa dised and valid ted i st ument [10]. The AGREE II tool com-
rises 23 items separ ted into six ns ((i) sco e and purpose; (ii) st keholder involve-
ment; (iii) rigour of ev lop ent; (iv) clarity of presentat on; (v) ppl c ility; and (vi) 
editorial in ependence) an  two global rating ite s ((i) v rall quality sc re and (ii) rec-
ommend tion for use in practice) [10]. E ch item within th  AGREE II tool as rated on a 
seven-point scale (f om 1 = strongly isa ree to 7 = strongly gree). Avera e appraisal 
scores w re calculated for each apprais r by using the ave a  rat ng (1 (strongly isagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  calculated for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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(Australia) 
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2 diab tes 2016  
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(Canada) 
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guid lines for th revention an  
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2018 
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Country-specific (New 
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Guidance  he managem t of t pe 
2 diabetes 2011 2011 
6 merican D abetes Association (ADA) [15] 
C ry-sp cif c (Unite  
States) Sta dards of edical c r  i  diab tes 2020 
7 National Institute fo  Health a d Ca e 
xcellence (NICE [16] 
Co ry- pecific 
(E l d an  W l s)
Type 2 diab t in adults: 
an ge ent 
2020 
8 Scottish Intercolle iat  Guidelines 
Network (SIGN) [17] 
Country- pecific
(Scotlan ) 
Ma ag nt of di e es: a national 
clin cal gui elin  
2017 
2.2. Comparison of Co e t f Selected Clinical Gu d lin s for Managing T2DM 
Th  co tent f the cli ical guid lines as c mpared bas d on the following topic  by 
sing a previou y pilo ed data extractio f r : blood glucose nagem nt; body weight 
a sessment a  anage e ; bl od pr ur  m asurement n  a ageme t; blood li-
pids m as rem nt n  manag m ; T2DM-assoc ted com lications assessment and 
manag ment; and other ealthc re-r la d i sues and a vice. Each guideline was read 
several times to identify topics/subt pics and r lated recommendations. A full st r “
” was a signe to t pics/s btopics w th adeq at formation. A lf-star “ ” was 
a sign  topics/ ub opics ith l mited inform tion. “NR” was a signed to topics/sub-
t pics that are n t reporte  i  the guideli e. Two in e endent revie ers (AN and GY) 
were inv lved i th  pr cess, and disag ements were resolved through dis ssion or 
with a th rd rev ew r (KC). 
2.3. Comparison of Quality of Sel ct d Clinic l Guidelines for Managi  T2DM 
The quality of the clin cal guidelines as ass s d in ep ndently by tw  reviewers 
(AN a d GY) u ing the Appr i l of Guidelines for Research and Ev luation II (AGREE 
II) tool, whic  is  stand r is d and valid ted instru e t [10]. The AGREE II t ol com-
pris s 23 tem  sep rated int ix dom ins ((i) scop  and purpos ; (ii) stakehol er i volve-
m nt; (iii) rigour of development; (iv) l r ty f pr sentation; (v) applicability; nd (vi) 
e it rial i epen nc ) and two g obal rati g items ((i) overall qual ty score and (i ) rec-
mmendat n for use i  prac ice) [10]. E ch item w hin t AGREE II tool was rat d on a
seven-point cale (from 1 = strongly di agre to 7 = trongly agree). Average appraisal 
scor s we  lculated for each appraiser by usi g t  ave ag rating (1 ( rongly disagre ) 
to 7 (strong y agree)) for all ite s in e ch do ain. Scaled percentages for each domain 
were then c lculated for inter-domain co pariso  by summing he appraisal ratings of 
tems within a single do ain (obta e score), scaling by aximum and mini um possi-
ble domain scor s, and by conv rting to a percentage [10]. The verall quality of all in-
clude  guidelines w s summarised and presented using sum ary statistics (mean). Mean 
score  of the dom ins were compared, the highest and lowest scores were identified. 
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2.2. Comp ris n of Co t f Selected Cli ic l Gu d ines for Managin  T2DM 
Th  conte t of the cli ical g d lines as co pared based on the following topics by 
usin  a pr vious y pil ted da  extracti  for : bl od glucose management; body weight 
sess e t and an ge e t; bl d pr ss r  easureme t nd management; blood li-
pids measurement n  man gement; T2DM-associ ted complicatio s assessment and 
manage n ; and other healt c re-rel t d issues an  advice. Each guideline was re d 
s veral i  to ide tify topics/subtopics a rel ed recom endation . A full st r “
” wa  as g ed to topics/subtopics ith d quate in ormation. A half- tar “ ” wa  
a sign  o topic /subtopics ith limited inform tion. “NR” was assigned to topics/sub-
topics that are t reporte  i  the guid li . Two ind pendent revie rs (AN and GY) 
were involved in th  proce s, and disagre m nts ere resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Comp riso  of Qual ty of Sel cted Clinical Gu delin s for Managing T2DM 
The qu ity of the clinica guid lines as ss ss d in epend ntly by t o reviewers 
(AN and GY) using th  Appr is l of Guidelines for Research and Ev luation II (AGREE 
II) ool, which is a s a dardised and valid ted inst u ent [10]. The AGREE II tool com-
rises 23 ite s sep r ted int  s x s (( ) sco e and purpose; (ii) stakeholder involve-
m nt; (iii) rig ur f v lo me t; (i ) larity of presentation; (v) appl cability; and (vi) 
editorial in ependenc )  two g obal rating items ((i) v rall quality sc re and (ii) rec-
ommend t on for use in pr ctice) [10]. E ch ite  within the AGREE II tool as rated on a 
ven-po t cal  (f om 1 = strongly isa re to 7 = trongly gree). Average appraisal 
scores w r  calculat d for each apprais r by using the avera  rat ng (1 (strongly disagree) 
to 7 (st ongly agree))  all items in each domain. Scaled percentages for each domain 
w re the  c lculated for nte -domain co pariso  by summing the appraisal ratings of 
items within a singl domain (obtaine score), scaling by maxi um and minimum possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
clude  guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
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2.2. Comp r s  f C tent of Selecte  C i ical Guid n s for M ing T2DM
The ntent of the cli ical guide ines was co pared based on the following topics by 
sing a p eviously piloted ata xtraction f rm: blood glucose management; body weight 
sse s e t and an g t; bl od pressure measurement nd management; blood li-
pi s measur me  and anageme t; T2DM-associated complications assessment and 
management; and ot er healt care-related issues nd advice. Each guideline was r a  
ev ral tim s to identi y topic /subtopics nd rel ted recommendat ons. A full star “
” as assigned to topics/subt pics with adequate inform tion. A half-star “ ” was 
assigned to op cs/subtopics with limited i formation. “NR” was assig ed to topics/sub-
topics that a  not report d i  th guideline. Two independ nt review rs (AN nd GY) 
we e involved i  the r ces , a d disagreements wer  resolve  through iscussion or 
with a third r viewer (KC). 
.3. Com ar on f Quality f Select d Cli ical Gui elines for Managing T2DM
T qu lity of the clinical gui lines was assessed in ependently by two reviewers 
(AN nd GY) usin  the pp isal of Guidelines for Research and Evaluation II (AGREE 
II) tool, whic  is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 it s separated into s x domains ((i) scope and purpose; (ii) stakeholder involve-
m t; ( ) rigour of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
edit ial ndependence) and two global r ti g items ((i) overall quality score and (ii) rec-
mmend tion for use in prac ic ) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly dis gree to 7 = strongly agree). Average appraisal 
scores were calcul ted for e ch ppraiser by us ng th  average rating (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each domain 
were then c lcul ted for inter-domain comp r son by summing the appraisal ratings of 
it m  within single do ain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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2.2. Com r s n of Conte of Selected Cli i al Gu de ines for Manag g T2DM 
Th  content of the clinical guidelines was co pared based on the following topics by 
using a previously pil ted ata xtraction for : blood glucose anagement; body weight 
asse ment and manag ment; blood pressure measurement and management; blood li-
pi s measureme t and man gement; T2DM-associated complicatio s assessment and 
managemen ; and other healthcare-rel ted issues nd a vice. Each guideline was read 
v ral ime  t  identi y topic /subtopics a d rel ed r commendations. A full star “
” w s s igned to topics/subtopics with adequate in rmatio . A half- tar “ ” as 
assigned to topics/subtopics with li ited inform tion. “NR” w s assigned to topics/sub-
top cs hat  not report d i  the guid line. Two ind pendent r viewers (AN and GY) 
we e involved in the proc s , d disagr em nts w re resolve  thr ugh discussion or 
ith a third reviewer (KC). 
2.3. Compar on of Qu l ty of S lect d Clin cal Gu de ines for Ma gi g T2DM
Th  qu it  of the clinical guid lines was assessed independ ntly by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ool, whic  is  tandardised and validated instrument [10]. The AGREE II tool com-
rises 23 it ms separ ted into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour f develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
edit rial independence) and two global rating items ((i) v rall quality score and (ii) rec-
mmendation f r use in prac ice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
sco es w re calculated for each pprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly ree)) for all ite s in each do ain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
items within a singl  do ain (obtained score), scaling by maximum and minimum possi-
b e domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s wa  summarised and presented using su mary statistics (mean). Mean 
scores of th  domains were compared, and the highest and lowest scores were identified. 
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2.2. om is n of Co t f Selected Clinical Guid in s fo  Managing T2DM 
The content of th  clinic l gui elines as compared based on the following topics by 
usi g a previous y piloted data extraction f r : blood glucose management; body weight 
sses  an  manageme t; blood pressure measurem nt and management; blood li-
pid mea urement nd management; T2DM-associ te  complications assessment and 
m nag m nt; and other healthc re-relat d ssues nd a vice. Each gui line was read 
several time  to identify topics/sub pics a d r lated recommend tions. A full star “
” wa  assigned o t p cs/subtopics with adequate inf rm tion. A half-star “ ” was 
assi n to top c /subtopics ith li ited information. “NR” w s assigned to topics/sub-
t pics that ar  n t rep rt d i  th  guideline. Two ind pendent r viewers (AN and GY) 
were in lved in the proc ss, d disa reement ere resolve  through discussion or 
with a third reviewer (KC). 
2.3. Compari  o  Qu ty of S l ted Clinical Guidelines for Man ging T2DM 
Th  qu lity of the clinic l guidelines was assessed independently by two reviewers 
(AN nd GY) using the Appr isal of Guidelines for ese rch and Evaluation II (AGREE 
II) tool, which s  standardised and validated instru ent [10]. The AGREE II tool com-
prises 23 it ms separated into ix dom ins ((i) scope and purpos ; (ii) stakeholder involve-
ment; (i i) rigour of development; (iv) l r ty of presentation; (v) applicability; and (vi) 
ditorial i depend nce) and two global rating items ((i) overall quality score and (ii) rec-
mm nd tion for use in practice) [10]. Each item within the AGREE II tool was rated on a 
s ven-poi t scale (from 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
scor  wer calculat d fo  each appraiser by using the average rating (1 (strongly disagree) 
to 7 (str ngly agree)) for all items in e ch domai . Scaled per entages for each domain 
were then calculated for inter-domain co parison by summing the appraisal ratings of 
items within a single domain (obt i e  score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
clude g id lines w s summarised nd presented using sum ary statistics (mean). Mean 
score of the dom ins were compared, and the highest and lowest scor s were identified. 
Antiplatelet tr atm nt
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2.2. Comparison of Co tent f Selected Clinical Guidelines for Managing T2DM 
The cont nt of the clinical guidelines was co pa ed based on the following topics by 
using a pre iously piloted data extraction for : blood glucose managemen ; b dy weight
assess ent and man gement; blood pressure meas r ment nd man gement; blood li-
pids meas rement and management; T2DM-ass ciated compli ation  ssessment and 
management; and ot r health are-rela ed is s and advice. Each guideli e was read 
several times to identify topics/subt pics nd r lat  rec mm ndations. A full star “
” was assigne  to top cs/sub opics with adeq a e nformation.  half-star “ ” was
assigned to topics/subtopics with limited i formatio . “NR” was assigned to topics/ ub-
topic that are not reported in the guideline. Two independent reviewe s (AN n  GY
were involved in the process, a d dis greements were esolved hrough discussion or
ith a third reviewer (KC). 
2.3. Co parison of Qu lity of Selected Clinical Guid li s f r Ma agi  T2DM
The quality of the clin cal guidelines was assesse independe t y by two reviewers
(AN and GY) using the Appraisal of Guidelines for Research and Ev uatio  II (AGREE 
II) tool, which is a standardised and validat d in trument [10]. The AGREE II ol com-
pris  23 items separated into six domains ((i) sc pe a d purpos ; (ii) stakehold r involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; an  (vi) 
editorial independe ce) and tw  global rating items ((i) verall quality score and (ii) rec-
ommendation for use in practice) [10]. Each ite  within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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The content of the cl ical guid lines was compa ed based o  the following topics by 
using a pre iously pil ted dat  extractio f r : bl od glucose m ag m nt; body weig t 
assessment and manageme t; bl od pressur  m as rement and management; bl d li-
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managemen ; an  other health ar -rel ted s s nd a vic . Each guide ine was re d 
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topics that are not reported i  the g id lin . Two in pe dent reviewer  ( N and GY) 
w re involved in the rocess, d d agreem nts were esolv  thr ugh discussion or 
ith a third eviewer (KC). 
2.3. Comparison of Qual ty of Selected Cli ic l Gu deli es for Managing T2DM 
The qu ity of the linic l guid lines was assesse  ind pen tly by tw  reviewers
(AN and GY) using the App aisal of G ideli s for Rese rch and Evaluation II (AGREE 
II) ool, which is a standar ised a d validated in rument [10]. The AGREE II ool com-
rises 23 items separ ted into six dom i s ((i) sc pe and purp se; (i ) akeh ld r inv lve-
ment; (iii) rigour of evelopment; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independe ce) and two global rating items ((i) v rall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
scores w re calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  calculated for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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ent; (iii) rigou  f evelopme t; (iv) clari y f pres t tio ; (v  ap lic bility; a  (vi) 
editorial ind p nd e) a d two global r ting items ((i) overall qualit  sco e and (ii) c-
menda i  for use in practice) [10]. Each it m within t  AGREE II t ol wa  rat d o  a 
seven-point scale (from 1 = strongl  dis gre  t  7 = trongly gree). Av rag  i l 
s wer  c lculat  for ach ppraiser b  usi g the av rage rati g (1 (strongly is gree) 
to 7 (stro gly agree)) for all items in each domain. Scaled perc tag s for a h do in 
were th n calculated for inter- omain comparison by summing th  appraisal rati g  of 
it ms within a si gle domain (obtain d score), scaling by aximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR NR
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Updated 
1 
Carib an Health Res rch Cou cil 
(CHR ) an  Pa  Americ  Health 
Org iza on (PAHO) [8] 
Country- pecifi  
(Caribb ) 
Managing diabetes in pri ary care i  
the Caribbean 2006 
2 Internatio al iabetes Federat on (IDF) [11] Inter a ion l  
Recommendations for ma aging type 
2 iabet s in primary care 2017 
3 
The Roy l Australi  College of Ge r l 
Pr ctition rs (RACGP) [12] 
Coun ry-specific 
(Australia)
General pr ctice management of type 
2 diabetes 2016  
4 
Di t  Ca ada a d Can d an Diab tes 
Asso i tion (CDA) [13]  
t - fi  
(C na a) 
Diab tes Canada 2018 linic l practice 
guideli es for the prevention nd 
m nagement of diabetes in Can a 
8 
5 New Z ala d Guidelines Gr up (NZGD) [14] 
Country- pecific (New 
Zealand) 
Guida c  on the manag m nt f ty  
2 diabetes 2011 2011 
6 Americ n Di betes Association (A A) [15] 
Country-sp cific (Unite  
St tes) Standards of medical care in di bete  2020 
7 Natio l Institut  for Health an  C r  
Exc llence (NICE) [16] 
Country-specific 
(Engla d nd Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Scottish I ercol egiat  ui elines 
N twork (SIGN) [17] 
Country-specific 
(Scotland) 
Management of diabetes: a national 
clinical guideline 
2017 
2.2. Comparison of Co tent of Selected Clinical Guidelines for Managing T2DM 
The cont nt of the clinical guidelines was compared based on the following topics by 
us  a pre iou ly piloted data extraction fo : blood glucose managemen ; b dy weight
ssess t and man gement; blood pressure measur ment nd management; blood li-
pi s meas r ment a d ma ag ment; T2DM-ass ciated complications assessment and 
agem t; and t  ealth are-r la e  is u s and advic . Each gu deli e was read 
s veral times to identify topics/subt pics nd related rec mmendations. A full star “
” was assigned o top cs/sub opics with dequate nformation. A half-star “ ” was
a igned to t pics/ ub opics with limited information. “NR” was assigned to topics/sub-
topic that e not r ported  the guideline. Two independent reviewe s (AN an  GY
we e inv lved i  the rocess, a d dis greements were resolved hrough discussion or
ith a third reviewer (KC). 
.3. Co ariso  of Q  of Selecte  Cli ic l Guid ines for Managing T2DM 
T e quality of the clin cal guidelines was asse sed independe tly by tw  reviewers 
(AN and GY) using the ppraisal of Guidelines for Research and Ev uation II (AGREE 
II) tool, which is a standardised validat d instrument [10]. The AGREE II tool com-
pris  23 it ms s parated into six domains (( ) scope a  purp s ; (ii) stakeholder i volve-
ment; ( i ) rigo r of development; (iv) clarity of presentation; (v) applicability; and (vi) 
e itorial in epende ce) and tw  global rating items ((i) overall quality score and (ii) rec-
mmendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then c lculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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1
C ribb H alth Res rch Cou cil
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Organiza ion (P HO) [8] 
Cou try-specific 
(Caribbean) 
M agi g i bet s in pr ary care in 
the Caribbea  2006 
2 Int rnation l Diab tes F deration (IDF) [11] I tern tional  
Recommendation  for managi g type 
2 i b t s in primary car  2017 
3 
Th  Royal Australian College of General 
Pra ition rs (RACGP) [12]
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Ge eral practice management of type 
2 diab tes 2016  
4 
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Associ tion (CDA) [13]  
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(Can a) 
Diabetes C nad  2018 linical practice 
uid li s f r th  pr vention and 
manage e t f abete  in Canada 
8 
5 New Z ala d Guidelines Gr p (NZGD) [14] 
Country- pecific (New 
Ze l n ) 
Guidance on the management of type 
2 diabet s 2011 2011 
6 Americ n D abetes s ciation (ADA) [15] 
Country-specific (Unite  
States) Stand s of medical care i  iabetes 20 0 
7 N tional Instit t  for H alth and Care 
Excellenc  (NICE) [16] 
Country-specific 
(England and Wales) 
Type 2 diabetes in adults: 
management 
20 0 
8 Scott h In collegiat  Guid li s 
N twork (SIGN) [17] 
Country-specific 
(Scotland) 
Management of diabetes: a national 
clinical guidel ne 
2017 
2.2. Comparison of Conte t of Selected Clinical Gu delines for Managing T2DM 
The content of the cli ical guidelines was compared based o  the followi g topics by 
using a pr ious pil ted dat  extractio  f r : blood glucose manag ment; body weight 
assessment and manageme t; bl od pressure measurement and management; blood li-
pi s measur me t a d man gement; T2DM-associated complicatio s assessment and 
manageme ; an  ot er health ar -rel ted i su s and advic . Each guideline was read 
s v ral ime  t  dentify topics/subtopics and rel ed recommendations. A full star “
” was as igne to t pics/ ubtopics with dequate in rmation. A half- tar “ ” was 
a sig ed to opics/subtopics with limited inform tion. “NR” was assigned to topics/sub-
topics that are not reported  th  guid lin . Two ind pe dent reviewers (AN and GY) 
w  involved in the pro ess, d disagreem nts were esolve  thr ugh discussion or 
ith a h r  eviewer (KC). 
2.3. Comparis n of Qual ty of Selected Clinical Gu delines for Ma aging T2DM 
The qu ity of the linical uid lines was assessed indepen ntly by two reviewers 
(AN and GY) usi g the App aisal f G ideli s for Research and Eval ation II (AGREE 
II) ool, which is  standardised a d validated in rument [10]. The AGREE II tool com-
rises 23 it ms separ ted i t  six dom i s ((i) sc pe and purpose; (i ) stakeholder involve-
ment; (iii) rigour of evelopment; (iv) clarity of presentatio ; (v) applicability; and (vi) 
editorial independe ce) an  two global rating items ((i) v rall quality score and (ii) rec-
mmendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
scores w re calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  calculated for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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(CHR ) an  P  American Health 
Org n zat o (PAHO) [8] 
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h  Roya Australia  ollege of Ge eral 
Pr ti ion rs (RACGP) [12] 
Country-specific 
(Australia) 
Gen r l practice management of type 
2 diabetes 2016  
4 
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As oc atio (CDA) [13]  
t - ifi  
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Diab tes Canada 2018 linical practice 
guid lin s for th  pr vention an  
m nag ment f iab te in Ca ada 
8 
5 New Zealand Guidelin s Grou  (NZGD) [14]
Coun ry-specific (New 
Ze land) 
G idanc  on the management of type 
2 diabet  2011 2011 
6 er can D bete Asso i ti n (ADA) [15] 
Cou try-specific (United 
States) St ards of edical care in diabetes 2020 
7 Natio al I stitute for Health n  Ca e 
Excellence (NICE) [16] 
Country-specific 
(Engl d and Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Scott sh Int rcoll giate Guidelines
N twork (SIGN) [17] 
Country-specific 
(Scotland) 
Manag ment of di betes: a national 
clinical guideline 
2017 
2.2. omp rison of Conte t of Selected Clinical Guidelines for Managing T2DM 
The content f th  cli ic l guidelines as compared based on the following topics by 
sin  a pre iou y piloted data extraction f rm: blo d glucose management; body weight 
ssessm nt an manag me t; blood pressure measurem nt and management; blood li-
pi s measurement nd managem nt; T2DM-associ te  complications assessment and 
manag ment; and other health re-related ssu s and a vice. Each gui eline was read 
sever times to id ntify topics/subt pics and related ommend tions. A full star “
” was assign d  top cs/subtopics with adequ  inform tion. A half-star “ ” was 
assign to top cs/ ub opics ith limited information. “NR” was assigned to topics/sub-
t pic  that are n t reported i  h  guideli e. Two ind pendent reviewers (AN and GY) 
w re inv lve  in the proc ss, a d di a re ment were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comp ris n of Qua ty of Sel cted Clinical Guidelines for Managing T2DM 
Th  qu lity f the clinic l guidelines was assessed independently by two reviewers 
(AN and GY) usi g the Appr isal of Guide nes or ese rch and Evaluation II (AGREE 
II) tool, which s  tandardised and validated i stru ent [10]. The AGREE II tool com-
rises 23 items separated into ix dom ins ((i) scope and purpos ; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) l r ty of prese tation; (v) applicability; and (vi) 
editorial independe ce) and two lobal rating items ((i) overall quality score and (ii) rec-
mm ndation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
s ven-point scale (from 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
scor  wer  calculated fo  each appraiser by using the average rating (1 (strongly disagree) 
to 7 (str ngly agree)) for all items in e ch domai . Scaled per entages for each domain 
were then calculated for inter-domain co parison by summing the appraisal ratings of 
items within a single domain (obt i e  score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
clude g id lines w s summarised nd presented using sum ary statistics (mean). Mean 
score of the dom ins were compared, and the highest and lowest scor s were identified. 
Perip eral arterial
dise se NR NR NR
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1
Caribbean Health Research Council 
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2 iabetes in primary care 7 
3 
The Royal Australian College of General 
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Country-specific 
(Australi ) 
General practice management of type 
2 iabetes 2016  
4
Di betes anada and Can dian Diabet s 
Association (CDA) [ 3]  
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(Can a) 
Diabetes Canada 2018 clinical practice 
guidel nes f r th  prev nti n and 
anagement of diabetes in Can da 
2018
5 New Zealand G i li s Group (NZGD) [14] 
Cou try-specific (New 
Zea and) 
Guidance on the management of type 
2 di b tes 2011 2011 
6 A erica  Diabetes Association (ADA) [15] 
Country-specific (United 
States) Stan ard of medi al c r in diabetes 2020 
7 National Inst ute for Health nd Care 
Excellence (NICE) [16] 
Country-specific
(England a d Wal s) 
Type 2 diabetes i adults: 
manage en  
2020 
8 Sc ttish Inter oll giate Gui lines 
N twork (SIGN) [17] 
Cou try-specific 
(Sc tla )
M n geme t of diabe s:  n ion l 
cli cal guidel ne 
2017 
2.2. Comparison of C nt t of Selected Clinical Guidel nes for Managing T2DM
T e c nt f th  cli ic l guid line  was c mpa ed b ed o t e oll wi top cs by 
u i g  pre i usly pilo  data extr ctio  for : l d gluc s  man ge n ; b dy eig t 
asses m t and management; blo  r sure easur me nd ma age nt; blood i-
pi s m as rem  and a g m nt; T2DM- cia d co pli t ons asses ent and 
man gem nt; nd o r ealthc r -relat d ssues a d dv ce. E ch guidel  w  re d 
several time  t  entify t ic /subtopics nd elat reco endati n . A full s a “
” was ssigned to topics/subt pics w th deq ate format o . A h lf- r “ ” wa  
signed o topics/ u opics with l ited infor ti . “NR” was a sign d to topi /sub
topics th t are not r p rt d in he guideline. Tw  ind p d nt revi w rs (AN an  GY) 
w re invo v d i the proces , a d disagreements w e res lv through d scu i or
with a thi  review r (KC). 
2.3. Co pariso  f Quality of Selec ed Clinic l Guideli e  f Managing T2DM
The quality of the cli ical uid line  w s ses d i depend ntly by two r vi wers 
(AN and GY usi g th  App isal of Guideline  f r R arch nd Ev luati  II (AGREE 
II) to l, which is  standardised and val da ed instrum nt [10]. The AGREE II t ol com
pr s  23 ite s p ated i o six domains ((i) s pe nd purpos ; (ii) s akeh de  inv lve
ment; (iii) rigour of evelop ent; (iv) clari y of p e tation; (v) applicability;  (vi) 
editorial i d p d ce) a d tw  gl b l rating it ms ((i) over ll qu lity core and (ii) r c-
ommendatio for use in practice) [10]. Each it  w thi  the AGREE II tool was r ted on  
even-point scale (f om 1 = str ngly disa to 7 = st o gly agree). Average appraisal 
scores were calculated for each ap raiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were the  calculated fo  inter- omain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
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2 diabetes 2011 2011 
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(Scotland)
M n gem n  of iabete :  na onal 
clinical guideline 
2017 
2.2. Compar son f C te t f S lected Cl ical Guidelines for Managi g T2DM 
The co t  f th clinic l guide in  was comp red b sed on e oll wing topics by 
usi  a re i usl pilot  d  ext ction f r : b d gluc  managem t; body weight 
asses m nt  man me t; bloo  ressu e m asur m t nd ma agem nt; blood li-
pids m a reme  a d a agement; T2DM- ciat d ompli t ons asses men  and 
ma gement; and o r al hc re-rel ted ss es and advice. E ch guideli e was re d 
s ver l t m s to id ify to ic /subtop cs d rela  r comme tions. A full star “
” was assigned  topic /subtopics with dequate inform tion. A half- t r “ ” was 
a sig ed to op cs/subt ics w th l it d f rmat . “NR” was as ign d to topics/sub
topi s th t ar  n t r port d in th  guid line. Tw  in p ndent rev w rs (AN n  GY) 
were involv d i th pr ce ,  d s gr ments were e olved through discussion or
ith a thi d r vi w  (KC).
2.3. Co rison of Quality of Se ected Cli c l Guideli es for Managing T2DM 
T  qu l ty of the clini al guid lines w  ss sed indep nde tly by tw  evi wers 
AN and GY) using the Appr isal of Gui line  for Re earch d Ev luation II (AGREE 
II) to l, which i  a standardised  valid ted instrum nt [10]. The AGREE II tool com
pris s 23 it ms s pa ated i o x domain  ((i) scope  purp s ; (ii) stakeho de  i volve
m nt; (i i) igo r of developmen ; ( v) cl rity of pr s ntation; (v) applicability; nd (vi) 
ito i l i end ce) and tw  global r ti g it ms ((i) verall quality core and (ii) c-
ommendation for use in ract ce) [10]. Each item within the AGREE II tool was r ted o  a 
ve -point scal (fr m 1 = str ngly di agr  to 7 = tro gly agree). Averag  apprais l 
s ores were calcul ted for e ch appraiser by us ng th  average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated f  inter-domain comp r son by summing the appraisal ratings of 
it m  within  single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines was su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
NR NR
Diab tic fo t (foot care)
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2.2. Comparison of Conte t f S lected Clinical Gu d in s fo Managi g T2DM 
The co t nt f the clinic l guid ines was co pared b ed on  llowing topics by 
u ing a pre i usly pilot  da a extraction for : blo d glucos  manage t; b dy weight 
asses ment and management; blood pr ssure measur me  nd ma ag ment; bl od li-
pids measuremen  and man gem nt; T2DM-associated c mplication  ass ssme t and 
management; and other healthcare-related issues and a vice. Each guideline was re d 
several time  to identify to ics/subtopics nd rela  r comme tions. A full star “
” was assigned to topics/subtopics with adequate inf rmation. A half-star “ ” was 
assigned to topics/subtopics with li ited i f rmati . “NR” was as ign  to topics/ ub-
topics that are not reported in the guideline. Two indepen ent rev w rs (AN and GY) 
were involv d i  th  pr cess, nd disagreements w re esolved through discussion or 
with a third reviewe  (KC). 
2.3. Co parison of Quality of Se ected Clinical Guidelin s for Managing T2DM 
The quality of the clinical guid lines wa  assess d indep nde tly by two vi w rs 
(AN and GY) using the Appr isal f Guid line  for R earch d Ev luati  II (AGREE 
II) tool, which is a standardised and validated ins rum nt [10]. The AGREE II ol com
pris s 23 items s parated i o six domains ((i) s ope a d purpo ; (ii) stakeho d  involv
ment; (iii) rigour of development; (iv) clarity of pres ntatio ; (v) applicability; a  (vi) 
editorial i depend ce) and tw  global r ting it ms ((i) verall quality co  an  (ii) c-
ommendation for use in practice) [10]. Each ite  within the AGREE II tool was r ted o  a 
even-point scale (from 1 = str ngly disagr  to 7 = tr gly agree). Average ap raisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
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General practice nagement of type 
2 diabetes 2016  
4 
Diabetes Cana a and Can dian Diabet s 
Association (CDA) [ 3]  
t s  
(Cana a) 
D abetes Can d  2018 clinical pract  
guid li es for the prevention and 
m n gem nt of iab t s in Canada 
18 
5 New Z aland Guidelines Group (NZGD) [14] 
Cou ry- p cific (New 
Zeala ) 
G idance o  t e manag ent f t pe 
2 diabe es 2011 2011 
6 erica  Diabetes Association (ADA) [15] 
Count y- pecif c (United 
Sta s) Sta rds of edical c re in diabete  2020 
7 National Institute for Health a d Care 
Excelle ce (NICE) [16] 
Cou try-specif c 
(E gl d and Wales) 
Type 2 d bete in adul s:
ma ge n  
2020 
8 Scottish Intercolle iat  uideline  
N twork (SIGN) [17] 
Cou try-specific
(Scotla ) 
Ma ag m n  f i bet s: a tio al 
clin cal guideline 
2017 
2.2. Co pari on of Conte t f S l cted Cli ical Guid l nes f r Managi g T2DM
T e co tent f th  cli ical guid i es s comp red b e  on t e llowi g topics by 
u ing  previ us y piloted da a ex ractio  for : blo  lucos  anagem n ; body weight 
asses me t a d anage ent; blood pr su  measur me t nd ma ag m nt; blood li-
pids measure e  n  man gement; T2DM-a oci t d complications assess  nd 
manag ment; and ther h althc re-relat d issues and advice. Each guideline w s r d 
sever l ti e  to i entify top c /subtopics a d r la  recom e atio s. A full s r “
” was assigned to topics/subt pics with dequate informat on. A half- t r “ ” w s 
assign  to topics/su topics ith limited i for ation. “NR” wa  a ign d to topic / ub-
topics th t re t reporte  i  the gu deline. Two i d pend nt v rs (AN and GY) 
were involved in th  pr cess, n i agreements w re es lve  thr gh discu i  r 
with a th r  rev ewe (KC). 
2.3. Comparison of Quality of Se ected Clinical Guidel s fo  Man ging T2DM 
The quality of the clinical uid lines ss s d i ep nde tly by tw  evi w rs 
(AN and GY) usi g t  Ap isal of Guid lines for R a ch d Ev luati n II (AGREE 
II) tool, which is a standardised d v lidated in ru nt [10]. The AGREE II tool com-
pr s s 23 items ep rated i  six dom ins ((i) sc pe a d urpose; (ii) stakeh lde  involve-
ment; (iii) rig ur of develop ent; (iv) larity of pre tation; (v) applicability; nd (vi) 
editorial i d p d ce) and tw  bal rating it ms ((i) v r ll quality score nd (ii) c-
ommendat o  for use in practic ) [10]. Each it m wi hin the AGREE II tool was r ted on  
even-point scale (from 1 = str ngly disag to 7 = t o gly agree). Av rage apprais l 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then c lculated for inter-domain compariso  by summing the appraisal ratings of 
items within a single do ain (obtaine score), scaling by maximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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The Royal Australian Col ege of General 
Practitioners (RACGP) [1 ] 
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Ge eral pr ctice manage ent of typ  
2 diabetes 2016  
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Diabetes Can da nd Can dia  Diabet s 
Association (CDA) [ 3]  
tr -s ecific 
(Can a) 
Diabet  C nad 2018 clinical practice 
guideli es for the preventi n and 
anagement f iabete  i  Can da 
2018
5 New Zealand Guidelines Gr p (NZGD) [14] 
Country-s cific (New 
Zea a d) 
Guidance n the ma age ent of type 
2 di b tes 2011 11
6 A eric  Diabetes s ociati n (ADA) [15] 
Cou ry-specific (United 
States) Stan d  of medical c r  in diabetes 
7 Nati nal Ins ute for H alth nd Care 
Exc llence (NICE) [16] (E gland and Wal s) 
Type 2 diabetes ad l s: 
ma a e e  
20
8 Scottish Int r oll giate Gui lines 
N twork (SIGN) [17] 
Country-specific 
(Sc tla )
Man gement of di be s:  n i n l 
cli c l guid l ne 
2017 
2.2. Comp rison f Cont nt of Se ected Clinic l Gu d es for Managing T2DM
T  c t f the cli ic l gu d line  was co pared b ed o  t e ollowin  top cs by
u i   pre i usly pil te data ex r ctio  for : blo d gluc s  an ge n ; b dy weig t 
s s t and anage nt; blood r sure m asur me  nd manag ment; blood li-
pi s m as remen  a d man gement; T2DM-a ocia d c plicatio s asses ent and 
managem n ; a  o r healthc re-rel ted ssues a d advice. E ch guidel  w  read 
s veral i  t  i e tify to ic /s btopics d el d recom e dati ns. A full s a “
” was as g ed to topics/subtopics ith dequate i ormat on. A h lf- r “ ” wa  
ass gned o topic / ubtopics with li ited infor t . “NR” was a sign d to t pi /sub
topic  th t are ot r ported in the gui lin . T  i d p d n  review rs (AN an  GY) 
were in olv d i the proce , a d disagreem nts w re res lv thr ugh d scu i or
ith a thi d review r (KC). 
2.3. Co p riso  f Qual ty of Selec ed Clinic l Gu deli e  f Managing T2DM
The qu ity of the cli ical uid line  w s s d i epend tly by two r vi wer  
(AN and GY) usi g th  App isal of Guideline  f r R arch nd Ev luati  II (AGREE 
II) ool, which is  standar ised a d valida ed i s rument [10]. The AGREE II t ol com
r s  23 items p r ted i o x d ains ((i) s p a d purpos ; (ii) akeh de  inv lve
m t; (iii) rig ur of velop e t; (i ) clari y of pre tation; (v) applicability;  (vi) 
editorial i d p d ce) nd tw  gl bal rating it ms ((i) v r ll quality core and (ii) r c-
ommendatio  for use in pr ctice) [10]. Each it m within the AGREE II tool was rated on  
even-point scal  (f om 1 = strongly disa  to 7 = st ongly gree). Average appraisal 
scores w r  calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree))  all items in each domain. Scaled percentages for each domain 
w re the  calculated for nte -domain co parison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maxi um and minimum possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
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1 
Caribbean Health Research Council 
(CHR ) n  P  Amer  Health 
Organization (PAHO) [8] 
Country-specif c
(Ca i bea ) 
Managi g di b tes i  pri ary car   
the Caribb an 2006 
2 International Di betes F deration (IDF) [11] Int r tio al  
R commendations for managing
2 iabetes in primary care 7 
3 
The Royal Australian College of  
Practit oners (RA GP) [1 ] 
Country-specific 
(Austr lia) 
G neral pr ctice ma age ent of typ  
2 diabetes 2016  
4 
Dia etes Ca ad  a  Can dian Diabet s 
As oci tion (C A) [ 3]  
o tr -s ecific 
(Cana a  
Diabet  Canada 2018 clinical practice 
guidelines for the prevention and 
m nagement f diabetes i  Canada 
2018 
5 New Z al nd Guidel nes Gr up (NZGD) [14] 
C un ry-spec fic (New 
Z aland)
Guidance on the ma agement of type 
2 diabetes 2011 11
6 Ameri an Diabetes Associ tion (ADA) [15]
Count y-specific (United 
Stat s) Standards of medical c re in diabetes 
7 Nati al In itute for Health d C re 
Exc len e (NICE) [16] (Engl nd and Wal s) 
Type 2 diabetes in ad l s: 
man emen  
20
8 Sco ish In ercollegiat  ui elines 
Network (SIGN) [17] 
C untry-specif c 
(Scotland)
M n gem n  of i bete :  n al 
clinical guidelin  
2017 
2.2. Com r son of C te t f S lec ed Cl ical Guid nes for Managi g T2DM
Th  co te t f th  clinic l guide ine  was comp red b sed on e oll wing topics by 
u in  a pre i u ly pilo  a xt acti n f r : b d luco  manage nt; body weight 
asses ment  manag me t; blood r ssu e m asur m t nd ma agem nt; blood li-
pi s m a reme  a d a agement; T2DM- ciat d ompli t ons ass s men  and 
an gement; and o r ealthc re-related ss es nd advice. Each guideline was re d 
ev ral t m s to identi y to ic /subtopics nd rel  r comme tions. A full star “
” was ssigned t  topics/subtopics with dequat  information. A half- t r “ ” was 
as igned t  o cs/sub o ics with l ited i f r at . “NR” was as ign d to topics/sub
topi s that a e n t r port d  th  guid line. Tw  in p ndent rev w rs (AN n  GY) 
we  involv d i th  pr ces ,  d s gr ments were solved through discussion or
with a thi d r vi w  (KC). 
2.3. Co r son of Q y of Se ecte  Clin c l Guideli es for Managing T2DM 
T  qu l ty of the clini al guid lines w  ss sed indep nde tly by tw  evi wers 
AN nd GY) using the pr isal of Gui line  for Re earch d Ev luation II (AGREE 
II) to l, whic  is a stand rdi ed  validated instrum nt [10]. The AGREE II tool com
pri s 23 it ms s parated i o s x d main  ((i) scope  purp s ; (ii) stakeho de  i volve
ment; (i i) rigo r of dev lop en ; ( v) clarity of pr ntation; (v) applicability; nd (vi) 
ito i l i p nd ce) and tw  global r ti g i ms ((i) v rall quality core and (ii) c-
mmendation for use in pr c ice) [10]. Each item within the AGREE II tool was r ted o  a 
ve -p int scal (fr m 1 = str ngly disagr  to 7 = stro gly agree). Averag  apprais l 
scores were calcul ted for e ch ppraiser by us ng th  average rating (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each domain 
were then calcul ted for inter-domain comp r son by summing the appraisal ratings of 
it m  within  single do ain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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Coun ry-specific (New 
Zealand) 
Guidance on the management of type 
2 diabetes 2011 2011 
6 America  Diab tes ss ciation (ADA) [15]
Coun y-specific (United 
States) St nd s of medical c re in diabetes 2020 
7 National In itut  for Health n  Care 
Excellence (NICE) [16] 
C untry-s ecif c
(England nd Wales) 
Type 2 d abetes i adults:
manage en  
20 0 
8 Scottish In collegiate uid li s 
Network (SIGN) [17] 
C u try-s ecific 
(Sc land)
Man gem n  f diabetes: a a ional
cli ical gui el ne 
2017 
2.2. Co p r on of Conte t of S l cted Cli i a  Gu del nes for Managing T2DM 
Th  co t nt f the cli ical guid l nes was co pare  b sed o  t e ollowi g topics by 
u ing a pr i u ly pilo ed ata x rac ion f r : blo d gluco  nagem nt; body weight 
ass ment an  manag m nt; blood pr ssure m as re e t and manag me t; blood li-
pi s meas reme  a d agement; T2DM- ociated co plicatio assessm  and 
ma agem ; a o r healthcar -rel ted ssues and vice. Each guid li e was re d 
ver l  t i enti y to ic /subtopics r l d rec mm n ations. A full star “
” w s as ign  o t pi s/subt pi s with dequa e in or tion. A half- ar “ ” w s 
assigned to ics/subt pic  with li ted inf r tio . “NR” was ssign d t  topics/s b
t pics th t  o  r ported i  the guid l . Two i d pend nt reviewers (AN an  GY)
w  i volv d i  the roc , a d di agr em t  were resolved thr ugh disc ssion or
ith  i d review  (KC). 
2.3. C par son of Quality of S lected Clinical Gu deli es for Managing T2DM 
T  qu ity of th  lini al uid lin s was as ssed ind pen ently by two reviewers 
(AN nd GY) u ing the Apprais l G id li e  for Re e rch nd Ev l ation II (AGREE 
II) ol, w ic  is a stand ised a  valid ted i strument [10]. The AGREE II tool com
ri s 23 it ms s p r ted i  six d mains ((i) sc p a d purpos ; (ii) takeho d  involve
ment; (iii) rig r of evelop t; (iv) cl rity of pr sentatio ; (v) applicability; and (vi) 
edit rial i dep nde ce)  two glob l rating it ms ((i) v rall qu l y core and (ii) c-
ommendation f r use in pr c ic ) [10]. Each item within the AGREE II tool was ated on a 
ven-p int scal (from 1 = strongly disa re  to 7 = strongly gre ). Average appraisal 
sco es w re calculated for each pprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly ree)) for all ite s in each domain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
items within a singl  do ain (obtained score), scaling by maximum and minimum possi-
b e domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s wa  summarised and presented using su mary statistics (mean). Mean 
scores of th  domains were compared, and the highest and lowest scores were identified. 
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The Roya  Australia  College of Ge eral 
Practiti ers (RACGP) [12] 
Country-specif  
(Aus rali ) 
Gen r l practice management of type 
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i te  C nad  a  Can dia  Diabe s 
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(C n da) 
Diab tes Canada 2018 clinical practice 
guid lines for the prevention and 
m nag m nt of diabetes in Canada 
2018 
5 New Z ala d Guide in s Grou  (NZGD) [14] 
Coun ry-specific (New 
Zealand) 
Guidanc  on the management of type 
2 diabetes 2011 2011 
6 eri n Di bet s Associat n (ADA) [15] 
ou try-sp cific (United
Stat s) Sta ards of edical c re in diabetes 2020 
7 Nation l Institute for Health  Ca e 
Excelle ce (NICE) [16] 
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(E gl d an  Wales) 
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8 Scot ish I rc l i te Guidel e  
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Ma g ment f di betes: a ional 
cl nical guidel ne 
2017 
2.2. o p rison f C nte  of Sel cted Cli ical Guidel n s f Managing T2DM
T co n  f th  cli ic l guidel nes as com ared b sed on t e ollowing topics by 
u i  a p i u y ilo data extraction f r : blo d luco  m nagem t; body weight 
sses  and ma agement; blo d pr ssure measure e t and management; blood li-
p d m a reme  nd managem nt; T2DM- oci te  complicati s assessment and 
m nag m t; nd r healthc re-relat d sues and a vice. Each gui li e was re d 
s ve l i  t  ide tify to ic /subt pics d relat d eco men tions. A full star “
” as ssigned o op cs/subt pic with dequate inform tion. A h f-s r “ ” w s 
a sign to t p c / u topics ith li ited i format . “NR” was ssign d to topics/s b
t ics th t are not r port d  th  guide e. Two ind pendent rev ewers (AN an  GY)
were inv lv d i the proce , a d di a re ment were r solve  through discussion or
with a thi d review r (KC). 
2.3. Co p rison o  Qua ty of Selected Clinical Guidel es f r Man ging T2DM
Th  qu l y of the clini l u delines was ss ssed independently by two reviewers 
AN nd GY) usi g the Appr isal of Guideline  for e e rch n  Ev luation II (AGREE 
II) to l, which s  tandardised d validated instru ent [10]. The AGREE II tool com
pris s 23 ms p rated i o ix dom ins ((i) scope and purpos ; (ii) stakeho de  involve
me t; (i i) rigour of devel pment; (iv) l r ty of prese ation; (v) applicability; and (vi) 
ditori l i d pende ce) and two lobal rating it m ((i) overall qual ty core and (ii) r c-
mm nd tio  for se in actice) [10]. Each it m within he AGREE II tool was rated on a 
ve -poin  scale (from 1 = stron ly disagre  to 7 = trongly agree). Average appraisal 
scor  wer calculat d fo  each appraiser by using the average rating (1 (strongly disagree) 
to 7 (str ngly agree)) for all items in e ch domai . Scaled per entages for each domain 
were then calculated for inter-domain co parison by summing the appraisal ratings of 
items within a single domain (obt i e  score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
clude g id lines w s summarised nd presented using sum ary statistics (mean). Mean 
score of the dom ins were compared, and the highest and lowest scor s were identified. 
Periodontal dis ase NR NR NR NR NR
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2.2. Comparison f Co te t of S lected Cl ical Guid nes f r Managi g T2DM
The cont t of th  clinical guidelines w s co pared based on the following topics by 
usin  a pre iously piloted data extr cti n for : blood glucos  manage nt; body weight 
assessment and an ge ent; blood pressure m asurement and management; blood li-
pids m as rement a d ma gement; T2DM- ciat d complications asses ment and 
ma gement; nd o r ealthc re-rel ted ss es and advice. Each guideli e was re d 
sev ral t m to id ify to i /subtopics a d relat d recomme d tions. A full st r “
” was assign d t  topics/subtopics wi h dequate information. A half-st r “ ” was 
a sig ed to o cs/subt ics w th l ited f rm t . “NR” was as ign d to topics/sub
topi s th t ar  n t r ported in the guideline. Tw  in p nden  rev wers (AN an  GY) 
were involv d i th  r ce , dis gr ements were esolve  through discussion or
with a thi d r vi w  (KC). 
2.3. Co rison of Quality f Se ected Cli c l Guideli es fo  M naging T2DM 
T  qual ty of the clini al guid lines was ss ssed in epende tly by tw  eviewers 
(AN and GY) using the Appraisal  Gui eline  for Re earch nd Ev luation II (AGREE 
II) tool, which is a standardised  validated instrument [10]. The AGREE II tool com
prises 23 it ms s parated int  six domains ((i) scope a  purp s ; (ii) stakeho der i volve
ment; (iii) rigo r of development; (iv) clarity of presentation; (v) applicability; and (vi) 
itorial in pende ce) an  tw  global rating items ((i) overall quality core and (ii) r c-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single do ain (obtained score), scaling by aximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR NR
Cancers NR NR
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u d li es f r the preven ion d 
manag me t f diab tes i  C da
2018 
5 New Zeala Guidelines Group (NZGD)[14] 
Cou t y- pec fic (New 
Zeal ) 
Guida c on the ma g m nt of ype 
2 ia te  2011 2011 
6 Ameri a  Diabetes As oc a ion ADA 5  
Count y-spe if c (Unit
States) St n ards of e ical ar  in di betes 2020 
7 National Institute for Health and Care 
Excellence (NI E) [16]
Country-specif  
(England and Wales) 
Type 2 di be s in dult : 
a gement 
2020 
8 Scottish Intercollegiate Guidelines 
Netw rk (SIGN) [17] 
Country-specific 
(Scotland) 
Manage ent of diabetes: a national 
clinical guideline 
2017
2.2. Comparis n of Co te t of S lecte  Cli ical Guidelines for Managing T2DM 
The c te t of the cli ic l guidelines was co p ed based o t  following topics by 
us g a previously piloted data extracti n form: od g uc s  ma ag men ; b d w ight 
ass ssment and ma agem nt; bl d pressure asur me t and m nage nt; bl od li-
ids e surem nt and manage ent; T2DM- ss ciat d co plicati ns s ssme t nd 
managemen ; and oth r heal hcare-related is ues nd dvi e. Each uid lin  s read
s ver l tim s to id tify t pics/subt ics nd rela ed rec mm nd tions. A full st r “
” was s ig d to o cs/ ubtopics th ad qu te infor tio . A half-st r “ ” was 
ass gn d t  t pics/subtopics with li e  i formation. “NR” w s assigned to t pics/sub-
top c  that are not reported in the guidel ne. Tw  ind pendent review s (AN and GY) 
were involv d in the pr ces , and dis greem nts were e lved through di cu io  or 
ith a third re iewer (KC . 
2.3. Co parison of Quality of Selected Clinical Guid lines for Managing T2DM 
The quality f th  clinical guidelines was assessed indep nd tly by tw  revie ers 
(AN and GY) using the Apprai al of Guidelin s for R s arch and Evalu tion II (AGREE 
II) to l, which is a standardised an  validated i strument [10]. The AGREE II tool com-
p ises 23 ite s separated into six do i s ((i) sc pe nd purpose; (ii) stakehol er involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; an  (vi) 
editorial i dependence) and two global rating items ((i) over ll quality score and (ii) rec-
om endation for se i  practice) [10]. E ch item within the AGREE II tool wa  rated on a 
sev n-point scale (fr m 1 = st ongly disagree t  7 = strongly agre ). Average appr isal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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Diab tes C d  2018 cli ical pra t
guideli  for h p eventio  an  
an gement  iabe es n C a 
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5 N w Zeala i eli es Gr (NZG )[14] 
Cou -specif c (New 
Zeal d) 
G a c n the manag nt of ype 
2 iab te  2011 2011 
6 Ameri an Diabetes s c ati n (ADA) [15] 
Country-sp cific (Unite
Sta e ) Sta d ds of c l care in diabete 2020 
7 National In titute f r H alth and C re 
Exc lle c  (NI E) [16] 
Country-specific 
(E glan   Wal s) 
Typ 2 diabe es i  dult : 
a ge ent 
2020 
8 Scottish Int rcollegiate Gui eli es
N twork (SIGN) [17] 
Country-specific 
(Scotland)
Manage ent of diabetes: a national 
clinical guidel ne
2017 
2.2. Comparison of Cont t of Select d Cli ical Gu elines for Managing T2DM 
Th  content of the cli ic l guidel nes w s compared as d on the following t i  by 
us g  pr viously piloted d t  extr cti  for : l od g uc s  man g ment; body weight 
assessm nt an  managem t; bl od pressur m asur me t a d management; blo d li-
ids asur m t and a g ment; T2DM-ass ciat d co p icat o s sses men  a d 
managemen ; and other healthcare-r l ed i su s nd dvic . Each uideli  w s re d 
s ver l im  t ide tify t pics/s bto cs a d rel e  recomm ndations. A full st r “
” was s ig to to ics/subtopics ith a qua e r tion. A half- t r “ ” was 
ass gn d t  topics/subtopics ith li it d i form tion. “NR” as ss gned to t pics/sub-
top cs that re not reported i  th  guid lin . T  ind pe ent revie rs (AN a d GY) 
w re involve i  th proces , disagree nt re e olve  thr ugh d scussio  or 
ith a third eviewer (KC . 
2.3. Co parison of Qual ty of Selected Clinical Gu delines for Managing T2DM 
The qu ity f th  clinical guid li es was assessed indep nd ntly by tw  reviewers 
(AN and GY) using the App ai al of Guidelin s for Res arch and Evalu tion II (AGREE 
II) o l, which is a st ndardised and validated i strument [10]. Th  AGREE II tool com-
rises 23 items separ ted i to six dom ins ((i) sc pe and purp s ; (ii) stakehol er inv lve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; an  (vi) 
editorial i dependence) and two global rating items ((i) v rall quality sco e and (ii) rec-
ommendation for se in practice) [10]. E ch item within the AGREE II tool wa  rated on a 
seven-point scale (f m 1 = t ongly disa ree t  7 = strongly gree). Average appr isal 
scores w re calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  calculated for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR NR
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Pr ti io ers (RACGP) [12] 
C untry- pec ic 
(Australia) 
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2 diab tes 2016  
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Diab e Canada and Canadia  abetes 
Ass ci i  (CDA) [13]  
Cou try- pecific 
(Canada) 
D ab t C a 2018 clinical pract e
gui eline  for th  prevention d 
a a e e t f di betes in Ca ad
2018 
5 N w Z ala  Gu d lin s Gr up (NZGD)[14] 
C u ry-specif c (N w
Z l nd) 
Gu a  n th ma ag m nt of typ  
2 iabetes 2011 2011 
6 Ameri n Diab es A oci ti n (ADA) [15]
C untry-specific (United
States) Sta dar s f d cal c re in diabete  2020 
7 N ional In titut for Health and Care 
Exc ll nce (NICE) [16] 
Country-specific 
(E gl  a  Wales) 
Type 2 diabe es in dult : 
man gement 
2020 
8 Scottish Int rcollegiate Guidelines 
Netw rk (SIGN) [17] 
C untry-specific 
(Scotland) 
Management of diabetes: a national 
clinical guideline 
2017 
2.2. Comp r son of Content of Selected Cli ic l Guidelines for Managing T2DM 
Th  ntent of th  clinical guideli es w s c mpared based on the following topics by 
usi g a viously pil ted ta xtraction for : bl od glucose management; body weight 
ssessm nt nd man g ment; bloo  pressur  m asur ment a d management; blood li-
pids m sur me t an  nag ment; T2DM-ass ciat d c plication  a essment and 
a ag m nt; a d oth r healthcare-rel ed issues and advice. Each guideline was read 
everal times t  identi y t pics/s btopics and re ated recommendatio s. A full star “
” w s assig to topics/ btop c  ith ad quate formation. A half-star “ ” was 
assigned to topic /subtopics with li ited inf rm . “NR” was ssigne  to topics/sub-
topic  th t  ot eported i  the gui elin . Two ind pendent reviewers (AN and GY) 
were involve i  the proc s , disagre ent  w re res l d t r ugh di cussi n o  
w th a thi d reviewer (KC). 
2.3. Compar son of Quality of Selected Clinical Guidelines for Managing T2DM 
Th  quality f th  cli ical guidelines was ass ss d ind pendentl  by two re iewers 
(AN nd GY) using the Appr isal of Guideline  f r Research nd Evaluation II (AGREE 
II) tool, whic  is a stand dised nd validated instrument [10]. The AGREE II tool com-
prises 23 it ms separ ted i to six do ains ((i) scope and purpose; (ii) st keholder involve-
ent; (iii) rigour f development; (iv) clarity of presentation; (v) applicability; and (vi) 
edit rial independen e) a d two global rating items ((i) verall quality sc re and (ii) rec-
o ndatio  f r u in prac ice) [10]. Each item withi  the AGREE II tool w s r ted on  
seven-p int scale (from 1 = stro gly disag  to 7 = strongly agree). Average appraisal 
sco es were calculated for each ppraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each domain 
were then calcul ted for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
b e domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines wa  summarised and presented using summary statistics (mean). Mean 
scores of th  domains were compared, and the highest and lowest scores were identified. 
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Excellence (NI E) [16] 
Country-specific 
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Type 2 diabe es i  dult : 
man gem nt 
2020 
8 Scottish I ercol giate uideli es 
Netw rk (SIGN) [17]
Country-specific 
(Scotland) 
Manag ment of di betes: a national 
clinical guideline 
2017 
2.2. Comp rison of Co t t of Selected Clinic l Guidelines for Managing T2DM 
Th  c tent of th  clinical guidelines was c mpared based on the following topics by 
using a reviously piloted data extraction f rm: lood glucose management; body weight 
ssess  a  m nagem nt; bl od pressure measur m nt and management; blood li-
id a urem nt and managem nt; T2DM- ssociated complication  a essment and 
m nag t; nd other healthca e-re ated ssu s and a vice. Each gui eline was read 
several tim s to identify topics/subtop cs d related recommend tions. A full star “
” was signed to top cs/sub opic th ad qu te inform tion. A half-star “ ” was 
ssign d to top c /subtopics with li ited i formation. “NR” was ssigned to topics/sub-
t pics that are ot eported in th  gui eline. Two independent reviewers (AN and GY) 
wer  inv lved in the proc ss, d disagre ments were esolved t rough discussion or 
w th a thi d re iewe  (KC). 
2.3. Comparison of Qua ty of Selected Clinical Guidelines for Managi g T2DM 
The quality f th  cli ic l guidelines was ass ssed ind endently by two reviewers 
(AN nd GY) u ing the Appraisal f Guidelines fo  Rese rch and Evaluation II (AGREE 
II) tool, which is  standardised n  validated instrument [10]. The AGREE II tool com-
prises 23 it s separated into six do ins ((i) sco e and purpos ; (ii) st keholder involve-
ment; (i i) rigour of d velopment; (iv) cl r ty of presentation; (v) applicability; and (vi) 
editorial i depend n e) and two global rating items ((i) over ll quality sc re and (ii) rec-
m d tion for s in practice) [10]. E ch item within the AGREE II tool was r ted on a 
s ven-p int scale (fr m 1 = strongly disagre  to 7 = strongly agree). Average appraisal 
scor s wer calculat d for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (str ngly agree)) for all items in e ch domai . Scaled per entages for each domain 
were then calculated for inter-domain co parison by summing the appraisal ratings of 
items within a single domain (obt i ed score), scaling by axi u  and minimum possi-
ble domain scores, and by conv rtin  to a perc ntage [10]. The verall quality of all in-
cluded g idelines w s summarised and presented using sum ary statistics (mean). Mean 
score of the dom ins were compared, and the highest and lowest scor s were identified. 
S xual prob ems in men
an wome g NR NR
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Exc llence (NI E) [16] 
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managem nt
2020
8 Scottish I erco legiate Gui eli es 
Network (SIGN) [17] 
Country- ecific 
(Scotl d) 
Manag ment f di bet s:  i al 
cli i al gui el  
2017 
2. . Compar son of C ntent of Sel cted Cli ic l Guidelines f r M nagin 2DM 
The content of the cli ical guidelines was omp r d based on the foll wing top cs by 
usi g  previously pilote  da a xtraction form: blood gl cos  man ge t; bod  weight
ass ssment and a ageme t; bloo ressur me urement and m agem nt; blood li-
pi s m a ur t nd m nageme t; T2DM-as ci t  mpl cation asse sment and
ma ag e t; nd ot er h althcar -rel t  is ues dvic . ac  guidelin  w s r a
several tim   i e tify t pics/subt pic  a d r l t d rec en ations. A full s ar “
” was ass gne  to cs/subtop s h deq te inform tion. A h lf-star “ ” w  
ssigned to t pic /su ics with limited i fo m ti . “NR” was assi to topics/sub-
t ic h t are ot eported  th guideli e. Tw  i epe den  r vi s (AN d GY)
were inv lv d in t  p c ss, an di gr e ts w r  r s v  through discu si n or
ith  third vi r (KC). 
.3. Comparison f Quality f Select Cli ical Guide i es f r Ma ing T2DM 
The quality of the clinic l guideli es w s assessed i de e ently by two revie ers 
(AN and GY) using th  Appr isal of Guid lines f r Res arch and Evaluati n II (AGREE 
II) tool, which is a standar ised and validated i stru nt [10]. Th  AGREE II tool co -
pris s 23 items separate  into six domains ((i) s p  and pur ose; (ii) st keholder involv -
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi)
editorial independence) and two global rating items ((i) overall quality score a d (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool w s rated on a
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appr isal 
scores were calculated for each appraiser by using the aver ge r ing (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal atings of 
items within a single domain (obtained score), scaling by maximum and inimum possi-
ble domain scores, and by converting to a per entage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. Co p ri on f Content of S lected Clinical Guideli es for M naging T2DM 
The c ntent of the cli ica g d l n was p r d ba d  th  f llowing top cs by 
u ing a previously piloted a  xtra ti  form: lo d glucos ma ag m t; bo  ight
ass s ment and ag m nt; blood pr sur me u em nt a  a age e t; blo li-
pids eas nt d n gem nt; T2DM-as ciat  c mpl c tion  a s ssme  
ma g ent; nd other healthcar -rel t d issues and advic . Ea h ui elin  was ad
several ti s to ide tif topics/subt pic a d related r c endatio s. A full star “
” w s ass gn d to topics/subtopics ith dequ te informatio . A ha f-st r “ ” was 
assigned to topic / u t pics with li ited i form ti n. “NR” was a si to top cs/ b-
topic th t ar  not report d  the guideline. Tw  ndependent revi w rs (AN a d GY)
were involv d in the process, an  di agr eme ts were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The qualit of th  clini al guideli  a  assessed independently by two revie rs
(AN and GY) using th  Appraisal of Guidelines for R s rch and Evaluation II (AGREE
II) t ol, which is a standardise  and validated instrument [10]. The AGREE II tool com-
prises 23 items eparated into six domains ((i) scope and purpose; (ii) stakeholder invo ve
m nt; (iii) rigour of development; (iv) clarity of p entation; (v) applicabi ; and (vi) 
editorial in ependence) and two global rating item  ((i) overall quali y s ore and (ii) rec-
ommendation for use in pra tice) [10]. Each i m within the AGREE II tool was rated on a
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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Int. J. Enviro . Res. P blic He l h 2021, 18, x FOR PEER REVIEW 3 of 13 
 
 
Tabl  1. Outli  of selected clinical gui elines for managing T2DM. 
 Publishi g
S cieties/Org n tion /Associ ions 
gr hy of the 
Gu del ne 
Nam  of the Guideline Last
Update  
1 
C rib ean H lth R search Counc l 
(CHRC) and P  American Health 
Organiza ion (PAHO) [8] 
Country- p cific
(Cari b an) 
M aging iab tes i  primary c re in 
the Caribbe  2006 
2 I ternational Di betes Federatio  (IDF) [11] Intern ional  
R commendations for man ging type 
2 diab tes i  rimary care 2017 
3 
The Royal Australian oll g  of n  
Practition rs (RACGP) [12] 
Country-specific 
(Au tralia)
Ge er l practi  management of type 
2 d abetes 2016  
4 
Diab tes Cana a and C nadian Diabe es 
Ass ati (CDA) [13]  
Cou try-specific 
( a ad ) 
Di betes nada 2018 clini al practi e 
guidelines for th  pr vent on and 
gement f i b t s i  Ca ada 
2018
5 New Ze l d Gu delines Group (NZGD) [14] 
Co ntr -specific (New 
Z al nd)
G idance on th  manage ent of type 
2 iabetes 2011 2011
6 A e ican Diab t  A oc ati  (AD ) [15] 
Country-s cifi  (United 
St t s) St n rd  of m dic l c re  i betes 2020 
7 Nati nal Institute for Health and C re 
Exce lence (NICE) [16] 
Country-spe ific 
(E gl nd and Wales
Typ  2 iabete  i  adults: 
anagement 
2020 
8 Scottish Intercoll giate Guideline  
N two k (SIGN) [17] 
Country- pecific 
(Sc tl ) 
a agement f di b tes: a nati al 
cli ic l guidel ne 
2017 
2.2. C mp o f C nte t of S lec ed Clinic l Guideli es for Managing T2DM 
Th c ntent of the cli ical g i n s was mp red b s on the foll w ng p cs by 
usi g  pr viousl pilo e a a xt a tion f : l od gluc s m geme t; body w igh
a s ssm nt nd ma agem nt; blo d pr ssur a u eme t and gement; blo d li-
p s e ur m n  nd nagem ; T2DM-ass ci ed ompl ca ion  assess e t a d
manage nt; nd other he thca -rel t  is es d advic . E ch gui eli  was rea
several t s to id ntify top cs/subtopic  an related r co men at ons. A full star “
” was s d to topics/subt pics wit  dequat formation. A h lf-star “ ” was
s igned to top c / ubt pics th l ited inform tio . “NR” was ssi ned to topic /su -
topic that are not report d i th  guid li . Two epende t revi wers (AN a d GY)
were involv  in the pr cess, an  isa r e ent  were resolved through discussion or 
with a third revi wer (KC). 
2.3. Comparison of Quality of Se ected Clinic l Gui eline for Managing T2DM 
Th  qu li y of th  clini al uidelines wa  assessed independently by two review rs
(AN and GY) using the Appraisal of Guidelines for Res arch and Evaluation II (AGREE
II) to l, which is a standardis  and v li ated instrument [10]. The AGREE II tool com-
prises 23 items eparated into s x domains ((i) scope and purpose; (ii) stakeholder involve
m nt; (i i) igour of development; ( v) clarity of presentation; (v) applicabi ; and (vi) 
edito ial i ependence) and two global rati g item  ((i) overall quali y s ore and (ii) rec-
ommendation for use in pra tice) [10]. Each it m within the AGREE II tool was rated on a
seven-point scale (f m 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calcul ted for e ch appraiser by us ng th  average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comp r son by summing the appraisal ratings of 
it m  within  single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines was su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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Prac ition rs (RACGP) [12] 
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(Aus ral a)
Ge er l practi e man g me t of type 
2 di betes 2016  
4
Diabetes C na  nd C nadian Diabetes 
A soci ti n (CDA) [13]  
Co ntry- pecific 
(Ca a ) 
Di betes C nad  2018 clinical practice 
guideli es for th prevention nd 
n me t o  iabetes in Ca d  
2018 
5 New Ze l d Guidel nes Gr p (NZGD) [14] 
Cou ry sp cific (New 
Zealand) 
G idance on the manage ent of type 
2 diabetes 2011 2011 
6 Americ n Diab te  Associ ti n (A A) [15]
Co ntry-spec fic (United 
St tes) Sta d ds of m d cal care n di be es 2020 
7 N t onal I titute for He lth n C re 
Excellence (NICE) [16] 
Country-specific 
(England and Wales) 
Type 2 di bet s dults: 
m nageme t 
2020 
8 Scottish Int rcoll giate Guid li  
N two k (SIGN) [17] 
C untry- p cific 
(Scotl ) 
Management f iabet s: a national 
clin cal guideline 
2017 
2.2. Comp r o f Conte t of S lec d Clinical Gu delines for M nagi g T2DM 
The ontent f the cl ical g del nes w s p r d based  the fo l wing to cs by
usi g a eviously pi t d ta xtr ction f r : blood glucos  a ag ment; body weight
s ssme t and ma g nt; blo d pressur a ur m t and man gem n ; blood li-
pid asureme t and gem nt; T2DM-assoc ated compl c tio sses ment a d
m nagemen ;  other he lthc r -rel ted issue  a  advic . Each gui elin  was read
several ime  to identi y topic /subtopic  nd rel e  reco endati ns. A full star “
” was s e  to topic /subt pics with d quate in orm tion.  half- tar “ ” was 
assigned to topic /subt p cs with limited inform tio . “NR” was a si ed to topics/sub-
topic that a  n t rep ed i  th  uid lin . Two ind pend nt revi wers (AN a d GY)
were involv d in the roc s , a  di agr em nt  were resolved thr ugh discus ion or 
ith a third review r (KC). 
2.3. Compar son of Qual ty f Selected Clinical Gu delin s for Managing T2DM 
Th qu ity of he clinical uid lines was assessed independ ntly by two reviewers 
( N nd GY) usi g th  Appraisal of Guidelines for Research an  Evaluation II (AGREE 
II) ool, whic  is  stand rdised and validated instrument [10]. The AGREE II tool com-
rises 23 t ms separ ted into ix domains ((i) scope and purpose; (ii) takeholder involve-
ment; (iii) rigou  of developm ; (iv) clarity of presentation; (v) applicability; and (vi) 
edit rial independe ce) and two global rating items ((i) v rall quality score and (ii) rec-
ommendati n for u e i  prac ice) [10]. Each item within th  AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
scores w re calculated for each pprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly ree)) for all ite s in each domain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s wa  summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
e tal h alth (including
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1 
Caribbea  Health Research Council 
(CHRC) and Pan American Health
Organization (PAHO) [8] 
Cou try-sp cific 
(Caribbean) 
M aging diabete  i  primary c re i  
 Caribbe n 2006 
2 International Diabetes Federatio  (IDF) [11] Int rn tional  
Recommendations for a aging yp  
2 diab tes i  prima y care 2017 
3 
Th  Royal Australian College of Gener l 
Practitioners (RACGP) [12] 
Country-specific 
(Australia)
Ge er l practi  anagement of typ  
2 diabe s 2016  
4 
Diabetes Canada and Canadian Diabetes 
Associati n (CDA) [13]  
Cou try- p cific 
Can da) 
Diab t s C ada 2018 cli ical p actice 
g lines f r th  prevention and
managem nt f diabetes in Canada 
2018 
5 New Zealand Guidelines Group (NZ D) [14] 
Co ntr -s ecific (New 
Zealan ) 
G idance n th manage e  of typ  
2 diabetes 2011 2011 
6 American Diabetes Associati n (ADA) [15] 
Cou try-s cif (Uni ed 
States) St d rds f m di l c r   i b tes 2020 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Country-specif c 
(England and Wales
Ty e 2 diabete  in ults: 
anage
2020 
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-specific 
(Sc tland) 
Manag ment f di b tes:  ati al 
cli ic l guid lin  
2017 
2.2. Comp rison f Cont t of Selected Clinical Gu d lines for M ging T2DM 
The c ntent of the cli ical guidel s as o p r d b s  on th foll wing top c  y 
usi g a previously pilote  ata extra tion form: bl od glucos  ma m n ; body weight
assessment and ma agem nt; blood pressur  mea urement and anagem t; blo li-
pids measurement and m nagement; T2DM-ass i ted ompli ations ass ssm t d 
management; nd other hea thca -related is ues and advic . E ch guideli  w s rea
several times to id ntify top cs/subtopics and rel ted r comme dations. A full tar “
” was assigned to topics/subtopics with adequat  infor ati n. A h lf-star “ ” a
assigned to topics/subt pics w th limited inform tio . “NR” w  ssi n d t  topic / ub-
topics that are not reported i  th  guideline. Two in ep nd nt revi w rs (AN an  GY) 
were involv d in the process, an  di agr ents wer  r solved th ough dis ussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelin s for Managin  T2DM 
The quality of the clini al guidelines wa  assessed independently by two review rs
(AN and GY) using the Appraisal of Guidelines for Re arch and Evaluation II (AGREE
II) tool, which is a standardise  and validated instrument [10]. The AGREE II to l co -
prises 23 items eparated into six do ains (( ) scope an purpose; (ii) stakeholder involve
m nt; (iii) rigour of development; (iv) cl rity f pr sentation; ( ) applica i ; a d (vi) 
editorial in ependence) and two global rat ng it m  ((i) overall quali y s ore and (ii) rec-
ommendation for use in pra tice) [10]. Each it m within the AGREE II tool was rated on
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2020
8 Scottish Int rcoll giate Guid li es 
N twork (SIGN) [17] 
Co ntry-s cific 
(Sc tland) 
Management f diab tes: a nati l 
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2017 
2.2. Comp rison f Content of Selec ed Clinical Gu de in s f M naging 2DM 
The ontent f th  cl ical gu eli s was mp r d based o th  fo l wing t  by 
usi g a previously pil ted da a x ra tion f r : blo d glucose a em n ; bo y eight
ass ssment and ma ge nt; blood pres ur a ureme t an  man gem nt; bl od li-
pids measuremen  and n gem nt; T2DM-associate  compl cation sses ment a d
managemen ; d other healthcare-rel ted issues and advic . E ch guid lin  was rea
several ime  to identify topics/subtopic  and rel ed r co en ations. A full star “
” was as gne  to topics/subtopics wit  d quat in rmation.  h lf- tar “ ”  
assigned to topic /subt pics ith i ited inform tio . “NR” w  s g to topic / u -
topic that are not rep rted i  the uid line. Two d p ent reviewer  (AN a d GY)
were involv d in the roc ss, an  is r em t re resolved th ugh cus i  or 
ith a third reviewer (KC). 
2.3. Comparison of Qual ty of Selected Clinical Gu deli s for M nag ng T2DM 
The qu ity of the clini  uid lines was ssessed independ ntly by two revie ers 
(AN and GY) using the Appraisal of Guidelin s for R search an  Evaluation II (AGREE
II) ool, which is a standardised n  validated instrument [10]. The AGREE II to l com-
rises 23 items separ ted into ix do ains (( ) scope an  pu pose; (ii) takeholder involve-
ment; (iii) rigou  of developm ; (iv) cl rity f presentation; ( ) pplicability; a d (vi) 
editorial independe ce) and two global rat ng t ms ((i) v rall qual ty score and (ii) rec-
ommendati n for use i  practice) [10]. Each ite  within th  AGREE II tool as ra ed on  
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
scores w re calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  calculated for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by aximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2.2. C p r s n f Conten  of Select d Cli ical Guide i es for Ma gi g T2DM 
The nt t of th  cl ica gu l n as r d bas d n th  f ll wing to cs by 
usi  a previous y p loted a a xtracti form: blo d glucos ma ag men ; bo  ight
s s nt an a a e t; blood pr s ur e ure t a  manag nt; blo li-
pid  meas r ment  n g me t; T2DM-as oci t c mpl c tion  s ssm  
ma agement; nd other healthcar -rel t d iss e  and advic . Ea h ui elin  was ad
several ti s to ide tif topics/subtopic a d related r co mendatio s. A full s ar “
” was ass g ed to to ics/subtopics th dequ te info matio .  ha f-st r “ ” w s 
assign  to t pic / u t pics ith li ited i form ti . “NR” wa  si to top cs/ b-
topic th t ar n t r p rte  i  th gu deline. Tw  ndep ndent r vi rs (AN a d GY)
were i volv d in th proce s, an  di agr e e ts were r solved th ou h di cussion or
with  th r r vi wer (KC). 
2.3. Co p riso  of Quality of Sel cted Clini al Guidelines for Man ging T2DM 
T e quality of the cli i al uid lin  a  ass s d in ependently by two revie s
(AN n GY) usin  the Appr isal of Guidelines for R s arch a Evaluati n II (AGREE
II) tool, which is a standardise  and validated instru en  [10]. The AGREE II ool co -
prises 23 ite s ep r ted int x d m ins ((i) scope a d p rpose; (ii) takeh lder invo v
m nt; (iii) rigou  of developm ; (i ) larity of p e tation; (v) applicabi ; a d (vi) 
ed torial in epende ce) and two g obal rating item  ((i) overall quali y s ore and (i ) rec-
omme at n for us i pr tice) [10]. Each i  within th  AGREE II tool as rated on a
seven-point scal  (from 1 = strongly disagre to 7 = trongly agree). Average appraisal 
scores wer  calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree))  all items in each domain. Scaled percentages for each domain 
were then c lculated for nte -domain co pariso  by summing the appraisal ratings of 
items within a single domain (obtaine score), scaling by maxi um and mini um possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
clude  guidelines was summ rised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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2 diabetes 2016  
4 
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2.2. Comp r s n f C nt  of Selected Cli ical Gu d s for M naging T2DM 
Th c t nt of the cli ical g ide n s as mp r d b s on the foll wing p c  by 
usi g  pr viously lote  a extra tion f : l od gluc s man em nt; body w gh
ss ss t nd a ag nt; blo d ressur a u eme t and gem t; blo d li-
p s me ur men nd nagem t; T2DM-ass ci ted ompl ca ion  assess e t a d
m agem n ; nd other h thca -rel t d i u  d advic . E ch guidelin  was read
se ral t s to id ntify op c /subtopic  a d related r co endat ons. A full s r “
” wa s g d to to ics/subt pics wit  dequat formation. A h lf-star “ ” was
s ign d to t c / ubt pics w th l ited inform tio . “NR” was s i ned to topic /su -
top c th t are not report i th  guid li . Two epende t revi wers (AN a d GY)
e e i volv  th r cess, n  isa r e nt  were r solved through di cussion or
with  th rd rev wer (KC). 
.3. Compari on of Quali y of Sel cted Clini al Guidelines for Managing T2DM 
T qu li y of he cli i al idelines w  assessed in ependently by two review r
(AN and GY) using the Appraisal of Guidelines for Res arch and Evaluation II (AGREE
II) to l, which is  stand rdise  and v lidated ins rument [10]. The AGREE II to l com-
pr ses 23 t ms eparated into s x domains ((i) sc pe a  p rpose; (ii) stakeholder involve
m nt; ( ) igou  of evelopment; ( v) clarity f presen ation; (v) applicabi ; a d (vi)
dito ial i ependence) and two global rati g it m ((i) ov rall quali y s ore and (ii) rec-
mmendation for u e in pra tice) [10]. Eac  it  within the AGREE II tool was rated on a
seven-point scale (f m 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calcul ted for e ch appraiser by us ng th  average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then c lculated for inter-domain comp r son by summing the appraisal ratings of 
it m  within single do ain (obtained score), scaling by maximum and mini um possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines was su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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manag ent; a  other h lthcare-relate  issues an  advice. Eac  guideline was read 
several times to ide tify t pi s/subtopics and related recommendations. A fu l star “
” w s assigned to topics/subtopics with adequate infor ation. A half-st r “ ” was 
a signed to to ic /subtopic  with limit d information. “NR” w s assi ned to topics/sub-
topics that r  n t reported i  the uideline. Two indepe d nt revi wers (AN and GY) 
w e i volv d in the proc ss, n  disagr ements ere resolv d through discussion or 
with  t ir  revi w r (KC). 
2.3. Compar so  of Quality of Selec ed Cli i al Guidelines for Managing T2DM 
The quality of the clinical guidelines w s assessed indepe ently by two reviewers 
(AN a d GY) using the Appraisal of Guidelines for R s arch a d Evaluation II (AGREE 
II) tool, which is a sta dar ised and v lidated in tru e t [10]. The AGREE II tool com-
p ises 23 items separated into ix domain  ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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P blishing 
Soci ties/Organisatio s/Associations 
Geog a y of th  
Gu d line 
Na e of th Guideline Last
Updated 
1 
aribbe  Health Re arch Council 
(CHRC) and Pan Am ric n He lth 
Organization (PAHO) [8] 
Coun ry-s fic 
(C rib ean) 
anaging diab tes in primary c re in 
the C ribbean 2006 
2 Internatio al Diab tes Fed ration (IDF) [11] I tern tion l  
Reco menda i ns for managing type 
2 diab tes in primary care 2017 
3 
Th  Royal Austr lia  College of Gen ral 
Pra titi ner  (RACGP) [12]
Country-sp cif c 
(Au tralia) 
Gen r l practi  management of type 
2 diabetes 2016  
4
i t  Canada  Cana ia  Di be es 
Ass ci ti n ( DA) [13]  
Cou try- p cific 
(C nada) 
Di b t s Ca ada 2018 clinical practice 
guidelines for the revention and 
m nagement of diabetes in Canada 
2018 
5 N w Z aland Guid li s Gr up (NZGD) [ 4] 
C n y-specific (New 
Zealand) 
G idance on the a age ent of type 
2 diabet  2011 2011 
6 i  Diab t s Ass ci t n (AD ) [15]
Cou try-sp cif Unite
States) St rds f m dic l care n d be es 2020 
7 National I st t te fo  Hea th nd C e 
Ex lle c  (NICE) [16] 
ount y-spec fic 
Engl  a  Wales) 
Type  diabetes in adults: 
an g ment 
2020 
8 Scottish I ercoll giate Guid lines 
Netw rk (SIGN) [17] 
ou t y-specific 
(Sc tland)
M agement f iab tes: a national 
clinic l guideli e 
2017 
2.2. p iso  f C ntent of Select d Cl ical Guidelin s for Managing 2DM
T e c nten  of th  cli ic gu del nes as p ed bas d n the foll wing topics by
usi g a pr vious y ilot d a a extrac o for : blood glucos  m n gement; body weight
s s nd a agem t; blood p ssur m a u ement and ma gem n ; blo d li-
pid me ur nt nd n g me t; T2DM- ssoci t compl cation  asses ment a d
ma ag m nt; nd oth r healthc r -r l t issues and advic . Each guidelin  was read
several ti  to identif topics/ bt pic  a d rel ted reco mendation . A full star “
” a ss g d  pics/ ubtopics with adequate information. A h lf-star “ ” was 
s gn to topic / ubt ics ith lim ted i for tion. “NR” was assigned to topics/sub-
t p c tha  ar  n t ported i  t  guidelin . Tw ndependent r viewers (AN a d GY)
were inv lved in the proc s, an di a r eme  w re resolved through discussion or 
with a third r view r (KC). 
2.3. C p rison o  Quality of Selected Clinical Guidelines for Managing T2DM 
Th  qu lity of the clini al guidelines a  ssessed indepen ently by two review rs
(AN nd GY) us g th  Ap r is l of Guidelines for arch and Evaluation II (AGREE
II) tool, which s a sta dardise and validated instru ent [10]. The AGREE II tool com-
pr s s 23 it ms ep rated into ix dom ins ((i) scope and purpose; (ii) stakeholder involve
m t; (i i) rigour of developm nt; (iv) lar ty of pr se tation; (v) applicabi ; and (vi) 
itorial in ep nd ce) and two global rating item (( ) overall quali y s ore and (ii) rec-
ommend t on for use in pra tice) [10]. Each it m within the AGREE II tool was rated on a
seven-point scale (from 1 = strongly disagre  to 7 = trongly agree). Average appraisal 
score  were calculat d fo  each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtaine  score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guid lines was summarised nd presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 



























Int. J. Environ. Res. Public Health 2021, 18, x FOR PEER REVIEW 3 of 13 
 
 
Table 1. Outline of selected clinical guidelines for managing T2DM. 
 Publishing 
Societies/Organisations/Associations 
Geography of the 
Guideline 
Name of the Guideline Last 
Updated 
1 
Caribbean Health Research Council 
(CHRC) and Pan American Health 
Organization (PAHO) [8] 
Country-specific 
(Caribbean) 
Managing diabetes in primary care in 
the Caribbean 2006 
2 International Diabetes Federation (IDF) [11] International  
Recommendations for managing type 
2 diabetes in primary care 2017 
3 
The Royal Australian College of General 
Practitioners (RACGP) [12] 
Country-specific 
(Australia) 
General practice management of type 
2 diabetes 2016  
4 
Diabetes Canada and Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Canada) 
Diabetes Canada 2018 clinical practice 
guidelines for the prevention and 
management of diabetes in Canada 
2018 
5 New Zealand Guidelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidance on the management of type 
2 diabetes 2011 2011 
6 American Diabetes Association (ADA) [15] 
Country-specific (United 
States) Standards of medical care in diabetes 2020 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Country-specific 
(England and Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-specific 
(Scotland) 
Management of diabetes: a national 
clinical guideline 
2017 
2.2. Comparison of Content of Selected Clinical Guidelines for Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: blood glucose management; body weight 
assessment and management; blood pressure measurement and management; blood li-
pids measurement and management; T2DM-associated complications assessment and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics and related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinical guidelines was assessed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
Int. J. Environ. Res. Public Health 2021, 18, x FOR PEER REVIEW 3 of 13 
 
 
Tabl  1. Outli e of selected clinical guidelines for managing T2DM. 
 Publishing 
Societies/Organ sations/Associations 
Geography of the 
Guideline 
Name of the Guideline Last 
Updated 
1 
Caribbean Health Research Council 
(CHRC) and Pan American Health 
Organization (PAHO) [8] 
Country-specific
(Cari bean) 
Managing diabetes in primary care in 
the Caribbean 2006 
2 International Diabetes Federation (IDF) [11] International  
R commendations for managing type 
2 diabetes in primary care 2017 
3 
The Royal Australian College of  
Practitioners (RACGP) [12] 
Country-specific 
(Australia) 
General practice management of type 
2 diabetes 2016  
4 
Diabetes Canada and Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Canada) 
Diabetes Canada 2018 clinical practice 
guidelines for the prevention and 
management of diabetes in Canada 
2018 
5 New Zealand Guidelines Group (NZGD) [14] 
Country-specific (New 
Z aland)
Guidance on the management of type 
2 diabetes 2011 2011 
6 American Diabetes Association (ADA) [15] 
Country-specific (United 
States) Standards of medical care in diabetes 2020 
7 National Institute for Health and Care 
Exce lence (NICE) [16] 
Country-specific 
(Engl nd and Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-specific 
(Scotland) 
Management of diabetes: a national 
clinical guideline 
2017 
2.2. Compar son of C ntent of Selected Clinical Guidelines for Managing T2DM 
The content of the clinical guide ines was compared based on the following topics by 
using a previously piloted data extraction f rm: blood glucose management; body weight 
assessment and manageme t; blood pressure measurement and management; blood li-
pids measuremen  and anagement; T2DM- ssociated complications assess nt and 
management; and other healthcare-related issues nd advice. Each guideline was read 
several tim s to identify topics/subtopics and related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to top cs/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not report d in th  guideline. Two independent reviewers (AN and GY) 
were involved in the pr cess, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The qu lity of the clinical guidelines was assessed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into s x domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (i i) rigour of development; ( v) clarity of presentation; (v) applicability; and (vi) 
edito ial independence) and two global rati g items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (f m 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calcul ted for e ch appraiser by us ng th  average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comp r son by summing the appraisal ratings of 
it m  within  single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines was su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
NR NR
Skin examination
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Table 1. Outline of selected clinical guidelines for managing T2DM. 
 Publishing 
Societies/Organisations/Associations 
Geography of the 
Guideline 
Name of the Guideline Last 
Updated 
1 
Caribbean Health Research Council 
(CHRC) and Pan American Health 
Organization (PAHO) [8] 
Country-specific 
(Caribbean) 
Managing diabetes in primary care in 
the Caribbean 2006 
2 International Diabetes Federation (IDF) [11] International  
Recommendations for managing type 
2 diabetes in primary care 2017 
3 
The Royal Australian College of General 
Practitioners (RACGP) [12] 
Country-specific 
(Australia) 
General pr ctice manag ment of type 
2 diabetes 2016  
4 
Diabetes Canada and Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Canada) 
Diabetes Canada 2018 clinical practice 
guidelines for the prevention and 
management of diabetes in Canada 
2018 
5 New Zealand Guidelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidance on the anagement of type 
2 diabetes 2011 2011 
6 American Diabetes Association (ADA) [15] 
Country-specific (United 
States) Standards of medical care in di bet s 2020 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Country-specific 
(England and Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-specific 
(Scotland) 
Management of diabetes: a national 
clinical guideline 
2017 
2.2. Comparison of Content of Selected Clinical Guidelines for Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: blood glucose management; body weight 
assessment and management; blood pressure measurement and management; blood li-
pids measurement and management; T2DM-associated co plications assessment and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics and related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinic l Guid lines for Managing T2DM 
The quality of the clinical guidelines was assessed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR NR NR NR
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Table 1. Outline of selected clinical guidelines for managing T2DM. 
 Publi hing 
Societies/Organisatio s/Associations 
Geography of the 
Guid li e 
Name of the Guideline Last 
Updated 
1 
Caribbean Health Research Council 
(CHRC) and Pan American Health 
Organization (PAHO) [8] 
C untry-specific 
(Caribbean) 
Managing i betes in prim ry care in 
th  Caribbean 06 
2 International Diabetes Federation (IDF) [11] International  
Recommendations for managing type 
2 diabetes in primary care 2017 
3 
The Royal Australian ollege of Gen ral 
Practitioners (RACGP) [12] 
tr -s ifi  
(Australia) 
General practice management of type 
2 diabetes 6  
4 
Diabet s Canada and Canadian Diabetes 
Association (CDA) [13]  
Country-spe ific 
(C n da) 
Diabetes Canada 2018 clinical practice 
guidelines for the prevention and 
management of diabetes in Canada 
8 
5 New Z ala d Guidelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidance on th  management of type 
2 diabetes 2011 2011 
6 Americ n Diabetes Association (ADA) [15] 
Country-specific (United 
States) Standards of medical care in diabetes 2020 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Country-specific 
(England and Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Scottish In ercollegiate Guidelines 
Network (SIGN) [17] 
Country-specific 
(Scotland) 
Management of diabetes: a national 
clinical guideline 
2017 
2.2. Comparison of Content of Selected Clinical Guidelines for Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: blood glucose management; body weight 
assessment and management; blood pressure measurement and management; blood li-
pi s measurement and management; T2DM-associated complications assessment and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics and related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
we e involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinical guidelines was assessed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
mmendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR NR
Older people NR
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Table 1. Outline of selected clinical guidelines for managing T2DM. 
 P blishing 
Societies/Organisations/Associations 
Geography of the 
Guideline 
Name of the Guideline Last 
Updated 
1 
Caribbean Health Research Council 
(CHRC) and Pan American Health 
Organization (PAHO) [8] 
Country-specific 
(Caribbean) 
Managing diabetes in primary care in 
the Caribbean 2006 
2 International Diabetes Federation (IDF) [11] International  
Recommendations for managing type 
2 diabetes in primary care 2017 
3 
The Royal Australian College of General 
Practitioners (RACGP) [12] 
Country-specific 
(Australia) 
General pr ctice management of type 
2 diabetes 2016  
4 
Diabetes Canada and Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Canada) 
D  Can d  2018 clinical practice 
guid lines f r the pr vention and 
management of diabetes in Canada 
2018 
5 New Zealand Guidelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidance on the management of type 
2 diabetes 2011 2011 
6 American Diabetes Association (ADA) [15] 
Country-specific (United 
States) Standards of medical care in diabetes 2020 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Country-specific 
(England and Wales) 
Type 2 d abetes n adults: 
management 
2020 
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-specific 
(Scotland) 
Management of diabetes: a national 
clinical guideline 
2017 
2.2. Comparison of Conte t f Selected Clini al Guidelines for Managing T2DM 
The content of the clinical guidelines was co red based on the following topics by 
using a previously piloted data extraction form: blood glucose anag ment; body weight 
assessment and management; blood pre ure measurement and management; blood li-
pids measurement and management; T2DM-associated complications assess ent and 
management; and other healthcare-related issues and advice. Each guideline as read 
everal times to identify topics/subtopics an  related recommendation . A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assig ed to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of S lected Clinical Guidelines for Managing T2DM 
The quality of the clinical guidelines was assessed independently by two revi wers 
(AN and GY) using the Appraisal of Guidelines for Research and Evalu tion II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakehold r involve-
ment; (iii) rigour of develop ent; (iv) clarity of pr sentation; (v) applicability; nd (vi) 
editorial independence) and two global rating items ((i) overall quality scor  nd (ii) rec-
ommendation for use in practice) [10]. Eac  item within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Averag  app aisal 
scores were calculated for each appraiser by using the verage rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each i  
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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Tab  1. Outline of selected clinical guidelines for managing T2DM. 
 Publishing 
Societies/Organisations/Associations 
Geography of the 
Guideline 
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Updated 
1 
Caribbean Health Research Council 
(CHRC) a d Pan American Health 
Organization (PAHO) [8] 
Country-specific 
(Caribbean) 
Managing diabetes  primary care in 
the Caribbean 2006 
2 Int rnational Diabetes Federation (IDF) [11] International  
Recom e dations for managing type 
2 diabetes in primary care 2017 
3 
The Roya  Australia  College of General 
Practitioners (RACGP) [12] 
Country-specifi  
(Australia) 
Gen ral practice management of type 
2 diabetes 2016  
4 
Diabetes Can da and Canadian Diabete  
ssociation (CDA) [13]  
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(Canada) 
Di betes Canada 2018 clinical practice 
guid lines for the prevention and 
manag ment of di betes in Canada 
2018 
5 New Z aland Guidelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidance on he management of t pe 
2 diabetes 2011 2011 
6 American D abetes Association (ADA) [15] 
Cou try-specif c (United 
States) Standards of medical care in diabetes 2020 
7 National Institute fo  Health and Care 
xcellence (NICE [16] 
Country-specific
(England an  Wales) 
Type 2 diabet in adults: 
management 
2020 
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-specific 
(Scotland) 
Manag ment of di betes: a national 
clinical guideline 
2017 
2.2. Comparison of Conte t f Selected Clinical Guidelines for Managing T2DM 
The content of the cl ical guidelines was c mpared based on the following topics by 
using a previously piloted data extrac on f rm: blood glucose management; b dy weight 
assessment and man gement; blo d re sure mea urement and management; l od li-
pids measurem nt and manage ent; T2DM-assoc ted complic ti  assessment and 
manag ment; and other healthcare- lated issues and a vice. Each guid lin  was r ad 
several times to identify topics/subtopics and related recommendations. A full star “
” was a signed to topics/subtopics with adequate information. A half-star “ ” was 
a signed to topics/sub opics with l mited in ormation. “NR” wa  a signed o topics/sub-
t pics that are not reported in the guideli e. Two independent revie ers (AN and GY) 
were inv lved i  the process, and disag ements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinical gui lines was ass ssed independently by two reviewers 
(AN and GY) u ing th  Apprai al of Guidelines for Rese rch and Evaluation II (AGREE 
II) tool, which is  standardised and validated instrum t [10]. The AGREE II tool com-
prises 23 item  separated into ix domains ((i) sco e and purpo ; (ii) st k hold r involve-
ment; (iii) rigour f development; (iv) cl rity of presentation; (v) pplicability; a d (vi) 
e itorial i epend nce) a d two global rating items ((i) overall qualit  score a d (ii) rec-
mmendation for use in prac ice) [10]. Each item within the AGREE II tool w s rated o  a 
seven-point cale (from 1 = str ngly disagree to 7 = strongly agree). Average appraisal 
scor s were alculated for each appraiser by using the ave age rating (1 (strongly disagree) 
to 7 (strong y agree)) for all items in e ch domain. S al d perc ntages for each dom in 
were then calculated for inter-domain co parison by summing he appraisal ratings of 
tems within a single domain (obta ed score), scaling by aximum and mini um possi-
ble domain scor s, and by conv rting to a percentage [10]. The verall quality of all in-
cluded guidelines w s summarised and presented using sum ary statistics (mean). Mean 
score  of the dom ins were compared, the highest and lowest scores were identified. 
NR NR
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specialists for advice or
treatment
Int. J. Environ. Res. Public Health 2021, 18, x FOR PEER REVIEW 3 of 13 
 
 
Table 1. Outline of selected clinical guidelines for managing T2DM. 
 Publishing 
Societies/Organisations/Associations 
Geography of the 
Guideline 
Name of the Guideline Last 
Updated 
1 
Caribbean Health Research Council 
(CHRC) and Pan American Health 
Organization (PAHO) [8] 
Country-specific 
(Caribbean) 
Managing diabetes in pri ary care in 
the Caribbean 2006 
2 International Diabetes Federation (IDF) [11] International  
Recommendations for m naging ty  
2 diabetes in primary care 2017 
3 
The Royal Australian College of General 
Practitioners (RACGP) [12] 
Country-specific 
(Australia) 
General practice manageme t of type 
2 diabetes 2016  
4 
Diabetes Canada and Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Canada) 
Diabet s Cana a 2018 clinical practice 
guidelines for the prevention  
management of diabetes in anada 
2018 
5 New Zealand Guidelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidance on the management of type 
2 diabetes 2011 2011 
6 American Diabetes Association (ADA) [15] 
Country-specific (United 
States) Standards of medical care in diabetes 2020 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Country-specific 
(England and Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-specific 
(Scotland) 
Management of diabetes: a nation l 
clinical guideline 
2017 
2.2. Comparison of Co tent of Selected Clinical Guidelines for Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: blood glucose management; body weight 
assessment and management; blood pressure measurement and management; blood li-
pids measurement and management; T2DM-associated complications assessment and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics and related recommendatio s. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assign d to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
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The c ntent of the clinical guidelines was compared b sed n th  followi g topi s by 
using a pr viously piloted ata extraction form: blood glucos  m agem nt; bo y weight 
assessment and managem nt; blood pressure measur me t and ma ag ment; blo d li-
pids measurement and management; T2DM-associated complications assessment and 
manag ment; nd other h althcare-related issues and advice. Each guid line was read 
several times to identify topics/s btopics and related rec mmendations. A full star “
” was a signed to topics/subtopics with adequate infor ation. A half-st r “ ” was 
ass gne  to topics/subtopics with limited information. “NR” was as igne  to t ics/sub-
topic  that are not reported in the gui eline. Two in e nde t re i w rs (AN a d GY) 
w re in olv d i  t e process, and disagreements were resolved th o gh discussion or 
with a third revie er (KC). 
2.3. Co parison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of th  clin al guid lin s wa  ss s ed in epen e tly by two review s 
(AN and GY) using th  Apprais l of Gui elines for Res a ch and Evaluati n II (AGREE 
II) tool, which is a standardise  a d validated instrument [10]. The AGREE II tool co -
pris s 23 items eparated into six domains ((i) scope and purpose; (ii) stakeh lder involve
m nt; (iii) rigour of develo ment; (iv) clarity of pr sentation; (v) pplicabili ; a d (vi) 
ditorial in ependence) and two global rating item  ((i) overall quali y s ore and (ii) rec-
ommendation for use in pra tice) [10]. Each it m within the AGREE II tool as rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
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Country-spe ific 
(C nada) 
Diabetes C nad  2018 clinical practice 
guideli es for the prevention and 
management of iabetes in Canada 
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5 New Zealand Guidelines Gro p (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidance on th  management of type 
2 diabetes 2011 2011 
6 American Diabetes ssociation (ADA) [15] 
Country-specific (United 
States) Stand ds  m dical care in diabetes 2020 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Country-specific 
(England and Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Scottish Int rcollegiate Guideli es 
Network (SIGN) [17] 
Country-sp cific 
(Scotland) 
Management of diab te : a nat on l 
clinical guideline 
2017 
2.2. Comparison of Content of Selected Clinical Gu deli es for Ma agi g T2DM 
The ontent of th  cli ical gui elin s was compared based o  th  fol owing topics by 
using a previously pil ted ata extraction for : blood glucos  management; body eight 
ass s ment and managem nt; blood pres ure measurement and management; blood li-
pids m asurement and an gement; T2DM-associat d complicatio s assessment and 
managem n ; and other healthcare-rel ted issues and advice. Each guideline was r ad 
s veral ime  to identify topics/subt pics and rel ed recommendations. A full star “
” was as igned t topics/subtopics w th dequate in o matio .  h lf- t r “ ” w s 
s ig ed to topics/s btop cs with li ited info m tion. “NR” was assigned to topics/ ub-
topics that re not reported in the gu d lin . Two ind p n ent reviewers (AN and GY) 
were inv lved in the proce s, and disagreem nts were resolved thr ugh discussion or 
ith  third revi wer (KC). 
2 3. Comparison of Qual ty of Selected Clinical Gu deli es for Man ging T2DM 
The q ty of the clinic l uid lin  as as es d independ ntly by two reviewers
(AN and GY) usi g the Appraisal of Gui elin s f r R search an Evaluation II (AGREE
II) ool, which is a standardised and validated instrument [10]. The AGREE II tool com-
ris s 23 item  separ ted into ix domains ((i) scope and purpose; (ii) takeholder involve-
me t; (iii) rigou  of developm ; (iv) clarity of p entation; (v) applicability; and (vi) 
itorial independe ce) and two global rating items ((i) v rall quality score and (ii) rec-
ommendati n for use in practice) [10]. Each i em within th  AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
scores w re calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree)) for all items in each domain. Scaled percentages for each domain 
w re the  calculated for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summarised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR NR NR
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Caribbean Health Research Council 
(CHRC) and Pan American Health 
Orga izatio  (PAHO) [8] 
Country-specific 
(Caribbean) 
Managing i betes in prim ry care in 
th  Caribbean 06 
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Recommendations for managing type 
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The Royal Aus ralian ollege of Gen ral 
Pr ctitioners (RACGP) [12] 
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(Australia) 
General practice management of type 
2 diabetes 6  
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Diab t s Canada and Canadian Diabetes 
Association (CDA) [13]  
C untry-spe ific 
(C n da) 
Diabetes Canada 2018 clinical practice 
guidelines for the prevention and 
management of diabetes in Canada 
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5 New Zeala d Guideli es Group (NZGD) [14] 
Country-specific (New 
Zealand) 
Guidance on th  management of type 
2 diabetes 2011 2011 
6 American Diabetes Association (ADA) [15] 
Country-specific (United 
States) Standards of medical care in diabetes 2020 
7 Nati n l Inst tute for Health and Care 
Excellence (NICE) [16] 
Country-specific 
(England nd Wales)
T pe 2 diabetes in adults: 
management 
2020 
8 Scottish I terc ll giate Guidelines 
Net ork (SIGN) [17] 
C untry-specific 
(Scotland) 
Management of diabetes: a national 
clinical guideline 
2017 
2.2. Comparison of Content of Selected Clinical Guidelines for Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
usi g a previously piloted data extraction form: blood glucose management; body weight 
assessment and management; blood pressure measurement and management; blood li-
pids measurement and management; T2DM-associated complications assessment and 
management; and other healthcare-related issues and advice. Each guideline was read 
several times to identify topics/subtopics a d related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
assigned to topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinical guidelines was assessed independently by two reviewers 
(AN and GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeholder involve-
ment; (iii) rigour of development; (iv) clarity of presentation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guid lines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
Holiday/travel NR NR
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Diabetes Canada and Canadian Diabetes 
Association (CDA) [13]  
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7 Nati nal Ins itute for H alth and Care 
Excellence (NICE) [16] (England a d Wales) 
Type 2 diabetes in adults: 
m na e ent 
20
8 Scottish Intercollegia e Guidelines 
Network (SIGN) [17] 
Country- pecific
(Sc tland) 
Management f diab tes: a national 
clinic l gu deline 
2017 
2.2. Comparis  of Co ten  of Select d Cl nical Guid ines for Managing T2DM 
The content of the clinical g deli s was compared based n the following topics by
usi g a previou ly pil ted ata extrac on form: bloo glucose m age ; bo y w ight
assessment and an ge nt; blo d e sure mea u ement and ma agement; blood li-
pids measurement and management; T2DM-as ociat d compl c ti s assessment and 
managem nt; and o her healthcar - late  issue  an  advice. Each guid lin  was r ad 
ever l times to id ntify t pic /sub opics a d related rec mm dations. A full s r “
” wa  ass gned to topics/subtopics with adequate nformation. A half-st r “ ” wa  
assign d t topics/subtopics w th limited in ormation. “NR” was assigne  to t cs/sub-
topics th t are not reporte  in the guideline. Tw  in epende t reviewers (AN an  GY) 
were i volved in th  process, and disagr ements were r solved thro gh di cussion or
with a th rd revi wer (KC). 
2.3. Comparison of Quality of Sel cted Clini al Guid line  f Man ging T2DM 
The q ality of the clinical gui elines was assessed in epe ently by two reviewers 
(AN and GY) usi g the Appraisal of Gui lines f r Rese rch and Evaluation II (AGREE 
II) to l, which is a stand rdised a d validated instrument [10]. The AGREE II tool com-
prises 23 items se arat d into six dom ins ((i) sco e and purpo e; (ii) st k holder involve-
m t; (iii) rigour f d velo ment; (iv) clarity of pres ntation; (v) applicability; a d (vi) 
e itorial ind pend nce) a d two global rating items ((i) over ll qualit  score and (ii) rec-
ommendation for use in practice) [10]. Each ite  within the AGREE II tool w s rated o  a 
seven-point scal  (from 1 = st ngly disagree to 7 = strongly agree). Average appraisal 
score  were c lculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in e ch domain. Scaled p rcentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and mini um possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR NR NR NR
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Guideline 
Name of he Guideline Last 
Updated 
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C b an Health Research Council 
(CHRC) nd P  American Health 
Orga ization (PAHO) [8] 
ountry-specific 
(Ca ibbean) 
Managing diabetes in pri ary care in 
the Caribbean 2006 
2 I ternational Di betes Federation (IDF) [11] International  
R commendations for managing
2 diabetes in primary care 2017
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The Royal Australia  College of General 
P actition rs (RACGP) [12] 
Country-specific 
(Australia) 
General pr ctice management of typ  
2 diabetes 2016  
4 
Diabetes Canada and Can dian Diabetes 
Associa ion (CDA) [13]  
Country-specific 
(Canada) 
Diabetes Canada 2018 clinical practice 
guidelines for the prevention and 
management of diabetes in Canada 
2018 
5 New Z land Guid lines Group (NZGD) [14] 
Country-specific (N w 
Ze land) 
Guidance on the management of type 
2 diabetes 2011 11
6 American Diabetes Association (ADA) [15] 
Country-specific (United 
States) Standards of medical care in diabetes 
7 Nati n l Ins itute for H alth and Care 
Excellence ( ICE) [16] (England and Wales) 
Type 2 diabetes in adults: 
mana ement 
20
8 Scottish Intercollegiate Guidelines 
Netw rk (SIGN) [17] 
Country-specific 
(Sc tland) 
Management of diabetes: a national 
clinical guideline 
2017 
2.2. Comparis n of Content of Selected Clinical Guide ines for Managing T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted da  extraction form: blood glucose management; body weight 
asses ent and management; blood pressure m asure ent and m nagement; blood li-
pids measurement and management; T2DM-associated complic tions assessment and 
manag ment; a d othe  healthcare-related issues a  advic . Each guideline was read 
several times to identify topics/subtopics a d related recommendations. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was 
as igned to t pics/s btopics with limited information. “NR” was assigned to topics/sub-
topics that are not reported in the guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disagreements were resolved through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of th  cli ical guid lines was asse sed independentl  by two review rs 
(AN a  GY) using the App isal f Guidelines for Research and Evaluation II (AGREE 
II) tool, which is a standardi ed and validat d instrument [10]. Th  AGREE II tool com-
pris  23 it ms separated into six domains ((i) scope and purpose; (ii) stakeholder involv -
ment; (iii) rigour of developm nt; (iv) clarity of presentation; (v) pplicability; and (vi) 
editorial independ nce) a d two lobal rating items ((i) overall quality score and (ii) rec-
ommend tion for use in practice) [10]. Each item within the AGREE II tool was rated n a 
sev n-poi t scal  (from 1 = strongly disagre  to 7 = strongly agre ). Aver ge appraisal 
scor s were calcul ted for each appr iser by using the average r ting (1 (strongly disagree) 
to 7 ( trongly agree)) for all it ms in e ch domain. Scale  percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
Insurance NR NR
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aribbean He th Research Council 
(CHRC) and Pan American He lth
Organization (PAHO) [8] 
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the C b an 2006 
2 International Diabetes Federation (IDF) [11] International  
Recommendations for managing type 
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(Australia) 
neral pract c  management of type 
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Di betes Canada and Canadian iabetes
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7 National Institute for Health and Care 
Excellence (NICE) [16] 
Co try-specific 
(England and Wale ) 
Type 2 diabetes in adults: 
management 
2020 
8 Scot ish Interc llegiate Guidelin
Network (SIGN) [17] 
Country-specific
(Scotl d) 
M n g me t of diab tes: a national 
cli ical gui elin  
2017 
2.2. Com ariso  of Conte t of Selec e  Clinical Guidelin s for M n ging T2DM 
The content of the clinical guidelines was compared based on the following topics by 
using a previously piloted data extraction form: blood glucose manage ent; body we ght
assessment and management; blood pressure measu ment and manageme t; blo d li-
pids measurement and management; T2DM-associated c mplic tions assess  and 
management; and other healthcare-related issues and advice. Each guideline was r ad 
several times to identify topic /subtopics and r lated recommendations. A fu l star “
” was a signed to topics/subtopics with a equ te information. A half-star “ ” as 
assigned to topics/subtopic  with limited infor ation. “NR” was assigned to topics/sub-
topics that are not eported in th  guideli e. Two independent reviewers (AN and GY) 
w e involv d i  the pr cess, a d disagreements were res lved through iscussion or 
with a third review  (KC). 
2.3. Co pariso  of Quality f Selec ed Cli ical Gu de ines for Ma aging T2DM 
The quality of the clinical guidelines was assessed independe tly by two review r  
(AN and GY) using the Appraisal of Guid lines for R search and Evaluation II (AGREE 
II) tool, which is a standardised and validated inst ument [10]. The AGREE II tool co -
prises 23 items separated into six domains ((i) scope an  purpose; (ii) st keh lder involve-
ment; (iii) rigour of development; (iv) clarity of pres ntation; (v) applicability; and (vi) 
editorial independence) and two global rating items ((i) overall quality score and (ii) rec-
ommendation for use in practice) [10]. Each item within the AGREE II tool wa  ra  on a 
seven-point scale (from 1 = strongly di agree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR NR
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Excel e ce (NICE) [16]
Country-specific 
(England and Wales) 
Type 2 diabetes in adults: 
management 
2020 




Management of di betes: a ational 
clinical guid line 
2017 
2.2. Comp r son of Content of Selecte  Clinical Guid lines for M ing T2DM 
Th  content of the clinical guid line  was co pared based on the following top cs by 
using a previously piloted ata xtraction f rm: blood gluc e management; body weight 
assessment and manag ment; bl o  ressure measurement and managem nt; blood li-
pids measureme t and management; T2DM-associated omplications ass ssment and 
management; and other healthcare-rela ed issues and advice. Each guideline was read 
seve al tim s to identi y topics/subtopics d related recomm ndations. A full star “
” was assigned to topics/subtopics with dequate informatio . A half-star “ ” was 
assigned t  topics/subtopics with limited information. “NR” was assigned to topics/sub-
topics that a  ot reported i  the guideline. Two independent reviewers (AN and GY) 
were involved in the proces , a d disagreements were resolved through di cussion or 
with a third reviewer (KC). 
2.3. Compar son of Quality of Selected Clinical Guidelines for Managing T2DM 
Th  quality of the clinical guidelines wa  sessed indep nde tly by two reviewers 
(AN nd GY) using the Appraisal of Guid line  for Research and Evaluation II (AGREE 
II) to l, wh c  i  a standardised and val dated instrument [10]. The AGREE II tool com-
prises 23 it ms separated into ix domains (( ) scope nd purpose; (ii) st keholder involve-
m nt; (iii) rigour of developmen ; (iv) cl r ty of pr se tation; (v) applicability; nd (vi) 
edit rial independence) and two global r ting items ((i) overall qual ty score and (ii) r c-
ommendation for use in practice) [10]. Each item wi hin th  AGREE II tool wa  rated o  a 
seven-point scale (from 1 = strongly disagr to 7 = trong y agree). Averag  apprais  
scores were calculated for each ppraiser by using the average ating (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for ach domain
were then calcul ted for inter-domain comparison by summi g the appr isal ratings of 
items within a single domain (obtain  score), scaling by aximum minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines wa  summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
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2.2. omp ison of Content of Selected Clinical Guidelines for Managing T2DM 
The c tent f th  clinical guidelines as compared b sed on t e ollowi g topics by 
u ing a previ us y piloted data xtraction form: bl d glucose managem nt; body weight
asses ment and managem nt; blood pr ssure measur me t and management; blood li-
pids measur men  nd management; T2DM-associ te  complications assessment and
m nagement; an  o her healthc re-related issues and advic . E ch guideline was read 
s veral time  to identify topics/subt p cs d related recommendations. A full star “
” wa assigned  topics/subtopics with ad quate i formatio . A half-star “ ” was
assign to top cs/subtopics ith lim ted information. “NR” was assigned to topics/sub-
topics at a  n t reported i  th  guideline. Two independent reviewers (AN and GY) 
were involved in the process, and disa reement  w re resolve  through discussion or
with  third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
Th  qu lity of the clinical guidelines was assessed i dependently by two reviewers 
(AN and GY) using th  Appr l of Guidelines for esearch nd Evaluati n II (AGREE 
II) tool, which s a standardise  and validated inst u ent [10]. The AGREE II tool com-
pr s  23 tems separat d o ix dom ins ((i) scope and purpose; (ii) stakeholde  involve
ment; (i i) rigour of evelopment; (iv) lar ty of presen ation; (v) applicability; and (v )
editorial dependence) and tw  obal r ting it ms ((i) verall quality sco e and (ii) rec
mmendation for use n pr tice) [10]. Each item within the AGREE II tool was rated on a
even-p int sc le (from 1 = s rongly disagre  to 7 = trongly agree). Ave age appraisal
sco  were calculated fo  each appr ser by using the average rating (1 (strongly disa ree)
to 7 (strongly agree)) f r ll items in each domain. Scaled percentages for each domain 
w re then calculated for inter-domain com a ison by summing th  ppraisal ratings of 
items within a single domain (obtaine  score), scaling by maximum nd minimum possi-
ble domain sc res, and by nverting to a percentage [10]. Th  overall quality of all in-
clude guid lines was summarised nd presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
Working/shif s NR NR NR NR NR NR NR NR
Principles of providing
care
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 P blishing 
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Geo ra hy f the 
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Updat d 
1 
Caribbean Health Research Council 
(CHRC) and Pan American Health 
Organiza ion (PAHO) [8] 
Country-specific 
(Caribbean) 
M aging diab tes i  primary care in 
the Caribbe n 2006 
2 International Diabetes Federatio  (IDF) [11] Int rnation l  
R commendations for man ging type 
2 d abetes in p i ary c re 2017 
3 
The Royal Australian Colleg  of General 
Practitioners (RACGP) [12] 
Country-specific 
(Au tr lia) 
General practi  management of type 
2 diabetes 2016  
4 
Diabetes Canada and Canadian Diabetes 
Association (CDA) [13]  
Country-sp cific 
(Canada) 
Diab t s Canada 2018 clinical p actice 
guidelines for th  prevention and 
m n gement f diabetes in Ca ada 
2018 
5 New Zealand Guidelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
G idance on th  manage ent of type 
2 diabete  2011 2011 
6 American Diabetes Association (ADA) [15] 
Cou try-sp cifi  (United 
States) Sta dard f medical c r  diabetes 2020 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Country-specific 
(England and Wales) 
Type 2 diabetes in adults: 
management 
2020
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-specific 
(Scotland) 
Managem  di betes:  national 
clinical guid line 
2017
2.2. Comparison of Content of Selected Clinical Guidelines for Ma aging T2DM 
The content of the cli ical guidelines was mp red based on the following topics by 
usi g a previously piloted data extraction f rm: bloo  glucose ma ge e t; b dy weight
assessment and ma agemen ; blood pressure mea ureme a d manag m nt; bl od l
pids measurement and m nage e t; T2DM-associated complication  ass ss e t a d
management; nd other heal hcare-related issues a d advice. Each guideli was read
several times to id ntify topics/subtopics an  rel ted recomm nda ions. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” as
assigned to topics/subt pics with l mited inform t on. “NR” was assigned to topics/sub
topics that are not reported i  the guideline. Two independent reviewers (AN and GY) 
were involv d in the process, an disag ements were resolved through discussion or
with a third reviewer (KC).
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinical guid lines wa  assess d independently by two reviewers 
(AN and GY) using the Appraisal f Guidelines for R earch and Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II ool com-
prises 23 items separated into six domains ((i) s ope and purpose; (ii) stakehold r involve-
ment; (iii) rigour of development; (iv) clar ty of presentatio ; (v) applicabil ty; and (vi)
editorial independence) and two global r ting items ((i) overall quality score and (ii) r c-
ommendation for use in practice) [10]. Each item within the AGREE II tool was rated o  a 
seven-point scale (from 1 = strongly disagr e to 7 = tr ngly agree). Average ap raisal 
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
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 Publishing 
S cieties/Organisatio s/Associations 
G ography of the 
Guideline 
Name of th  Guideli e Last 
Updated 
1
Caribbean Health Research Council 
(CHR ) an  P  Americ  Health 
Organization (PAHO) [8] 
(Carib ean) 
M aging di b tes i pri ary c re in
the Caribb an 0
2 International Di betes Feder tion (IDF) [11] International  
Reco men ation  for anagi g type 
2 diabetes in primary care 7
3 
The Royal Australian College of Gen ral 
Practitioners (RACGP) [12] 
Country-sp cific 
(Australia) 
G neral practice manag me t of typ  
2 diabetes 2016  
4 
Diabetes Canada and Can dian Diabet  
Association (CD ) [ 3]  
t - ifi  
(Cana a) 
Di betes Canada 2018 clinical practice 
guidelines for the prev n i  and 
management of diabetes in Canada 
18 
5 N w Zealand Guid li es Gr up (NZGD)[14] 
C nt y- pecific (New 
Zealand) 
Guidance o  th  anagement of type 
2 iabete  2011 2011 
6 merican Diabetes Associati n (ADA) [15]
Country-specific (Unite  
States) S and rds of med cal care in di bete  2020 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Country-specific 
(Engl d and Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Scottish Intercollegiat  Guidel nes 
Network (SIGN) [17] 
C untry-spec fic
(Scotlan ) 
M nagement of diabete : a at onal 
clinical g ideline 
2017 
2.2. Comparison of Conte t of Selected Clinical Guidelines for Managing T2DM 
The co tent f the clin cal guid lines as compared b sed on t  llowing topics by
u ing a previ us y pilot  a a extraction form: blo d glucose manage nt; bo y weight 
assessment and anagement; blood pr ssure measur e t an  ma agement; blo d i-
pids measur en   managemen ; T2DM-associ ted complications assessmen  and
management; a  other healthc r -relat d issues an  advice. Ea h guideline was read 
several time  to dentify to ics/subtop cs nd r la  recommen ations. A ull star “
” was assigned to topics/subtopics with dequ e informatio . A half-star “ ” was 
assign  to topics/su topics ith limited f rmati n. “NR” was a si n  t  topics/sub-
topics th t are n t reporte  i  the guideline. Two inde ende t revi wers (AN a  GY) 
were involved in th  process, and di agreeme ts were resolved through disc ssion or 
with a third rev ewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guideli es for Managing T2DM 
The quality of the clinical guidelines a  ass ss d ndep ndently by two revi wers 
(AN and GY) using the Appr isal of Guid lines for Research d Evaluation II (AGREE
II) tool, which is a standardised and validated instru nt [10]. The AGREE II tool com-
pris s 23 items sep rated  six dom ins ((i) scope and purpose; (ii) stakeholde  involve-
ment; (i i) rig ur of development; (iv) larity of pres ntation; (v) applicability; and (v )
editorial i depend nce) and tw  g obal rating it ms ((i) verall quality score and (ii) ec
ommendat on for use in practice) [10]. Each item within the AGREE II tool was r ted on a
even-point scale (from 1 = str ngly disagre to 7 = tro gly agree). Average appraisal
scores were calculated for each appraiser by using the average rating (1 (strongly disagree) 
to 7 (strongly agree)) for all items in each domain. Scaled percentages for each domain 
were then c lculated for inter-domain compariso  by summing the appraisal ratings of 
items within a single do ain (obtaine score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentage [10]. The overall quality of all in-
clude  guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
Int. J. Envi o . Res. Public Health 2021, 18, x FOR PEER REVIEW 3 of 13 
 
 
Table 1. Outline of select d clinic l guidelines for managi g T2DM. 
 Publishing 
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Ge gra hy of the 
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Name  he Guideli e Last 
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1
Car bbean H alth Research uncil 
(CHR ) a  P  American Health 
Organization (PAHO) [8] 
Country-specific
(Caribbean) 
M i g di be s in primary c re in 
he ribb  2006 
2 I t r tion l Di betes Fed ration (IDF) [11] International  
R co mend tions for managing type 
2 diabet s i  primary care 2017 
3 
The Royal Australian Col ege of Gen ral 
Practitioners (RACGP) [1 ] 
Country-sp cific 
(Australia) 
Ge eral practice man gement of typ  
2 diabetes 2016  
4 
Diabetes Can d  nd Can dian Diab t s 
Association (C ) [ 3]  
t - ifi  
(Cana a) 
Diabetes C nad  2018 clinical practice 
guideli es for th  prevention nd 
management of iabetes in Canada 
18 
5 N w Zea an Guideli es Gr up (NZGD) [14] 
Co ntry-s cific (New 
Zeal nd) 
Guidance on the management of type 
2 iabetes 2011 2011 
6 American Diabetes ssociation (ADA) [15] 
Country-specific (Unite  
States) Sta s f medical care in diabetes 2020 
7 National Institute for Health and Care 
Exc llence (NICE) [16] 
Country-specific 
(England and Wales) 
Type 2 diabetes in adults: 
management 
2020 
8 Scottish Int collegiat  Guideli es 
Network (SIGN) [17] 
Country- pec fi  
(Scotla ) 
M nag me t of diab tes: a n on  
clinica  guidel e 
2017 
2.2. Comp rison of Content of Selected Clinical Gu deline  for Managing T2DM 
The co t t of he clinical gu delin was compared b sed n t e ollowing topics by
u in  a previ usly p ted data extraction for : blo d glucose managem nt; bod  weight 
s s t and a age nt; blood pressure asurem t and management; blood li-
pids measuremen  and m g me t; T2DM-associate  complicatio s assessment and
ma ageme ; and other healthca e-re ted ssues and advice. Each ui eline was read 
s veral i  to i e tify topi s/subtop cs nd r l ed r co endations. A full star “
” was as g ed to to ics/s btop cs ith dequ te in ormatio . A half- tar “ ” was 
assigned to topic /subtopics with limited inform tion. “NR” was assig e  to topics/sub-
topics that ar not reported i  the guid lin . Tw  ind pendent re iewers (AN and Y) 
were involved in the proce s, and disagree nts were resolved thr ugh discussion or 
ith  third r viewer (KC). 
2.3. Comp riso  of Qual ty of Selected Clinical Gu deli es for Managing T2DM 
The qu ity of the clinical guid lines was ass ssed independently by two reviewers 
(AN and GY) using the Appraisal of Guid lines for Research nd Evaluation II (AGREE
II) ool, which is a standar ised and validated i strument [10]. The AGREE II tool com-
ris s 23 items sep r ted o s x d mains ((i) scop and purpose; (ii) takeholde  involve-
m nt; (i i) rig ur of evelop e t; (i ) clarity of presentation; (v) applicability; and (v ) 
editorial i dependence) nd two global rating it ms ((i) v rall qua ity score and (ii) rec
ommendation for use in pr ctice) [10]. Each item within the AGREE II tool was rated on a
even-point scal  (from 1 = strongly disa re  to 7 = strongly gree). Average appraisal
scores w r  calculated for each apprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly agree))  all items in each domain. Scaled percentages for each domain 
w re the  calculated for nte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, nd by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s was summ rised and presented using su mary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
NR
Int. J. Environ. Res. Public Health 2021, 18, x FOR PEER REVIEW 3 of 13 
 
 
Tabl  1. Outli e of selected clinical guidelines for managing T2DM. 
 Publishing 
Societies/Org n sations/Associations 
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1 
Caribbea  Health R s arch uncil 
(CHRC) and Pan Ameri an Health 
Organization (PAHO) [8] 
Country-specific
(Cari bea ) 
Managing diabetes in primary care in 
the Caribbean 2006 
2 International Di b es F deration (IDF) [11] I ter tional  
R co mendations for managing type 
2 diabetes i  primary care 2017 
3 
The Royal Australi n Coll g  of  
Practitioners (RACGP) [12] 
Country-specific 
(Austr lia) 
General practice management of typ  
2 diabetes 2016  
4 
Diabetes Cana a and Canadian Diabetes 
As ociation (CD ) [13]  
Country-specific 
(Canada) 
Diabetes Canada 2018 clinical practice 
guidelines for the prevention and 
management of diabetes in Canada 
2018 
5 New Z al d Guidelines Group (NZGD) [14] 
Coun ry-specific (New 
Z ala d)
Guidance on the management o  type 
2 diabetes 2011 2011 
6 Americ n Diabetes Associati  (ADA) [15]
Country-specific (United 
States) Stand rds of med cal care in di betes 2020 
7 National Institute for Health and Care 
Exce lenc  (NICE) [16] 
Country-specific 
(Engl nd and Wales) 
Type 2 diabetes  adults: 
management 
2020 
8 Scottish In ercoll giate Guidelines 
Network (SIGN) [17] 
C untry-spec fic 
(Scotlan ) 
Managem o  di betes: a national 
clinical guideline 
2017 
2.2. Comp r son of C ntent of Sel cted Clinical Guidelin s for Ma aging T2DM 
Th co tent of the cli ical guide ines was mp red based on the following topics by 
s g a previously pilo ed ta xtraction f rm: blood glucose man gement; body weight
assessment a d ma ag me ; blood pressure mea urement and managem nt; blood li
i s measureme  and nagement; T2DM-associated complications assessme t a d
m nagement;  other heal hcare-related issues  advice. Each guidelin was read
everal tim s to id ntify topic /subtopics an  rel ted recomm nda ions. A full star “
” was assigned to topics/subtopics with adequate information. A half-star “ ” was
assig ed to top cs/subt pics with l mite  inform t on. “NR” was assigned to topics/sub
to ics that a  not report d i  th  guideline. Two i depende t reviewers (AN and GY) 
we e inv lv d in the pr ces , a disag ements were res lved through disc ssion r
with a third reviewer (KC).
2.3. Compar son of Quality of Selected Cli ical G idelines for Managing T2DM 
Th  qu lity of the clinical guidelines w s asse sed independently by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) tool, whic  is a stand rdised and validated instrument [10]. The AGREE II tool com-
pri es 23 t ms separated into s x d main  ((i) scope and purpose; (ii) stakeholder involve-
ment; (i i) rigour of develop ent; ( v) clarity of presentation; (v) applicability; and (vi) 
edito i l ind p ndence) and two global ra i g items ((i) overall quality score and (ii) rec-
mmendation for use in pr c ice) [10]. Each item within the AGREE II tool was rated on a 
seve -p int scal (f m 1 = strongly disagre  to 7 = strongly agree). Average appraisal 
scores were calcul ted for e ch ppraiser by us ng th  average rating (1 (strongly disagree) 
to 7 (strongly ree)) for all ite s in each domain. Scaled percentages for each domain 
were then calcul ted for inter-domain comp r son by summing the appraisal ratings of 
it m  within  single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by con ting to a percentage [10]. The overall quality of all in-
clu ed guid lines wa  su marised and prese ted using summary statistics (mean). Mean 
scores of the domains were compa d, and th  highest and lowest scores were identified. 
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As oci tion (C ) [13]  
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ma agement of iabetes in Canada 
2018 
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Coun ry-specific (New 
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Guidance on the management of type 
2 diabetes 2011 2011 
6 American Diab te  ssoci tion (ADA) [15]
Country-specific (United 
States) Sta d ds of medical care in diabetes 2020 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Country-specific 
(England nd Wales) 
Type 2 diabet in adults: 
management
2020 
8 Scott h Int rc llegiate Guideli es 
Network (SIGN) [17] 
C untry-specifi  
(Scotla d)
M na me t f diabetes: a national
clinic l guideline 
2017 
2.2. Comp r son of Conte t of Selected Cli ical Gu eline  for Managing T2DM 
Th  content f the clinical guidelines was compared based o  the following topics by 
using a previou ly pil ed ata xtraction f r : blood glucose m agement; body weight 
asse sme t and man g ment; blood pressure measurement and management; blood li-
ids meas reme t and man gement; T2DM-associated complications assessment and 
ma agemen ; a d other healthcare-rel ted issues and advice. Each guideline was read 
veral ime  to ide ti y topics/subtopics and rel d rec mendations. A full star “
” w s as igne  to topics/s btopics with dequa e in ormation. A half- tar “ ” was 
assigned to topics/subtopics with limited inform tio . “NR” was assigned to t pics/sub-
topics that  not rep rted i  the uid lin . Two ind pe dent reviewers (AN and GY) 
were involved in the roc s , a d disagreem nt  were resolved thr ugh discussion or 
th a third reviewer (KC). 
2.3. Compar son of Qual ty of Selected Clinic l Gu delines f r Managing T2DM 
Th  qu ity of the clinical guid lines was assessed independ ntly by two reviewers 
(AN nd GY) using the Appraisal of Guidelines for Research and Evaluation II (AGREE 
II) ol, w ic  is a stand rdised and validated instrument [10]. The AGREE II tool com-
ri es 23 t ms separ ted into six d mains ((i) scope and purpose; (ii) stakeholder involve-
ment; ( ii) rigour of develop ent; (iv) clarity of presentation; (v) applicability; and (vi) 
edit rial indep ndence) and two global rating items ((i) v rall quality score and (ii) rec-
om endation f r use in pr c ice) [10]. Each item within the AGREE II tool was rated on a 
s ven-p int scal (from 1 = strongly disa ree to 7 = strongly gree). Average appraisal 
sco es w re calculated for each pprais r by using the avera e rat ng (1 (strongly disagree) 
to 7 (st ongly ree)) for all ite s in each domain. Scaled percentages for each domain 
w re the  calcul ted for inte -domain comparison by summing the appraisal ratings of 
items within a singl  domain (obtained score), scaling by maximum and minimum possi-
b e domain scores, and by converting to a percentage [10]. The overall quality of all in-
cluded guidelin s wa  summarised and presented using su mary statistics (mean). Mean 
scores of th  domains were compared, and the highest and lowest scores were identified. 
NR
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1 
Caribbean Health Research Council 
(CHRC) and Pan American Health 
Organization (PAHO) [8] 
Country-specific 
(Caribbean) 
Managing diabetes in primary care in 
the Caribbean 2006 
2 International Diabetes Federation (IDF) [11] International  
Rec mmend tions for managi g type 
 diabetes in primary care 2017 
3 
The Royal Australian College of General 
Practitioners (RACGP) [12] 
Country-specific 
(Australia) 
General ractice management of type 
2 diabetes 2016  
4 
Diabetes Canada and Canadian Diabetes 
Association (CDA) [13]  
Country-specific 
(Canada) 
Diabetes Canada 2018 clinical practice 
g ideli es for the prevention and 
management of d abetes in Ca ada 
2018 
5 New Zealand Guidelines Group (NZGD) [14] 
Country-specific (New 
Zealand) 
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2 diabetes 2011 2011 
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Country-spec fic (United 
States) Standards of medical care in diabetes 2020 
7 National Institute for Health and Care 
Excellence (NICE) [16] 
Country-specific 
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Ty e 2 d abetes in adults: 
management
2020 
8 Scottish Intercollegiate Guidelines 
Network (SIGN) [17] 
Country-specific 
(Scotland) 
Management of diabetes: a national 
clinical guid line 
2017 
2.2. Comparison of Content of Selected Clinical Guidelines for Managing T2DM 
The content of the clinical guidelines was co par d bas d on th  foll wing topics by
using a previously piloted data extraction for : blood glucos  management; body weight 
assessment and management; blood pres ur  m asurement and management; bloo  li-
pids measurement and management; T2DM-associated c plications sses ment an  
management; and other healthcare-related issues and advice. Each guidelin  was r ad 
several times to identify topics/subtopics and related recomm ndations. A full star “
” was assigned to topics/subtopics with ad qua e i formation. A half-star “ ” w s
assigned to topics/subtopics with limited information. “NR” wa  assigned to topics/ ub-
topics that are not reported in the guideline. Two independ nt r viewers (AN  GY) 
were involved in the process, and disagreements were resolv  through discussion or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines for Managing T2DM 
The quality of the clinical guidelines was assessed independently by wo review rs
(AN and GY) using the Appraisal of Guidelines for Re earch nd Evaluation II (AGREE 
II) tool, which is a standardised and validated instrument [10]. The AGREE II tool com-
prises 23 items separated into six domains ((i) scope and purpose; (ii) stakeho der nvolv -
ment; (iii) rigour of development; (iv) clarity of prese tation; (v) appl ability; and (vi) 
editorial independence) and two global rating items ((i) overall quality scor  an  (ii) r c-
ommendation for use in practice) [10]. Each item ithin the AGREE II tool was rated on  
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Average appraisal 
scores were calculated for each appraiser by using the averag  rating (1 (str ngly disagree) 
to 7 (strongly agree)) for all items in each domain. Sc led percentages for ach domain
were then calculated for inter-domain comparison by summing the appraisal ratings of 
items within a single domain (obtained score), scaling by maximum and minimum possi-
ble domain scores, and by converting to a percentag  [10]. The overall qu lity of all in-
cluded guidelines was summarised and presented using summary statistics (mean). Mean 
scores of the domains were compared, and the highest and lowest scores were identified. 
Found as a heading or subheading in the guideline.
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clinical guidelin  
2017 
2.2. Comparison of Content of Selected Clinical Guidelines for Managing T2DM 
The co t nt of the cl nica  guideline  was mp red bas  o  the foll w  to ics y 
using a previously pi te  dat  ext action for : bloo  glucose a agem t; b dy w ight 
assess ent and manag ment; bloo  pres ure easur me t and a age nt; blood li-
pids me suremen  a d m n m nt; T2DM-associate complication ssm nt and
m nagement; and othe  healthc re-relat d issues nd advice. Each guideline was read 
sever l times to identify topi /subtopics and related re ommen ations. A full star “
” was a signed to t pic / ubtopics with adequ e informatio . A alf-star “ ” w s 
signed to topics/ ubtopics w h limited nf rmation. “NR” was assign d to topics/sub-
topics th t a e not eport  in the guideli e. Tw  in ependent r viewers (AN and GY) 
w r  involved in the process, and d sagreements wer  r solved through iscuss on or 
with a third reviewer (KC). 
2.3. Comparison of Quality of Selected Clinical Guidelines f r Ma aging T2DM 
The quality of the clinical guidelines was assessed independe tly by two reviewers 
(AN and GY) using the Appraisal of Guideli es for Re arch an  Ev luation II (AGREE 
II) tool, which is a standardis d and v li t  i st ument [10]. Th AGREE II tool co -
prises 23 items separated into six domains ((i) sco e nd purpos ; (ii) t kehol er nvol e-
ment; (iii) rigour of developme t; (iv) cl r ty of pres ta ion; (v) appl cability; a d (vi) 
editorial inde endence) an  two global rating ite s ((i) ov ra l qual ty sc re and ( i) r c-
omm ndation for use in practice) [10]. Each item wi hi  the GREE II tool w s rated on a 
seven-point scale (from 1 = strongly disagree to 7 = strongly agree). Av rag app is  
scores were calculat d for e ch appraiser by using the verag  rating (1 (stro g y disagree) 
to 7 (strongly agree)) for all items in each do ain. Scal d e ce ages for a h dom in 
were th n calculated for inter-domain co pariso by summing the ap raisal rat ng  of 
items within a single domain (obtain d score), scali g by maximum and minimu  possi-
ble domain scores, and by converting to  percent ge [10]. The overall qu lity of all in-
cluded guidelines was summarised and prese ted using summary statistic  (m an). M an 
scores of the domain  were comp red, and the highest and lowest scores were identified. 
Limited informati n (i.e., briefly mentioned in the guideline but ot as a he ing o subheading). NR—not reported in the guideline. a Medical
nutrition therapy is a therapeutic approach for treating T2DM and its sy ptoms by using a specifically tailored diet devised and monitored by a medical doctor or registered dietitian/nutritionist. b Monotherapy
is the initial treatmen re m with one oral drug, usually metformin. c Dual therapy is the ddition of a second dru to a regimen in which one drug for T2DM is not ma aging a person’s blood glucose. d
Triple th rapy is the addition of a third rug t a regimen in which tw drugs for T2DM ar ot managing a p so ’s b ood glucose. e Anti-obesity drugs are also known as weight loss medications that reduce or
control body weight. f Bariatric/metabolic su gery is a weight loss surge y that is used as a treatment f r people who ar very obese and to reduce risk for other diseases, such as metabolic or cardiovascular
disease complications. g Sexual dysfunction in men and women includes ow testosterone in men an vagi l d y ess in wom n, respectively.
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Table 3. Comparison of quality of selected T2DM management clinical guidelines.















Caribbean (CHRC/PAHO) [8] 58% 64% 3% 58% 38% 50% 3 No
International (IDF) [11] 100% 61% 23% 94% 35% 4% 4 Yes, with modifications
Australia (RACGP) [12] 25% 36% 35% 100% 58% 25% 4 Yes, with modifications
Canada (Diabetes
Canada/CDA) [13] 94% 94% 85% 100% 73% 71% 6 Yes
New Zealand (NZGD) [14] 25% 42% 16% 58% 31% 25% 2 No
United States of America
(ADA) [15] 69% 64% 51% 100% 65% 46% 5 Yes, with modifications
England (NICE) [16] 100% 92% 99% 97% 92% 67% 7 Yes
Scotland (SIGN) [17] 100% 100% 91% 97% 92% 92% 7 Yes
Mean 71.4 69.1 50.4 88 60.5 39.5
Int. J. Environ. Res. Public Health 2021, 18, 12868 10 of 13
4. Discussion
This study has identified that the country-specific clinical guideline for managing
T2DM developed by CHRC and PAHO for the Caribbean in 2006 [8] contained similar or
higher levels of relevant content when compared to the selected international and high-
income country-specific T2DM management clinical guidelines; however, the quality of the
clinical guideline from the Caribbean [8] was poor and, therefore, cannot be recommended
for use in clinical practice. We identified three high-income, country-specific clinical guide-
lines that were of sufficient quality to be recommended for clinical practice [13,16,17]. We
also identified two country-specific clinical guidelines (US and Australia [12,15]) and one
international clinical guideline, developed by IDF [11], that could only be recommended
for use in clinical practice with modifications. Previous research has highlighted variations
in the content of clinical guidelines in relation to managing diabetic neuropathy [20]. In our
study, we found that, although the clinical guideline for the Caribbean [8] and several of the
comparator clinical guidelines referred to most of the relevant topics, a few subtopics were
missing in some of the clinical guidelines, which was a common finding with previous
T2DM management guideline appraisal studies [20,21]. The subtopics that were missing
from the T2DM management clinical guidelines developed in the Caribbean [8] include
triple therapy, bariatric/metabolic surgery, lipid profile, peripheral arterial disease, peri-
odontal disease, cancers, sexual problems in men and women, immunisations for influenza,
hepatitis B, pneumonia, bacteraemia and meningitis, older people, fasting (Ramadan),
driving, holiday/travel, insurance, and working/shifts. However, even if these subtopics
were included in future updates of the clinical guideline, it should be noted that amending
the content is not sufficient for being rated as a good quality guideline since the guideline
development process plays a vital role [22].
A high-quality clinical guideline can aid in the clinical decision-making process and
delivery of high-quality care to T2DM patients in the Caribbean [23]; however, the develop-
ment of the guideline depends on the availability of resources and a robust development
process [24]. Low-quality clinical guidelines can have non-evidence-based, incorrect, con-
tradictory, or not easily identifiable content (and recommendations) [22], thereby impacting
healthcare practitioners’ decision making, which can result in significant variations in
T2DM management [6]. Thus, low-quality clinical guidelines can result in the use of in-
effective interventions, inefficient use of scarce resources, and, most importantly, harm
to patients [10,25]. Furthermore, the implementation of clinical guidelines can be chal-
lenging due to the influence of a complex set of factors, including political, economic,
social, cultural, organisational, and technical factors, and the influence of patients and
the public [26,27].
Similar to previous research [21,23,28], we found that two domains, rigour of develop-
ment and editorial independence, scored poorly for the Caribbean clinical guideline [8] and
had mean scores of 50.4% and 39.5%, respectively, across all selected clinical guidelines,
thereby highlighting these domains as areas that are generally neglected and require atten-
tion. None of the domains in the country-specific clinical guideline from the Caribbean [8]
scored highly, resulting in an overall low-quality score. In order to improve the quality of
this clinical guideline, an update that ensures editorial independence and follows a rigorous
guideline development process is required [7]. For example, a systematic approach was
not used to gather or synthesise evidence or to formulate or update the recommendations
(e.g., using the Grading of Recommendations Assessment, Development, and Evaluation
(GRADE) approach). In addition, the guideline development group should have a greater
representation of local T2DM specialists, as this was not adequately addressed before. It
should be noted that, although the culture within the Caribbean is similar, other important
issues, such as the economic status of individual countries, are different.
Although the Caribbean clinical guideline [8] was first produced in 1995, the last
update occurred more than a decade ago in 2006, thus increasing the potential for the
guidance to poorly reflect current best practices. This clinical guideline [8] was origi-
nally developed based on the economic situation, culture, and healthcare systems in the
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Caribbean region and was designed to improve patient care and reduce morbidity and
mortality by effective management of diabetes. Since this guideline was updated [8], there
have been significant advancements in the field of diabetes and T2DM management, such
as new and effective medicines including glucagon-like peptide-1 (GLP-1) receptor agonists
as well as its alternatives; individualised care regimes tailored to the patient’s health status;
prediction models; and recommendations to change current therapeutic practices made by
the American College of Physicians [16,29–33], therefore resulting in potential inadequacies
and inconsistencies in the guideline. This implies that healthcare professionals in the
Caribbean region are not receiving the appropriate clinical guidance needed to ensure the
provision of adequate care for patients’ management of T2DM, which could result in poor
quality healthcare and poor health outcomes (high mortality and morbidity rate).
In order to improve the clinical guideline in the future and, ultimately, to improve
the overall quality of primary, secondary, and tertiary care, and individual outcomes in
T2DM, a change from reactive to predictive, preventive, and personalised medicine is
required [33–35]. For example, models, such as the nomogram, can help in identifying and
predicting persons who are at risk of T2DM more efficiently as well as allow persons to
develop strategies to combat or prevent the onset of T2DM [33]. The use of personalised
medicine in ensuring that a person’s genetic makeup can be used to develop approaches
for treating and monitoring T2DM should also be considered [33,34].
A strength of this study is that a recognised and validated tool was used to assess the
quality of the clinical guidelines. The AGREE II tool was developed to address variability in
guideline quality [10,19,21,23,36] and is recommended by the World Health Organization
(WHO), the Guidelines International Network (GIN), and the Council of Europe for its
reliability in appraising clinical guidelines [37]. We decided to compare the existing
Caribbean clinical guideline with clinical guidelines from high-income countries as the
latter would set a benchmark. In contrast, clinical guidelines from low-income and middle-
income countries (LMICs) would not have served the purpose of setting the benchmark
due to multiple issues, including approaches used to develop the guidelines. In addition, it
would have been difficult to select one LMIC clinical guideline over another for comparison
and to justify the selection. Finally, in many LMICs, such clinical guidelines are not
available. Clinical guidelines written in English were included, and the selection of clinical
guidelines was not systematic, which could have resulted in a biased sample of guidelines;
however, we attempted to overcome this bias by choosing a range of international and
high-income country-specific guidelines published by leading societies, organisations, or
associations. Although the Caribbean comprises mainly LMICs and, therefore, access to
funding and resources for developing a clinical guideline is likely reduced compared to
high-income countries, it was deemed important that comparisons were made with such
leading societies, organisations, or associations in order to reflect potential gold standards
and minimise the potential for inadvertently identifying low-quality clinical guidelines.
Another limitation of this study was that only clinical guidelines published in the English
language were considered, thereby potentially introducing English language bias.
5. Conclusions
The clinical guideline developed and used within the Caribbean region for managing
T2DM was found to contain high level content with regards to relevant topics but was of
insufficient quality to be used in clinical practice. Therefore, it is recommended that the
existing high-quality clinical guideline as identified within this study should be adopted
and used for the clinical management of T2DM within the Caribbean region until a high-
quality region-specific guideline is developed.
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